
<html lang="en"     class="pb-page"  data-request-id="2189eb87-4ace-4ccd-9a43-b90481d145d0"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.9b01252;issue:issue:10.1021/jmcmar.2019.62.issue-24;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Pyrazole-4-Carboxamide (YW2065): A Therapeutic Candidate for Colorectal Cancer via Dual Activities of Wnt/β-Catenin Signaling Inhibition and AMP-Activated Protein Kinase (AMPK) Activation" /></meta><meta name="dc.Creator" content="Wei  Yang" /></meta><meta name="dc.Creator" content="Yingjun  Li" /></meta><meta name="dc.Creator" content="Yong  Ai" /></meta><meta name="dc.Creator" content="Obinna N.  Obianom" /></meta><meta name="dc.Creator" content="Dong  Guo" /></meta><meta name="dc.Creator" content="Hong  Yang" /></meta><meta name="dc.Creator" content="Srilatha  Sakamuru" /></meta><meta name="dc.Creator" content="Menghang  Xia" /></meta><meta name="dc.Creator" content="Yan  Shu" /></meta><meta name="dc.Creator" content="Fengtian  Xue" /></meta><meta name="dc.Description" content="Dysregulation of the Wnt/β-catenin signaling pathway has been widely recognized as a pathogenic mechanism for colorectal cancer (CRC). Although numerous Wnt inhibitors have been developed, they com..." /></meta><meta name="Description" content="Dysregulation of the Wnt/β-catenin signaling pathway has been widely recognized as a pathogenic mechanism for colorectal cancer (CRC). Although numerous Wnt inhibitors have been developed, they com..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="November 26, 2019" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.9b01252" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2019 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b01252" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.9b01252" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b01252" /></link>
        
    
    

<title>Pyrazole-4-Carboxamide (YW2065): A Therapeutic Candidate for Colorectal Cancer via Dual Activities of Wnt/β-Catenin Signaling Inhibition and AMP-Activated Protein Kinase (AMPK) Activation | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.9b01252" /></meta><meta property="og:title" content="Pyrazole-4-Carboxamide (YW2065): A Therapeutic Candidate for Colorectal Cancer via Dual Activities of Wnt/β-Catenin Signaling Inhibition and AMP-Activated Protein Kinase (AMPK) Activation" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01252/20191219/images/large/jm9b01252_0013.jpeg" /></meta><meta property="og:description" content="Dysregulation of the Wnt/β-catenin signaling pathway has been widely recognized as a pathogenic mechanism for colorectal cancer (CRC). Although numerous Wnt inhibitors have been developed, they commonly suffer from toxicity and unintended effects. Moreover, concerns have been raised in targeting this pathway because of its critical roles in maintaining stem cells and regenerating tissues and organs. On the basis of the anthelmintic drug pyrvinium and previous lead FX1128, we have developed a compound YW2065 (1c) which demonstrated excellent anti-CRC effects in vitro and in vivo. YW2065 achieves its inhibitory activity for Wnt signaling by stabilizing Axin-1, a scaffolding protein that regulates proteasome degradation of β-catenin. Simultaneously, YW2065 also led to the activation of the tumor suppressor AMPK, providing an additional anticancer mechanism. In addition, YW2065 showed favorable pharmacokinetic properties without obvious toxicity. The anti-CRC effect of YW2065 was highlighted by its promising efficacy in a mice xenograft model." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.9b01252"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b01252">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-14/achre4.2021.54.issue-14/20210720/achre4.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-29/aamick.2021.13.issue-29/20210728/aamick.2021.13.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-14/acncdm.2021.12.issue-14/20210721/acncdm.2021.12.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-29/acsodf.2021.6.issue-29/20210727/acsodf.2021.6.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-29/ascecg.2021.9.issue-29/20210726/ascecg.2021.9.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-29/ancham.2021.93.issue-29/20210727/ancham.2021.93.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-29/bichaw.2021.60.issue-29/20210727/bichaw.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-27/cgeabj.2021.99.issue-27/20210726-01/cgeabj.2021.99.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-14/esthag.2021.55.issue-14/20210720/esthag.2021.55.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-29/iecred.2021.60.issue-29/20210728/iecred.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-14/inocaj.2021.60.issue-14/20210719/inocaj.2021.60.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-29/jafcau.2021.69.issue-29/20210728/jafcau.2021.69.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-29/jacsat.2021.143.issue-29/20210728/jacsat.2021.143.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-29/langd5.2021.37.issue-29/20210727/langd5.2021.37.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.9b01252&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.9b01252&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.9b01252&amp;href=/doi/10.1021/acs.jmedchem.9b01252" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2019</span><span class="cit-fg-volume">, 62</span><span class="cit-fg-issue">, 24</span><span class="cit-fg-pageRange">, 11151-11164</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/62/24" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.9b01229" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.9b01280" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Pyrazole-4-Carboxamide (YW2065): A Therapeutic Candidate for Colorectal Cancer via Dual Activities of Wnt/β-Catenin Signaling Inhibition and AMP-Activated Protein Kinase (AMPK) Activation</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Wei Yang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Wei Yang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, Baltimore, Maryland 21201, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Wei++Yang">Wei Yang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Yingjun Li</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yingjun Li</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, Baltimore, Maryland 21201, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yingjun++Li">Yingjun Li</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Yong Ai</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yong Ai</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, Baltimore, Maryland 21201, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yong++Ai">Yong Ai</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Obinna N. Obianom</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Obinna N. Obianom</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, Baltimore, Maryland 21201, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Obinna+N.++Obianom">Obinna N. Obianom</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Dong Guo</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Dong Guo</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, Baltimore, Maryland 21201, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Dong++Guo">Dong Guo</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Hong Yang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Hong Yang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, Baltimore, Maryland 21201, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Hong++Yang">Hong Yang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Srilatha Sakamuru</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Srilatha Sakamuru</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">National Center for Advancing Translational Sciences, National Institutes of Health, 9800 Medical Center Drive, Bethesda, Maryland 20892, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Srilatha++Sakamuru">Srilatha Sakamuru</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Menghang Xia</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Menghang Xia</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">National Center for Advancing Translational Sciences, National Institutes of Health, 9800 Medical Center Drive, Bethesda, Maryland 20892, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Menghang++Xia">Menghang Xia</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-7285-8469" title="Orcid link">http://orcid.org/0000-0001-7285-8469</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Yan Shu</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yan Shu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, Baltimore, Maryland 21201, United States</div><div class="loa-info-affiliations-info">School and Hospital of Stomatology, Guangzhou Medical University, Guangzhou 510140, China</div></div><span class="conrtib-corresp"><strong>*</strong>Phone, 410-706-7493; fax, 410-706-0886; e-mail, <a href="/cdn-cgi/l/email-protection#add4dec5d8eddfd583d8c0ccdfd4c1ccc3c983c8c9d8"><span class="__cf_email__" data-cfemail="e29b918a97a2909acc978f83909b8e838c86cc878697">[email protected]</span></a></span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yan++Shu">Yan Shu</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8492-1437" title="Orcid link">http://orcid.org/0000-0001-8492-1437</a></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Fengtian Xue</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Fengtian Xue</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, Baltimore, Maryland 21201, United States</div></div><span class="conrtib-corresp"><strong>*</strong>Phone, 410-706-8512; fax, 410-706-0886; e-mail, <a href="/cdn-cgi/l/email-protection#fe98868b9bbe8c86d08b939f8c87929f909ad09b9a8b"><span class="__cf_email__" data-cfemail="81e7f9f4e4c1f3f9aff4ece0f3f8ede0efe5afe4e5f4">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Fengtian++Xue">Fengtian Xue</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-4132-9887" title="Orcid link">http://orcid.org/0000-0002-4132-9887</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b01252&amp;href=/doi/10.1021%2Facs.jmedchem.9b01252" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2019</span></span><span class="cit-volume">, 62</span><span class="cit-issue">, 24</span><span class="cit-pageRange">, 11151–11164</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">November 26, 2019</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>31 July 2019</li><li><span class="item_label"><b>Published</b> online</span>26 November 2019</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 26 December 2019</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.9b01252" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01252</a></div><div class="article_header-article-copyright"><strong>Copyright © 2019 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D11151%26pageCount%3D14%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DWei%2BYang%252C%2BYingjun%2BLi%252C%2BYong%2BAi%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D62%26issueNum%3D24%26contentID%3Dacs.jmedchem.9b01252%26title%3DPyrazole-4-Carboxamide%2B%2528YW2065%2529%253A%2BA%2BTherapeutic%2BCandidate%2Bfor%2BColorectal%2BCancer%2Bvia%2BDual%2BActivities%2Bof%2BWnt%252F%25CE%25B2-Catenin%2BSignaling%2BInhibition%2Band%2BAMP-Activated%2BProtein%2BKinase%2B%2528AMPK%2529%2BActivation%26numPages%3D14%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D11164%26publicationDate%3DDecember%2B2019">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.9b01252"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1322</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">10</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.9b01252" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Pyrazole-4-Carboxamide (YW2065): A Therapeutic Candidate for Colorectal Cancer via Dual Activities of Wnt/β-Catenin Signaling Inhibition and AMP-Activated Protein Kinase (AMPK) Activation&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Wei&quot;,&quot;last_name&quot;:&quot;Yang&quot;},{&quot;first_name&quot;:&quot;Yingjun&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Yong&quot;,&quot;last_name&quot;:&quot;Ai&quot;},{&quot;first_name&quot;:&quot;Obinna&quot;,&quot;last_name&quot;:&quot;N. Obianom&quot;},{&quot;first_name&quot;:&quot;Dong&quot;,&quot;last_name&quot;:&quot;Guo&quot;},{&quot;first_name&quot;:&quot;Hong&quot;,&quot;last_name&quot;:&quot;Yang&quot;},{&quot;first_name&quot;:&quot;Srilatha&quot;,&quot;last_name&quot;:&quot;Sakamuru&quot;},{&quot;first_name&quot;:&quot;Menghang&quot;,&quot;last_name&quot;:&quot;Xia&quot;},{&quot;first_name&quot;:&quot;Yan&quot;,&quot;last_name&quot;:&quot;Shu&quot;},{&quot;first_name&quot;:&quot;Fengtian&quot;,&quot;last_name&quot;:&quot;Xue&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2019&quot;,&quot;month&quot;:&quot;11&quot;,&quot;day&quot;:&quot;26&quot;,&quot;issue&quot;:&quot;24&quot;,&quot;volume&quot;:&quot;62&quot;,&quot;pages&quot;:&quot;11151-11164&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.9b01252&quot;},&quot;abstract&quot;:&quot;Dysregulation of the Wnt/β-catenin signaling pathway has been widely recognized as a pathogenic mechanism for colorectal cancer (CRC). Although numerous Wnt inhibitors have been developed, they commonly suffer from toxicity and unintended effects. Moreover, concerns have been raised in targeting this pathway because of its critical roles in maintaining stem cells and regenerating tissues and organs. On the basis of the anthelmintic drug pyrvinium and previous lead FX1128, we have developed a compound YW2065 (1c) which demonstrated excellent anti-CRC effects in vitro and in vivo. YW2065 achieves its inhibitory activity for Wnt signaling by stabilizing Axin-1, a scaffolding protein that regulates proteasome degradation of β-catenin. Simultaneously, YW2065 also led to the activation of the tumor suppressor AMPK, providing an additional anticancer mechanism. In addition, YW2065 showed favorable pharmacokinetic properties without obvious toxicity. The anti-CRC effect of YW2065 was highlighted by its promising effi&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01252&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01252" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01252&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01252" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01252&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01252" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b01252&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01252&amp;href=/doi/10.1021/acs.jmedchem.9b01252" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.9b01252" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.9b01252" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01252&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.9b01252%26sid%3Dliteratum%253Aachs%26pmid%3D31769984%26genre%3Darticle%26aulast%3DYang%26date%3D2019%26atitle%3DPyrazole-4-Carboxamide%2B%2528YW2065%2529%253A%2BA%2BTherapeutic%2BCandidate%2Bfor%2BColorectal%2BCancer%2Bvia%2BDual%2BActivities%2Bof%2BWnt%252F%25CE%25B2-Catenin%2BSignaling%2BInhibition%2Band%2BAMP-Activated%2BProtein%2BKinase%2B%2528AMPK%2529%2BActivation%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D62%26issue%3D24%26spage%3D11151%26epage%3D11164%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (3)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291297" title="Cell signaling">Cell signaling</a>,</li><li><a href="/action/doSearch?ConceptID=291011" title="High-performance liquid chromatography">High-performance liquid chromatography</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/62/24" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/jmcmar.2019.62.issue-24/20191226/jmcmar.2019.62.issue-24.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01252/20191219/images/medium/jm9b01252_0013.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01252/20191219/images/large/jm9b01252_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01252&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Dysregulation of the Wnt/β-catenin signaling pathway has been widely recognized as a pathogenic mechanism for colorectal cancer (CRC). Although numerous Wnt inhibitors have been developed, they commonly suffer from toxicity and unintended effects. Moreover, concerns have been raised in targeting this pathway because of its critical roles in maintaining stem cells and regenerating tissues and organs. On the basis of the anthelmintic drug pyrvinium and previous lead FX1128, we have developed a compound YW2065 (<b>1c</b>) which demonstrated excellent anti-CRC effects in vitro and in vivo. YW2065 achieves its inhibitory activity for Wnt signaling by stabilizing Axin-1, a scaffolding protein that regulates proteasome degradation of β-catenin. Simultaneously, YW2065 also led to the activation of the tumor suppressor AMPK, providing an additional anticancer mechanism. In addition, YW2065 showed favorable pharmacokinetic properties without obvious toxicity. The anti-CRC effect of YW2065 was highlighted by its promising efficacy in a mice xenograft model.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_50640" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_50640" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Colorectal cancer (CRC) is the third most frequently occurring cancer and the second leading cause of cancer-related death in the United States.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1,2)</a> Although patients with early-stage CRC can be treated with surgical resection followed by adjuvant therapy, approximately 50% of CRC patients will develop metastases, which require systemic medical treatment and lead to high mortality rates.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Available drugs for metastatic CRC (mCRC) are limited to chemotherapies such as the thymidylate synthase inhibitors (e.g., 5-FU and folinic acid) and DNA-alkylating agents (e.g., oxaliplatin and irinotecan). Recently, biologics targeting the vascular endothelial growth factor (VEGF; bevacizumab) and epidermal growth factor receptor (EGFR; cetuximab and panitumumab) started to emerge;<a onclick="showRef(event, 'ref4 ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref4 ref5 ref6">(4−6)</a> however, they fail to improve patients’ survival rate significantly.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Thus, novel therapeutics for the treatment of mCRC are still urgently needed.</div><div class="NLM_p">Over 90% of mCRC patients carry genetic mutations associated with upregulated Wnt signaling,<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> which makes this pathway an attractive target against mCRC.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> The Wnt/β-catenin signaling pathway regulates the expression of its target genes through the Wnt ligands and intracellular signal transducer β-catenin (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). During the “off state” of the pathway when Wnt proteins are not interacting with the LRP6 and Fz receptors, a cytoplasmic “destruction complex” is formed by the scaffolding protein Axin and adenomatous polyposis coli (APC). This complex facilitates the phosphorylation of β-catenin by casein kinase 1α (CK1α) and glycogen synthase kinase 3β (GSK3β), leading to the proteasomal degradation of β-catenin. During the “on-state”, the formation of the destruction complex is prohibited. As a result, β-catenin is accumulated and translocated into the nucleus, where it binds to the transcriptional factor LEF/TCF along with other transcriptional coactivators (CBP, P300, PYGO, and BCL9), and activates the expression of its target genes to promote cell proliferation, differentiation, and growth.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01252/20191219/images/medium/jm9b01252_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01252/20191219/images/large/jm9b01252_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Wnt/β-catenin signaling pathway and examples of known inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01252/20191219/images/large/jm9b01252_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01252&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Several classes of Wnt inhibitors are known by targeting different components of the pathway (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>).<a onclick="showRef(event, 'ref9 ref10 ref11 ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref11 ref12 ref13">(9−13)</a> The Novartis clinical candidate LGK974<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> and its analogs<a onclick="showRef(event, 'ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref15 ref16">(15,16)</a> (e.g., IWP-2) are porcupine inhibitors, which function by blocking the secretion of the Wnt ligands. In addition, inhibitors have been developed to target key protein–protein interactions (PPI) involving β-catenin in the nucleus. For example, CGP049090<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> and iCRT3 analogs<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> inhibit the PPI between β-catenin and LEF/TCF, while the Prism/Eisai pharmaceuticals clinical candidate PRI-724 selectively blocks the PPI of β-catenin with CBP.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Although targeting the downstream PPIs demonstrated unique specificities, these compounds have suffered from varying degrees of toxicity and unintended effects on tissue homeostasis. Moreover, XAV939,<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> IWR-1,<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> G007-LK,<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> and NVP-TNKS656<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> are inhibitors of tankyrase (TNKS), a member of poly(ADP-ribose) polymerases (PARPs). However, competitive inhibitors of TNKS turned out to be insufficient because polymerization of TNKS, via SAM domains, promotes Wnt signaling independently of the catalytic activity.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> In addition, TNKS recruits and PARylates numerous protein partners<a onclick="showRef(event, 'ref24 ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref24 ref25 ref26">(24−26)</a> via an ankyrin (ANK)-repeat domain for various biological purposes; therefore, targeting the active site may also lead to potential toxicities.<a onclick="showRef(event, 'ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref27 ref28">(27,28)</a> Finally, the anthelmintic drug pyrvinium has been reported as a Wnt inhibitor by activating CK1α.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> However, pyrvinium has extremely low oral bioavailability and high toxicity, which prohibits its further application as an anticancer therapeutic agent.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Using pyrvinium as a template, our laboratory recently developed a compound FX1128 (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>), which demonstrated excellent inhibitory potency for Wnt signaling, although the antiproliferation efficacy of FX1128 was limited (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01252/suppl_file/jm9b01252_si_001.pdf" class="ext-link">Figure S1</a>).<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a></div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01252/20191219/images/medium/jm9b01252_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01252/20191219/images/large/jm9b01252_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Design strategy of pyrazole-based compounds <b>1a</b>–<b>s</b> and <b>2a</b>–<b>e</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01252/20191219/images/large/jm9b01252_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01252&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In addition to genetic alteration, reprogramming of cellular metabolic pathways is also commonly associated with mCRC.<a onclick="showRef(event, 'ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref32 ref33">(32,33)</a> The adenosine monophosphate (AMP)-activated protein kinase (AMPK), as a metabolic switch, plays a crucial role in metabolic disorders and carcinogenesis in the intestine.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Activated AMPK phosphorylates the serine and threonine residues on its substrates, resulting in energy restoration and tumor suppression.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> For instance, AMPK activation was reported to be a prognostic factor for mCRC patients receiving chemotherapy in combination with the VEGF-targeting monoclonal antibody drug bevacizumab.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> It was also known that AMPK activators, such as metformin and aspirin, induced antiproliferative cytotoxicity against CRC cells.<a onclick="showRef(event, 'ref37 ref38 ref39 ref40'); return false;" href="javascript:void(0);" class="ref ref37 ref38 ref39 ref40">(37−40)</a> The complexity of mCRC usually requires combination therapies that attack multiple anticancer machineries. Therefore, drugs that target dual or multiple pathways often result in improved anticancer efficacy and delayed drug resistance.<a onclick="showRef(event, 'ref40 ref41'); return false;" href="javascript:void(0);" class="ref ref40 ref41">(40,41)</a> We hypothesized that compounds that simultaneously inhibit Wnt signaling and activate the AMPK pathway can be promising therapeutics for  treatment of mCRC.<a onclick="showRef(event, 'ref41 ref42'); return false;" href="javascript:void(0);" class="ref ref41 ref42">(41,42)</a></div><div class="NLM_p last">Herein, we report the synthesis and characterization of a new series of anti-mCRC compounds (<b>1a</b>–<b>s</b> and <b>2a</b>–<b>e</b>) with dual activities of Wnt inhibition and AMPK activation (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). The chemical structures of new inhibitors were based on our previous lead FX1128 by replacing its triazole core, which caused weak anticancer activity and poor aqueous solubility, with a pyrazole ring, a widely used drug-like group in small molecule drug design. One new compound of the series, YW2065, not only maintained excellent inhibitory potency for the Wnt signaling but also potently activated the AMPK pathway. The dual-functional compound YW2065 demonstrated promising anti-mCRC effects in vitro and in vivo.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_47427" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_47427" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Synthesis</h3><div class="NLM_p">The syntheses of compounds <b>1a</b>–<b>s</b> are detailed in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. Condensation of ethyl acetoacetate (<b>3</b>) with <i>N</i>,<i>N</i>-dimethylformamide dimethyl acetal in EtOH provided compound <b>4</b> in good yields. Next, pyrazole formation using compound <b>4</b> and a substituted hydrazine in the presence of DIPEA led to the generation of the ester intermediate, which was submitted to hydrolysis using aqueous NaOH to afford carboxylic acids <b>5a</b>–<b>p</b> in good yields. Finally, PyCIU-mediated coupling of acids <b>5a</b>–<b>p</b> with various aromatic amines yielded the final products <b>1a</b>–<b>s</b> in moderate to good yields.</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01252/20191219/images/medium/jm9b01252_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01252/20191219/images/large/jm9b01252_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Compounds <b>1a</b>–<b>s</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01252/20191219/images/large/jm9b01252_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01252&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) DMF-DMA, EtOH, 60 °C, 97%; (b) R<sub>3</sub>-NHNH<sub>2</sub>, DIPEA, EtOH, 60 °C; (c) NaOH, EtOH/H<sub>2</sub>O, reflux, 40–98% for two steps; (d) aromatic amines, PyCIU, DIPEA, DCE, 80 °C, 24–88%.</p></p></figure><div class="NLM_p">The synthesis of compounds <b>2a</b>–<b>e</b> began with anilines <b>6a</b>–<b>c</b> (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>). Diazotization of the amino group of compounds <b>6a</b>–<b>c</b> using NaNO<sub>2</sub> in HCl (aq) followed by condensation of the diazotized anilines with ethyl 2-chloro-3-oxobutanoate in the presence of NaOAc yielded hydrazonoyl chlorides <b>7a</b>–<b>c</b>. Next, reaction of compounds <b>7a</b>–<b>c</b> with either diethyl (2-oxopropyl) phosphonate, 4-(cyclopent-1-en-1-yl)morpholine, or 4-(cyclohex-1-en-1-yl)morpholine triggered a cyclization reaction to give the ethyl esters. Then saponification of the ethyl esters in aqueous NaOH provided pyrazole-3-carboxylic acids <b>8a</b>–<b>e</b> in good yields. Finally, the PyCIU-mediated coupling of acids <b>8a</b>–<b>e</b> with 2-aminoquinoline yielded compounds <b>2a</b>–<b>e</b> in moderate to good yields.</div><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01252/20191219/images/medium/jm9b01252_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01252/20191219/images/large/jm9b01252_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Compounds <b>2a</b>–<b>e</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01252/20191219/images/large/jm9b01252_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01252&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) (i) NaNO<sub>2</sub>, HCl (aq.), 0 °C; (ii) ethyl 2-chloroacetoacetate NaOAc, EtOH/H<sub>2</sub>O, 0–25 °C, 88–95%; (b) (i) for <b>8a</b>–<b>c</b>, diethyl (2-oxopropyl)phosphonate, DME, LiOH, rt, 10 h; for <b>8d</b>,<b>e</b>, (ii) 4-(cyclopent-1-en-1-yl)morpholine or 4-(cyclohex-1-en-1-yl)morpholine, Et<sub>3</sub>N, 12 h, rt; (c) NaOH, MeOH, reflux, 70–85% for two steps; (d) 2-aminoquinoline, PyCIU, DIPEA, DCE, 80 °C, 63–71%.</p></p></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Structure–Activity Relationship (SAR)</h3><div class="NLM_p">The inhibitory potency of the synthesized compounds against the Wnt signaling pathway was determined using the Wnt-HEK293 luciferase gene reporter assay that was described previously (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>).<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> Compound 5-methyl-1-phenyl-<i>N</i>-(quinolin-2-yl)-1<i>H</i>-pyrazole-4-carboxamide (<b>1a</b>) had an IC<sub>50</sub> value of 2.2 nM, which was similar to that of FX1128 while >300-fold and >200-fold more potent than pyrvinium and TNKS inhibitor XAV939, respectively. We then studied substitution effects on the phenyl ring. Replacement of the methyl group with an F atom resulted in a new inhibitor (<b>1b</b>) with excellent potency (IC<sub>50</sub> = 0.92 nM), while  Br (<b>1c</b>) and Et (<b>1d</b>) groups at the same position yielded compounds with similarly good potencies. A second F (<b>1e</b>) or Br (<b>1f</b>) substituent at the ortho position was well tolerated. However, an additional halogen at the para (<b>1g</b>) or meta position (<b>1h</b>) was detrimental to the potency. The 2,5- and 2,6-dimethyl analogs (<b>1i</b> and <b>1j</b>) indicated IC<sub>50</sub> values of 14 and 26 nM, respectively. These results indicated that a single substituent at the ortho position of the ring is preferred. Interestingly, inclusion of a nitrogen atom to the phenyl ring (<b>1k</b>) restored the high potency of the inhibitor, indicating that polar aromatic characteristics can be tolerated.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Inhibition of the Wnt/β-Catenin Signaling Pathway by Compounds <b>1a</b>–<b>s</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01252/20191219/images/medium/jm9b01252_0010.gif" alt="" id="GRAPHIC-d7e699-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01252/20191219/images/medium/jm9b01252_0011.gif" alt="" id="gr10" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">The values of IC<sub>50</sub> for each compound were calculated, and data are expressed as mean IC<sub>50</sub> (nM) ± SD from three independent experiments.</p></div></div><div></div></div><div class="NLM_p">Next, the effect of R<sub>1</sub> on the pyrazole ring was studied. Replacing the Me group of <b>1a</b> with a Cl (<b>1l</b>) decreased the potency by 13-fold, while substitution of the Me group with a larger Br (<b>1m</b>) or Et (<b>1n</b>) group retained high potency. However, further increase of the size to an <i>i</i>-Pr resulted in an analog (<b>1o</b>) with significantly decreased potency, although the similar sized <i>N</i>,<i>N</i>-dimethyl amino (<b>1p</b>) restored the potency of the compound.</div><div class="NLM_p">Then we sought out to substitute the 2-aminoquinoline moiety using compound <b>1d</b> as a template. The naphthyl analog <b>1q</b> and its regioisomer <b>1r</b> showed no obvious inhibitory activity at concentrations up to 1 μM. These results highlighted the importance of the presence and location of the quinoline nitrogen atom in maintaining high potency. Truncation of the quinoline yielded a new compound <b>1s</b>, which was >300-fold less potent than compound <b>1d</b>. This result demonstrated that the phenyl ring of the quinoline fragment was also critical.</div><div class="NLM_p">We  also synthesized and tested the regioisomers of the pyrazole core (<b>2a</b>–<b>e</b>). As shown in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>, compounds <b>2a</b>–<b>e</b> indicated significantly decreased potency compared to those in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>. These results indicated that the position of the amide substitution on the pyrazole core plays a critical role in the inhibitory activity of inhibitors.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Inhibition of the Wnt/β-Catenin Signaling Pathway by Compounds <b>2a</b>–<b>e</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01252/20191219/images/medium/jm9b01252_0012.gif" alt="" id="GRAPHIC-d7e797-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center"><i>n</i></th><th class="colsep0 rowsep0" align="center" char="±">IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2a</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="±">637 ± 67</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2b</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="±">250 ± 13</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2c</b></td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="±">67 ± 9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2d</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="char" char="±">140 ± 4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2e</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="char" char="±">260 ± 42</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">The IC<sub>50</sub> values were calculated, and data are expressed as mean IC50 (nM) ± SD from three independent experiments.</p></div></div></div><div class="NLM_p">Next, compounds <b>1a</b>–<b>p</b>, which showed promising potencies in the luciferase gene reporter assays, were further tested for their activities in killing human CRC SW480 cells (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>A). Nine compounds that showed over 50% growth inhibition at 50 μM were then tested in full dose responses to obtain their GI<sub>50</sub> values (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>B). Compounds <b>1c</b> (YW2065) and <b>1f</b> demonstrated good potencies with GI<sub>50</sub> values of 2.4  and 3.9 μM, respectively. The TANK inhibitor XAV939 indicated a GI<sub>50</sub> value of >50 μM. Note that GI<sub>50</sub> values of our new inhibitors in the CRC cell-killing assays were significantly higher than the corresponding IC<sub>50</sub> values obtained from the gene reporter assays. We reasoned that the reporter assay was designed with high sensitivity and responded rapidly to perturbations of the Wnt signaling pathway. However, when the compounds were tested in killing the much more complex cancer cells, the effects usually took a longer time to take place. Therefore, we observed significantly decreased sensitivities of inhibitors in killing the SW480 cells. Moreover, the effects of Wnt inhibition can be alleviated by the function of other biological pathways, which might also contribute to the delayed cell death.</div><figure id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01252/20191219/images/medium/jm9b01252_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01252/20191219/images/large/jm9b01252_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (A) Antiproliferation activity of selected compounds on the growth of SW480 cells. (B)  GI<sub>50</sub> values were calculated, and data are expressed as mean GI<sub>50</sub> (μM) ± SD from three independent experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01252/20191219/images/large/jm9b01252_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01252&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Encouraged by the activity of YW2065 in both luciferase gene reporter assay and CRC cell killing assay, we next studied the mechanism of action of this compound (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). Similar to pyrvinium and FX1128, YW2065 induced β-catenin degradation in HEK293 cells (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>B). Interestingly, YW2065 was found to enhance the expression of Axin-1 in fluorescent imaging (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>A) and Western blot analysis (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>B). Axin-1 is not only a master scaffolding protein for the destruction complex of β-catenin but also a key regulator of multiple pathways. It was reported that Axin-1 enhances AMPK activation through the Axin-LKB1-AMPK complex, which facilitates the Thr172 phosphorylation and subsequent activation of AMPK.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> To verify the relationship between Axin-1 and AMPK, we overexpressed Axin-1 in HEK293 cells and found that the overexpression of Axin-1 led to increased AMPK phosphorylation (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>C). Similar activation of AMPK was also observed when HEK293 cells were exposed to compound YW2065 and several analogs, while the effect was abolished by Axin-1 knockdown (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>D, <a href="/doi/suppl/10.1021/acs.jmedchem.9b01252/suppl_file/jm9b01252_si_001.pdf" class="ext-link">Figure S2</a>). These results suggested that YW2065 achieved its dual activities of Wnt inhibition and AMPK activation through the mechanism of Axin-1 stabilization. Note that TNKS inhibitors (e.g., XAV939) also function by stabilizing Axin. However, our previous results showed that the YW2065 analog FX1128 did not bind to TNKS in SPR binding assay.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> More importantly, TNKS inhibitor XAV939 failed to activate AMPK.<a onclick="showRef(event, 'ref31 ref44'); return false;" href="javascript:void(0);" class="ref ref31 ref44">(31,44)</a> These data highlighted that YW2065 achieved dual activities of Wnt inhibition and AMPK activation through Axin-1 stabilization via a novel mechanism different from TNKS inhibitors. The mechanism for YW2065 to activate AMPK is also likely different from those of other known AMPK activators such as metformin, AICAR, and salicylates. Whereas metformin and AICAR activate AMPK via the disruption of the adenylate charge in the cell, salicylates directly act on the AMPK β1-subunit.<a onclick="showRef(event, 'ref45 ref45a ref46'); return false;" href="javascript:void(0);" class="ref ref45 ref45a ref46">(4547)</a> Currently, additional investigations are being done to elucidate whether YW2065 stabilized Axin-1 through direct binding or another indirect mechanism.</div><figure id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01252/20191219/images/medium/jm9b01252_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01252/20191219/images/large/jm9b01252_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Dual function of YW2065 for Wnt signaling inhibition and AMPK activation. (A) Enhanced Axin-1 protein expression by YW2065 (1 μM) treatment. HEK293 cells were stained with anti-Axin-1 antibody and DAPI, and  images were taken under fluorescence microscopy. (B) Enhanced Axin-1 expression and increased β-catenin degradation by YW2065 or its analog FX1128 in HEK293 cells. (C) Increased AMPK phosphorylation by Axin-1 overexpression (empty pcDNA 3 vs. pcDNA3-Axin-1) in HEK293 cells. (D) Axin-1 knockdown abolished the effect of AMPK activation by YW2065 in HEK293 cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01252/20191219/images/large/jm9b01252_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01252&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Next, the activity of YW2065 was further investigated using human CRC SW480 and SW620 cells (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>). SW480 and SW620 cells are derived from the primary and metastatic sites of the same patient, respectively. Both cells contain a hyperactivated Wnt signaling pathway. Similar to the results from gene reporter assays using HEK293 cells (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>), YW2065 demonstrated excellent inhibitory potencies (IC<sub>50</sub> = 1.15  and 0.19 nM, respectively) in the TOPflash reporter assays using both SW480 and SW620 cells (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>A). Because the lymph node metastatic site derived SW620 cells have been widely used as a mCRC cellular model, additional Western blot and RT-PCR analyses were performed using this cell line. Upon treatment of YW2065, the protein level of Axin-1 was increased dose dependently, while the protein level of β-catenin was significantly decreased (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>B). We also confirmed that the mRNA levels of Wnt target genes, including <i>c-Myc</i>, <i>cyclin D1</i>, <i>MMP7</i>, and <i>S100A4</i>, were significantly decreased upon  treatment of YW2065 (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>C). Moreover, YW2065 activated AMPK through phosphorylation, which in turn led to the phosphorylation of the downstream substrate acetyl-CoA carboxylase (<i>ACC</i>) in a dose-dependent manner (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>D). These results confirmed YW2065’s dual activities of Wnt inhibition and AMPK activation in CRC cells.</div><figure id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01252/20191219/images/medium/jm9b01252_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01252/20191219/images/large/jm9b01252_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Inhibition of the Wnt/β-catenin pathway, and activation of AMPK by YW2065 in CRC cells. (A) TOPflash reporter assay was performed in SW480 and SW620 cells. (B) Dose response of β-catenin and Axin-1 levels upon treatment of YW2065. (C) Decreased mRNA levels of Wnt target genes in SW620 cells upon exposure to YW2065 for 24 h. (D) Dose response of AMPK and ACC phosphorylation upon  treatment of YW2065.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01252/20191219/images/large/jm9b01252_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01252&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To characterize the in vitro anti-CRC activities of YW2065, we performed the colony formation assay using SW480, SW620, and an additional human CRC HT29 cell line (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>A). The results showed that compound YW2065 dose dependently inhibited  colony formation of all three cell lines. In addition, as analyzed by flow cytometry, treatment of YW2065 dose dependently caused apoptosis in all three CRC cells (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>B and data not shown). Importantly, SW620 cells became resistant to the cytotoxicity of YW2065 when constitutively active β-catenin mutant (S33Y) was overexpressed or the Axin-1 gene was knocked down (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>C). These results were inconsistent with the mechanistic engagement of Wnt signaling as a critical part of the action of YW2065.</div><figure id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01252/20191219/images/medium/jm9b01252_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01252/20191219/images/large/jm9b01252_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. YW2065 inhibited CRC cell proliferation and growth in vitro. (A) Inhibition of colony formation of CRC cells by YW2065 treatment. Cells (500 cells/well in 6-well plate) were treated with vehicle or YW2065 until visible colonies formed. (B) Induction of apoptosis by YW2065 treatment in SW620 cells. SW620 cells were treated with YW2065 for 48 h,  stained with AAD-7 and annexin V, and then analyzed by flow cytometry. (C) SW620 cells became resistant to YW2065 cytotoxicity when Axin-1 was knocked down by lentivrus encoding shRNA against Axin-1 or a constitutively active β-catenin mutant (S33Y) was overexpressed. Cells were treated with YW2065 or vehicle for 72 h.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01252/20191219/images/large/jm9b01252_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01252&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To further study the target specificity of YW2065, it was tested against a panel of 273 kinases. The results indicated that YW2065 inhibited none of the tested kinases with over 40% at a concentration of 1000 nM. It displayed a moderate inhibitory activity (39% inhibition) for RPS6KA3 and weak activities against 10 other kinases including CDK17, GSK3A, MAP4K4, MAPKAPK3, MELK, NEK6, NTRK1, PAK3, PRKCQ, and SRC (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01252/suppl_file/jm9b01252_si_001.pdf" class="ext-link">Table S1</a>).</div><div class="NLM_p">Next, the pharmacokinetic (PK) profile of compound YW2065 was determined (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). Compound YW2065 was administrated as a single dose at 5 mg/kg, either intravenously (iv) or orally (po). The maximum serum concentration (<i>C</i><sub>max</sub>) was determined to be approximately 5 μg/mL, and the <i>T</i><sub>max</sub> was measured to be around 18 min. Compared to the extremely low bioavailability of pyrvinium, the bioavailability (F%) of YW2065 was improved to be about 23%. The area under the curve (AUC) values of iv and po were calculated to be 57.5  and 13.2 μg·h/mL, respectively. Finally, the half-life (<i>T</i><sub>1/2</sub>) of compound YW2065 was determined to be about 3 h.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Single Dose Pharmacokinetics of YW2065<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">route of administration</th><th class="colsep0 rowsep0" align="center" char=".">iv (<i>n</i> = 3)</th><th class="colsep0 rowsep0" align="center" char=".">po (<i>n</i> = 5)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">dose (mg/kg)</td><td class="colsep0 rowsep0" align="char" char=".">5.0</td><td class="colsep0 rowsep0" align="char" char=".">5.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>C</i><sub>max</sub> (μg/mL)</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">5.2 ± 2.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>T</i><sub>max</sub> (min)</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">18.0 ± 6.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>F</i> (%)</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">22.9 ± 9.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AUC<sub>(0-inf)</sub> (μg·h/mL)</td><td class="colsep0 rowsep0" align="char" char=".">57.5 ± 16.1</td><td class="colsep0 rowsep0" align="char" char=".">13.2 ± 3.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>T</i><sub>1/2</sub> (h)</td><td class="colsep0 rowsep0" align="char" char=".">3.1 ± 1.5</td><td class="colsep0 rowsep0" align="char" char=".">2.9 ± 1.6</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">Pharmacokinetic parameters of YW2065 derived from Phoenix WinNonlin 7.3 using the noncompartmental analysis. Data is presented as estimates average ± standard deviation.</p></div></div></div><div class="NLM_p">Considering the favorable PK properties of YW2065, we proceeded to evaluate its anti-CRC efficacy in vivo using an SW620 tumor xenograft mice model (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>).<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(48)</a> SW620 cells were implanted subcutaneously in the female nude mice on the right flank. After tumors reached a volume of 100–200 mm<sup>2</sup>, mice (<i>n</i> = 6/group) received YW2065 (10  or 50 mg/kg) or vehicle intraperitoneally (ip). Compound YW2065 reduced both tumor volume (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>A) and final tumor weight (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>B). The tumor volume in the high-dosage group (50 mg/kg/day) was decreased by 49% compared to the vehicle group in the last measurement. In addition, YW2065 was also well tolerated based on body weight and liver/kidney function tests (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01252/suppl_file/jm9b01252_si_001.pdf" class="ext-link">Figures S3 and S4</a>). Mouse body weight gain showed no significant difference in the control and YW2065-treated groups. In a 21-day toxicity test at a dose of 100 mg/kg/day (ip), a minimal system toxicity of compound YW2065 was observed. To assess β-catenin inhibition and AMPK activation, the tumor tissues were harvested and subjected to Western blot and RT-PCR analysis. Compared to the samples from the vehicle group, the phosphorylation of AMPK and ACC was increased in those from the YW2065-treated group (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>C). In addition, the transcripts of Wnt target genes <i>Axin-2</i>, <i>MMP-7</i>, and <i>S100A4</i> were reduced upon treatment of compound YW2065 (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>D). It should be noted that the tolerability and efficacy of YW2065 has yet to be fully elucidated in the context of systemic exposure for specific routes of dosing. Nevertheless, as proof of concepts, we  demonstrated that YW2065 has exhibited  improved pharmacokinetic properties as compared to the parent pyrvinium and, importantly, the therapeutic effects against in vivo colon cancer growth.</div><figure id="fig7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01252/20191219/images/medium/jm9b01252_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01252/20191219/images/large/jm9b01252_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. YW2065 suppressed SW620 tumor growth in vivo. Six-week old nude mice were injected with 2 × 10<sup>6</sup> SW620 cells subcutaneous. After tumors reach a volume of 100–200 mm<sup>2</sup>, mice were received ip injection of vehicle or 10 or 50 mg/kg of YW2065 each day (<i>n</i> = 6 each group). Tumor growth (A) was measured every other day. *<i>P</i> < 0.05 as compared to the vehicle control in <i>t</i> test. Mice were euthanized at day 32, and tumors were weighed (B). Phosphorylation of AMPK and ACC in the tumor tissues was detected by Western blot (C). Expression of Wnt pathway target genes (<i>Axin-2</i>, <i>MMP-7</i>, and <i>S100A4</i>) in tumor tissues was detected by RT-PCR (D).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01252/20191219/images/large/jm9b01252_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01252&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_68128" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_68128" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">The mCRC, with complex genetic profiles and poor prognoses, remains a significant cause of cancer-related morbidity worldwide. We reported a series of pyrazole-based small molecules that displayed potent anti-CRC activities in vitro and in vivo. One of the compounds, YW2065, displayed dual activities of Wnt inhibition and AMPK activation, which was convergent by Axin-1 stabilization. Moreover, YW2065 demonstrated favorable PK properties and suppressed tumor growth in a xenograft mouse model. Therefore, YW2065 represents a promising new lead for further development of anti-CRC therapeutics.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_07264" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_07264" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Chemical Analysis</h3><div class="NLM_p last">All chemicals were obtained from commercial suppliers and used without further purification. Analytical thin layer chromatography was visualized by ultraviolet light at 256 nM. <sup>1</sup>H NMR spectra were recorded on a Varian (400 MHz) spectrometer. Data are presented as follows: chemical shift (in ppm on the δ scale relative to δ = 0.00 ppm for the protons in tetramethylsilane (TMS)), integration, multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet, br = broad), and coupling constant (<i>J</i>/Hz). <sup>13</sup>C NMR spectra were recorded at 100 MHz, and all chemical shifts values are reported in parts per million on the δ scale with an internal reference of δ 77.0 or 39.0 for CDCl<sub>3</sub> or DMSO-<i>d</i><sub>6</sub>, respectively. The purities of the title compounds were determined by analytic HPLC, performed on an Agilent 1100 instrument and a reverse-phase column (Waters XTerrra RP18, 5 μM, 4.6 × 250 mm). All compounds were eluted with 45% acetonitrile/55% water (containing 0.1% TFA) over 20 min with detection at 260 nM and a flow rate at 1.0 mL/min. All tested compounds were >95% pure. Yields were not optimized. <b>4b</b>–<b>f</b> were commercially available. Pyrazole compounds <b>5e</b>, <b>5f</b>, <b>5l–p</b>, and <b>8e</b> were prepared as reported previously.<a onclick="showRef(event, 'ref48 ref49'); return false;" href="javascript:void(0);" class="ref ref48 ref49">(49,50)</a></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> General Procedure A: Synthesis of Compounds <b>1a–s</b></h3><div class="NLM_p last">To a solution of <b>5</b> (1.2 mmol) and aromatic amines (1.0 mmol) in dichloroethane (5.0 mL) were added 1-(chloro-1-pyrrolidinylmethylene)pyrrolidinium hexafluorophosphate (398 mg, 1.2 mmol) and DIPEA (516 mg, 4 mmol). The mixture was allowed to stir at 80 °C overnight. The solvent was removed under vacuum, and the resulting residue was redissolved in ethyl acetate (15 mL). The resulting solution was washed with H<sub>2</sub>O and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated. The crude material was purified by column chromatography to give compounds <b>1a</b>–<b>s</b> (24–88%).</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> 5-Methyl-1-phenyl-<i>N</i>-(quinolin-2-yl)-1<i>H</i>-pyrazole-4-carboxamide (<b>1a</b>)</h3><div class="NLM_p last">The title compound was synthesized according to General Procedure A (81%): <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.74 (s, 1H), 8.55–8.53 (d, <i>J</i> = 9.6 Hz, 1H), 8.20–8.18 (d, <i>J</i> = 9.6 Hz, 1H), 8.09 (s, 1H), 7.84–7.82 (d, <i>J</i> = 8.8 Hz, 1H), 7.79–7.77 (d, <i>J</i> = 8.0 Hz, 1H), 7.68–7.64 (t, <i>J</i> = 8.0 Hz, 1H), 7.53–7.49 (m, 2H), 7.47–7.43 (m, 4H), 2.66 (s, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 162.2, 151.2, 146.4, 143.6, 138.6, 138.4, 130.1, 129.3, 128.8, 127.6, 127.0, 126.3, 125.5, 125.1, 115.4, 114.5, 12.1. HRMS [M + H]<sup>+</sup> (ESI-TOF) calcd for C<sub>20</sub>H<sub>17</sub>N<sub>4</sub>O 329.1402, found 329.1409. HPLC: <i>t</i><sub>R</sub> = 5.45 min, 99.9%.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> 1-(2-Fluorophenyl)-5-methyl-<i>N</i>-(quinolin-2-yl)-1<i>H</i>-pyrazole-4-carboxamide (<b>1b</b>)</h3><div class="NLM_p last">The title compound was synthesized according to General Procedure A (82%, a white solid): <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.93 (s, 1H), 8.64 (s, 1H), 8.39 (m, 2H). 7.96–7.94 (d, <i>J</i> = 8.0 Hz, 1H), 7.90–7.88 (d, <i>J</i> = 8.0 Hz, 1H), 7.55–7.71 (t, <i>J</i> = 8.0 Hz, 1H), 7.65–7.61 (m, 2H), 7.57–7.50 (m, 2H), 7.46–7.42 (t, <i>J</i> = 8.0 Hz, 1H), 2.46 (s, 3H); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 167.5, 162.7, 160.2, 157.2, 151.6, 150.1, 145.8, 145.6, 143.1, 136.9, 136.8, 135.1, 134.6, 132.9, 132.1, 130.9, 130.6, 130.1, 122.0, 121.9, 120.6, 119.8, 16.2. HRMS [M + H]<sup>+</sup> (ESI-TOF) calcd for C<sub>20</sub>H<sub>16</sub>FN<sub>4</sub>O 347.1308, found 347.1300. HPLC: <i>t</i><sub>R</sub> = 5.83 min, 99.7%.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> 1-(2-Bromophenyl)-5-methyl-<i>N</i>-(quinolin-2-yl)-1<i>H</i>-pyrazole-4-carboxamide (<b>1c</b>, YW2065)</h3><div class="NLM_p last">The title compound was synthesized according to General Procedure A (65%, a yellow solid): <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.74 (s, 1H), 8.55–8.53 (d, <i>J</i> = 8.0 Hz, 1H), 8.20–8.18 (d, <i>J</i> = 8.8 Hz, 1H), 8.11 (s, 1H), 7.84–7.82 (d, <i>J</i> = 8.8 Hz, 1H), 7.79–7.77 (d, <i>J</i> = 8.8 Hz, 1H), 7.74–7.72 (d, <i>J</i> = 8.8 Hz, 1H), 7.68–7.64 (t, <i>J</i> = 8.0 Hz, 1H), 7.49–7.44 (m, 2H), 7.42–7.37 (m, 2H), 2.50 (s, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 162.1, 151.2, 146.6, 145.2, 138.8, 138.5, 137.8, 133.6, 131.4, 130.0, 129.6, 128.4, 127.6, 127.2, 126.3, 125.1, 122.3, 114.8, 114.5, 11.4. HRMS [M + H]<sup>+</sup> (ESI-TOF) calcd for C<sub>20</sub>H<sub>15</sub>BrN<sub>4</sub>O 407.0507, found 407.0513. HPLC: <i>t</i><sub>R</sub> = 10.8 min, 100%.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> 1-(2-Ethylphenyl)-5-methyl-<i>N</i>-(quinolin-2-yl)-1<i>H</i>-pyrazole-4-carboxamide (<b>1d</b>)</h3><div class="NLM_p last">The title compound was synthesized according to General Procedure A (84%, a brown solid): <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.85 (s, 1H), 8.62 (s, 1H), 8.39 (m, 2H), 7.96–7.94 (d, <i>J</i> = 8.0 Hz, 1H), 7.90–7.88 (d, <i>J</i> = 8.0 Hz, 1H), 7.55–7.71 (t, <i>J</i> = 8.0 Hz, 1H), 7.53–7.50 (m, 3H), 7.42–7.38 (t, <i>J</i> = 8.0 Hz, 1H), 7.34–7.32 (d, <i>J</i> = 8.0 Hz, 1H), 2.36–2.31 (m, 5H), 1.03–1.0 (q, <i>J</i> = 8.0 Hz, 3H); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 167.7, 157.2, 151.6, 149.4, 146.5, 144.7, 143.1, 142.1, 135.2, 135.1, 134.8, 133.0, 132.9, 132.1, 131.9, 130.8, 130.1, 120.6, 119.1, 28.6, 19.7, 16.5. HRMS [M + H]<sup>+</sup> (ESI-TOF) calcd for C<sub>22</sub>H<sub>21</sub>N<sub>4</sub>O 357.1715, found 357.1715. HPLC: <i>t</i><sub>R</sub> = 9.03 min, 99.2%.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> 1-(2,6-Difluorophenyl)-5-methyl-<i>N</i>-(quinolin-2-yl)-1<i>H</i>-pyrazole-4-carboxamide (<b>1e</b>)</h3><div class="NLM_p last">The title compound was synthesized according to General Procedure A (64%, a yellow foam): <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.91 (s, 1H), 8.53–8.51 (d, <i>J</i> = 9.6 Hz, 1H), 8.18 (s, 1H), 8.18–8.16 (d, <i>J</i> = 8.8 Hz, 1H), 7.82–7.80 (d, <i>J</i> = 8.4 Hz, 1H), 7.77–7.75 (d, <i>J</i> = 8.0 Hz, 1H), 7.65–7.61 (t, <i>J</i> = 7.2 Hz, 1H), 7.48–7.40 (m, 2H), 7.11–7.07 (t, <i>J</i> = 8.0 Hz, 1H), 2.53 (s, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 161.9, 159.6, 157.1, 157.0, 151.2, 146.4, 139.9, 138.6, 131.6, 131.5, 131.4, 130.0, 127.6, 127.1, 126.3, 125.1, 115.2, 114.6, 112.5, 112.3, 10.9. HRMS [M + H]<sup>+</sup> (ESI-TOF) calcd for C<sub>20</sub>H<sub>15</sub>F<sub>2</sub>N<sub>4</sub>O 365.1214, found 365.1210. HPLC: <i>t</i><sub>R</sub> = 7.08 min, 99.5%.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> 1-(2-Bromo-6-fluorophenyl)-5-methyl-<i>N</i>-(quinolin-2-yl)-1<i>H</i>-pyrazole-4-carboxamide (<b>1f</b>)</h3><div class="NLM_p last">The title compound was synthesized according to General Procedure A (69%, a white solid): <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.89 (s, 1H), 8.55–8.53 (d, <i>J</i> = 8.8 Hz, 1H), 8.20–8.18 (t, <i>J</i> = 4.8 Hz, 2H), 7.83–7.81 (d, <i>J</i> = 8.0 Hz, 1H), 7.78–7.76 (d, <i>J</i> = 8.8 Hz, 1H), 7.67–7.63 (t, <i>J</i> = 8.0 Hz, 1H), 7.54–7.52 (d, <i>J</i> = 8.0 Hz, 1H), 7.45–7.41 (t, <i>J</i> = 8.0 Hz, 1H), 7.40–7.35 (m, 1H), 7.25–7.21 (t, <i>J</i> = 8.0 Hz, 1H), 2.50 (s, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 161.9, 160.2, 157.6, 151.2, 146.5, 145.9, 139.7, 138.6, 132.3, 132.2, 130.1, 128.9, 127.6, 127.1, 126.5, 126.3, 125.1, 123.9, 115.9, 115.8, 115.1, 114.6, 10.9. HRMS [M + H]<sup>+</sup> (ESI-TOF) calcd for C<sub>20</sub>H<sub>15</sub>BrFN<sub>4</sub>O 425.0413, found 425.0416. HPLC: <i>t</i><sub>R</sub> = 9.03 min, 99.9%.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> 1-(2,4-Difluorophenyl)-5-methyl-<i>N</i>-(quinolin-2-yl)-1<i>H</i>-pyrazole-4-carboxamide (<b>1g</b>)</h3><div class="NLM_p last">The title compound was synthesized according to General Procedure A (82%, a brown solid): <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.75 (s, 1H), 8.54–8.52 (d, <i>J</i> = 8.8 Hz, 1H), 8.22–8.20 (d, <i>J</i> = 8.8 Hz, 1H), 8.14 (s, 1H), 7.84–7.82 (d, <i>J</i> = 8.8 Hz, 1H), 7.81–7.79 (d, <i>J</i> = 8.8 Hz, 1H), 7.69–7.65 (t, <i>J</i> = 8.8 Hz, 1H), 7.50–7.44 (m, 2H), 7.06–7.02 (m, 2H), 2.55 (s, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 164.4, 164.3, 161.9, 158.4, 155.7, 151.1, 146.4, 145.6, 139.4, 138.7, 130.1, 130.0, 127.6, 127.0, 126.3, 125.2, 115.2, 114.5, 112.4, 112.2, 105.4, 105.2, 104.9, 11.2. HRMS [M + H]<sup>+</sup> (ESI-TOF) calcd for C<sub>20</sub>H<sub>15</sub>F<sub>2</sub>N<sub>4</sub>O 365.1214, found 365.1202. HPLC: <i>t</i><sub>R</sub> = 6.07 min, 99.8%.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> 1-(3-Chloro-2-fluorophenyl)-5-methyl-<i>N</i>-(quinolin-2-yl)-1<i>H</i>-pyrazole-4-carboxamide (<b>1h</b>)</h3><div class="NLM_p last">The title compound was synthesized according to General Procedure A (56%, a white solid): <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.70 (s, 1H), 8.54–8.52 (d, <i>J</i> = 8.4 Hz, 1H), 8.22–8.20 (d, <i>J</i> = 8.8 Hz, 1H), 8.14 (s, 1H), 7.84–7.82 (d, <i>J</i> = 8.8 Hz, 1H), 7.81–7.79 (d, <i>J</i> = 8.0 Hz, 1H), 7.69–7.65 (t, <i>J</i> = 7.2 Hz, 1H), 7.58–7.54 (t, <i>J</i> = 7.2 Hz, 1H), 7.48–7.44 (t, <i>J</i> = 7.2 Hz, 1H), 7.41–7.37 (t, <i>J</i> = 7.2 Hz, 1H), 7.28–7.24 (t, <i>J</i> = 8.0 Hz, 1H), 2.58 (s, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 161.8, 154.2, 151.6, 151.1, 146.5, 145.6, 139.5, 138.6, 131.8, 130.1, 127.6, 127.3, 127.2, 126.3, 125.2, 124.9, 124.8, 122.7, 115.4, 114.5, 11.3. HRMS [M + H]<sup>+</sup> (ESI-TOF) calcd for C<sub>20</sub>H<sub>15</sub>ClFN<sub>4</sub>O 381.0918, found 381.0928. HPLC: <i>t</i><sub>R</sub> = 10.21 min, 99.8%.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> 1-(2,5-Dimethylphenyl)-5-methyl-<i>N</i>-(quinolin-2-yl)-1<i>H</i>-pyrazole-4-carboxamide (<b>1i</b>)</h3><div class="NLM_p last">The title compound was synthesized according to General Procedure A (56%, a yellow oil): <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.84 (s, 1H), 8.56–8.54 (d, <i>J</i> = 8.8 Hz, 1H), 8.20–8.18 (d, <i>J</i> = 8.8 Hz, 1H), 8.11 (s, 1H), 7.84–7.82 (d, <i>J</i> = 8.8 Hz, 1H), 7.79–7.77 (d, <i>J</i> = 8.8 Hz, 1H), 7.68–7.64 (t, <i>J</i> = 8.0 Hz, 1H), 7.46–7.42 (t, <i>J</i> = 8.0 Hz, 1H), 7.21–7.18 (m, 2H), 7.04 (s, 1H), 2.45 (s, 3H), 2.35 (s, 3H), 1.98 (s, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 162.4, 151.3, 146.4, 144.4, 138.6, 138.4, 137.3, 136.7, 132.5, 130.9, 130.6, 130.0, 127.6, 127.1, 126.2, 125.1, 114.6, 114.4, 20.7, 16.7, 11.3. HRMS [M + H]<sup>+</sup> (ESI-TOF) calcd for C<sub>22</sub>H<sub>21</sub>N<sub>4</sub>O 357.1715, found 357.1728. HPLC: <i>t</i><sub>R</sub> = 8.39 min, 99.9%.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> 1-(2,6-Dimethylphenyl)-5-methyl-<i>N</i>-(quinolin-2-yl)-1<i>H</i>-pyrazole-4-carboxamide (<b>1j</b>)</h3><div class="NLM_p last">The title compound was synthesized according to General Procedure A (74%, a yellow foam): <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.85 (s, 1H), 8.67 (s, 1H), 8.39 (m, 2H), 7.96–7.94 (d, <i>J</i> = 8.0 Hz, 1H), 7.90–7.88 (d, <i>J</i> = 8.0 Hz, 1H), 7.76–7.72 (t, <i>J</i> = 8.0 Hz, 1H), 7.54–7.50 (t, <i>J</i> = 8.0 Hz, 1H), 7.40–7.36 (t, <i>J</i> = 8.0 Hz, 1H), 7.29–7.27 (m, 2H), 2.29 (s, 3H), 1.91 (s, 6H); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 167.7, 157.2, 151.6, 149.1, 145.2, 143.1, 141.8, 141.1, 135.1, 134.8, 133.5, 132.9, 132.1, 130.8, 130.1, 120.6, 119.1, 21.9, 15.8. HRMS [M + H]<sup>+</sup> (ESI-TOF) calcd for C<sub>22</sub>H<sub>21</sub>N<sub>4</sub>O 357.1715, found 357.1714. HPLC: <i>t</i><sub>R</sub> = 7.82 min, 99.6%.</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> 5-Methyl-1-(3-methylpyridin-2-yl)-<i>N</i>-(quinolin-2-yl)-1<i>H</i>-pyrazole-4-carboxamide (<b>1k</b>)</h3><div class="NLM_p last">The title compound was synthesized according to General Procedure A (24%, a white solid): <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.55 (s, 1H), 8.53 (s, 1H), 8.47–8.46 (d, <i>J</i> = 4.0 Hz, 1H), 8.21–8.19 (d, <i>J</i> = 8.8 Hz, 1H), 8.01 (s, 1H), 7.85–7.83 (d, <i>J</i> = 8.0 Hz, 1H), 7.81–7.79 (d, <i>J</i> = 8.0 Hz, 1H), 7.77–7.75 (d, <i>J</i> = 8.0 Hz, 1H), 7.70–7.66 (t, <i>J</i> = 8.0 Hz, 1H), 7.47–7.43 (t, <i>J</i> = 8.0 Hz, 1H), 7.39–7.36 (m, 1H), 2.58 (s, 3H), 2.20 (s, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 162.1, 151.1, 150.0, 146.7, 144.7, 140.6, 138.5, 131.0, 130.0, 127.6, 127.3, 126.3, 125.1, 124.8, 114.9, 114.5, 17.2, 11.4. HRMS [M + H]<sup>+</sup> (ESI-TOF) calcd for C<sub>20</sub>H<sub>18</sub>N<sub>5</sub>O 344.1511, found 344.1507. HPLC: <i>t</i><sub>R</sub> = 3.73 min, 99.6%.</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> 5-Chloro-1-phenyl-<i>N</i>-(quinolin-2-yl)-1<i>H</i>-pyrazole-4-carboxamide (<b>1l</b>)</h3><div class="NLM_p last">The title compound was synthesized according to General Procedure A (55%, a white solid): <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.93 (s, 1H), 8.53 (s, 1H), 8.27 (s, 1H), 8.22–8.20 (d, <i>J</i> = 8.0 Hz, 1H), 7.86–7.84 (d, <i>J</i> = 8.0 Hz, 1H), 7.80–7.78 (d, <i>J</i> = 8.0 Hz, 1H), 7.68–7.64 (t, <i>J</i> = 8.0 Hz, 1H), 7.55–7.45 (m, 5H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 159.5, 150.8, 141.6, 139.9, 138.7, 138.6, 130.0, 129.6, 129.4, 129.2, 127.4, 126.5, 126.1, 125.3, 119.5, 115.3, 114.6. HRMS [M + H]<sup>+</sup> (ESI-TOF) calcd for C<sub>19</sub>H<sub>14</sub>ClN<sub>4</sub>O 349.0856, found 349.0652. HPLC: <i>t</i><sub>R</sub> = 13.58 min, 99.0%.</div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> 5-Bromo-1-phenyl-<i>N</i>-(quinolin-2-yl)-1<i>H</i>-pyrazole-4-carboxamide (<b>1m</b>)</h3><div class="NLM_p last">The title compound was synthesized according to General Procedure A (60%, a white solid): <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.94 (s, 1H), 8.56–8.54 (d, <i>J</i> = 8.0 Hz, 1H), 8.29 (s, 1H), 8.22–8.20 (d, <i>J</i> = 8.0 Hz, 1H), 7.87–7.85 (d, <i>J</i> = 8.4 Hz, 1H), 7.81–7.79 (d, <i>J</i> = 8.0 Hz, 1H), 7.70–7.66 (t, <i>J</i> = 8.0 Hz, 1H), 7.54 (m, 5H), 7.48–7.44 (d, <i>J</i> = 8.0 Hz, 1H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 161.0, 150.8, 142.1, 138.7, 138.2, 130.0, 129.5, 129.2, 127.6, 127.4, 126.5, 126.2, 125.3, 119.6, 117.9, 114.8, 114.6. HRMS [M + H]<sup>+</sup> (ESI-TOF) calcd for C<sub>19</sub>H<sub>14</sub>BrN<sub>4</sub>O 393.0351, found 393.0355. HPLC: <i>t</i><sub>R</sub> = 13.12 min, 99.2%.</div></div><div id="sec4_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> 5-Ethyl-1-phenyl-<i>N</i>-(quinolin-2-yl)-1<i>H</i>-pyrazole-4-carboxamide (<b>1n</b>)</h3><div class="NLM_p last">The title compound was synthesized according to General Procedure A (66%, a white solid): <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.66 (s, 1H), 8.55–8.53 (d, <i>J</i> = 9.6 Hz, 1H), 8.20–8.18 (d, <i>J</i> = 9.6 Hz, 1H), 8.06 (s, 1H), 7.85–7.83 (d, <i>J</i> = 8.4 Hz, 1H), 7.80–7.78 (d, <i>J</i> = 8.0 Hz, 1H), 7.69–7.65 (t, <i>J</i> = 8.0 Hz, 1H), 7.54–7.43 (m, 6H), 3.09–3.04 (q, <i>J</i> = 8.0 Hz, 2H), 1.25–1.21 (t, <i>J</i> = 8.0 Hz, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 161.8, 151.2, 149.6, 146.7, 138.8, 138.5, 138.5, 130.0, 129.3, 129.1, 127.6, 127.2, 126.3, 125.9, 125.1, 114.5, 18.7, 13.7. HRMS [M + H]<sup>+</sup> (ESI-TOF) calcd for C<sub>21</sub>H<sub>19</sub>N<sub>4</sub>O 343.1559, found 343.1558. HPLC: <i>t</i><sub>R</sub> = 3.63 min, 95.0%.</div></div><div id="sec4_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> 5-Isopropyl-1-phenyl-<i>N</i>-(quinolin-2-yl)-1<i>H</i>-pyrazole-4-carboxamide (<b>1o</b>)</h3><div class="NLM_p last">The title compound was synthesized according to General Procedure A (56%, a white solid): <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.83 (s, 1H), 8.55–8.53 (d, <i>J</i> = 8.4 Hz, 1H), 8.19–8.17 (d, <i>J</i> = 8.8 Hz, 1H), 8.00 (s, 1H), 7.83–7.81 (d, <i>J</i> = 8.8 Hz, 1H), 7.79–7.77 (d, <i>J</i> = 8.0 Hz, 1H), 7.66–7.62 (t, <i>J</i> = 8.0 Hz, 1H), 7.51–7.49 (m, 3H), 7.45–7.41 (t, <i>J</i> = 8.0 Hz, 1H), 7.39–7.37 (d, <i>J</i> = 7.2 Hz, 2H), 3.35–3.31 (m, 1H), 1.42–1.40 (d, <i>J</i> = 7.2 Hz, 6H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 162.1, 152.6, 151.4, 146.7, 139.4, 138.5, 129.9, 129.3, 129.2, 127.6, 127.2, 126.6, 126.3, 125.0, 114.8, 114.5, 26.5, 20.5. HRMS [M + H]<sup>+</sup> (ESI-TOF) calcd for C<sub>22</sub>H<sub>20</sub>N<sub>4</sub>O 357.1715, found 357.1719. HPLC: <i>t</i><sub>R</sub> = 12.86 min, 99.9%.</div></div><div id="sec4_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> 5-(Dimethylamino)-1-phenyl-<i>N</i>-(quinolin-2-yl)-1<i>H</i>-pyrazole-4-carboxamide (<b>1p</b>)</h3><div class="NLM_p last">The title compound was synthesized according to General Procedure A (80%, a white solid): <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.81 (s, 1H), 8.59–8.57 (d, <i>J</i> = 8.8 Hz, 1H), 8.19–8.17 (d, <i>J</i> = 8.8 Hz, 1H), 8.15 (s, 1H), 7.86–7.84 (d, <i>J</i> = 8.0 Hz, 1H), 7.79–7.77 (d, <i>J</i> = 8.8 Hz, 1H), 7.67–7.63 (t, <i>J</i> = 8.0 Hz, 1H), 7.55–7.46 (m, 5H), 7.45–7.41 (t, <i>J</i> = 8.0 Hz, 1H), 2.84 (s, 6H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 161.1, 151.4, 150.5, 146.8, 141.2, 139.7, 138.3, 129.8, 129.3, 129.1, 127.5, 127.4, 126.3, 125.7, 124.8, 114.7, 109.5, 43.1. HRMS [M + H]<sup>+</sup> (ESI-TOF) calcd for C<sub>21</sub>H<sub>20</sub>N<sub>5</sub>O 358.1668, found 358.1666. HPLC: <i>t</i><sub>R</sub> = 12.40 min, 97.8%.</div></div><div id="sec4_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> 1-(2-Ethylphenyl)-5-methyl-<i>N</i>-(naphthalen-2-yl)-1<i>H</i>-pyrazole-4-carboxamide (<b>1q</b>)</h3><div class="NLM_p last">The title compound was synthesized according to General Procedure A (80%): <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.29 (s, 1H), 8.19 (s, 1H), 8.06 (s, 1H), 7.78–7.76 (m, 3H), 7.58–7.56 (d, <i>J</i> = 8.0 Hz, 1H), 7.46–7.38 (m, 4H), 7.31–7.27 (t, <i>J</i> = 8.0 Hz, 1H), 7.17–7.15 (d, <i>J</i> = 8.0 Hz, 1H), 2.42 (s, 3H), 2.38–2.32 (q, <i>J</i> = 8.0 Hz, 2H), 1.10–1.06 (t, <i>J</i> = 8.0 Hz, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 162.3, 144.2, 141.8, 137.9, 136.9, 135.6, 133.9, 130.6, 130.1, 129.5, 128.6, 127.7, 127.5, 126.7, 126.4, 124.9, 120.4, 117.0, 114.9, 23.9, 14.4, 11.4. HRMS [M + H]<sup>+</sup> (ESI-TOF) calcd for C<sub>23</sub>H<sub>22</sub>N<sub>3</sub>O 356.1763, found 356.1766. HPLC: <i>t</i><sub>R</sub> = 12.83 min, 98.0%.</div></div><div id="sec4_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> 1-(2-Ethylphenyl)-<i>N</i>-(isoquinolin-3-yl)-5-methyl-1<i>H</i>-pyrazole-4-carboxamide (<b>1r</b>)</h3><div class="NLM_p last">The title compound was synthesized according to General Procedure A (82%): <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.98 (s, 1H), 8.70 (s, 1H), 8.65 (s, 1H), 8.08 (s, 1H), 7.88–7.7.86 (d, <i>J</i> = 8.8 Hz, 1H), 7.83–7.81 (d, <i>J</i> = 8.8 Hz, 1H), 7.64–7.60 (t, <i>J</i> = 8.0 Hz, 1H), 7.47–7.43 (m, 2H), 7.40–7.38 (d, <i>J</i> = 8.0 Hz, 1H), 7.33–7.29 (t, <i>J</i> = 7.2 Hz, 1H), 7.21–7.19 (d, <i>J</i> = 8.4 Hz, 1H), 2.47 (s, 3H), 2.39–2.34 (q, <i>J</i> = 7.2 Hz, 2H), 1.10–1.06 (t, <i>J</i> = 7.2 Hz, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 161.9, 151.1, 146.5, 144.2, 141.8, 138.0, 136.9, 130.8, 130.0, 129.5, 127.7, 126.8, 126.7, 126.4, 125.7, 114.6, 107.9, 23.9, 14.4, 11.5. HRMS [M + H]<sup>+</sup> (ESI-TOF) calcd for C<sub>22</sub>H<sub>21</sub>N<sub>4</sub>O 357.1715, found 357.1709. HPLC: <i>t</i><sub>R</sub> = 10.40 min, 99.9%.</div></div><div id="sec4_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> 1-(2-Ethylphenyl)-5-methyl-<i>N</i>-(6-methylpyridin-2-yl)-1<i>H</i>-pyrazole-4-carboxamide (<b>1s</b>)</h3><div class="NLM_p last">The title compound was synthesized according to General Procedure A (88%): <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.52 (s, 1H), 8.12–8.10 (d, <i>J</i> = 8.0 Hz, 1H), 8.00 (s, 1H), 7.60–7.56 (t, <i>J</i> = 8.0 Hz, 1H), 7.43–7.39 (t, <i>J</i> = 8.0 Hz, 1H), 7.37–7.35 (d, <i>J</i> = 8.0 Hz, 1H), 7.30–7.26 (t, <i>J</i> = 8.0 Hz, 1H), 7.17–7.15 (d, <i>J</i> = 8.0 Hz, 1H), 6.87–6.85 (d, <i>J</i> = 8.0 Hz, 1H), 2.42 (s, 3H), 2.39 (s, 3H), 2.35–2.29 (q, <i>J</i> = 8.0 Hz, 2H), 1.06–1.02 (t, <i>J</i> = 8.0 Hz, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 161.9, 156.7, 150.9, 144.3, 141.7, 138.6, 138.1, 136.9, 130.0, 129.5, 127.7, 126.6, 119.0, 114.5, 110.9, 23.9, 23.8, 14.4, 11.4. HRMS [M + H]<sup>+</sup> (ESI-TOF) calcd for C<sub>19</sub>H<sub>21</sub>N<sub>4</sub>O321.1715, found 321.1712. HPLC: t<sub>R</sub> = 5.18 min, 99.0%.</div></div><div id="sec4_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> General Procedure B: Synthesis of Compounds <b>2a–e</b></h3><div class="NLM_p last">Compounds <b>2a</b>–<b>e</b> were prepared from compound <b>8a</b>–<b>e</b> in a similar manner to that described for compounds <b>1a</b>–<b>s</b>.</div></div><div id="sec4_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> 5-Methyl-1-phenyl-<i>N</i>-(quinolin-2-yl)-1<i>H</i>-pyrazole-3-carboxamide (<b>2a</b>)</h3><div class="NLM_p last">The title compound was synthesized according to General Procedure B (71%, a white solid): <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.65 (s, 1H), 8.62–8.60 (d, <i>J</i> = 9.6 Hz, 1H), 8.21–8.18 (d, <i>J</i> = 9.6 Hz, 1H), 7.86–7.84 (d, <i>J</i> = 8.4 Hz, 1H), 7.79–7.77 (d, <i>J</i> = 8.8 Hz, 1H), 7.67–7.63 (t, <i>J</i> = 7.2 Hz, 1H), 7.56–7.41 (m, 6H), 6.86 (s, 1H), 2.39 (s, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 160.6, 150.9, 146.8, 146.1, 141.4, 139.1, 138.4, 129.8, 129.2, 128.6, 127.5, 127.4, 126.3, 125.0, 124.9, 114.4, 107.8, 12.6. HRMS [M + H]<sup>+</sup> (ESI-TOF) calcd for C<sub>20</sub>H<sub>17</sub>N<sub>4</sub>O 329.1402, found 329.1406. HPLC: <i>t</i><sub>R</sub> = 20.42 min, 99.9%.</div></div><div id="sec4_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> 5-Methyl-<i>N</i>-(quinolin-2-yl)-1-(<i>o</i>-tolyl)-1<i>H</i>-pyrazole-3-carboxamide (<b>2b</b>)</h3><div class="NLM_p last">The title compound was synthesized according to General Procedure B (68%, a white solid): <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.63 (s, 1H), 8.61–8.59 (d, <i>J</i> = 9.6 Hz, 1H), 8.19–8.17 (d, <i>J</i> = 9.6 Hz, 1H), 7.82–7.80 (d, <i>J</i> = 8.8 Hz, 1H), 7.78–7.76 (d, <i>J</i> = 8.0 Hz, 1H), 7.65–7.61 (t, <i>J</i> = 7.2 Hz, 1H), 7.45–7.28 (m, 4H), 7.28–7.26 (d, <i>J</i> = 7.2 Hz, 1H), 6.86 (s, 1H), 2.16 (s, 3H), 2.08 (s, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 160.7, 150.9, 146.9, 146.1, 142.2, 138.3, 137.8, 135.9, 131.2, 129.8, 129.7, 127.5, 127.4, 127.4, 126.8, 126.2, 124.9, 114.3, 106.3, 17.2, 11.5. HRMS [M + H]<sup>+</sup> (ESI-TOF) calcd for C<sub>21</sub>H<sub>19</sub>N<sub>4</sub>O 343.1559, found 343.1558. HPLC: <i>t</i><sub>R</sub> = 8.54 min, 99.9%.</div></div><div id="sec4_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> 1-(2-Ethylphenyl)-5-methyl-<i>N</i>-(quinolin-2-yl)-1<i>H</i>-pyrazole-3-carboxamide (<b>2c</b>)</h3><div class="NLM_p last">The title compound was synthesized according to General Procedure B (66%, a yellow solid): <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.63 (s, 1H), 8.62–8.60 (d, <i>J</i> = 8.8 Hz, 1H), 8.19–8.17 (d, <i>J</i> = 8.8 Hz, 1H), 7.8–7.80 (d, <i>J</i> = 8.8 Hz, 1H), 7.77–7.75 (d, <i>J</i> = 8.0 Hz, 1H), 7.64–7.60 (t, <i>J</i> = 7.2 Hz, 1H), 7.50–7.39 (m, 3H), 7.37–7.33 (t, <i>J</i> = 7.6 Hz, 1H), 7.25–7.23 (d, <i>J</i> = 8.0 Hz, 1H), 6.86 (s, 1H), 2.44–2.40 (t, <i>J</i> = 8.0 Hz, 2H), 2.15 (s, 3H), 1.13–1.09 (d, <i>J</i> = 8.0 Hz, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 160.7, 150.9, 146.9, 146.0, 142.4, 141.7, 138.3, 137.3, 130.1, 129.8, 129.6, 127.6, 127.5, 126.7, 126.2, 124.9, 114.3, 106.3, 23.9, 14.5, 11.6. HRMS [M + H]<sup>+</sup> (ESI-TOF) calcd for C<sub>22</sub>H<sub>21</sub>N<sub>4</sub>O 357.1715, found 357.1717. HPLC: <i>t</i><sub>R</sub> = 11.11 min, 99.7%.</div></div><div id="sec4_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> 1-Phenyl-<i>N</i>-(quinolin-2-yl)-1,4,5,6-tetrahydrocyclopenta[<i>c</i>]pyrazole-3-carboxamide (<b>2d</b>)</h3><div class="NLM_p last">The title compound was synthesized according to General Procedure B (63%): <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.62 (s, 1H), 8.63–8.51 (d, <i>J</i> = 9.6 Hz, 1H), 8.19–8.17 (d, <i>J</i> = 8.8 Hz, 1H), 7.90–7.88 (d, <i>J</i> = 8.4 Hz, 1H), 7.79–7.77 (d, <i>J</i> = 8.0 Hz, 1H), 7.75–7.7.73 (d, <i>J</i> = 8.0 Hz, 1H), 7.69–7.65 (t, <i>J</i> = 8.0 Hz, 1H), 7.50–7.42 (m, 3H), 7.34–7.30 (t, <i>J</i> = 8.0 Hz, 1H), 3.05–3.01 (t, <i>J</i> = 7.2 Hz, 2H), 2.98–2.94 (t, <i>J</i> = 7.2 Hz, 2H), 2.71–2.66 (m, 2H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 160.9, 151.0, 150.9, 146.8, 139.9, 139.7, 138.4, 131.5, 129.9, 129.4, 127.5, 127.4, 126.8, 126.3, 124.9, 119.5, 114.3, 31.0, 26.8, 23.5. HRMS [M + H]<sup>+</sup> (ESI-TOF) calcd for C<sub>22</sub>H<sub>19</sub>N<sub>4</sub>O 355.1559, found 355.1564. HPLC: <i>t</i><sub>R</sub> = 13.14 min, 99.8%.</div></div><div id="sec4_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> 1-Phenyl-<i>N</i>-(quinolin-2-yl)-4,5,6,7-tetrahydro-1<i>H</i>-indazole-3-carboxamide (<b>2e</b>)</h3><div class="NLM_p last">The title compound was synthesized according to General Procedure B (65%): <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.69 (s, 1H), 8.63–8.61 (d, <i>J</i> = 8.8 Hz, 1H), 8.18–8.16 (d, <i>J</i> = 8.8 Hz, 1H), 7.87–7.85 (d, <i>J</i> = 8.8 Hz, 1H), 7.77–7.75 (d, <i>J</i> = 8.0 Hz, 1H), 7.66–7.64 (d, <i>J</i> = 8.0 Hz, 1H), 7.67–7.63 (t, <i>J</i> = 8.0 Hz, 1H), 7.57–7.55 (d, <i>J</i> = 8.0 Hz, 2H), 7.52–7.48 (t, <i>J</i> = 8.0 Hz, 2H), 7.43–7.40 (m, 2H), 2.97 (m, 2H), 2.73 (m, 2H), 1.82 (m, 4H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 161.6, 151.1, 146.9, 142.4, 140.9, 139.2, 138.3, 129.8, 129.2, 127.7, 127.5, 127.4, 126.2, 124.8, 123.5, 120.6, 114.3, 23.8, 22.6, 22.4, 21.6. HRMS [M + H]<sup>+</sup> (ESI-TOF) calcd for C<sub>23</sub>H<sub>21</sub>N<sub>4</sub>O 369.1715, found 369.1717. HPLC: <i>t</i><sub>R</sub> = 14.85 min, 99.9%.</div></div><div id="sec4_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> (<i>E</i>)-Ethyl 2-((dimethylamino)methylene)-3-oxobutanoate (<b>4a</b>)</h3><div class="NLM_p last">To a solution of ethyl acetoacetate (2.6 g, 20 mmol) in ethanol (10 mL) was added <i>N,N</i>-dimethylformamide dimethyl acetal (2.5 g, 21 mmol). The mixture was allowed to stir at 60 °C for 3 h,  cooled to room temperature, and concentrated under vacuum to give a crude product <b>5a</b> (3.6 g, 97%), which was used without further purification.</div></div><div id="sec4_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> General Procedure C: Synthesis of Compounds <b>5a–p</b></h3><div class="NLM_p">To a solution of <b>4a</b>–<b>f</b> (19.5 mmol) in ethanol (20 mL) were added DIPEA (2.71 g, 21 mmol) and substituted hydrazine (21 mmol). The mixture was allowed to stir at 60 °C for 3 h. Then the mixture was cooled to room temperature and concentrated to give the crude product as an oil, which was used in the next step without further purification.</div><div class="NLM_p last">To the above crude material (10 mmol) in EtOH (20 mL) was added a solution of NaOH (50 mmol) in H<sub>2</sub>O (5 mL). The resulting reaction mixture was heated under reflux for 2 h,  cooled to room temperature, and concentrated. The resulting aqueous solution was neutralized using HCl (1 N). The precipitate was filtered, washed with H<sub>2</sub>O, and dried under vacuum at 50 °C to afford compounds <b>5a</b>–<b>p</b> (40–98%).</div></div><div id="sec4_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> 5-Methyl-1-phenyl-1<i>H</i>-pyrazole-4-carboxylic Acid (<b>5a</b>)</h3><div class="NLM_p last">The title compound was synthesized according to General Procedure C (80%): <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.45 (s, 1H), 7.98 (s, 1H), 7.59–7.49 (m, 5H), 2.51 (s, 3H); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 169.7, 148.4, 146.8, 143.8, 134.5, 133.7, 130.5, 118.2, 16.7.</div></div><div id="sec4_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> 1-(2-Fluorophenyl)-5-methyl-1<i>H</i>-pyrazole-4-carboxylic Acid (<b>5b</b>)</h3><div class="NLM_p last">The title compound was synthesized according to General Procedure C (94%): <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.56 (s, 1H), 8.03 (s, 1H), 7.64–7.58 (m, 2H), 7.53–7.748 (t, <i>J</i> = 8.8 Hz, 1H), 7.43–7.39 (t, <i>J</i> = 8.8 Hz, 1H), 2.37 (s, 3H); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 169.5, 162.9, 160.2, 149.9, 147.3, 136.9, 136.8, 134.5, 130.5, 130.5, 122.0, 121.8, 117.9, 15.8.</div></div><div id="sec4_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> 1-(2-Bromophenyl)-5-methyl-1<i>H</i>-pyrazole-4-carboxylic Acid (<b>5c</b>)</h3><div class="NLM_p last">The title compound was synthesized according to General Procedure C (98%): <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.45 (s, 1H), 7.99 (s, 1H), 7.89–7.87 (d, <i>J</i> = 8.0 Hz, 1H), 7.61–7.54 (m, 3H), 2.28 (s, 3H); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 169.6, 149.5, 146.8, 142.7, 138.5, 137.0, 135.2, 134.1, 126.6, 117.5, 16.0.</div></div><div id="sec4_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> 1-(2-Ethylphenyl)-5-methyl-1<i>H</i>-pyrazole-4-carboxylic Acid (<b>5d</b>)</h3><div class="NLM_p last">The title compound was synthesized according to General Procedure C (78%): <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.41 (s, 1H), 7.98 (s, 1H), 7.53–7.47 (m, 2H), 7.40–7.36 (t, <i>J</i> = 8.0 Hz, 1H), 7.32–7.30 (d, <i>J</i> = 8.0 Hz, 1H), 2.29–2.67 (m, 5H), 1.00–0.96 (t, <i>J</i> = 8.0 Hz, 3H); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 169.7, 149.2, 146.4, 146.4, 142.0, 135.1, 134.8, 132.9, 131.9, 117.1, 28.6, 19.6, 16.2.</div></div><div id="sec4_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> 1-(2,4-Difluorophenyl)-5-methyl-1<i>H</i>-pyrazole-4-carboxylic Acid (<b>5g</b>)</h3><div class="NLM_p last">The title compound was synthesized according to General Procedure C (83%): <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.49 (s, 1H), 8.01 (s, 1H), 7.72–7.66 (m, 1H), 7.62–7.56 (m, 1H), 7.33–7.29 (m, 1H), 2.36 (s, 3H); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 169.5, 168.9, 168.8, 166.4, 166.3, 163.3, 163.1, 160.7, 160.6, 150.2, 147.4, 136.0, 135.9, 117.9, 117.8, 117.6, 117.6, 110.8, 110.5, 110.3, 15.8.</div></div><div id="sec4_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> 1-(3-Chloro-2-fluorophenyl)-5-methyl-1<i>H</i>-pyrazole-4-carboxylic Acid (<b>5h</b>)</h3><div class="NLM_p last">The title compound was synthesized according to General Procedure C (86%): <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.45 (s, 1H), 8.04 (s, 1H), 7.84–7.80 (t, <i>J</i> = 7.2 Hz, 1H), 7.63–7.59 (t, <i>J</i> = 7.2 Hz, 1H), 7.46–7.42 (t, <i>J</i> = 7.2 Hz, 1H), 2.38 (s, 3H); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 169.4, 158.7, 156.1, 150.2, 147.6, 137.1, 133.5, 132.6, 132.5, 131.0, 130.9, 126.2, 126.0, 118.1, 15.9.</div></div><div id="sec4_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> 1-(2,5-Dimethylphenyl)-5-methyl-1<i>H</i>-pyrazole-4-carboxylic Acid (<b>5i</b>)</h3><div class="NLM_p last">The title compound was synthesized according to General Procedure C (75%): <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.11 (s, 1H), 7.96 (s, 1H), 7.31–7.29 (d, <i>J</i> = 8.0 Hz, 1H), 7.26–7.24 (d, <i>J</i> = 8.0 Hz, 1H), 7.13 (s, 1H), 2.32 (s, 3H), 2.26 (s, 3H), 1.90 (s, 3H); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 169.8, 148.9, 146.4, 142.5, 141.5, 137.3, 135.9, 135.5, 133.1, 117.1, 25.4, 21.4, 15.9.</div></div><div id="sec4_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> 1-(2,6-Dimethylphenyl)-5-methyl-1<i>H</i>-pyrazole-4-carboxylic Acid (<b>5j</b>)</h3><div class="NLM_p last">The title compound was synthesized according to General Procedure C (48%): <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.44 (s, 1H), 8.01 (s, 1H), 7.39–7.35 (t, <i>J</i> = 8.0 Hz, 1H), 7.27–7.25 (d, <i>J</i> = 8.0 Hz, 1H), 2.20 (s, 3H), 1.88 (s, 6H); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 169.8, 148.9, 146.9, 141.8, 141.0, 134.8, 133.5, 117.0, 21.9, 15.4.</div></div><div id="sec4_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> 5-Methyl-1-(3-methylpyridin-2-yl)-1<i>H</i>-pyrazole-4-carboxylic Acid (<b>5k</b>)</h3><div class="NLM_p last">The title compound was synthesized according to General Procedure C (48%): <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.27 (s, 1H), 8.47–8.46 (d, <i>J</i> = 4.0 Hz, 1H), 7.99–7.96 (m, 2H), 7.56–7.53 (m, 1H), 2.37 (s, 3H), 2.11 (s, 3H); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 169.6, 154.9, 151.7, 149.1, 146.6, 146.1, 135.8, 130.3, 117.5, 21.8, 16.0.</div></div><div id="sec4_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> General Procedure D: Synthesis of Compounds <b>7a–c</b></h3><div class="NLM_p last">A solution of aniline (0.11 mol), concentrated HCl (28 mL), EtOH (14 mL), and H<sub>2</sub>O (14 mL) was cooled at −5 °C, and then a solution of sodium nitrite (8.28 g, 0.12 mol) in H<sub>2</sub>O (38 mL) was added dropwise while the temperature was maintained below 5 °C. A cold solution of ethyl 2-chloroacetoacetate (18.1 g, 15.2 mL, 0.11 mol), sodium acetate trihydrate (22.5 g, 1.27 mol) in EtOH (270 mL), and H<sub>2</sub>O (30 mL) was added, and the reaction was stirred at −5 °C for 4 h. The reaction was quenched with H<sub>2</sub>O (4 L) and kept stirring overnight. The solid was collected and recrystallized from EtOH to give compounds <b>7a</b>–<b>c</b>.</div></div><div id="sec4_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> (<i>Z</i>)-Ethyl 2-Chloro-2-(2-phenylhydrazono)acetate (<b>7a</b>)</h3><div class="NLM_p last">The title compound was synthesized according to General Procedure D (95%, a yellow solid): <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.40 (s, 1H), 7.35–7.31(t, <i>J</i> = 8.0 Hz, 2H), 7.24–7.22 (d, <i>J</i> = 8.0 Hz, 2H), 7.06–7.02 (t, <i>J</i> = 8.0 Hz, 1H), 4.41–4.36 (q, <i>J</i> = 7.2 Hz, 2H), 1.42–1.38 (t, <i>J</i> = 7.2 Hz, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 159.7, 141.6, 129.4, 123.1, 115.9, 114.5, 62.8, 14.2.</div></div><div id="sec4_41" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> (<i>Z</i>)-Ethyl 2-Chloro-2-(2-(o-tolyl)hydrazono)acetate (<b>7b</b>)</h3><div class="NLM_p last">The title compound was synthesized according to General Procedure D (88%, a yellow solid): <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.27 (s, 1H), 7.56–7.54 (d, <i>J</i> = 8.0 Hz, 1H), 7.26–7.22 (t, <i>J</i> = 8.0 Hz, 1H), 7.26–7.22 (t, <i>J</i> = 8.0 Hz, 1H), 7.15–7.13 (d, <i>J</i> = 8.0 Hz, 1H), 4.43–4.37 (q, <i>J</i> = 7.2 Hz, 2H), 2.31 (s, 3H), 1.43–1.39 (t, <i>J</i> = 7.2 Hz, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 159.7, 139.4, 130.7, 127.4, 122.8, 122.3, 116.8, 114.5, 62.8, 16.7, 14.2.</div></div><div id="sec4_42" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> (<i>Z</i>)-Ethyl 2-Chloro-2-(2-(2-ethylphenyl)hydrazono)acetate (<b>7c</b>)</h3><div class="NLM_p last">The title compound was synthesized according to General Procedure D (90%, a yellow solid): <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.39 (s, 1H), 7.58–7.56 (d, <i>J</i> = 8.0 Hz, 1H), 7.26–7.22 (t, <i>J</i> = 8.0 Hz, 1H), 7.17–7.15 (d, <i>J</i> = 8.0 Hz, 1H), 7.03–6.99 (t, <i>J</i> = 8.0 Hz, 1H), 4.42–4.37 (q, <i>J</i> = 7.2 Hz, 2H), 2.68–2.62 (q, <i>J</i> = 8.0 Hz, 2H), 1.43–1.39 (t, <i>J</i> = 7.2 Hz, 3H), 1.32–1.28 (t, <i>J</i> = 8.0 Hz, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ159.7, 138.8, 128.7, 128.3, 127.4, 123.1, 116.6, 114.9, 62.7, 23.6, 14.2, 13.4.</div></div><div id="sec4_43" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> General Procedure E: Synthesis of Compounds <b>8a–c</b></h3><div class="NLM_p">Compound <b>7</b> (1.0 mmol) and diethyl (2-oxopropyl)phosphonate (1.0 mmol) were dissolved in DME (3 mL). LiOH (48 mg, 2.0 mmol) was added to the reaction mixture. The reaction mixture was allowed to stir at room temperature for 10 h. H<sub>2</sub>O (6 mL) was added to the reaction mixture; the reaction mixture was then stirred overnight. Pyrazole-ester was then filtered, dried, and used in the next step without further purification.</div><div class="NLM_p last">To pyrazole-ester (10 mmol) in EtOH (20 mL) was added a solution of NaOH (50 mmol) in H<sub>2</sub>O (5 mL). The reaction was heated under reflux for 2 h, cooled to room temperature, and concentrated. The resulting aqueous solution was neutralized by slow addition of HCl (1 N). The precipitate formed was filtered, washed with water, and dried under vacuum at 50 °C to afford compounds <b>8a</b>–<b>c</b>.</div></div><div id="sec4_44" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> 5-Methyl-1-phenyl-1<i>H</i>-pyrazole-3-carboxylic Acid (<b>8a</b>)</h3><div class="NLM_p last">The title compound was synthesized according to General Procedure E (85% for two steps): <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.51–7.47 m, 5H), 6.79 (s, 1H), 2.34 (s, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ166.3, 142.8, 141.0, 138.9, 129.2, 128.8, 125.3, 109.6, 12.4.</div></div><div id="sec4_45" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> 5-Methyl-1-(<i>o</i>-tolyl)-1<i>H</i>-pyrazole-3-carboxylic Acid (<b>8b</b>)</h3><div class="NLM_p last">The title compound was synthesized according to General Procedure E (80% for two steps): <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.41–7.38 (t, <i>J</i> = 6.8 Hz, 1H), 7.34–7.32 (d, <i>J</i> = 8.4 Hz, 1H), 7.30–7.28 (d, <i>J</i> = 8.4 Hz, 1H), 7.26–7.22 (t, <i>J</i> = 6.8 Hz, 1H), 6.79 (s, 1H), 2.13 (s, 3H), 2.04 (s, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 166.1, 142.7, 141.9, 137.7, 135.8, 131.0, 129.9, 127.5, 126.6, 108.2, 17.1, 11.4.</div></div><div id="sec4_46" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> 1-(2-Ethylphenyl)-5-methyl-1<i>H</i>-pyrazole-3-carboxylic Acid (<b>8c</b>)</h3><div class="NLM_p last">The title compound was synthesized according to General Procedure E (70% for two steps): <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.47–7.43 (t, <i>J</i> = 6.8 Hz, 1H), 7.40–7.38 (d, <i>J</i> = 6.8. Hz, 1H), 7.33–7.29 (d, <i>J</i> = 6.8 Hz, 1H), 7.22–7.02 (d, <i>J</i> = 7.6 Hz, 1H), 6.79 (s, 1H), 2.38–2.33 (q, <i>J</i> = 7.2 Hz, 2H), 2.14 (s, 3H), 1.10–1.06 (t, <i>J</i> = 7.2 Hz, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 165.8, 142.6, 142.1, 141.6, 137.1, 130.1, 129.4, 127.6, 126.6, 108.2, 23.8, 14.3, 11.5.</div></div><div id="sec4_47" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> 1-Phenyl-1,4,5,6-tetrahydrocyclopenta[<i>c</i>]pyrazole-3-carboxylic Acid (<b>8d</b>)</h3><div class="NLM_p">In a three-necked flask 6.7 g (0.04 mol) of freshly distilled enamine and 4.1 g (0.04 mol) of dry Et<sub>3</sub>N were dissolved in dry chloroform (50 mL). A solution of phenylhydrazone (<b>7</b>), 10.8 g (0.04 mol), dissolved in chloroform (100 mL) was added dropwise at room temperature. The reaction mixture was stirred at room temperature for 12 h and then washed H<sub>2</sub>O (3×). The organic layer was dried on dry Na<sub>2</sub>SO<sub>4</sub>. Evaporation of the solvent under reduced pressure yielded a thick oil which was used in the next step without further purification.</div><div class="NLM_p last">To the obtained oil product (10 mmol) in EtOH (20 mL) was added a solution of NaOH (50 mmol) in H<sub>2</sub>O (5 mL). The mixture was heated under reflux for 2 h. Then the organic solvents were evaporated, and the resulting aqueous phase was neutralized by slow addition of HCl (1 N). The precipitate formed was filtered, washed with water, and dried under vacuum at 50 °C to afford compound <b>8d</b> as a brown solid (78% for two steps): <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.57 (s, 1H), 7.54–7.52 (d, <i>J</i> = 8.0 Hz, 2H), 7.37–7.33 (t, <i>J</i> = 8.0 Hz, 2H), 7.21–7.17 (t, <i>J</i> = 8.0 Hz, 1H), 2.89–2.85 (t, <i>J</i> = 7.2 Hz, 2H), 2.57–2.53 (t, <i>J</i> = 7.2 Hz, 2H), 2.42–2.34 (m, 2H); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 168.3, 155.2, 144.4, 143.3, 136.7, 134.6, 131.9, 124.5, 35.3, 30.9, 28.4.</div></div><div id="sec4_48" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> Cell Culture</h3><div class="NLM_p last">HEK293, SW480, and HT29 cells were maintained in Dulbecco’s Modified Eagle’s Medium (DMEM) with fetal bovine serum (10%) and 1% PS (penicillin/streptomycin). SW620 cells were maintained in RPMI 1640 medium with fetal bovine serum (10%) and 1% PS. All cells were incubated in 37 °C incubator with 5% CO<sub>2</sub>.</div></div><div id="sec4_49" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> Cell Proliferation Assay</h3><div class="NLM_p last">Cells of log phase were used. From 1000 to 3000 cells/well were seeded in 96-well plates with a volume of 100 μL. Cells were allowed to settle for 24 h in 37 °C incubators with 5% CO<sub>2</sub>. Different concentrations of 1000× stock solutions of the drug were made in DMSO. For IC<sub>50</sub> determination, a 5-fold serial dilution of drugs starting from 50 mM was used. The mixture (100 μL) was correspondingly added to the 96-well plate; each concentration had three replicates. DMSO instead of the compound solution was used as the 0% inhibitor control. After incubation for 72 h, CCK-8 (10 μL) was added. Three hours later, the absorbance at 450 nm was measured. The data was calculated using GraphPad Prism. The IC<sub>50</sub> were fitted using a nonlinear regression model with a sigmoidal dose response.</div></div><div id="sec4_50" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> Wnt-HEK293 Luciferase Reporter Assay in a 1536-Well Plate Format</h3><div class="NLM_p last">Stably transfected Wnt-HEK293 cells were dispensed at 2000/well in 4 μL of the Dulbecco’s Modified Eagle Medium supplemented with 10% fetal bovine serum into white-solid 1536-well plates (Greiner Bio-One North America Inc., Monroe, NC) using flying reagent dispenser (FRD, Aurora Discovery, San Diego, CA). The assay plates were incubated  overnight at 37 °C. Then 23 nL of test compounds was transferred to the assay plates using a pintool station (Wako, San Diego, CA) followed by the addition of 1 μL of 200 ng/mL recombinant human Wnt-3a (R&D Systems Inc., Minneapolis, MN) using an FRD to all of the wells except in the top half portions of the first four columns which received the control assay medium instead. The assay plates were incubated for 24 h at 37 °C. For cell viability assay, 1 μL/well CellTiter-Fluor reagent (Promega Corporation, Madison, WI) was added using an FRD and fluorescence signal was measured through a ViewLux plate reader (PerkinElmer, Boston, MA) after 30 min incubation at 37 °C. For luciferase reporter assay, 4 μL/well ONE-Glo reagent (Promega Corp.) was added using an FRD and luminescence signal was measured through a ViewLux plate reader after 30 min incubation at room temperature. Data were expressed as relative fluorescence units (cell viability assay) and relative luminescence units (luciferase reporter assay).</div></div><div id="sec4_51" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> TCF/LEF Dual-Luciferase Reporter Assay</h3><div class="NLM_p last">SW480 and SW620 cells were seeded in 24-well plates at a density of 200 000 cells/well. Twenty-four hours after seeding, transit transfections of TCF/LEF-Firefly luciferase expression construct (TOPflash, a gift from Randall Moon, Addgene plasmid #12456)<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(47)</a> and pRLTK-Renilla vector were performed with lipofectamine 2000 (Invitrogen) according to the manufacturer’s instruction. After 16 h of transfection, the medium was changed to a new medium with different concentrations of compounds; each concentration had three replicates. Twenty-four hours later, luciferase activity was measured using a dual-luciferase reporter assay system (Promega) according to the manufacturer’s instruction.</div></div><div id="sec4_52" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> Gene Overexpression and Knockdown</h3><div class="NLM_p last">For overexpression and knockdown studies, the human pcDNA3-wild type and pcDNA3-S33Y β-catenin were gifts from Eric Fearon (Addgene plasmid #19286 and #16828), while the pLKO.1 control vector and shAxin plasmid were purchased from Sigma. The IC<sub>50</sub> values were fitted using a nonlinear regression model with a sigmoidal dose response.</div></div><div id="sec4_53" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> Western Blot</h3><div class="NLM_p last">Cultured SW620 cells or tumor tissues were lysed with RIPA buffer containing protease inhibitor (Sigma). Protein concentrations were determined by DC protein assay kits (Biorad) and diluted to 2 mg/mL. Samples were denatured (98 °C for 5 min), and 20 μL was loaded onto 7.5% SDS-PAGE protein gels for protein separation. After transferring to a nitrocellulose membrane, the membrane was blocked with 5% bovine serum albumin for 1 h. Primary rabbit antibody against either Axin-1 (1:1000), β-catenin (1:2000), Axin-2 (1:1000), ACC (1:1000), pACC (1:1000), AMPK (1:1000), pAMPK (1:1000), or β-actin (1:2000) was incubated overnight at 4 °C. Then HRP-linked rabbit secondary antibody (1:8000) was incubated for 2 h at room temperature. Blots were developed by enhanced chemiluminescence (Thermo), and images were taken using a LICOR Odyssey Fc Imaging System.</div></div><div id="sec4_54" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> Colony Formation Assay</h3><div class="NLM_p last">SW480, SW620, and HT29 cells were seeded in 6-well plates at a concentration of 300/well in medium (3 mL). Then drugs at a series of concentrations were added. After 14 days, the plates were fixed with formaldehyde (4%) and stained with 0.5% crystal violet solution in MeOH aqueous solution (25%). Representative pictures of colonies were captured.</div></div><div id="sec4_55" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> 7-AAD/Annexin V Staining</h3><div class="NLM_p last">SW620 cells (1 × 10<sup>6</sup>) were seeded into a 10 cm culture dish and recovered overnight. Different concentrations of compound YW2065 or DMSO were added for 48 h. The cells were harvested and stained with FITC Annexin V Apoptosis Detection Kit with 7-AAD (biolegend) according to manufacturer’s protocol. Cell distribution was then analyzed by a BD FACSCanto II Cytometer and processed by Flowjo software.</div></div><div id="sec4_56" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> In Vivo Efficacy Study</h3><div class="NLM_p last">Female nude mice were purchased from the Jackson Laboratory. All procedures were carried out in accordance with NIH guidelines for animal experimentation and  approved by the Institutional Animal Care and Use Committee (IACUC) of the School of Medicine, University of Maryland Baltimore. SW620 cells (2 × 10<sup>6</sup>) were injected subcutaneously into the right flank of each mouse. Mice were randomly grouped (6 mice/group) based on the tumor volume when the mean tumor volume reached 100–200 mm<sup>3</sup>. YW2065 were dissolved in 10% DMSO, 10% Kolliphor, and 80% saline. Mice were treated for 32 consecutive days via ip with YW2065 (50 mg/kg once daily, 10 mg/kg once daily) and vehicle. Tumor volume and body weight were monitored twice a week. Tumor volume was calculated as the <i>L</i> × <i>W</i> × <i>W</i>/2 (where <i>L</i> and <i>W</i> are the length and width of the tumor, respectively). After the last measurement, mice were sacrificed and the tumors were separated for RNA extraction and Western blot analyses.</div></div><div id="sec4_57" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> Reverse Transcription and Real-Time PCR</h3><div class="NLM_p last">SW620 cells were seeded into 6-well plates and incubated for 24 h. Different concentrations of drugs were added to each well; each concentration had three replicates. After 24 h, cells were harvested and total RNA was isolated using the Trizol and phenol–chloroform method. The total RNA (2 μg) was reversely transcribed using a high-capability reverse transcript kit (Roche Applied Science). The RT-PCR was performed on ABI PRISM 7700 (Applied Biosystems). The following primes were used. Axin-2: forward, 5′-TACACTCCTTATTGGGCGATCA;  reverse, 5′-TTGGCTACTCGTAAAGTTTTGGT. MMP-7: forward, 5′- GAGTGAGCTACAGTG GGAACA-3′; . reverse, 5′- CTATGACGCGGGAGTTTAACAT-3′. S100A4: forward, 5′- GATGAGCAACTTGGACAGCAA-3′;  reverse, 5′- CTGGGCTGCTTATCTGG GAAG-3′.</div></div><div id="sec4_58" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> Pharmacokinetic Studies in Mice</h3><div class="NLM_p last">Breeding pairs of C57BL/6J mice were purchased from Jackson Laboratory (Bar Harbor, ME) and housed in a room having a temperature restraint of 21 ± 2 °C with a humidity of 60 ± 10% and maintained at a 12 h light/dark cycle. The mice were provided with filtered water and food ad libitum and bred to produce offspring for our studies. For the PK experiments, male mice of 2–3 months weighing 23–26 g (<i>n</i> = 8) were used. All of the procedures were carried out according to the NIH guidelines for animal experimentation and with the approval of the University of Maryland at Baltimore School of Medicine Institutional Animal Care and Use Committee. Each of the mice received 5 mg/kg of YW2065 prepared in 5% Kolliphor in saline; 3 mice were administered with this dosage intravenously and 5 via oral gavage. At six time points (0.25, 0.5, 1, 4, 8, 12 h) blood samples were collected from the tail vein of each mouse and immediately centrifuged at 8000 rpm for 15 min to collect the plasma. Aliquots of the plasma sample were added to acetonitrile containing 0.5 μM   internal standard (a YW2065 analog YW2013). The mixture was centrifuged at 13 000 rpm for 15 min, and the supernatant was analyzed with an ultraperformance liquid chromatography instrument (an Agilent 1200 series from Agilent Technologies, California) that is equipped with a hybrid triple-quadrupole 4000 QTRAP system (AB SCIEX, Massachusetts). The column used was a Cortecs C18+ 2.7 μm 2.1 × 75 mm column (Waters Corp., Milford, MA). Each sample was run for a total of 5 min with a gradient setup from −95% to 5% of mobile phase A over 1.5 min,from 95% to 5% of B over 2 min, and 95% of A over 1.5 min. Mobile phase A was made up of 0.1% formic acid and 10 mM ammonium acetate in water, while B was made up of 0.1% formic acid in acetonitrile. The ion transition used to detect YW2065 is 406.841 > 155.062 in the positive ion electrospray ionization (ES+) mode.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i71"><a href="/doi/suppl/10.1021/acs.jmedchem.9b01252" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_64704" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_64704" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.9b01252?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b01252</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">SW480 cell viability assay for FX1128, mice weight gain study, 21-day mice toxicity study, and HPLC trace for YW2065 (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01252/suppl_file/jm9b01252_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline"><sup>1</sup>H/<sup>13</sup>C NMR spectra of new compounds (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01252/suppl_file/jm9b01252_si_002.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01252/suppl_file/jm9b01252_si_003.xls" class="ext-link">XLS</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01252/suppl_file/jm9b01252_si_001.pdf">jm9b01252_si_001.pdf (262.28 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01252/suppl_file/jm9b01252_si_002.pdf">jm9b01252_si_002.pdf (1.01 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01252/suppl_file/jm9b01252_si_003.xls">jm9b01252_si_003.xls (95.5 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.9b01252" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_16845" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_16845" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yan Shu</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmaceutical Sciences, University of
Maryland School of Pharmacy, Baltimore, Maryland 21201, United States</span>; 
    <span class="hlFld-Affiliation affiliation">School
and Hospital of Stomatology, Guangzhou Medical
University, Guangzhou 510140, China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8492-1437" title="Orcid link">http://orcid.org/0000-0001-8492-1437</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#532a203b2613212b7d263e32212a3f323d377d363726"><span class="__cf_email__" data-cfemail="a3dad0cbd6e3d1db8dd6cec2d1dacfc2cdc78dc6c7d6">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Fengtian Xue</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmaceutical Sciences, University of
Maryland School of Pharmacy, Baltimore, Maryland 21201, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-4132-9887" title="Orcid link">http://orcid.org/0000-0002-4132-9887</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#294f515c4c695b51075c44485b504548474d074c4d5c"><span class="__cf_email__" data-cfemail="c5a3bdb0a085b7bdebb0a8a4b7bca9a4aba1eba0a1b0">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wei Yang</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmaceutical Sciences, University of
Maryland School of Pharmacy, Baltimore, Maryland 21201, United States</span>; 
    <span>Present Address:
                        W.Y.: School of Pharmaceutical Engineering, Jiangsu Food & Pharmaceutical Science College, Huaian, Jiangsu 223005, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yingjun Li</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmaceutical Sciences, University of
Maryland School of Pharmacy, Baltimore, Maryland 21201, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yong Ai</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmaceutical Sciences, University of
Maryland School of Pharmacy, Baltimore, Maryland 21201, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Obinna N. Obianom</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmaceutical Sciences, University of
Maryland School of Pharmacy, Baltimore, Maryland 21201, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dong Guo</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmaceutical Sciences, University of
Maryland School of Pharmacy, Baltimore, Maryland 21201, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hong Yang</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmaceutical Sciences, University of
Maryland School of Pharmacy, Baltimore, Maryland 21201, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Srilatha Sakamuru</span> - <span class="hlFld-Affiliation affiliation">National
Center for Advancing Translational Sciences, National Institutes of Health, 9800 Medical Center Drive, Bethesda, Maryland 20892, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Menghang Xia</span> - <span class="hlFld-Affiliation affiliation">National
Center for Advancing Translational Sciences, National Institutes of Health, 9800 Medical Center Drive, Bethesda, Maryland 20892, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-7285-8469" title="Orcid link">http://orcid.org/0000-0001-7285-8469</a></span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>W.Y. and Y.L.: These authors contributed equally to this work.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i74">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_45688" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_45688" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank the Maryland Innovation Initiative (MII) for the research grant to F.X. and Y.S. and the Chinese National Natural Science Foundation [no. 21702073] to W.Y. and F.X. Y.S. is a cofounder for and owns equity in Optivia Biotechnology. This work was supported in part by the Intramural Research Program of the National Center for Advancing Translational Sciences (NCATS).</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">PPI</td><td class="NLM_def"><p class="first last">protein–protein interactions</p></td></tr><tr><td class="NLM_term">CRC</td><td class="NLM_def"><p class="first last">colorectal cancer</p></td></tr><tr><td class="NLM_term">VEGF</td><td class="NLM_def"><p class="first last">vascular endothelial growth factor</p></td></tr><tr><td class="NLM_term">EGFR</td><td class="NLM_def"><p class="first last">epidermal growth factor receptor</p></td></tr><tr><td class="NLM_term">APC</td><td class="NLM_def"><p class="first last">adenomatous polyposis coli</p></td></tr><tr><td class="NLM_term">CK1α</td><td class="NLM_def"><p class="first last">casein kinase 1α</p></td></tr><tr><td class="NLM_term">GSK3β</td><td class="NLM_def"><p class="first last">glycogen synthase kinase 3β</p></td></tr><tr><td class="NLM_term">TNKS</td><td class="NLM_def"><p class="first last">tankyrase</p></td></tr><tr><td class="NLM_term">CBP</td><td class="NLM_def"><p class="first last">CREB-binding protein</p></td></tr><tr><td class="NLM_term">BCL9</td><td class="NLM_def"><p class="first last">B cell CLL/lymphoma 9</p></td></tr><tr><td class="NLM_term">AMPK</td><td class="NLM_def"><p class="first last">adenosine monophosphate (AMP)-activated protein kinase</p></td></tr><tr><td class="NLM_term">ATP</td><td class="NLM_def"><p class="first last">adenosine triphosphate</p></td></tr><tr><td class="NLM_term">AICAR</td><td class="NLM_def"><p class="first last">5-aminoimidazole-4-carboxamide-ribonucleoside</p></td></tr><tr><td class="NLM_term">DMF-DMA</td><td class="NLM_def"><p class="first last">dimethylformamid-dimethylacetal</p></td></tr><tr><td class="NLM_term">EtOH</td><td class="NLM_def"><p class="first last">ethanol</p></td></tr><tr><td class="NLM_term">DIPEA</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-diisopropylethylamine</p></td></tr><tr><td class="NLM_term">NaOH</td><td class="NLM_def"><p class="first last">sodium hydroxide</p></td></tr><tr><td class="NLM_term">PyCIU</td><td class="NLM_def"><p class="first last">1-(chloro-1-pyrrolidinylmethylene) pyrrolidinium</p></td></tr><tr><td class="NLM_term">DCE</td><td class="NLM_def"><p class="first last">1,2-dichloroethane</p></td></tr><tr><td class="NLM_term">HCl</td><td class="NLM_def"><p class="first last">hydrochloric acid</p></td></tr><tr><td class="NLM_term">NaOAc</td><td class="NLM_def"><p class="first last">sodium acetate</p></td></tr><tr><td class="NLM_term">LiOH</td><td class="NLM_def"><p class="first last">lithium hydroxide</p></td></tr><tr><td class="NLM_term">Et<sub>3</sub>N</td><td class="NLM_def"><p class="first last">triethylamine</p></td></tr><tr><td class="NLM_term">MeOH</td><td class="NLM_def"><p class="first last">methanol</p></td></tr><tr><td class="NLM_term">ACC</td><td class="NLM_def"><p class="first last">acetyl-CoA carboxylase</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i76">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_72773" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_72773" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 50 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jemal, A.</span></span> <span> </span><span class="NLM_article-title">Cancer statistics, 2015</span>. <i>Ca-Cancer J. Clin.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">5</span>– <span class="NLM_lpage">29</span>, <span class="refDoi"> DOI: 10.3322/caac.21254</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=10.3322%2Fcaac.21254" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=25559415" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=1%3ACAS%3A280%3ADC%252BC2Mvjs1ersw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2015&pages=5-29&author=R.+L.+Siegelauthor=K.+D.+Millerauthor=A.+Jemal&title=Cancer+statistics%2C+2015&doi=10.3322%2Fcaac.21254"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer statistics, 2015</span></div><div class="casAuthors">Siegel Rebecca L; Miller Kimberly D; Jemal Ahmedin</div><div class="citationInfo"><span class="NLM_cas:title">CA: a cancer journal for clinicians</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">5-29</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Each year the American Cancer Society estimates the numbers of new cancer cases and deaths that will occur in the United States in the current year and compiles the most recent data on cancer incidence, mortality, and survival.  Incidence data were collected by the National Cancer Institute (Surveillance, Epidemiology, and End Results [SEER] Program), the Centers for Disease Control and Prevention (National Program of Cancer Registries), and the North American Association of Central Cancer Registries.  Mortality data were collected by the National Center for Health Statistics.  A total of 1,658,370 new cancer cases and 589,430 cancer deaths are projected to occur in the United States in 2015.  During the most recent 5 years for which there are data (2007-2011), delay-adjusted cancer incidence rates (13 oldest SEER registries) declined by 1.8% per year in men and were stable in women, while cancer death rates nationwide decreased by 1.8% per year in men and by 1.4% per year in women.  The overall cancer death rate decreased from 215.1 (per 100,000 population) in 1991 to 168.7 in 2011, a total relative decline of 22%.  However, the magnitude of the decline varied by state, and was generally lowest in the South (∼15%) and highest in the Northeast (≥20%).  For example, there were declines of 25% to 30% in Maryland, New Jersey, Massachusetts, New York, and Delaware, which collectively averted 29,000 cancer deaths in 2011 as a result of this progress.  Further gains can be accelerated by applying existing cancer control knowledge across all segments of the population.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR7d8BN92t5_sNIRw0GKUoEfW6udTcc2eZdk2-F_AhcGrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2Mvjs1ersw%253D%253D&md5=9b569d8b3f5e9da465900f1c428a9218</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.3322%2Fcaac.21254&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3322%252Fcaac.21254%26sid%3Dliteratum%253Aachs%26aulast%3DSiegel%26aufirst%3DR.%2BL.%26aulast%3DMiller%26aufirst%3DK.%2BD.%26aulast%3DJemal%26aufirst%3DA.%26atitle%3DCancer%2520statistics%252C%25202015%26jtitle%3DCa-Cancer%2520J.%2520Clin.%26date%3D2015%26volume%3D65%26spage%3D5%26epage%3D29%26doi%3D10.3322%2Fcaac.21254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desantis, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jemal, A.</span></span> <span> </span><span class="NLM_article-title">Colorectal cancer statistics, 2014</span>. <i>Ca-Cancer J. Clin.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">104</span>– <span class="NLM_lpage">117</span>, <span class="refDoi"> DOI: 10.3322/caac.21220</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=10.3322%2Fcaac.21220" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=24639052" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=1%3ACAS%3A280%3ADC%252BC2crksVyhsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2014&pages=104-117&author=R.+Siegelauthor=C.+Desantisauthor=A.+Jemal&title=Colorectal+cancer+statistics%2C+2014&doi=10.3322%2Fcaac.21220"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Colorectal cancer statistics, 2014</span></div><div class="casAuthors">Siegel Rebecca; Desantis Carol; Jemal Ahmedin</div><div class="citationInfo"><span class="NLM_cas:title">CA: a cancer journal for clinicians</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">104-17</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Colorectal cancer is the third most common cancer and the third leading cause of cancer death in men and women in the United States.  This article provides an overview of colorectal cancer statistics, including the most current data on incidence, survival, and mortality rates and trends.  Incidence data were provided by the National Cancer Institute's Surveillance, Epidemiology, and End Results program and the North American Association of Central Cancer Registries.  Mortality data were provided by the National Center for Health Statistics.  In 2014, an estimated 71,830 men and 65,000 women will be diagnosed with colorectal cancer and 26,270 men and 24,040 women will die of the disease.  Greater than one-third of all deaths (29% in men and 43% in women) will occur in individuals aged 80 years and older.  There is substantial variation in tumor location by age.  For example, 26% of colorectal cancers in women aged younger than 50 years occur in the proximal colon, compared with 56% of cases in women aged 80 years and older.  Incidence and death rates are highest in blacks and lowest in Asians/Pacific Islanders; among males during 2006 through 2010, death rates in blacks (29.4 per 100,000 population) were more than double those in Asians/Pacific Islanders (13.1) and 50% higher than those in non-Hispanic whites (19.2).  Overall, incidence rates decreased by approximately 3% per year during the past decade (2001-2010).  Notably, the largest drops occurred in adults aged 65 and older.  For instance, rates for tumors located in the distal colon decreased by more than 5% per year.  In contrast, rates increased during this time period among adults younger than 50 years.  Colorectal cancer death rates declined by approximately 2% per year during the 1990s and by approximately 3% per year during the past decade.  Progress in reducing colorectal cancer death rates can be accelerated by improving access to and use of screening and standard treatment in all populations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTAbMaHe6k5ARdUSIfHIn4FfW6udTcc2eZdk2-F_AhcGrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2crksVyhsg%253D%253D&md5=74be82effbcba53a25422ac832e5a8af</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.3322%2Fcaac.21220&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3322%252Fcaac.21220%26sid%3Dliteratum%253Aachs%26aulast%3DSiegel%26aufirst%3DR.%26aulast%3DDesantis%26aufirst%3DC.%26aulast%3DJemal%26aufirst%3DA.%26atitle%3DColorectal%2520cancer%2520statistics%252C%25202014%26jtitle%3DCa-Cancer%2520J.%2520Clin.%26date%3D2014%26volume%3D64%26spage%3D104%26epage%3D117%26doi%3D10.3322%2Fcaac.21220" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chibaudel, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tournigand, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andre, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Gramont, A.</span></span> <span> </span><span class="NLM_article-title">Therapeutic strategy in unresectable metastatic colorectal cancer</span>. <i>Ther. Adv. Med. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">75</span>– <span class="NLM_lpage">89</span>, <span class="refDoi"> DOI: 10.1177/1758834011431592</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=10.1177%2F1758834011431592" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=22423266" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=1%3ACAS%3A528%3ADC%252BC38XlsV2ltLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2012&pages=75-89&author=B.+Chibaudelauthor=C.+Tournigandauthor=T.+Andreauthor=A.+de+Gramont&title=Therapeutic+strategy+in+unresectable+metastatic+colorectal+cancer&doi=10.1177%2F1758834011431592"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic strategy in unresectable metastatic colorectal cancer</span></div><div class="casAuthors">Chibaudel, Benoist; Tournigand, Christophe; Andre, Thierry; de Gramont, Aimery</div><div class="citationInfo"><span class="NLM_cas:title">Therapeutic Advances in Medical Oncology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">75-89</span>CODEN:
                <span class="NLM_cas:coden">TAMOB8</span>;
        ISSN:<span class="NLM_cas:issn">1758-8340</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications Ltd.</span>)
        </div><div class="casAbstract">A review.  While surgery is the cornerstone treatment for early-stage colorectal cancer, chemotherapy is the first treatment option for metastatic disease when tumor lesions are frequently not fully resectable at presentation.  Mortality from colon cancer has decreased over the past 30 years, but there is still a huge heterogeneity in survival rates that can be mainly explained by patient and tumor characteristics, host response factors, and treatment modalities.  The management of unresectable metastatic colorectal cancer is a global treatment strategy, which applies several lines of therapy, salvage surgery, maintenance, and treatment-free intervals.  The individualization of cancer treatment is based on the evaluation of prognostic factors for survival (serum lactate dehydrogenase level, performance status), and predictive factors for treatment efficacy [Kirsten rat sarcoma viral oncogene homolog (KRAS) mutation status].  The available treatment modalities for metastatic colorectal cancer are chemotherapy (fluoropyrimidine, oxaliplatin, irinotecan), anti-angiogenic agents (e.g. bevacizumab), and anti-epidermal growth factor agents (cetuximab, panitumumab).  The increasing no. of active compds. dictates the strategy of trials evaluating these treatments either in combination or sequentially.  Alternative outcomes that can be measured earlier than overall survival are needed to shorten the duration and reduce the size and cost of clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDdZ-yKhZQ4rVg90H21EOLACvtfcHk0li85xG6mfQIFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlsV2ltLw%253D&md5=cb5771a779b8a5389d8794b59531c049</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1177%2F1758834011431592&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1758834011431592%26sid%3Dliteratum%253Aachs%26aulast%3DChibaudel%26aufirst%3DB.%26aulast%3DTournigand%26aufirst%3DC.%26aulast%3DAndre%26aufirst%3DT.%26aulast%3Dde%2BGramont%26aufirst%3DA.%26atitle%3DTherapeutic%2520strategy%2520in%2520unresectable%2520metastatic%2520colorectal%2520cancer%26jtitle%3DTher.%2520Adv.%2520Med.%2520Oncol.%26date%3D2012%26volume%3D4%26spage%3D75%26epage%3D89%26doi%3D10.1177%2F1758834011431592" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gustavsson, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carlsson, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Machover, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petrelli, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmoll, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tveit, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibson, F.</span></span> <span> </span><span class="NLM_article-title">A review of the evolution of systemic chemotherapy in the management of colorectal cancer</span>. <i>Clin. Colorectal Cancer</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">10</span>, <span class="refDoi"> DOI: 10.1016/j.clcc.2014.11.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=10.1016%2Fj.clcc.2014.11.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=25579803" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=1%3ACAS%3A280%3ADC%252BC2MvlsFantA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2015&pages=1-10&author=B.+Gustavssonauthor=G.+Carlssonauthor=D.+Machoverauthor=N.+Petrelliauthor=A.+Rothauthor=H.+J.+Schmollauthor=K.+M.+Tveitauthor=F.+Gibson&title=A+review+of+the+evolution+of+systemic+chemotherapy+in+the+management+of+colorectal+cancer&doi=10.1016%2Fj.clcc.2014.11.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">A review of the evolution of systemic chemotherapy in the management of colorectal cancer</span></div><div class="casAuthors">Gustavsson Bengt; Carlsson Goran; Machover David; Petrelli Nicholas; Roth Arnaud; Schmoll Hans-Joachim; Tveit Kjell-Magne; Gibson Fernando</div><div class="citationInfo"><span class="NLM_cas:title">Clinical colorectal cancer</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-10</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Herein we present a historical review of the development of systemic chemotherapy for colorectal cancer (CRC) in the metastatic and adjuvant treatment settings.  We describe the discovery of 5-fluorouracil (5-FU) by Heidelberger and colleagues in 1957, the potentiation of 5-FU cytotoxicity by the reduced folate leucovorin, and the advent of novel cytotoxic agents, including the topoisomerase I inhibitor irinotecan, the platinum-containing agent oxaliplatin, and the 5-FU prodrug capecitabine.  The combination therapies, FOLFOX (5-FU/leucovorin and oxaliplatin) and FOLFIRI (5-FU/leucovorin and irinotecan), have become established as efficacious cytotoxic regimens for the treatment of metastatic CRC, resulting in overall survival times of approximately 2 years.  When used as adjuvant therapy, FOLFOX also improves survival and is now the gold standard of care in this setting.  Biological agents have been discovered that enhance the effect of cytotoxic therapy, including bevacizumab (a humanized monoclonal antibody that targets vascular endothelial growth factor, a central regulator of angiogenesis) and cetuximab/panitumumab (monoclonal antibodies directed against the epidermal growth factor receptor).  Despite the ongoing development of novel antitumor agents and therapeutic principles as we enter the era of personalized cancer medicine, systemic chemotherapy involving infusional 5-FU/leucovorin continues to be the cornerstone of treatment for patients with CRC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQnb7jb2mUwwLjnyZkbE8yXfW6udTcc2ebZtmVmeYvKY7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MvlsFantA%253D%253D&md5=4d0583247d91277974430ca002021d8a</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.clcc.2014.11.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.clcc.2014.11.002%26sid%3Dliteratum%253Aachs%26aulast%3DGustavsson%26aufirst%3DB.%26aulast%3DCarlsson%26aufirst%3DG.%26aulast%3DMachover%26aufirst%3DD.%26aulast%3DPetrelli%26aufirst%3DN.%26aulast%3DRoth%26aufirst%3DA.%26aulast%3DSchmoll%26aufirst%3DH.%2BJ.%26aulast%3DTveit%26aufirst%3DK.%2BM.%26aulast%3DGibson%26aufirst%3DF.%26atitle%3DA%2520review%2520of%2520the%2520evolution%2520of%2520systemic%2520chemotherapy%2520in%2520the%2520management%2520of%2520colorectal%2520cancer%26jtitle%3DClin.%2520Colorectal%2520Cancer%26date%3D2015%26volume%3D14%26spage%3D1%26epage%3D10%26doi%3D10.1016%2Fj.clcc.2014.11.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Venook, A. P.</span></span> <span> </span><span class="NLM_article-title">Epidermal growth factor receptor-targeted treatment for advanced colorectal carcinoma</span>. <i>Cancer</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>103</i></span>,  <span class="NLM_fpage">2435</span>– <span class="NLM_lpage">2446</span>, <span class="refDoi"> DOI: 10.1002/cncr.21123</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=10.1002%2Fcncr.21123" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=15880563" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlvVCktL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2005&pages=2435-2446&author=A.+P.+Venook&title=Epidermal+growth+factor+receptor-targeted+treatment+for+advanced+colorectal+carcinoma&doi=10.1002%2Fcncr.21123"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Epidermal growth factor receptor-targeted treatment for advanced colorectal carcinoma</span></div><div class="casAuthors">Venook, Alan P.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2435-2446</span>CODEN:
                <span class="NLM_cas:coden">CANCAR</span>;
        ISSN:<span class="NLM_cas:issn">0008-543X</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  Substantial effort has focused on the development of novel targeted agents for treating patients with late-stage colorectal carcinoma.  These agents are designed specifically to inhibit biochem. processes assocd. with pathogenesis.  Numerous mols. targeting the epidermal growth factor receptor have been investigated as therapeutic agents and appear to herald a shift in the treatment paradigm for colorectal carcinoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptbkdBEYtEgLVg90H21EOLACvtfcHk0liSg8otoAPkBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlvVCktL4%253D&md5=97639c5493a6b77360b58fdc8e952946</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1002%2Fcncr.21123&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcncr.21123%26sid%3Dliteratum%253Aachs%26aulast%3DVenook%26aufirst%3DA.%2BP.%26atitle%3DEpidermal%2520growth%2520factor%2520receptor-targeted%2520treatment%2520for%2520advanced%2520colorectal%2520carcinoma%26jtitle%3DCancer%26date%3D2005%26volume%3D103%26spage%3D2435%26epage%3D2446%26doi%3D10.1002%2Fcncr.21123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, W.</span></span> <span> </span><span class="NLM_article-title">Angiogenesis in metastatic colorectal cancer and the benefits of targeted therapy</span>. <i>J. Hematol. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">63</span>, <span class="refDoi"> DOI: 10.1186/1756-8722-5-63</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=10.1186%2F1756-8722-5-63" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=23057939" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFWqt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2012&pages=63&author=W.+Sun&title=Angiogenesis+in+metastatic+colorectal+cancer+and+the+benefits+of+targeted+therapy&doi=10.1186%2F1756-8722-5-63"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Angiogenesis in metastatic colorectal cancer and the benefits of targeted therapy</span></div><div class="casAuthors">Sun, Weijing</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Hematology & Oncology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">63</span>CODEN:
                <span class="NLM_cas:coden">JHOOAO</span>;
        ISSN:<span class="NLM_cas:issn">1756-8722</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">A review.  The diverse pathways and mols. involved in angiogenesis, the formation of new blood vessels, have been targeted for the treatment of colorectal and other cancers.  Vascular endothelial growth factor (VEGF)-A binding to VEGF receptor (VEGFR)-2 is believed to be the key signaling pathway mediating angiogenesis.  Other VEGF pathways involved in angiogenesis include VEGF-A, VEGF-B, and placental growth factor binding to VEGFR-1, and VEGF-C and VEGF-D binding to VEGFR-2 and VEGFR-3.  VEGF signaling also intersects with other pathways, including angiopoietin/Tie, Notch, hypoxia-inducible factor, and integrin pathways.  The roles of these pathways in tumor angiogenesis and in various human cancers will be explored in this article.  In addn., preclin. and clin. data on bevacizumab, aflibercept (known as ziv-aflibercept in the US), and investigational antiangiogenic agents in development for the treatment of colorectal and other cancers will be reviewed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnzUshgX4HurVg90H21EOLACvtfcHk0liSg8otoAPkBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFWqt7o%253D&md5=28d560d9e2cfdc0fcee38d375d6a0dc4</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1186%2F1756-8722-5-63&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1756-8722-5-63%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DW.%26atitle%3DAngiogenesis%2520in%2520metastatic%2520colorectal%2520cancer%2520and%2520the%2520benefits%2520of%2520targeted%2520therapy%26jtitle%3DJ.%2520Hematol.%2520Oncol.%26date%3D2012%26volume%3D5%26spage%3D63%26doi%3D10.1186%2F1756-8722-5-63" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Muzny, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bainbridge, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, K.</span></span> <span> </span><span class="NLM_article-title">Comprehensive molecular characterization of human colon and rectal cancer</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>487</i></span>,  <span class="NLM_fpage">330</span>– <span class="NLM_lpage">337</span>, <span class="refDoi"> DOI: 10.1038/nature11252</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=10.1038%2Fnature11252" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=22810696" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVKnu7%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=487&publication_year=2012&pages=330-337&author=D.+Muznyauthor=M.+Bainbridgeauthor=K.+Chang&title=Comprehensive+molecular+characterization+of+human+colon+and+rectal+cancer&doi=10.1038%2Fnature11252"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Comprehensive molecular characterization of human colon and rectal cancer</span></div><div class="casAuthors">Muzny, Donna M.; Bainbridge, Matthew N.; Chang, Kyle; Dinh, Huyen H.; Drummond, Jennifer A.; Fowler, Gerald; Kovar, Christie L.; Lewis, Lora R.; Morgan, Margaret B.; Newsham, Irene F.; Reid, Jeffrey G.; Santibanez, Jireh; Shinbrot, Eve; Trevino, Lisa R.; Wu, Yuan-Qing; Wang, Min; Gunaratne, Preethi; Donehower, Lawrence A.; Creighton, Chad J.; Wheeler, David A.; Gibbs, Richard A.; Lawrence, Michael S.; Voet, Douglas; Jing, Rui; Cibulskis, Kristian; Sivachenko, Andrey; Stojanov, Petar; McKenna, Aaron; Lander, Eric S.; Gabriel, Stacey; Getz, Gad; Ding, Li; Fulton, Robert S.; Koboldt, Daniel C.; Wylie, Todd; Walker, Jason; Dooling, David J.; Fulton, Lucinda; Delehaunty, Kim D.; Fronick, Catrina C.; Demeter, Ryan; Mardis, Elaine R.; Wilson, Richard K.; Chu, Andy; Chun, Hye-Jung E.; Mungall, Andrew J.; Pleasance, Erin; Robertson, A. Gordon; Stoll, Dominik; Balasundaram, Miruna; Birol, Inanc; Butterfield, Yaron S. N.; Chuah, Eric; Coope, Robin J. N.; Dhalla, Noreen; Guin, Ranabir; Hirst, Carrie; Hirst, Martin; Holt, Robert A.; Lee, Darlene; Li, Haiyan I.; Mayo, Michael; Moore, Richard A.; Schein, Jacqueline E.; Slobodan, Jared R.; Tam, Angela; Thiessen, Nina; Varhol, Richard; Zeng, Thomas; Zhao, Yongjun; Jones, Steven J. M.; Marra, Marco A.; Bass, Adam J.; Ramos, Alex H.; Saksena, Gordon; Cherniack, Andrew D.; Schumacher, Stephen E.; Tabak, Barbara; Carter, Scott L.; Pho, Nam H.; Nguyen, Huy; Onofrio, Robert C.; Crenshaw, Andrew; Ardlie, Kristin; Beroukhim, Rameen; Winckler, Wendy; Getz, Gad; Meyerson, Matthew; Protopopov, Alexei; Zhang, Juinhua; Hadjipanayis, Angela; Lee, Eunjung; Xi, Ruibin; Yang, Lixing; Ren, Xiaojia; Zhang, Hailei; Sathiamoorthy, Narayanan; Shukla, Sachet; Chen, Peng-Chieh; Haseley, Psalm; Xiao, Yonghong; Lee, Semin; Seidman, Jonathan; Chin, Lynda; Park, Peter J.; Kucherlapati, Raju; Todd Auman, J.; Hoadley, Katherine A.; Du, Ying; Wilkerson, Matthew D.; Shi, Yan; Liquori, Christina; Meng, Shaowu; Li, Ling; Turman, Yidi J.; Topal, Michael D.; Tan, Donghui; Waring, Scot; Buda, Elizabeth; Walsh, Jesse; Jones, Corbin D.; Mieczkowski, Piotr A.; Singh, Darshan; Wu, Junyuan; Gulabani, Anisha; Dolina, Peter; Bodenheimer, Tom; Hoyle, Alan P.; Simons, Janae V.; Soloway, Matthew; Mose, Lisle E.; Jefferys, Stuart R.; Balu, Saianand; O'Connor, Brian D.; Prins, Jan F.; Chiang, Derek Y.; Neil Hayes, D.; Perou, Charles M.; Hinoue, Toshinori; Weisenberger, Daniel J.; Maglinte, Dennis T.; Pan, Fei; Berman, Benjamin P.; Van Den Berg, David J.; Shen, Hui; Triche, Timothy, Jr.; Baylin, Stephen B.; Laird, Peter W.; Getz, Gad; Noble, Michael; Voet, Doug; Saksena, Gordon; Gehlenborg, Nils; Di Cara, Daniel; Zhang, Juinhua; Zhang, Hailei; Wu, Chang-Jiun; Liu, Spring Yingchun; Shukla, Sachet; Lawrence, Michael S.; Zhou, Lihua; Sivachenko, Andrey; Lin, Pei; Stojanov, Petar; Jing, Rui; Park, Richard W.; Nazaire, Marc-Danie; Robinson, Jim; Thorvaldsdottir, Helga; Mesirov, Jill; Park, Peter J.; Chin, Lynda; Thorsson, Vesteinn; Reynolds, Sheila M.; Bernard, Brady; Kreisberg, Richard; Lin, Jake; Iype, Lisa; Bressler, Ryan; Erkkilae, Timo; Gundapuneni, Madhumati; Liu, Yuexin; Norberg, Adam; Robinson, Tom; Yang, Da; Zhang, Wei; Shmulevich, Ilya; de Ronde, Jorma J.; Schultz, Nikolaus; Cerami, Ethan; Ciriello, Giovanni; Goldberg, Arthur P.; Gross, Benjamin; Jacobsen, Anders; Gao, Jianjiong; Kaczkowski, Bogumil; Sinha, Rileen; Arman Aksoy, B.; Antipin, Yevgeniy; Reva, Boris; Shen, Ronglai; Taylor, Barry S.; Chan, Timothy A.; Ladanyi, Marc; Sander, Chris; Akbani, Rehan; Zhang, Nianxiang; Broom, Bradley M.; Casasent, Tod; Unruh, Anna; Wakefield, Chris; Hamilton, Stanley R.; Cason, R. Craig; Baggerly, Keith A.; Weinstein, John N.; Haussler, David; Benz, Christopher C.; Stuart, Joshua M.; Benz, Stephen C.; Zachary Sanborn, J.; Vaske, Charles J.; Zhu, Jingchun; Szeto, Christopher; Scott, Gary K.; Yau, Christina; Ng, Sam; Goldstein, Ted; Ellrott, Kyle; Collisson, Eric; Cozen, Aaron E.; Zerbino, Daniel; Wilks, Christopher; Craft, Brian; Spellman, Paul; Penny, Robert; Shelton, Troy; Hatfield, Martha; Morris, Scott; Yena, Peggy; Shelton, Candace; Sherman, Mark; Paulauskis, Joseph; Gastier-Foster, Julie M.; Bowen, Jay; Ramirez, Nilsa C.; Black, Aaron; Pyatt, Robert; Wise, Lisa; White, Peter; Bertagnolli, Monica; Brown, Jen; Chan, Timothy A.; Chu, Gerald C.; Czerwinski, Christine; Denstman, Fred; Dhir, Rajiv; Doerner, Arnulf; Fuchs, Charles S.; Guillem, Jose G.; Iacocca, Mary; Juhl, Hartmut; Kaufman, Andrew; Kohl, Bernard, III; Le, Xuan Van; Mariano, Maria C.; Medina, Elizabeth N.; Meyers, Michael; Nash, Garrett M.; Paty, Phillip B.; Petrelli, Nicholas; Rabeno, Brenda; Richards, William G.; Solit, David; Swanson, Pat; Temple, Larissa; Tepper, Joel E.; Thorp, Richard; Vakiani, Efsevia; Weiser, Martin R.; Willis, Joseph E.; Witkin, Gary; Zeng, Zhaoshi; Zinner, Michael J.; Zornig, Carsten; Jensen, Mark A.; Sfeir, Robert; Kahn, Ari B.; Chu, Anna L.; Kothiyal, Prachi; Wang, Zhining; Snyder, Eric E.; Pontius, Joan; Pihl, Todd D.; Ayala, Brenda; Backus, Mark; Walton, Jessica; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">487</span>
        (<span class="NLM_cas:issue">7407</span>),
    <span class="NLM_cas:pages">330-337</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">To characterize somatic alterations in colorectal carcinoma, we conducted a genome-scale anal. of 276 samples, analyzing exome sequence, DNA copy no., promoter methylation and mRNA and microRNA expression.  A subset of these samples (97) underwent low-depth-of-coverage whole-genome sequencing.  In total, 16% of colorectal carcinomas were found to be hypermutated: three-quarters of these had the expected high microsatellite instability, usually with hypermethylation and MLH1 silencing, and one-quarter had somatic mismatch-repair gene and polymerase ε (POLE) mutations.  Excluding the hypermutated cancers, colon and rectum cancers were found to have considerably similar patterns of genomic alteration.  Twenty-four genes were significantly mutated, and in addn. to the expected APC, TP53, SMAD4, PIK3CA and KRAS mutations, we found frequent mutations in ARID1A, SOX9 and FAM123B.  Recurrent copy-no. alterations include potentially drug-targetable amplifications of ERBB2 and newly discovered amplification of IGF2.  Recurrent chromosomal translocations include the fusion of NAV2 and WNT pathway member TCF7L1.  Integrative analyses suggest new markers for aggressive colorectal carcinoma and an important role for MYC-directed transcriptional activation and repression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIGEnTdXSes7Vg90H21EOLACvtfcHk0liSg8otoAPkBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVKnu7%252FP&md5=082a16335ddd81779d2cd4c9e6458c75</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnature11252&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature11252%26sid%3Dliteratum%253Aachs%26aulast%3DMuzny%26aufirst%3DD.%26aulast%3DBainbridge%26aufirst%3DM.%26aulast%3DChang%26aufirst%3DK.%26atitle%3DComprehensive%2520molecular%2520characterization%2520of%2520human%2520colon%2520and%2520rectal%2520cancer%26jtitle%3DNature%26date%3D2012%26volume%3D487%26spage%3D330%26epage%3D337%26doi%3D10.1038%2Fnature11252" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Clevers, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nusse, R.</span></span> <span> </span><span class="NLM_article-title">Wnt/beta-catenin signaling and disease</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>149</i></span>,  <span class="NLM_fpage">1192</span>– <span class="NLM_lpage">1205</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2012.05.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=10.1016%2Fj.cell.2012.05.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=22682243" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=1%3ACAS%3A528%3ADC%252BC38XosVaktrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=149&publication_year=2012&pages=1192-1205&author=H.+Cleversauthor=R.+Nusse&title=Wnt%2Fbeta-catenin+signaling+and+disease&doi=10.1016%2Fj.cell.2012.05.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Wnt/β-catenin signaling and disease</span></div><div class="casAuthors">Clevers, Hans; Nusse, Roel</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">149</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1192-1205</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  The WNT signal transduction cascade controls myriad biol. phenomena throughout development and adult life of all animals.  In parallel, aberrant Wnt signaling underlies a wide range of pathologies in humans.  In this Review, we provide an update of the core Wnt/β-catenin signaling pathway, discuss how its various components contribute to disease, and pose outstanding questions to be addressed in the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDPj3TZSiR1rVg90H21EOLACvtfcHk0lgrPxh-_9IoMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XosVaktrg%253D&md5=441540f5c9e168b2a4e657a19bbe31c7</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2012.05.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2012.05.012%26sid%3Dliteratum%253Aachs%26aulast%3DClevers%26aufirst%3DH.%26aulast%3DNusse%26aufirst%3DR.%26atitle%3DWnt%252Fbeta-catenin%2520signaling%2520and%2520disease%26jtitle%3DCell%26date%3D2012%26volume%3D149%26spage%3D1192%26epage%3D1205%26doi%3D10.1016%2Fj.cell.2012.05.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bahrami, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amerizadeh, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">ShahidSales, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khazaei, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghayour-Mobarhan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadeghnia, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maftouh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hassanian, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avan, A.</span></span> <span> </span><span class="NLM_article-title">Therapeutic potential of targeting Wnt/beta-catenin pathway in treatment of colorectal cancer: rational and progress</span>. <i>J. Cell. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>118</i></span>,  <span class="NLM_fpage">1979</span>– <span class="NLM_lpage">1983</span>, <span class="refDoi"> DOI: 10.1002/jcb.25903</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=10.1002%2Fjcb.25903" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=28109136" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmsVejsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2017&pages=1979-1983&author=A.+Bahramiauthor=F.+Amerizadehauthor=S.+ShahidSalesauthor=M.+Khazaeiauthor=M.+Ghayour-Mobarhanauthor=H.+R.+Sadeghniaauthor=M.+Maftouhauthor=S.+M.+Hassanianauthor=A.+Avan&title=Therapeutic+potential+of+targeting+Wnt%2Fbeta-catenin+pathway+in+treatment+of+colorectal+cancer%3A+rational+and+progress&doi=10.1002%2Fjcb.25903"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic Potential of Targeting Wnt/β-Catenin Pathway in Treatment of Colorectal Cancer: Rational and Progress</span></div><div class="casAuthors">Bahrami, Afsane; Amerizadeh, Forouzan; ShahidSales, Soodabeh; Khazaei, Majid; Ghayour-Mobarhan, Majid; Sadeghnia, Hamid Reza; Maftouh, Mina; Hassanian, Seyed Mahdi; Avan, Amir</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cellular Biochemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">118</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1979-1983</span>CODEN:
                <span class="NLM_cas:coden">JCEBD5</span>;
        ISSN:<span class="NLM_cas:issn">0730-2312</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Wnt/β-catenin pathway is one of the main/frequent dysregulated pathways in several tumor types, including colon cancer.  Aberrant activation of this pathway is assocd. with cell proliferation, invasive behaviors, and cell resistance, suggesting its potential value as a therapeutic target in treatment of CRC.  Several agents have been developed for targeting of this pathway (e.g, natural agents: curcumin, 3,3-diindolylmethane, phytoestrogen; Synthetic/small Wnt inhibitors: Rofecoxib; PRI-724, CWP232291; and monoclonal antibody against frizzled receptors, Vanituctumab).  This review summarizes the current knowledge about the therapeutic potential of targeting Wnt pathway with particular emphasis on preclin./clin. studies in treatment of colorectal cancer.  J. Cell. Biochem. 9999: 1-5, 2017. © 2017 Wiley Periodicals, Inc.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDz4pOeyoB8LVg90H21EOLACvtfcHk0lgrPxh-_9IoMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmsVejsrY%253D&md5=f1a22336b05c41bbacef61389a34b679</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1002%2Fjcb.25903&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcb.25903%26sid%3Dliteratum%253Aachs%26aulast%3DBahrami%26aufirst%3DA.%26aulast%3DAmerizadeh%26aufirst%3DF.%26aulast%3DShahidSales%26aufirst%3DS.%26aulast%3DKhazaei%26aufirst%3DM.%26aulast%3DGhayour-Mobarhan%26aufirst%3DM.%26aulast%3DSadeghnia%26aufirst%3DH.%2BR.%26aulast%3DMaftouh%26aufirst%3DM.%26aulast%3DHassanian%26aufirst%3DS.%2BM.%26aulast%3DAvan%26aufirst%3DA.%26atitle%3DTherapeutic%2520potential%2520of%2520targeting%2520Wnt%252Fbeta-catenin%2520pathway%2520in%2520treatment%2520of%2520colorectal%2520cancer%253A%2520rational%2520and%2520progress%26jtitle%3DJ.%2520Cell.%2520Biochem.%26date%3D2017%26volume%3D118%26spage%3D1979%26epage%3D1983%26doi%3D10.1002%2Fjcb.25903" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farr, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopes, F. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Raay, T. J.</span></span> <span> </span><span class="NLM_article-title">Wnt drug discovery: weaving through the screens, patents and clinical trials</span>. <i>Cancers</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">82</span>, <span class="refDoi"> DOI: 10.3390/cancers8090082</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=10.3390%2Fcancers8090082" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=1%3ACAS%3A528%3ADC%252BC1cXoslamt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2016&pages=82&author=B.+Luauthor=B.+A.+Greenauthor=J.+M.+Farrauthor=F.+C.+Lopesauthor=T.+J.+Van+Raay&title=Wnt+drug+discovery%3A+weaving+through+the+screens%2C+patents+and+clinical+trials&doi=10.3390%2Fcancers8090082"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Wnt drug discovery: weaving through the screens, patents and clinical trials</span></div><div class="casAuthors">Lu, Benjamin; Green, Brooke A.; Farr, Jacqueline M.; Lopes, Flavia C. M.; Van Raay, Terence J.</div><div class="citationInfo"><span class="NLM_cas:title">Cancers</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">82/1-82/15</span>CODEN:
                <span class="NLM_cas:coden">CANCCT</span>;
        ISSN:<span class="NLM_cas:issn">2072-6694</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">The Wnt signaling pathway is intricately involved in many aspects of development and is the root cause of an increasing no. of diseases.  For example, colorectal cancer is the second leading cause of death in the industrialized world and aberration of Wnt signaling within the colonic stem cell is the cause of more than 90% of these cancers.  Despite our advances in successfully targeting other pathways, such as Human Epidermal Growth Factor Receptor 2 (HER2), there are no clin. relevant therapies available for Wnt-related diseases.  Here, we investigated where research activities are focused with respect to Wnt signaling modulators by searching the United States Patent and Trade Office (USPTO) for patents and patent applications related to Wnt modulators and compared this to clin. trials focusing on Wnt modulation.  We found that while the transition of intellectual property surrounding the Wnt ligand-receptor interface to clin. trials is robust, this is not true for specific inhibitors of β-catenin, which is constitutively active in many cancers.  Considering the ubiquitous use of the synthetic T-cell Factor/Lymphoid Enhancer Factor (TCF/Lef) reporter system and its success in identifying novel modulators in vitro, we speculate that this model of drug discovery does not capture the complexity of in vivo Wnt signaling that may be required if we are to successfully target the Wnt pathway in the clinic.  Notwithstanding, increasingly more complex models are being developed, which may not be high throughput, but more pragmatic in our pursuit to control Wnt signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1HKmzswkzsLVg90H21EOLACvtfcHk0lipI5vuP41iMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXoslamt7w%253D&md5=bccbdd5dd4138747c9ea2226871151c5</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.3390%2Fcancers8090082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fcancers8090082%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DB.%26aulast%3DGreen%26aufirst%3DB.%2BA.%26aulast%3DFarr%26aufirst%3DJ.%2BM.%26aulast%3DLopes%26aufirst%3DF.%2BC.%26aulast%3DVan%2BRaay%26aufirst%3DT.%2BJ.%26atitle%3DWnt%2520drug%2520discovery%253A%2520weaving%2520through%2520the%2520screens%252C%2520patents%2520and%2520clinical%2520trials%26jtitle%3DCancers%26date%3D2016%26volume%3D8%26spage%3D82%26doi%3D10.3390%2Fcancers8090082" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, J.</span></span> <span> </span><span class="NLM_article-title">Development of anticancer agents targeting the Wnt/beta-catenin signaling</span>. <i>Am. J. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">2344</span>– <span class="NLM_lpage">2360</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=26396911" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=1%3ACAS%3A528%3ADC%252BC1cXls1KjsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=2344-2360&author=X.+Zhangauthor=J.+Hao&title=Development+of+anticancer+agents+targeting+the+Wnt%2Fbeta-catenin+signaling"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Development of anticancer agents targeting the Wnt/β-catenin signaling</span></div><div class="casAuthors">Zhang, Xiangqian; Hao, Jijun</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Cancer Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2344-2360</span>CODEN:
                <span class="NLM_cas:coden">AJCRFT</span>;
        ISSN:<span class="NLM_cas:issn">2156-6976</span>.
    
            (<span class="NLM_cas:orgname">e-Century Publishing Corp.</span>)
        </div><div class="casAbstract">Wnt/β-catenin signaling plays indispensable roles in both embryonic development and adult homeostasis.  Abnormal regulation of this pathway is implicated in many types of cancer.  Consequently, substantial efforts have made to develop therapeutic agents as anticancer drugs by specifically targeting the Wnt/β-catenin pathway.  Here we systematically review the potential therapeutic agents that have been developed to date for inhibition of the Wnt/β-catenin cascade as well as current status of clin. trials of some of these agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozJYSqo-TjeLVg90H21EOLACvtfcHk0lipI5vuP41iMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXls1KjsL0%253D&md5=a23ae5ff959b5666c014b59bfd11fa3e</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DHao%26aufirst%3DJ.%26atitle%3DDevelopment%2520of%2520anticancer%2520agents%2520targeting%2520the%2520Wnt%252Fbeta-catenin%2520signaling%26jtitle%3DAm.%2520J.%2520Cancer%2520Res.%26date%3D2015%26volume%3D5%26spage%3D2344%26epage%3D2360" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lenz, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kahn, M.</span></span> <span> </span><span class="NLM_article-title">Safely targeting cancer stem cells via selective catenin coactivator antagonism</span>. <i>Cancer Sci.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>105</i></span>,  <span class="NLM_fpage">1087</span>– <span class="NLM_lpage">1092</span>, <span class="refDoi"> DOI: 10.1111/cas.12471</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=10.1111%2Fcas.12471" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=24975284" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFymu7rN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2014&pages=1087-1092&author=H.+J.+Lenzauthor=M.+Kahn&title=Safely+targeting+cancer+stem+cells+via+selective+catenin+coactivator+antagonism&doi=10.1111%2Fcas.12471"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Safely targeting cancer stem cells via selective catenin coactivator antagonism</span></div><div class="casAuthors">Lenz, Heinz-Josef; Kahn, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Science</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1087-1092</span>CODEN:
                <span class="NLM_cas:coden">CSACCM</span>;
        ISSN:<span class="NLM_cas:issn">1349-7006</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Throughout our life, long-lived somatic stem cells (SSC) regenerate adult tissues both during homeostatic processes and repair after injury.  The role of aberrant regulation of SSC has also recently gained prominence in the field of cancer research.  Following malignant transformation, so termed cancer stem cells (CSC), endowed with the same properties as SSC (i.e. the ability to both self-renew and generate differentiated progenitors), play a major part in tumor initiation, therapy resistance and ultimately relapse.  The same signaling pathways involved in regulating SSC maintenance are involved in the regulation of CSC.  CSC exist in a wide array of tumor types, including leukemias, and brain, breast, prostate and colon tumors.  Consequently, one of the key goals in cancer research over the past decade has been to develop therapeutic strategies to safely eliminate the CSC population without damaging the endogenous SSC population.  A major hurdle to this goal lies in the identification of the key mechanisms that distinguish CSC from the normal endogenous tissue stem cells.  This review will discuss the discovery of the specific CBP/catenin antagonist ICG-001 and the ongoing clin. development of the second generation CBP/catenin antagonist PRI-724.  Importantly, specific CBP/catenin antagonists appear to have the ability to safely eliminate CSC by taking advantage of an intrinsic differential preference in the way SSC and CSC divide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpb-k-p-7uTHrVg90H21EOLACvtfcHk0lipI5vuP41iMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFymu7rN&md5=dc580aeb47d1aeb8d95b1c02f428fca8</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1111%2Fcas.12471&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcas.12471%26sid%3Dliteratum%253Aachs%26aulast%3DLenz%26aufirst%3DH.%2BJ.%26aulast%3DKahn%26aufirst%3DM.%26atitle%3DSafely%2520targeting%2520cancer%2520stem%2520cells%2520via%2520selective%2520catenin%2520coactivator%2520antagonism%26jtitle%3DCancer%2520Sci.%26date%3D2014%26volume%3D105%26spage%3D1087%26epage%3D1092%26doi%3D10.1111%2Fcas.12471" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Blagodatski, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poteryaev, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katanaev, V. L.</span></span> <span> </span><span class="NLM_article-title">Targeting the Wnt pathways for therapies</span>. <i>Mol. Cell. Thera.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">28</span>, <span class="refDoi"> DOI: 10.1186/2052-8426-2-28</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=10.1186%2F2052-8426-2-28" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=26056595" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2014&pages=28&author=A.+Blagodatskiauthor=D.+Poteryaevauthor=V.+L.+Katanaev&title=Targeting+the+Wnt+pathways+for+therapies&doi=10.1186%2F2052-8426-2-28"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1186%2F2052-8426-2-28&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F2052-8426-2-28%26sid%3Dliteratum%253Aachs%26aulast%3DBlagodatski%26aufirst%3DA.%26aulast%3DPoteryaev%26aufirst%3DD.%26aulast%3DKatanaev%26aufirst%3DV.%2BL.%26atitle%3DTargeting%2520the%2520Wnt%2520pathways%2520for%2520therapies%26jtitle%3DMol.%2520Cell.%2520Thera.%26date%3D2014%26volume%3D2%26spage%3D28%26doi%3D10.1186%2F2052-8426-2-28" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsieh, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasibhatla, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuller, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tompkins, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pferdekamper, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steffy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kowal, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phung, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flynn, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brenner, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villarroel, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schultz, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNamara, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sellers, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petruzzelli, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boral, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seidel, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLaughlin, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Che, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carey, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanasse, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, J. L.</span></span> <span> </span><span class="NLM_article-title">Targeting Wnt-driven cancer through the inhibition of porcupine by LGK974</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>110</i></span>,  <span class="NLM_fpage">20224</span>– <span class="NLM_lpage">20229</span>, <span class="refDoi"> DOI: 10.1073/pnas.1314239110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=10.1073%2Fpnas.1314239110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=24277854" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFKmsL%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=20224-20229&author=J.+Liuauthor=S.+Panauthor=M.+H.+Hsiehauthor=N.+Ngauthor=F.+Sunauthor=T.+Wangauthor=S.+Kasibhatlaauthor=A.+G.+Schullerauthor=A.+G.+Liauthor=D.+Chengauthor=J.+Liauthor=C.+Tompkinsauthor=A.+Pferdekamperauthor=A.+Steffyauthor=J.+Chengauthor=C.+Kowalauthor=V.+Phungauthor=G.+Guoauthor=Y.+Wangauthor=M.+P.+Grahamauthor=S.+Flynnauthor=J.+C.+Brennerauthor=C.+Liauthor=M.+C.+Villarroelauthor=P.+G.+Schultzauthor=X.+Wuauthor=P.+McNamaraauthor=W.+R.+Sellersauthor=L.+Petruzzelliauthor=A.+L.+Boralauthor=H.+M.+Seidelauthor=M.+E.+McLaughlinauthor=J.+Cheauthor=T.+E.+Careyauthor=G.+Vanasseauthor=J.+L.+Harris&title=Targeting+Wnt-driven+cancer+through+the+inhibition+of+porcupine+by+LGK974&doi=10.1073%2Fpnas.1314239110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Wnt-driven cancer through the inhibition of Porcupine by LGK974</span></div><div class="casAuthors">Liu, Jun; Pan, Shifeng; Hsieh, Mindy H.; Ng, Nicholas; Sun, Fangxian; Wang, Tao; Kasibhatla, Shailaja; Schuller, Alwin G.; Li, Allen G.; Cheng, Dai; Li, Jie; Tompkins, Celin; Pferdekamper, Anne Marie; Steffy, Auzon; Cheng, Jane; Kowal, Colleen; Phung, Van; Guo, Guirong; Wang, Yan; Graham, Martin P.; Flynn, Shannon; Brenner, J. Chad; Li, Chun; Villarroel, M. Cristina; Schultz, Peter G.; Wu, Xu; McNamara, Peter; Sellers, William R.; Petruzzelli, Lilli; Boral, Anthony L.; Seidel, H. Martin; McLaughlin, Margaret E.; Che, Jianwei; Carey, Thomas E.; Vanasse, Gary; Harris, Jennifer L.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">50</span>),
    <span class="NLM_cas:pages">20224-20229,S20224/1-S20224/10</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Wnt signaling is one of the key oncogenic pathways in multiple cancers, and targeting this pathway is an attractive therapeutic approach.  However, therapeutic success was limited because of the lack of therapeutic agents for targets in the Wnt pathway and the lack of a defined patient population that would be sensitive to a Wnt inhibitor.  We developed a screen for small mols. that block Wnt secretion.  This effort led to the discovery of LGK974, a potent and specific small-mol. Porcupine (PORCN) inhibitor.  PORCN is a membrane-bound O-acyltransferase that is required for and dedicated to palmitoylation of Wnt ligands, a necessary step in the processing of Wnt ligand secretion.  We show that LGK974 potently inhibits Wnt signaling in vitro and in vivo, including redn. of the Wnt-dependent LRP6 phosphorylation and the expression of Wnt target genes, such as AXIN2.  LGK974 is potent and efficacious in multiple tumor models at well-tolerated doses in vivo, including murine and rat mechanistic breast cancer models driven by MMTV-Wnt1 and a human head and neck squamous cell carcinoma model (HN30).  We also show that head and neck cancer cell lines with loss-of-function mutations in the Notch signaling pathway have a high response rate to LGK974.  Together, these findings provide both a strategy and tools for targeting Wnt-driven cancers through the inhibition of PORCN.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAJMitDc62tbVg90H21EOLACvtfcHk0lh3CB-hp4GFhg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFKmsL%252FL&md5=5fac5db1bd762356350f11706f1a70ae</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1314239110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1314239110%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DPan%26aufirst%3DS.%26aulast%3DHsieh%26aufirst%3DM.%2BH.%26aulast%3DNg%26aufirst%3DN.%26aulast%3DSun%26aufirst%3DF.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DKasibhatla%26aufirst%3DS.%26aulast%3DSchuller%26aufirst%3DA.%2BG.%26aulast%3DLi%26aufirst%3DA.%2BG.%26aulast%3DCheng%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DTompkins%26aufirst%3DC.%26aulast%3DPferdekamper%26aufirst%3DA.%26aulast%3DSteffy%26aufirst%3DA.%26aulast%3DCheng%26aufirst%3DJ.%26aulast%3DKowal%26aufirst%3DC.%26aulast%3DPhung%26aufirst%3DV.%26aulast%3DGuo%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DGraham%26aufirst%3DM.%2BP.%26aulast%3DFlynn%26aufirst%3DS.%26aulast%3DBrenner%26aufirst%3DJ.%2BC.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DVillarroel%26aufirst%3DM.%2BC.%26aulast%3DSchultz%26aufirst%3DP.%2BG.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DMcNamara%26aufirst%3DP.%26aulast%3DSellers%26aufirst%3DW.%2BR.%26aulast%3DPetruzzelli%26aufirst%3DL.%26aulast%3DBoral%26aufirst%3DA.%2BL.%26aulast%3DSeidel%26aufirst%3DH.%2BM.%26aulast%3DMcLaughlin%26aufirst%3DM.%2BE.%26aulast%3DChe%26aufirst%3DJ.%26aulast%3DCarey%26aufirst%3DT.%2BE.%26aulast%3DVanasse%26aufirst%3DG.%26aulast%3DHarris%26aufirst%3DJ.%2BL.%26atitle%3DTargeting%2520Wnt-driven%2520cancer%2520through%2520the%2520inhibition%2520of%2520porcupine%2520by%2520LGK974%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2013%26volume%3D110%26spage%3D20224%26epage%3D20229%26doi%3D10.1073%2Fpnas.1314239110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsieh, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasibhatla, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tompkins, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steffy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seidel, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, S.</span></span> <span> </span><span class="NLM_article-title">Discovery of pyridinyl acetamide derivatives as potent, selective, and orally bioavailable porcupine inhibitors</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">676</span>– <span class="NLM_lpage">680</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.6b00038</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.6b00038" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=1%3ACAS%3A528%3ADC%252BC28XnsFWitb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=676-680&author=D.+Chengauthor=J.+Liuauthor=D.+Hanauthor=G.+Zhangauthor=W.+Gaoauthor=M.+H.+Hsiehauthor=N.+Ngauthor=S.+Kasibhatlaauthor=C.+Tompkinsauthor=J.+Liauthor=A.+Steffyauthor=F.+Sunauthor=C.+Liauthor=H.+M.+Seidelauthor=J.+L.+Harrisauthor=S.+Pan&title=Discovery+of+pyridinyl+acetamide+derivatives+as+potent%2C+selective%2C+and+orally+bioavailable+porcupine+inhibitors&doi=10.1021%2Facsmedchemlett.6b00038"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Pyridinyl Acetamide Derivatives as Potent, Selective, and Orally Bioavailable Porcupine Inhibitors</span></div><div class="casAuthors">Cheng, Dai; Liu, Jun; Han, Dong; Zhang, Guobao; Gao, Wenqi; Hsieh, Mindy H.; Ng, Nicholas; Kasibhatla, Shailaja; Tompkins, Celin; Li, Jie; Steffy, Auzon; Sun, Fangxian; Li, Chun; Seidel, H. Martin; Harris, Jennifer L.; Pan, Shifeng</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">676-680</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Blockade of aberrant Wnt signaling is an attractive therapeutic approach in multiple cancers.  We developed and performed a cellular high-throughput screen for inhibitors of Wnt secretion and pathway activation.  A lead structure (GNF-1331) was identified from the screen.  Further studies identified the mol. target of GNF-1331 as Porcupine, a membrane bound O-acyl transferase.  Structure-activity relationship studies led to the discovery of a novel series of potent and selective Porcupine inhibitors.  Compd. 19, GNF-6231, demonstrated excellent pathway inhibition and induced robust antitumor efficacy in a mouse MMTV-WNT1 xenograft tumor model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPGZaZIx4MI7Vg90H21EOLACvtfcHk0ljRzDxAQl2jEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XnsFWitb8%253D&md5=b4634dbc71bdfade7e5a71de96b37e2b</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.6b00038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.6b00038%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DHan%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DG.%26aulast%3DGao%26aufirst%3DW.%26aulast%3DHsieh%26aufirst%3DM.%2BH.%26aulast%3DNg%26aufirst%3DN.%26aulast%3DKasibhatla%26aufirst%3DS.%26aulast%3DTompkins%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DSteffy%26aufirst%3DA.%26aulast%3DSun%26aufirst%3DF.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DSeidel%26aufirst%3DH.%2BM.%26aulast%3DHarris%26aufirst%3DJ.%2BL.%26aulast%3DPan%26aufirst%3DS.%26atitle%3DDiscovery%2520of%2520pyridinyl%2520acetamide%2520derivatives%2520as%2520potent%252C%2520selective%252C%2520and%2520orally%2520bioavailable%2520porcupine%2520inhibitors%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26spage%3D676%26epage%3D680%26doi%3D10.1021%2Facsmedchemlett.6b00038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dodge, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, C.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kilgore, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amatruda, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lum, L.</span></span> <span> </span><span class="NLM_article-title">Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">100</span>– <span class="NLM_lpage">107</span>, <span class="refDoi"> DOI: 10.1038/nchembio.137</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=10.1038%2Fnchembio.137" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=19125156" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlWjtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&pages=100-107&author=B.+Chenauthor=M.+E.+Dodgeauthor=W.+Tangauthor=J.+Luauthor=Z.+Maauthor=C.-W.+Fanauthor=S.+Weiauthor=W.+Haoauthor=J.+Kilgoreauthor=N.+S.+Williamsauthor=M.+G.+Rothauthor=J.+F.+Amatrudaauthor=C.+Chenauthor=L.+Lum&title=Small+molecule-mediated+disruption+of+Wnt-dependent+signaling+in+tissue+regeneration+and+cancer&doi=10.1038%2Fnchembio.137"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer</span></div><div class="casAuthors">Chen, Baozhi; Dodge, Michael E.; Tang, Wei; Lu, Jianming; Ma, Zhiqiang; Fan, Chih-Wei; Wei, Shuguang; Hao, Wayne; Kilgore, Jessica; Williams, Noelle S.; Roth, Michael G.; Amatruda, James F.; Chen, Chuo; Lum, Lawrence</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">100-107</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The pervasive influence of secreted Wnt signaling proteins in tissue homeostasis and tumorigenesis has galvanized efforts to identify small mols. that target Wnt-mediated cellular responses.  By screening a diverse synthetic chem. library, we have discovered two new classes of small mols. that disrupt Wnt pathway responses; whereas one class inhibits the activity of Porcupine, a membrane-bound acyltransferase that is essential to the prodn. of Wnt proteins, the other abrogates destruction of Axin proteins, which are suppressors of Wnt/β-catenin pathway activity.  With these small mols., we establish a chem. genetic approach for studying Wnt pathway responses and stem cell function in adult tissue.  We achieve transient, reversible suppression of Wnt/β-catenin pathway response in vivo, and we establish a mechanism-based approach to target cancerous cell growth.  The signal transduction mechanisms shown here to be chem. tractable addnl. contribute to Wnt-independent signal transduction pathways and thus could be broadly exploited for chem. genetics and therapeutic goals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAMJCu3QDiYrVg90H21EOLACvtfcHk0lgUHQT9He0Iyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlWjtw%253D%253D&md5=32516a31ce8f691b654ee33c0df83bc5</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.137&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.137%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DB.%26aulast%3DDodge%26aufirst%3DM.%2BE.%26aulast%3DTang%26aufirst%3DW.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DMa%26aufirst%3DZ.%26aulast%3DFan%26aufirst%3DC.-W.%26aulast%3DWei%26aufirst%3DS.%26aulast%3DHao%26aufirst%3DW.%26aulast%3DKilgore%26aufirst%3DJ.%26aulast%3DWilliams%26aufirst%3DN.%2BS.%26aulast%3DRoth%26aufirst%3DM.%2BG.%26aulast%3DAmatruda%26aufirst%3DJ.%2BF.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DLum%26aufirst%3DL.%26atitle%3DSmall%2520molecule-mediated%2520disruption%2520of%2520Wnt-dependent%2520signaling%2520in%2520tissue%2520regeneration%2520and%2520cancer%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2009%26volume%3D5%26spage%3D100%26epage%3D107%26doi%3D10.1038%2Fnchembio.137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lepourcelet, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">France, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crews, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petersen, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruseo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shivdasani, R. A.</span></span> <span> </span><span class="NLM_article-title">Small-molecule antagonists of the oncogenic Tcf/beta-catenin protein complex</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">91</span>– <span class="NLM_lpage">102</span>, <span class="refDoi"> DOI: 10.1016/S1535-6108(03)00334-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=10.1016%2FS1535-6108%2803%2900334-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=14749129" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtFGrsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2004&pages=91-102&author=M.+Lepourceletauthor=Y.+N.+Chenauthor=D.+S.+Franceauthor=H.+Wangauthor=P.+Crewsauthor=F.+Petersenauthor=C.+Bruseoauthor=A.+W.+Woodauthor=R.+A.+Shivdasani&title=Small-molecule+antagonists+of+the+oncogenic+Tcf%2Fbeta-catenin+protein+complex&doi=10.1016%2FS1535-6108%2803%2900334-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecule antagonists of the oncogenic Tcf/β-catenin protein complex</span></div><div class="casAuthors">Lepourcelet, Maina; Chen, Ying-Nan P.; France, Dennis S.; Wang, Huisheng; Crews, Phillip; Petersen, Frank; Bruseo, Charles; Wood, Alexander W.; Shivdasani, Ramesh A.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">91-102</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Key mol. lesions in colorectal and other cancers cause β-catenin-dependent transactivation of T cell factor (Tcf)-dependent genes.  Disruption of this signal represents an opportunity for rational cancer therapy.  To identify compds. that inhibit assocn. between Tcf4 and β-catenin, we screened libraries of natural compds. in a high-throughput assay for immunoenzymic detection of the protein-protein interaction.  Selected compds. disrupt Tcf/β-catenin complexes in several independent in vitro assays and potently antagonize cellular effects of β-catenin-dependent activities, including reporter gene activation, c-myc or cyclin D1 expression, cell proliferation, and duplication of the Xenopus embryonic dorsal axis.  These compds. thus meet predicted criteria for disrupting Tcf/β-catenin complexes and define a general std. to establish mechanism-based activity of small mol. inhibitors of this pathogenic protein-protein interaction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGHpdE0U0vA7Vg90H21EOLACvtfcHk0lgUHQT9He0Iyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtFGrsbw%253D&md5=ddf90ca6f63e3d11421138f5e2bccc17</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2FS1535-6108%2803%2900334-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1535-6108%252803%252900334-9%26sid%3Dliteratum%253Aachs%26aulast%3DLepourcelet%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DY.%2BN.%26aulast%3DFrance%26aufirst%3DD.%2BS.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DCrews%26aufirst%3DP.%26aulast%3DPetersen%26aufirst%3DF.%26aulast%3DBruseo%26aufirst%3DC.%26aulast%3DWood%26aufirst%3DA.%2BW.%26aulast%3DShivdasani%26aufirst%3DR.%2BA.%26atitle%3DSmall-molecule%2520antagonists%2520of%2520the%2520oncogenic%2520Tcf%252Fbeta-catenin%2520protein%2520complex%26jtitle%3DCancer%2520Cell%26date%3D2004%26volume%3D5%26spage%3D91%26epage%3D102%26doi%3D10.1016%2FS1535-6108%2803%2900334-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gonsalves, F. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klein, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carson, B. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ekas, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagourney, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cardozo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DasGupta, R.</span></span> <span> </span><span class="NLM_article-title">An RNAi-based chemical genetic screen identifies three small-molecule inhibitors of the Wnt/wingless signaling pathway</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>108</i></span>,  <span class="NLM_fpage">5954</span>– <span class="NLM_lpage">5963</span>, <span class="refDoi"> DOI: 10.1073/pnas.1017496108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=10.1073%2Fpnas.1017496108" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=21393571" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=1%3ACAS%3A528%3ADC%252BC3MXltVymt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2011&pages=5954-5963&author=F.+C.+Gonsalvesauthor=K.+Kleinauthor=B.+B.+Carsonauthor=S.+Katzauthor=L.+A.+Ekasauthor=S.+Evansauthor=R.+Nagourneyauthor=T.+Cardozoauthor=A.+M.+Brownauthor=R.+DasGupta&title=An+RNAi-based+chemical+genetic+screen+identifies+three+small-molecule+inhibitors+of+the+Wnt%2Fwingless+signaling+pathway&doi=10.1073%2Fpnas.1017496108"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">An RNAi-based chemical genetic screen identifies three small-molecule inhibitors of the Wnt/wingless signaling pathway</span></div><div class="casAuthors">Gonsalves, Foster C.; Klein, Keren; Carson, Brittany B.; Katz, Shauna; Ekas, Laura A.; Evans, Steve; Nagourney, Robert; Cardozo, Timothy; Brown, Anthony M. C.; Das Gupta, Ramanuj</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">5954-5963, S5954/1-S5954/9</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Misregulated β-catenin responsive transcription (CRT) has been implicated in the genesis of various malignancies, including colorectal carcinomas, and it is a key therapeutic target in combating various cancers.  Despite significant effort, successful clin. implementation of CRT inhibitory therapeutics remains a challenging goal.  This is, in part, because of the challenge of identifying inhibitory compds. that specifically modulate the nuclear transcriptional activity of β-catenin while not affecting its cytoskeletal function in stabilizing adherens junctions at the cell membrane.  Here, we report an RNAi-based modifier screening strategy for the identification of CRT inhibitors.  Our data provide support for the specificity of these inhibitory compds. in antagonizing the transcriptional function of nuclear β-catenin.  We show that these inhibitors efficiently block Wnt/β-catenin-induced target genes and phenotypes in various mammalian and cancer cell lines.  Importantly, these Wnt inhibitors are specifically cytotoxic to human colon tumor biopsy cultures as well as colon cancer cell lines that exhibit deregulated Wnt signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr94ZMZYTd807Vg90H21EOLACvtfcHk0ljWIwKKcDdRsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXltVymt70%253D&md5=566aa3c22ccee9ae88aeda4e523699db</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1017496108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1017496108%26sid%3Dliteratum%253Aachs%26aulast%3DGonsalves%26aufirst%3DF.%2BC.%26aulast%3DKlein%26aufirst%3DK.%26aulast%3DCarson%26aufirst%3DB.%2BB.%26aulast%3DKatz%26aufirst%3DS.%26aulast%3DEkas%26aufirst%3DL.%2BA.%26aulast%3DEvans%26aufirst%3DS.%26aulast%3DNagourney%26aufirst%3DR.%26aulast%3DCardozo%26aufirst%3DT.%26aulast%3DBrown%26aufirst%3DA.%2BM.%26aulast%3DDasGupta%26aufirst%3DR.%26atitle%3DAn%2520RNAi-based%2520chemical%2520genetic%2520screen%2520identifies%2520three%2520small-molecule%2520inhibitors%2520of%2520the%2520Wnt%252Fwingless%2520signaling%2520pathway%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2011%26volume%3D108%26spage%3D5954%26epage%3D5963%26doi%3D10.1073%2Fpnas.1017496108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Emami, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeong, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eguchi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moon, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teo, J.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oh, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moon, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ha, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kahn, M.</span></span> <span> </span><span class="NLM_article-title">A small molecule inhibitor of beta-catenin/CREB-binding protein transcription [corrected]</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>101</i></span>,  <span class="NLM_fpage">12682</span>– <span class="NLM_lpage">12687</span>, <span class="refDoi"> DOI: 10.1073/pnas.0404875101</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=10.1073%2Fpnas.0404875101" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=15314234" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnsVent70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2004&pages=12682-12687&author=K.+H.+Emamiauthor=C.+Nguyenauthor=H.+Maauthor=D.+H.+Kimauthor=K.+W.+Jeongauthor=M.+Eguchiauthor=R.+T.+Moonauthor=J.-L.+Teoauthor=S.+W.+Ohauthor=H.+Y.+Kimauthor=S.+H.+Moonauthor=J.+R.+Haauthor=M.+Kahn&title=A+small+molecule+inhibitor+of+beta-catenin%2FCREB-binding+protein+transcription+%5Bcorrected%5D&doi=10.1073%2Fpnas.0404875101"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">A small molecule inhibitor of β-catenin/cyclic AMP response element-binding protein transcription</span></div><div class="casAuthors">Emami, Katayoon H.; Nguyen, Cu; Ma, Hong; Kim, Dae Hoon; Jeong, Kwang Won; Eguchi, Masakatsu; Moon, Randall T.; Teo, Jia-Ling; Oh, Se Wong; Kim, Hak Yeop; Moon, Sung Hwan; Ha, Jong Ryul; Kahn, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">34</span>),
    <span class="NLM_cas:pages">12682-12687</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Inherited and somatic mutations in the adenomatous polyposis coli occur in most colon cancers, leading to activation of β-catenin-responsive genes.  To identify small mol. antagonists of this pathway, the authors challenged transformed colorectal cells with a secondary structure-templated chem. library, looking for compds. that inhibit a β-catenin-responsive reporter.  The authors identified ICG-001, a small mol. that down-regulates β-catenin/T cell factor signaling by specifically binding to cAMP response element-binding protein.  ICG-001 selectively induces apoptosis in transformed cells but not in normal colon cells, reduces in vitro growth of colon carcinoma cells, and is efficacious in the Min mouse and nude mouse xenograft models of colon cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGok6tlzXLGU-rVg90H21EOLACvtfcHk0ljWIwKKcDdRsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnsVent70%253D&md5=51d20409871c490734e66d23987348ee</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0404875101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0404875101%26sid%3Dliteratum%253Aachs%26aulast%3DEmami%26aufirst%3DK.%2BH.%26aulast%3DNguyen%26aufirst%3DC.%26aulast%3DMa%26aufirst%3DH.%26aulast%3DKim%26aufirst%3DD.%2BH.%26aulast%3DJeong%26aufirst%3DK.%2BW.%26aulast%3DEguchi%26aufirst%3DM.%26aulast%3DMoon%26aufirst%3DR.%2BT.%26aulast%3DTeo%26aufirst%3DJ.-L.%26aulast%3DOh%26aufirst%3DS.%2BW.%26aulast%3DKim%26aufirst%3DH.%2BY.%26aulast%3DMoon%26aufirst%3DS.%2BH.%26aulast%3DHa%26aufirst%3DJ.%2BR.%26aulast%3DKahn%26aufirst%3DM.%26atitle%3DA%2520small%2520molecule%2520inhibitor%2520of%2520beta-catenin%252FCREB-binding%2520protein%2520transcription%2520%255Bcorrected%255D%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2004%26volume%3D101%26spage%3D12682%26epage%3D12687%26doi%3D10.1073%2Fpnas.0404875101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mishina, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheung, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stegmeier, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michaud, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charlat, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiellette, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiessner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hild, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mickanin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Myer, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fazal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomlinson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serluca, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shultz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schirle, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlegl, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghidelli, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fawell, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curtis, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirschner, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lengauer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finan, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tallarico, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouwmeester, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porter, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cong, F.</span></span> <span> </span><span class="NLM_article-title">Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>461</i></span>,  <span class="NLM_fpage">614</span>– <span class="NLM_lpage">620</span>, <span class="refDoi"> DOI: 10.1038/nature08356</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=10.1038%2Fnature08356" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=19759537" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFentbzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=461&publication_year=2009&pages=614-620&author=S.+M.+Huangauthor=Y.+M.+Mishinaauthor=S.+Liuauthor=A.+Cheungauthor=F.+Stegmeierauthor=G.+A.+Michaudauthor=O.+Charlatauthor=E.+Wielletteauthor=Y.+Zhangauthor=S.+Wiessnerauthor=M.+Hildauthor=X.+Shiauthor=C.+J.+Wilsonauthor=C.+Mickaninauthor=V.+Myerauthor=A.+Fazalauthor=R.+Tomlinsonauthor=F.+Serlucaauthor=W.+Shaoauthor=H.+Chengauthor=M.+Shultzauthor=C.+Rauauthor=M.+Schirleauthor=J.+Schleglauthor=S.+Ghidelliauthor=S.+Fawellauthor=C.+Luauthor=D.+Curtisauthor=M.+W.+Kirschnerauthor=C.+Lengauerauthor=P.+M.+Finanauthor=J.+A.+Tallaricoauthor=T.+Bouwmeesterauthor=J.+A.+Porterauthor=A.+Bauerauthor=F.+Cong&title=Tankyrase+inhibition+stabilizes+axin+and+antagonizes+Wnt+signalling&doi=10.1038%2Fnature08356"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling</span></div><div class="casAuthors">Huang, Shih-Min A.; Mishina, Yuji M.; Liu, Shanming; Cheung, Atwood; Stegmeier, Frank; Michaud, Gregory A.; Charlat, Olga; Wiellette, Elizabeth; Zhang, Yue; Wiessner, Stephanie; Hild, Marc; Shi, Xiaoying; Wilson, Christopher J.; Mickanin, Craig; Myer, Vic; Fazal, Aleem; Tomlinson, Ronald; Serluca, Fabrizio; Shao, Wenlin; Cheng, Hong; Shultz, Michael; Rau, Christina; Schirle, Markus; Schlegl, Judith; Ghidelli, Sonja; Fawell, Stephen; Lu, Chris; Curtis, Daniel; Kirschner, Marc W.; Lengauer, Christoph; Finan, Peter M.; Tallarico, John A.; Bouwmeester, Tewis; Porter, Jeffery A.; Bauer, Andreas; Cong, Feng</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">461</span>
        (<span class="NLM_cas:issue">7264</span>),
    <span class="NLM_cas:pages">614-620</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The stability of the Wnt pathway transcription factor β-catenin is tightly regulated by the multi-subunit destruction complex.  Deregulated Wnt pathway activity has been implicated in many cancers, making this pathway an attractive target for anticancer therapies.  However, the development of targeted Wnt pathway inhibitors has been hampered by the limited no. of pathway components that are amenable to small mol. inhibition.  Here, we used a chem. genetic screen to identify a small mol., XAV939, which selectively inhibits β-catenin-mediated transcription.  XAV939 stimulates β-catenin degrdn. by stabilizing axin, the concn.-limiting component of the destruction complex.  Using a quant. chem. proteomic approach, we discovered that XAV939 stabilizes axin by inhibiting the poly-ADP-ribosylating enzymes tankyrase 1 and tankyrase 2.  Both tankyrase isoforms interact with a highly conserved domain of axin and stimulate its degrdn. through the ubiquitin-proteasome pathway.  Thus, our study provides new mechanistic insights into the regulation of axin protein homeostasis and presents new avenues for targeted Wnt pathway therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGom3c1M4OoOarVg90H21EOLACvtfcHk0ljzZf6Kv1arTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFentbzP&md5=6a76dfa7ed2a57b29e0c1ee367bd652c</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1038%2Fnature08356&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature08356%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DS.%2BM.%26aulast%3DMishina%26aufirst%3DY.%2BM.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DCheung%26aufirst%3DA.%26aulast%3DStegmeier%26aufirst%3DF.%26aulast%3DMichaud%26aufirst%3DG.%2BA.%26aulast%3DCharlat%26aufirst%3DO.%26aulast%3DWiellette%26aufirst%3DE.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DWiessner%26aufirst%3DS.%26aulast%3DHild%26aufirst%3DM.%26aulast%3DShi%26aufirst%3DX.%26aulast%3DWilson%26aufirst%3DC.%2BJ.%26aulast%3DMickanin%26aufirst%3DC.%26aulast%3DMyer%26aufirst%3DV.%26aulast%3DFazal%26aufirst%3DA.%26aulast%3DTomlinson%26aufirst%3DR.%26aulast%3DSerluca%26aufirst%3DF.%26aulast%3DShao%26aufirst%3DW.%26aulast%3DCheng%26aufirst%3DH.%26aulast%3DShultz%26aufirst%3DM.%26aulast%3DRau%26aufirst%3DC.%26aulast%3DSchirle%26aufirst%3DM.%26aulast%3DSchlegl%26aufirst%3DJ.%26aulast%3DGhidelli%26aufirst%3DS.%26aulast%3DFawell%26aufirst%3DS.%26aulast%3DLu%26aufirst%3DC.%26aulast%3DCurtis%26aufirst%3DD.%26aulast%3DKirschner%26aufirst%3DM.%2BW.%26aulast%3DLengauer%26aufirst%3DC.%26aulast%3DFinan%26aufirst%3DP.%2BM.%26aulast%3DTallarico%26aufirst%3DJ.%2BA.%26aulast%3DBouwmeester%26aufirst%3DT.%26aulast%3DPorter%26aufirst%3DJ.%2BA.%26aulast%3DBauer%26aufirst%3DA.%26aulast%3DCong%26aufirst%3DF.%26atitle%3DTankyrase%2520inhibition%2520stabilizes%2520axin%2520and%2520antagonizes%2520Wnt%2520signalling%26jtitle%3DNature%26date%3D2009%26volume%3D461%26spage%3D614%26epage%3D620%26doi%3D10.1038%2Fnature08356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Voronkov, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holsworth, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waaler, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ekblad, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perdreau-Dahl, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinh, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drewes, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hopf, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morth, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krauss, S.</span></span> <span> </span><span class="NLM_article-title">Structural basis and SAR for G007-LK, a lead stage 1,2,4-triazole based specific tankyrase 1/2 inhibitor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">3012</span>– <span class="NLM_lpage">3023</span>, <span class="refDoi"> DOI: 10.1021/jm4000566</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm4000566" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjslGht7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=3012-3023&author=A.+Voronkovauthor=D.+D.+Holsworthauthor=J.+Waalerauthor=S.+R.+Wilsonauthor=B.+Ekbladauthor=H.+Perdreau-Dahlauthor=H.+Dinhauthor=G.+Drewesauthor=C.+Hopfauthor=J.+P.+Morthauthor=S.+Krauss&title=Structural+basis+and+SAR+for+G007-LK%2C+a+lead+stage+1%2C2%2C4-triazole+based+specific+tankyrase+1%2F2+inhibitor&doi=10.1021%2Fjm4000566"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis and SAR for G007-LK, a Lead Stage 1,2,4-Triazole Based Specific Tankyrase 1/2 Inhibitor</span></div><div class="casAuthors">Voronkov, Andrew; Holsworth, Daniel D.; Waaler, Jo; Wilson, Steven R.; Ekblad, Bie; Perdreau-Dahl, Harmonie; Dinh, Huyen; Drewes, Gerard; Hopf, Carsten; Morth, Jens P.; Krauss, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3012-3023</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Tankyrases 1 and 2 (TNKS1/2) are promising pharmacol. biotargets with possible applications for the development of novel anticancer therapeutics.  A focused structure-activity relationship study was conducted based on the tankyrase inhibitor JW74 (1).  Chem. analoging of 1 improved the 1,2,4-triazole based core and led to 4-{5-[(E)-2-{4-(2-chlorophenyl)-5-[5-(methylsulfonyl)pyridin-2-yl]-4H-1,2,4-triazol-3-yl}ethenyl]-1,3,4-oxadiazol-2-yl}benzonitrile (G007-LK), a potent, "rule of 5" compliant and a metabolically stable TNKS1/2 inhibitor.  G007-LK (66) displayed high selectivity toward tankyrases 1 and 2 with biochem. IC50 values of 46 nM and 25 nM, resp., and a cellular IC50 value of 50 nM combined with an excellent pharmacokinetic profile in mice.  The PARP domain of TNKS2 was cocrystd. with 66, and the X-ray structure was detd. at 2.8 Å resoln. in the space group P3221.  The structure revealed that 66 binds to unique structural features in the extended adenosine binding pocket which forms the structural basis for the compd.'s high target selectivity and specificity.  Our study provides a significantly optimized compd. for targeting TNKS1/2 in vitro and in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvUxhCxkLuYbVg90H21EOLACvtfcHk0ljzZf6Kv1arTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjslGht7o%253D&md5=f2bee61f0fdc326e3e798b3705072e9d</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm4000566&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4000566%26sid%3Dliteratum%253Aachs%26aulast%3DVoronkov%26aufirst%3DA.%26aulast%3DHolsworth%26aufirst%3DD.%2BD.%26aulast%3DWaaler%26aufirst%3DJ.%26aulast%3DWilson%26aufirst%3DS.%2BR.%26aulast%3DEkblad%26aufirst%3DB.%26aulast%3DPerdreau-Dahl%26aufirst%3DH.%26aulast%3DDinh%26aufirst%3DH.%26aulast%3DDrewes%26aufirst%3DG.%26aulast%3DHopf%26aufirst%3DC.%26aulast%3DMorth%26aufirst%3DJ.%2BP.%26aulast%3DKrauss%26aufirst%3DS.%26atitle%3DStructural%2520basis%2520and%2520SAR%2520for%2520G007-LK%252C%2520a%2520lead%2520stage%25201%252C2%252C4-triazole%2520based%2520specific%2520tankyrase%25201%252F2%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D3012%26epage%3D3023%26doi%3D10.1021%2Fjm4000566" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shultz, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheung, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirby, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Firestone, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chin, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dipietro, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fazal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fortin, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gould, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lagu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lei, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lenoir, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Majumdar, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ochala, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palermo, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pham, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stams, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomlinson, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toure, B. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Visser, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waters, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, W.</span></span> <span> </span><span class="NLM_article-title">Identification of NVP-TNKS656: the use of structure-efficiency relationships to generate a highly potent, selective, and orally active tankyrase inhibitor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">6495</span>– <span class="NLM_lpage">6511</span>, <span class="refDoi"> DOI: 10.1021/jm400807n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400807n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtV2msbfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=6495-6511&author=M.+D.+Shultzauthor=A.+K.+Cheungauthor=C.+A.+Kirbyauthor=B.+Firestoneauthor=J.+Fanauthor=C.+H.+Chenauthor=Z.+Chenauthor=D.+N.+Chinauthor=L.+Dipietroauthor=A.+Fazalauthor=Y.+Fengauthor=P.+D.+Fortinauthor=T.+Gouldauthor=B.+Laguauthor=H.+Leiauthor=F.+Lenoirauthor=D.+Majumdarauthor=E.+Ochalaauthor=M.+G.+Palermoauthor=L.+Phamauthor=M.+Puauthor=T.+Smithauthor=T.+Stamsauthor=R.+C.+Tomlinsonauthor=B.+B.+Toureauthor=M.+Visserauthor=R.+M.+Wangauthor=N.+J.+Watersauthor=W.+Shao&title=Identification+of+NVP-TNKS656%3A+the+use+of+structure-efficiency+relationships+to+generate+a+highly+potent%2C+selective%2C+and+orally+active+tankyrase+inhibitor&doi=10.1021%2Fjm400807n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of NVP-TNKS656: The Use of Structure-Efficiency Relationships To Generate a Highly Potent, Selective, and Orally Active Tankyrase Inhibitor</span></div><div class="casAuthors">Shultz, Michael D.; Cheung, Atwood K.; Kirby, Christina A.; Firestone, Brant; Fan, Jianmei; Chen, Christine Hiu-Tung; Chen, Zhouliang; Chin, Donovan N.; DiPietro, Lucian; Fazal, Aleem; Feng, Yun; Fortin, Pascal D.; Gould, Ty; Lagu, Bharat; Lei, Huangshu; Lenoir, Francois; Majumdar, Dyuti; Ochala, Etienne; Palermo, M. G.; Pham, Ly; Pu, Minying; Smith, Troy; Stams, Travis; Tomlinson, Ronald C.; Toure, B. Barry; Visser, Michael; Wang, Run Ming; Waters, Nigel J.; Shao, Wenlin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">6495-6511</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Tankyrase 1 and 2 have been shown to be redundant, druggable nodes in the Wnt pathway.  As such, there has been intense interest in developing agents suitable for modulating the Wnt pathway in vivo by targeting this enzyme pair.  By utilizing a combination of structure-based design and LipE-based structure efficiency relationships, the core of XAV939 was optimized into a more stable, more efficient, but less potent dihydropyran motif 7.  This core was combined with elements of screening hits 2, 19, and 33 and resulted in highly potent, selective tankyrase inhibitors that are novel three pocket binders.  NVP-TNKS656 (43) was identified as an orally active antagonist of Wnt pathway activity in the MMTV-Wnt1 mouse xenograft model.  With an enthalpy-driven thermodn. signature of binding, highly favorable physicochem. properties, and high lipophilic efficiency, NVP-TNKS656 is a novel tankyrase inhibitor that is well suited for further in vivo validation studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDGWOimaJ0I7Vg90H21EOLACvtfcHk0lh_uYLHIAow8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtV2msbfE&md5=db3f1a471ca757e0219a5175c5017e9b</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm400807n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400807n%26sid%3Dliteratum%253Aachs%26aulast%3DShultz%26aufirst%3DM.%2BD.%26aulast%3DCheung%26aufirst%3DA.%2BK.%26aulast%3DKirby%26aufirst%3DC.%2BA.%26aulast%3DFirestone%26aufirst%3DB.%26aulast%3DFan%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DC.%2BH.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DChin%26aufirst%3DD.%2BN.%26aulast%3DDipietro%26aufirst%3DL.%26aulast%3DFazal%26aufirst%3DA.%26aulast%3DFeng%26aufirst%3DY.%26aulast%3DFortin%26aufirst%3DP.%2BD.%26aulast%3DGould%26aufirst%3DT.%26aulast%3DLagu%26aufirst%3DB.%26aulast%3DLei%26aufirst%3DH.%26aulast%3DLenoir%26aufirst%3DF.%26aulast%3DMajumdar%26aufirst%3DD.%26aulast%3DOchala%26aufirst%3DE.%26aulast%3DPalermo%26aufirst%3DM.%2BG.%26aulast%3DPham%26aufirst%3DL.%26aulast%3DPu%26aufirst%3DM.%26aulast%3DSmith%26aufirst%3DT.%26aulast%3DStams%26aufirst%3DT.%26aulast%3DTomlinson%26aufirst%3DR.%2BC.%26aulast%3DToure%26aufirst%3DB.%2BB.%26aulast%3DVisser%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DR.%2BM.%26aulast%3DWaters%26aufirst%3DN.%2BJ.%26aulast%3DShao%26aufirst%3DW.%26atitle%3DIdentification%2520of%2520NVP-TNKS656%253A%2520the%2520use%2520of%2520structure-efficiency%2520relationships%2520to%2520generate%2520a%2520highly%2520potent%252C%2520selective%252C%2520and%2520orally%2520active%2520tankyrase%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D6495%26epage%3D6511%26doi%3D10.1021%2Fjm400807n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mariotti, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Templeton, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ranes, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paracuellos, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cronin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beuron, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guettler, S.</span></span> <span> </span><span class="NLM_article-title">Tankyrase requires SAM domain-dependent polymerization to support Wnt-beta-catenin signaling</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">498</span>– <span class="NLM_lpage">513</span>, <span class="refDoi"> DOI: 10.1016/j.molcel.2016.06.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=10.1016%2Fj.molcel.2016.06.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=27494558" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlWjtbjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2016&pages=498-513&author=L.+Mariottiauthor=C.+M.+Templetonauthor=M.+Ranesauthor=P.+Paracuellosauthor=N.+Croninauthor=F.+Beuronauthor=E.+Morrisauthor=S.+Guettler&title=Tankyrase+requires+SAM+domain-dependent+polymerization+to+support+Wnt-beta-catenin+signaling&doi=10.1016%2Fj.molcel.2016.06.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Tankyrase Requires SAM Domain-Dependent Polymerization to Support Wnt-β-Catenin Signaling</span></div><div class="casAuthors">Mariotti, Laura; Templeton, Catherine M.; Ranes, Michael; Paracuellos, Patricia; Cronin, Nora; Beuron, Fabienne; Morris, Edward; Guettler, Sebastian</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">498-513</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">The poly(ADP-ribose) polymerase (PARP) Tankyrase (TNKS and TNKS2) is paramount to Wnt-β-catenin signaling and a promising therapeutic target in Wnt-dependent cancers.  The pool of active β-catenin is normally limited by destruction complexes, whose assembly depends on the polymeric master scaffolding protein AXIN.  Tankyrase, which poly(ADP-ribosyl)ates and thereby destabilizes AXIN, also can polymerize, but the relevance of these polymers has remained unclear.  We report crystal structures of the polymg. TNKS and TNKS2 sterile alpha motif (SAM) domains, revealing versatile head-to-tail interactions.  Biochem. studies informed by these structures demonstrate that polymn. is required for Tankyrase to drive β-catenin-dependent transcription.  We show that the polymeric state supports PARP activity and allows Tankyrase to effectively access destruction complexes through enabling avidity-dependent AXIN binding.  This study provides an example for regulated signal transduction in non-membrane-enclosed compartments (signalosomes), and it points to novel potential strategies to inhibit Tankyrase function in oncogenic Wnt signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryzcx6EN_QfbVg90H21EOLACvtfcHk0lhA-I1JVWeZJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlWjtbjK&md5=58094437e4a6509989c5db6355ccb7d0</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2016.06.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2016.06.019%26sid%3Dliteratum%253Aachs%26aulast%3DMariotti%26aufirst%3DL.%26aulast%3DTempleton%26aufirst%3DC.%2BM.%26aulast%3DRanes%26aufirst%3DM.%26aulast%3DParacuellos%26aufirst%3DP.%26aulast%3DCronin%26aufirst%3DN.%26aulast%3DBeuron%26aufirst%3DF.%26aulast%3DMorris%26aufirst%3DE.%26aulast%3DGuettler%26aufirst%3DS.%26atitle%3DTankyrase%2520requires%2520SAM%2520domain-dependent%2520polymerization%2520to%2520support%2520Wnt-beta-catenin%2520signaling%26jtitle%3DMol.%2520Cell%26date%3D2016%26volume%3D63%26spage%3D498%26epage%3D513%26doi%3D10.1016%2Fj.molcel.2016.06.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sbodio, J. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chi, N. W.</span></span> <span> </span><span class="NLM_article-title">Identification of a tankyrase-binding motif shared by IRAP, TAB182, and human TRF1 but not mouse TRF1. NuMA contains this RXXPDG motif and is a novel tankyrase partner</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>277</i></span>,  <span class="NLM_fpage">31887</span>– <span class="NLM_lpage">31892</span>, <span class="refDoi"> DOI: 10.1074/jbc.M203916200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=10.1074%2Fjbc.M203916200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=12080061" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=1%3ACAS%3A528%3ADC%252BD38XmslOqtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=2002&pages=31887-31892&author=J.+I.+Sbodioauthor=N.+W.+Chi&title=Identification+of+a+tankyrase-binding+motif+shared+by+IRAP%2C+TAB182%2C+and+human+TRF1+but+not+mouse+TRF1.+NuMA+contains+this+RXXPDG+motif+and+is+a+novel+tankyrase+partner&doi=10.1074%2Fjbc.M203916200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a tankyrase-binding motif shared by IRAP, TAB182, and human TRF1 but not mouse TRF1. NuMA contains this RXXPDG motif and is a novel tankyrase partner</span></div><div class="casAuthors">Sbodio, Juan I.; Chi, Nai-Wen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">277</span>
        (<span class="NLM_cas:issue">35</span>),
    <span class="NLM_cas:pages">31887-31892</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Tankyrase-1 and -2 are closely related poly(ADP-ribose) polymerases that use an ankyrin-repeat domain to bind diverse proteins, including TRF (telomere-repeat binding factor)-1, IRAP (insulin-responsive aminopeptidase), and TAB182 (182-kDa tankyrase-binding protein).  TRF1 binding allows tankyrase to regulate telomere dynamics in human cells, whereas IRAP binding presumably allows tankyrase to regulate the targeting of IRAP.  The mechanism by which tankyrase binds to diverse proteins has not been investigated.  Herein we describe a novel RXXPDG motif shared by IRAP, TAB182, and human TRF1 that mediates their binding to tankyrases.  Interestingly, mouse TRF1 lacks this motif and thus does not bind either tankyrase-1 or -2.  Using the ankyrin domain of tankyrase as a bait in a yeast two-hybrid screen, we also found the RXXPDG motif in six candidate tankyrase partners, including the nuclear/mitotic app. protein (NuMA).  We verified NuMA as an RXXPDG-mediated partner of tankyrase and suggest that this interaction contributes to the known colocalization of tankyrase and NuMA at mitotic spindle poles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0bIhUisnbdLVg90H21EOLACvtfcHk0lhA-I1JVWeZJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XmslOqtbc%253D&md5=a29cff4af939c58fd7d74d9191da7aa5</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M203916200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M203916200%26sid%3Dliteratum%253Aachs%26aulast%3DSbodio%26aufirst%3DJ.%2BI.%26aulast%3DChi%26aufirst%3DN.%2BW.%26atitle%3DIdentification%2520of%2520a%2520tankyrase-binding%2520motif%2520shared%2520by%2520IRAP%252C%2520TAB182%252C%2520and%2520human%2520TRF1%2520but%2520not%2520mouse%2520TRF1.%2520NuMA%2520contains%2520this%2520RXXPDG%2520motif%2520and%2520is%2520a%2520novel%2520tankyrase%2520partner%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2002%26volume%3D277%26spage%3D31887%26epage%3D31892%26doi%3D10.1074%2Fjbc.M203916200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, J.</span></span> <span> </span><span class="NLM_article-title">USP25 regulates Wnt signaling by controlling the stability of tankyrases</span>. <i>Genes Dev.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">1024</span>– <span class="NLM_lpage">1035</span>, <span class="refDoi"> DOI: 10.1101/gad.300889.117</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=10.1101%2Fgad.300889.117" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=28619731" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFKnt7fP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2017&pages=1024-1035&author=D.+Xuauthor=J.+Liuauthor=T.+Fuauthor=B.+Shanauthor=L.+Qianauthor=L.+Panauthor=J.+Yuan&title=USP25+regulates+Wnt+signaling+by+controlling+the+stability+of+tankyrases&doi=10.1101%2Fgad.300889.117"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">USP25 regulates Wnt signaling by controlling the stability of tankyrases</span></div><div class="casAuthors">Xu, Daichao; Liu, Jianping; Fu, Tao; Shan, Bing; Qian, Lihui; Pan, Lifeng; Yuan, Junying</div><div class="citationInfo"><span class="NLM_cas:title">Genes & Development</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1024-1035</span>CODEN:
                <span class="NLM_cas:coden">GEDEEP</span>;
        ISSN:<span class="NLM_cas:issn">0890-9369</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">Aberrant activation of the Wnt signaling pathway plays an important role in human cancer development.  Wnt signaling is neg. regulated by Axin, a scaffolding protein that controls a rate-limiting step in the destruction of β-catenin, the central activator of the Wnt pathway.  In Wnt-stimulated cells, Axin is rapidly modified by tankyrase-mediated poly(ADP-ribosyl)ation, which promotes the proteolysis of Axin and consequent stabilization of β-catenin.  Thus, regulation of the levels and activity of tankyrases is mechanistically important in controlling Wnt signaling.  Here, we identify ubiquitin-specific protease 25 (USP25) as a pos. regulator of Wnt/β-catenin signaling.  We found that USP25 directly interacted with tankyrases to promote their deubiquitination and stabilization.  We demonstrated that USP25 deficiency could promote the degrdn. of tankyrases and consequent stabilization of Axin to antagonize Wnt signaling.  We further characterized the interaction between TNKS1 and USP25 by X-ray crystal structure detn.  Our results provide important new insights into the mol. mechanism that regulates the turnover of tankyrases and the possibility of targeting the stability of tankyrases by antagonizing their interaction with USP25 to modulate the Wnt/β-catenin pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiEk5oDBHsgbVg90H21EOLACvtfcHk0li47TOKOdDc9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFKnt7fP&md5=062e583d7984c1ebec175850903fc91c</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1101%2Fgad.300889.117&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.300889.117%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DFu%26aufirst%3DT.%26aulast%3DShan%26aufirst%3DB.%26aulast%3DQian%26aufirst%3DL.%26aulast%3DPan%26aufirst%3DL.%26aulast%3DYuan%26aufirst%3DJ.%26atitle%3DUSP25%2520regulates%2520Wnt%2520signaling%2520by%2520controlling%2520the%2520stability%2520of%2520tankyrases%26jtitle%3DGenes%2520Dev.%26date%3D2017%26volume%3D31%26spage%3D1024%26epage%3D1035%26doi%3D10.1101%2Fgad.300889.117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eisemann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCauley, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langelier, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Duyne, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pascal, J. M.</span></span> <span> </span><span class="NLM_article-title">Tankyrase-1 ankyrin repeats form an adaptable binding platform for targets of ADP-ribose modification</span>. <i>Structure</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">1679</span>– <span class="NLM_lpage">1692</span>, <span class="refDoi"> DOI: 10.1016/j.str.2016.07.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=10.1016%2Fj.str.2016.07.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=27594684" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVOqsLzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2016&pages=1679-1692&author=T.+Eisemannauthor=M.+McCauleyauthor=M.+F.+Langelierauthor=K.+Guptaauthor=S.+Royauthor=G.+D.+Van+Duyneauthor=J.+M.+Pascal&title=Tankyrase-1+ankyrin+repeats+form+an+adaptable+binding+platform+for+targets+of+ADP-ribose+modification&doi=10.1016%2Fj.str.2016.07.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Tankyrase-1 Ankyrin Repeats Form an Adaptable Binding Platform for Targets of ADP-Ribose Modification</span></div><div class="casAuthors">Eisemann, Travis; McCauley, Michael; Langelier, Marie-France; Gupta, Kushol; Roy, Swati; Van Duyne, Gregory D.; Pascal, John M.</div><div class="citationInfo"><span class="NLM_cas:title">Structure (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1679-1692</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The poly(ADP-ribose) polymerase enzyme Tankyrase-1 (TNKS) regulates multiple cellular processes and interacts with diverse proteins using five ankyrin repeat clusters (ARCs).  There are limited structural insights into functional roles of the multiple ARCs of TNKS.  Here we present the ARC1-3 crystal structure and employ small-angle X-ray scattering (SAXS) to investigate soln. conformations of the complete ankyrin repeat domain.  Mutagenesis and binding studies using the bivalent TNKS binding domain of Axin1 demonstrate that only certain ARC combinations function together.  The phys. basis for these restrictions is explained by both rigid and flexible ankyrin repeat elements detd. in our structural anal.  SAXS anal. is consistent with a dynamic ensemble of TNKS ankyrin repeat conformations modulated by Axin1 interaction.  TNKS ankyrin repeat domain is thus an adaptable binding platform with structural features that can explain selectivity toward diverse proteins, and has implications for TNKS positioning of bound targets for poly(ADP-ribose) modification.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrm8oxgI6qS5bVg90H21EOLACvtfcHk0li47TOKOdDc9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVOqsLzJ&md5=b6887cad0ba9a862d8d78a6c2ccbec4f</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.str.2016.07.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.str.2016.07.014%26sid%3Dliteratum%253Aachs%26aulast%3DEisemann%26aufirst%3DT.%26aulast%3DMcCauley%26aufirst%3DM.%26aulast%3DLangelier%26aufirst%3DM.%2BF.%26aulast%3DGupta%26aufirst%3DK.%26aulast%3DRoy%26aufirst%3DS.%26aulast%3DVan%2BDuyne%26aufirst%3DG.%2BD.%26aulast%3DPascal%26aufirst%3DJ.%2BM.%26atitle%3DTankyrase-1%2520ankyrin%2520repeats%2520form%2520an%2520adaptable%2520binding%2520platform%2520for%2520targets%2520of%2520ADP-ribose%2520modification%26jtitle%3DStructure%26date%3D2016%26volume%3D24%26spage%3D1679%26epage%3D1692%26doi%3D10.1016%2Fj.str.2016.07.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katavolos, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lau, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boggs, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sambrone, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merchant, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harstad, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schutten, M.</span></span> <span> </span><span class="NLM_article-title">Tankyrase inhibition causes reversible intestinal toxicity in mice with a therapeutic index < 1</span>. <i>Toxicol. Pathol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">267</span>– <span class="NLM_lpage">278</span>, <span class="refDoi"> DOI: 10.1177/0192623315621192</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=10.1177%2F0192623315621192" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=26692561" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlWgsLvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2016&pages=267-278&author=Y.+Zhongauthor=P.+Katavolosauthor=T.+Nguyenauthor=T.+Lauauthor=J.+Boggsauthor=A.+Sambroneauthor=D.+Kanauthor=M.+Merchantauthor=E.+Harstadauthor=D.+Diazauthor=M.+Costaauthor=M.+Schutten&title=Tankyrase+inhibition+causes+reversible+intestinal+toxicity+in+mice+with+a+therapeutic+index+%3C+1&doi=10.1177%2F0192623315621192"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Tankyrase inhibition causes reversible intestinal toxicity in mice with a therapeutic index < 1</span></div><div class="casAuthors">Zhong, Yu; Katavolos, Paula; Nguyen, Trung; Lau, Ted; Boggs, Jason; Sambrone, Amy; Kan, David; Merchant, Mark; Harstad, Eric; Diaz, Dolores; Costa, Mike; Schutten, Melissa</div><div class="citationInfo"><span class="NLM_cas:title">Toxicologic Pathology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">267-278</span>CODEN:
                <span class="NLM_cas:coden">TOPADD</span>;
        ISSN:<span class="NLM_cas:issn">0192-6233</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">Activated Wnt/β-catenin signaling is frequently assocd. with colorectal cancer.  Wnt inhibitors, including tankyrase inhibitors, are being explored as potential anticancer agents.  Wnt signaling is also crit. for intestinal tissue homeostasis, and Wnt inhibitors have been shown to cause intestinal toxicity in mice by affecting intestinal stem cells.  This study sought to characterize the intestinal toxicity of tankyrase inhibitors, including reversibility, and to assess their therapeutic index.  Novel tankyrase inhibitor G-631 caused dose-dependent intestinal toxicity with a therapeutic index < 1 after 14 days of dosing in mice.  At a tolerated subtherapeutic dose level, the intestinal toxicity was composed of enteritis characterized by villus blunting, epithelial degeneration, and inflammation, which fully reversed after 14 days of recovery.  Doubled exposure showed weak antitumor activity in a xenograft colorectal cancer model but also caused more severe intestinal toxicity characterized by multifocal-regionally extensive necrotizing and ulcerative enteritis leading to morbidity or moribundity in some animals.  This toxicity was only partially reversed after 14 days of recovery, with evidence of crypt and villus regeneration, mildly blunted villi, and/or scarring in assocn. with chronic inflammation of the submucosa.  Therefore, the clin. utility of tankyrase inhibitors is likely limited by the on-target intestinal toxicity and a therapeutic index < 1 in mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrE6KF-WKDKTrVg90H21EOLACvtfcHk0lgf3lGhKBaKQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlWgsLvF&md5=b4276e4b15fae2aa0bbc53d0f9f1f680</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1177%2F0192623315621192&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F0192623315621192%26sid%3Dliteratum%253Aachs%26aulast%3DZhong%26aufirst%3DY.%26aulast%3DKatavolos%26aufirst%3DP.%26aulast%3DNguyen%26aufirst%3DT.%26aulast%3DLau%26aufirst%3DT.%26aulast%3DBoggs%26aufirst%3DJ.%26aulast%3DSambrone%26aufirst%3DA.%26aulast%3DKan%26aufirst%3DD.%26aulast%3DMerchant%26aufirst%3DM.%26aulast%3DHarstad%26aufirst%3DE.%26aulast%3DDiaz%26aufirst%3DD.%26aulast%3DCosta%26aufirst%3DM.%26aulast%3DSchutten%26aufirst%3DM.%26atitle%3DTankyrase%2520inhibition%2520causes%2520reversible%2520intestinal%2520toxicity%2520in%2520mice%2520with%2520a%2520therapeutic%2520index%2520%253C%25201%26jtitle%3DToxicol.%2520Pathol.%26date%3D2016%26volume%3D44%26spage%3D267%26epage%3D278%26doi%3D10.1177%2F0192623315621192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mariotti, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pollock, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guettler, S.</span></span> <span> </span><span class="NLM_article-title">Regulation of Wnt/beta-catenin signalling by tankyrase-dependent poly(ADP-ribosyl)ation and scaffolding</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>174</i></span>,  <span class="NLM_fpage">4611</span>– <span class="NLM_lpage">4636</span>, <span class="refDoi"> DOI: 10.1111/bph.14038</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=10.1111%2Fbph.14038" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=28910490" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslGqs7bE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=174&publication_year=2017&pages=4611-4636&author=L.+Mariottiauthor=K.+Pollockauthor=S.+Guettler&title=Regulation+of+Wnt%2Fbeta-catenin+signalling+by+tankyrase-dependent+poly%28ADP-ribosyl%29ation+and+scaffolding&doi=10.1111%2Fbph.14038"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of Wnt/β-catenin signalling by tankyrase-dependent poly(ADP-ribosyl)ation and scaffolding</span></div><div class="casAuthors">Mariotti, Laura; Pollock, Katie; Guettler, Sebastian</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">174</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">4611-4636</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The Wnt/β-catenin signalling pathway is pivotal for stem cell function and the control of cellular differentiation, both during embryonic development and tissue homeostasis in adults.  Its activity is carefully controlled through the concerted interactions of concn.-limited pathway components and a wide range of post-translational modifications, including phosphorylation, ubiquitylation, sumoylation, poly(ADP-ribosyl)ation (PARylation) and acetylation.  Regulation of Wnt/β-catenin signalling by PARylation was discovered relatively recently.  The PARP tankyrase PARylates AXIN1/2, an essential central scaffolding protein in the β-catenin destruction complex, and targets it for degrdn., thereby fine-tuning the responsiveness of cells to the Wnt signal.  The past few years have not only seen much progress in our understanding of the mol. mechanisms by which PARylation controls the pathway but also witnessed the successful development of tankyrase inhibitors as tool compds. and promising agents for the therapy of Wnt-dependent dysfunctions, including colorectal cancer.  Recent work has hinted at more complex roles of tankyrase in Wnt/β-catenin signalling as well as challenges and opportunities in the development of tankyrase inhibitors.  Here we review some of the latest advances in our understanding of tankyrase function in the pathway and efforts to modulate tankyrase activity to re-tune Wnt/β-catenin signalling in colorectal cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbg-X7McNWebVg90H21EOLACvtfcHk0lgf3lGhKBaKQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslGqs7bE&md5=4ba71faa4fc2064e57390dae08b88c0f</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1111%2Fbph.14038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.14038%26sid%3Dliteratum%253Aachs%26aulast%3DMariotti%26aufirst%3DL.%26aulast%3DPollock%26aufirst%3DK.%26aulast%3DGuettler%26aufirst%3DS.%26atitle%3DRegulation%2520of%2520Wnt%252Fbeta-catenin%2520signalling%2520by%2520tankyrase-dependent%2520poly%2528ADP-ribosyl%2529ation%2520and%2520scaffolding%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2017%26volume%3D174%26spage%3D4611%26epage%3D4636%26doi%3D10.1111%2Fbph.14038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thorne, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanson, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tahinci, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orton, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cselenyi, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jernigan, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyers, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hang, B. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waterson, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melancon, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghidu, V. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sulikowski, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaFleur, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salic, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, E.</span></span> <span> </span><span class="NLM_article-title">Small-molecule inhibition of Wnt signaling through activation of casein kinase 1 alpha</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">829</span>– <span class="NLM_lpage">836</span>, <span class="refDoi"> DOI: 10.1038/nchembio.453</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=10.1038%2Fnchembio.453" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=20890287" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1elu7zO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=829-836&author=C.+A.+Thorneauthor=A.+J.+Hansonauthor=J.+Schneiderauthor=E.+Tahinciauthor=D.+Ortonauthor=C.+S.+Cselenyiauthor=K.+K.+Jerniganauthor=K.+C.+Meyersauthor=B.+I.+Hangauthor=A.+G.+Watersonauthor=K.+Kimauthor=B.+Melanconauthor=V.+P.+Ghiduauthor=G.+A.+Sulikowskiauthor=B.+LaFleurauthor=A.+Salicauthor=L.+A.+Leeauthor=D.+M.+Millerauthor=E.+Lee&title=Small-molecule+inhibition+of+Wnt+signaling+through+activation+of+casein+kinase+1+alpha&doi=10.1038%2Fnchembio.453"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecule inhibition of Wnt signaling through activation of casein kinase 1α</span></div><div class="casAuthors">Thorne, Curtis A.; Hanson, Alison J.; Schneider, Judsen; Tahinci, Emilios; Orton, Darren; Cselenyi, Christopher S.; Jernigan, Kristin K.; Meyers, Kelly C.; Hang, Brian I.; Waterson, Alex G.; Kim, Kwangho; Melancon, Bruce; Ghidu, Victor P.; Sulikowski, Gary A.; LaFleur, Bonnie; Salic, Adrian; Lee, Laura A.; Miller, David M.; Lee, Ethan</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">829-836</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Wnt/β-catenin signaling is critically involved in metazoan development, stem cell maintenance and human disease.  Using Xenopus laevis egg ext. to screen for compds. that both stabilize Axin and promote β-catenin turnover, we identified an FDA-approved drug, pyrvinium, as a potent inhibitor of Wnt signaling (EC50 of ∼ 10 nM).  We show pyrvinium binds all casein kinase 1 (CK1) family members in vitro at low nanomolar concns. and pyrvinium selectively potentiates casein kinase 1α (CK1α) kinase activity.  CK1α knockdown abrogates the effects of pyrvinium on the Wnt pathway.  In addn. to its effects on Axin and β-catenin levels, pyrvinium promotes degrdn. of Pygopus, a Wnt transcriptional component.  Pyrvinium treatment of colon cancer cells with mutation of the gene for adenomatous polyposis coli (APC) or β-catenin inhibits both Wnt signaling and proliferation.  Our findings reveal allosteric activation of CK1α as an effective mechanism to inhibit Wnt signaling and highlight a new strategy for targeted therapeutics directed against the Wnt pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqr7QzU0tiGpLVg90H21EOLACvtfcHk0ljqnGz9mvlqwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1elu7zO&md5=1412b6b25b26689f9191145151e91608</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.453&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.453%26sid%3Dliteratum%253Aachs%26aulast%3DThorne%26aufirst%3DC.%2BA.%26aulast%3DHanson%26aufirst%3DA.%2BJ.%26aulast%3DSchneider%26aufirst%3DJ.%26aulast%3DTahinci%26aufirst%3DE.%26aulast%3DOrton%26aufirst%3DD.%26aulast%3DCselenyi%26aufirst%3DC.%2BS.%26aulast%3DJernigan%26aufirst%3DK.%2BK.%26aulast%3DMeyers%26aufirst%3DK.%2BC.%26aulast%3DHang%26aufirst%3DB.%2BI.%26aulast%3DWaterson%26aufirst%3DA.%2BG.%26aulast%3DKim%26aufirst%3DK.%26aulast%3DMelancon%26aufirst%3DB.%26aulast%3DGhidu%26aufirst%3DV.%2BP.%26aulast%3DSulikowski%26aufirst%3DG.%2BA.%26aulast%3DLaFleur%26aufirst%3DB.%26aulast%3DSalic%26aufirst%3DA.%26aulast%3DLee%26aufirst%3DL.%2BA.%26aulast%3DMiller%26aufirst%3DD.%2BM.%26aulast%3DLee%26aufirst%3DE.%26atitle%3DSmall-molecule%2520inhibition%2520of%2520Wnt%2520signaling%2520through%2520activation%2520of%2520casein%2520kinase%25201%2520alpha%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2010%26volume%3D6%26spage%3D829%26epage%3D836%26doi%3D10.1038%2Fnchembio.453" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smith, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kinkei, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gryczko, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goulet, J. R.</span></span> <span> </span><span class="NLM_article-title">Absorption of pyrvinium pamoate</span>. <i>Clin. Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">1976</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">802</span>– <span class="NLM_lpage">806</span>, <span class="refDoi"> DOI: 10.1002/cpt1976196802</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=10.1002%2Fcpt1976196802" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=1269218" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=1%3ACAS%3A528%3ADyaE28XksFKmsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1976&pages=802-806&author=T.+C.+Smithauthor=A.+W.+Kinkeiauthor=C.+M.+Gryczkoauthor=J.+R.+Goulet&title=Absorption+of+pyrvinium+pamoate&doi=10.1002%2Fcpt1976196802"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Absorption of pyrvinium pamoate</span></div><div class="casAuthors">Smith, T. C.; Kinkel, A. W.; Gryczko, C. M.; Goulet, J. R.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacology & Therapeutics (St. Louis, MO, United States)</span>
        (<span class="NLM_cas:date">1976</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">802-6</span>CODEN:
                <span class="NLM_cas:coden">CLPTAT</span>;
        ISSN:<span class="NLM_cas:issn">0009-9236</span>.
    </div><div class="casAbstract">Pyrvinium pamoate (I) [3546-41-6] tablets and suspension, was administered as single 350-mg doses to volunteers to det. whether there had been any systemic absorption.  Six subjects received tablets and 6 received suspension on the 1st day; on day 8, subjects received the other dose form.  Up to 4 days after administration there was no evidence of drug in blood and urine by spectrofluorometric assay.  Metabolic studies in rats showed minute quantities of drug in the liver and plasma but not of any metabolites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsgG9D2rQd_7Vg90H21EOLACvtfcHk0ljqnGz9mvlqwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE28XksFKmsr0%253D&md5=b75842be1943ee8afced9ce38b5fec0c</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1002%2Fcpt1976196802&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcpt1976196802%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DT.%2BC.%26aulast%3DKinkei%26aufirst%3DA.%2BW.%26aulast%3DGryczko%26aufirst%3DC.%2BM.%26aulast%3DGoulet%26aufirst%3DJ.%2BR.%26atitle%3DAbsorption%2520of%2520pyrvinium%2520pamoate%26jtitle%3DClin.%2520Pharmacol.%2520Ther.%26date%3D1976%26volume%3D19%26spage%3D802%26epage%3D806%26doi%3D10.1002%2Fcpt1976196802" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Obianom, O. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakamuru, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shu, Y.</span></span> <span> </span><span class="NLM_article-title">Triazole-based inhibitors of the Wnt/β-catenin signaling pathway improve glucose and lipid metabolisms in diet-induced obese mice</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">727</span>– <span class="NLM_lpage">741</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01408</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01408" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=1%3ACAS%3A528%3ADC%252BC1MXktV2htA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=727-741&author=O.+N.+Obianomauthor=Y.+Aiauthor=Y.+Liauthor=W.+Yangauthor=D.+Guoauthor=H.+Yangauthor=S.+Sakamuruauthor=M.+Xiaauthor=F.+Xueauthor=Y.+Shu&title=Triazole-based+inhibitors+of+the+Wnt%2F%CE%B2-catenin+signaling+pathway+improve+glucose+and+lipid+metabolisms+in+diet-induced+obese+mice&doi=10.1021%2Facs.jmedchem.8b01408"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Triazole-based inhibitors of the Wnt/β-catenin signaling pathway improve glucose and lipid metabolisms in diet-induced obese mice</span></div><div class="casAuthors">Obianom, Obinna N.; Ai, Yong; Li, Yingjun; Yang, Wei; Guo, Dong; Yang, Hong; Sakamuru, Srilatha; Xia, Menghang; Xue, Fengtian; Shu, Yan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">727-741</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Wnt/β-catenin signaling pathway is implicated in the etiol. and progression of metabolic disorders.  Although lines of genetic evidence suggest that blockage of this pathway yields favorable outcomes in treating such ailments, few inhibitors have been used to validate the promising genetic findings.  Here, we synthesized and characterized a novel class of triazole-based Wnt/β-catenin signaling inhibitors and assessed their effects on energy metab.  One of the top inhibitors, I, promoted Axin stabilization, which led to the proteasome degrdn. of β-catenin and subsequent inhibition of the Wnt/β-catenin signaling in cells.  Treatment of hepatocytes and high fat diet-fed mice with I resulted in significantly decreased hepatic lipid accumulation.  Moreover, I improved glucose tolerance of high fat diet-fed mice without noticeable toxicity, while downregulating the genes involved in the glucose and fatty acid anabolisms.  The new inhibitors are expected to be further developed for the treatment of metabolic disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXKGFvqIaGm7Vg90H21EOLACvtfcHk0ljqnGz9mvlqwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXktV2htA%253D%253D&md5=687c708054033b18b9185f2ebca1d82b</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01408&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01408%26sid%3Dliteratum%253Aachs%26aulast%3DObianom%26aufirst%3DO.%2BN.%26aulast%3DAi%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DGuo%26aufirst%3DD.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DSakamuru%26aufirst%3DS.%26aulast%3DXia%26aufirst%3DM.%26aulast%3DXue%26aufirst%3DF.%26aulast%3DShu%26aufirst%3DY.%26atitle%3DTriazole-based%2520inhibitors%2520of%2520the%2520Wnt%252F%25CE%25B2-catenin%2520signaling%2520pathway%2520improve%2520glucose%2520and%2520lipid%2520metabolisms%2520in%2520diet-induced%2520obese%2520mice%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D727%26epage%3D741%26doi%3D10.1021%2Facs.jmedchem.8b01408" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hagland, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berg, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jolma, I. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carlsen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soreide, K.</span></span> <span> </span><span class="NLM_article-title">Molecular pathways and cellular metabolism in colorectal cancer</span>. <i>Dig. Surg.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">12</span>– <span class="NLM_lpage">25</span>, <span class="refDoi"> DOI: 10.1159/000347166</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=10.1159%2F000347166" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=23595116" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVGlt73I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2013&pages=12-25&author=H.+R.+Haglandauthor=M.+Bergauthor=I.+W.+Jolmaauthor=A.+Carlsenauthor=K.+Soreide&title=Molecular+pathways+and+cellular+metabolism+in+colorectal+cancer&doi=10.1159%2F000347166"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Pathways and Cellular Metabolism in Colorectal Cancer</span></div><div class="casAuthors">Hagland, Hanne R.; Berg, Marianne; Jolma, Ingunn W.; Carlsen, Arne; Soreide, Kjetil</div><div class="citationInfo"><span class="NLM_cas:title">Digestive Surgery</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">12-25</span>CODEN:
                <span class="NLM_cas:coden">DSIUAN</span>;
        ISSN:<span class="NLM_cas:issn">0253-4886</span>.
    
            (<span class="NLM_cas:orgname">S. Karger AG</span>)
        </div><div class="casAbstract">A review.  Colorectal cancer (CRC) is, for sporadic forms, most strongly related to lifestyle factors.  The epidemic of obesity and phys. inactivity has great impact on disease patterns.  Likewise, an altered metab. has consequences at the cellular and mol. level with implications for cancer initiation and growth.  Understanding the genetic hallmarks of cancers has improved over the years and now also includes cancer metabolic reprogramming.  The initiation of cancer through genetic instability, including chromosomal instability, microsatellite instability and epigenetic silencing through the CpG island methylator phenotype follows pathways with distinct clin., pathol., and genetic characteristics.  These can potentially be used for mol. classification and comprehensive tumor profiling for improved diagnostics, prognosis and treatment in CRC.  For one, epidermal growth factor receptor-directed treatment now considerably prolongs survival in metastatic disease, but defining the true responders from non-responders has emerged as complex.  Further, the use of both non-steroidal anti-inflammatory drugs including cyclooxygenase-2 inhibitors is assocd. with a decreased incidence of adenoma and reduced mortality rate of CRC.  This review gives a brief yet updated overview of the current understanding of CRC as a genetic and mol. disease with potential for clin. pathways of prevention, improved prediction and better prognosis in the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrogpMoI8_yQrVg90H21EOLACvtfcHk0ljKbU4JI-ZLbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVGlt73I&md5=8470fa5f1d0f5e7d4e5d013cfe4b9b1a</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1159%2F000347166&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000347166%26sid%3Dliteratum%253Aachs%26aulast%3DHagland%26aufirst%3DH.%2BR.%26aulast%3DBerg%26aufirst%3DM.%26aulast%3DJolma%26aufirst%3DI.%2BW.%26aulast%3DCarlsen%26aufirst%3DA.%26aulast%3DSoreide%26aufirst%3DK.%26atitle%3DMolecular%2520pathways%2520and%2520cellular%2520metabolism%2520in%2520colorectal%2520cancer%26jtitle%3DDig.%2520Surg.%26date%3D2013%26volume%3D30%26spage%3D12%26epage%3D25%26doi%3D10.1159%2F000347166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pelucchi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Negri, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talamini, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giacosa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crispo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bidoli, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montella, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franceschi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La Vecchia, C.</span></span> <span> </span><span class="NLM_article-title">Metabolic syndrome is associated with colorectal cancer in men</span>. <i>Eur. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">1866</span>– <span class="NLM_lpage">1872</span>, <span class="refDoi"> DOI: 10.1016/j.ejca.2010.03.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=10.1016%2Fj.ejca.2010.03.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=20395126" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=1%3ACAS%3A280%3ADC%252BC3crgvVKruw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2010&pages=1866-1872&author=C.+Pelucchiauthor=E.+Negriauthor=R.+Talaminiauthor=F.+Leviauthor=A.+Giacosaauthor=A.+Crispoauthor=E.+Bidoliauthor=M.+Montellaauthor=S.+Franceschiauthor=C.+La+Vecchia&title=Metabolic+syndrome+is+associated+with+colorectal+cancer+in+men&doi=10.1016%2Fj.ejca.2010.03.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolic syndrome is associated with colorectal cancer in men</span></div><div class="casAuthors">Pelucchi Claudio; Negri Eva; Talamini Renato; Levi Fabio; Giacosa Attilio; Crispo Anna; Bidoli Ettore; Montella Maurizio; Franceschi Silvia; La Vecchia Carlo</div><div class="citationInfo"><span class="NLM_cas:title">European journal of cancer (Oxford, England : 1990)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1866-72</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">AIM OF THE STUDY:  We assessed the relation between metabolic syndrome (MetS) and its components and colorectal cancer.  METHODS:  We analysed data from a multicentre case-control study conducted in Italy and Switzerland, including 1378 cases of colon cancer, 878 cases of rectal cancer and 4661 controls.  All cases were incident and histologically confirmed.  Controls were subjects admitted to the same hospitals as cases with acute non-malignant conditions.  MetS was defined according to the International Diabetes Federation criteria.  Odds ratios (ORs) and the corresponding 95% confidence intervals (CIs) were estimated by multiple logistic regression models, including terms for major identified confounding factors for colorectal cancer.  RESULTS:  With reference to each component of the MetS, the ORs of colorectal cancer in men were 1.27 (95% CI, 0.95-1.69) for diabetes, 1.24 (95% CI, 1.03-1.48) for hypertension, 1.14 (95% CI, 0.93-1.40) for hypercholesterolaemia and 1.26 (95% CI, 1.08-1.48) for overweight at age 30.  The corresponding ORs in women were 1.20 (95% CI, 0.82-1.75), 0.87 (95% CI, 0.71-1.06), 0.83 (95% CI, 0.66-1.03) and 1.06 (95% CI, 0.86-1.30).  Colorectal cancer risk was increased in men (OR=1.86; 95% CI, 1.21-2.86), but not in women (OR=1.13; 95% CI, 0.66-1.93), with MetS.  The ORs were 2.09 (95% CI, 1.38-3.18) in men and 1.15 (95% CI, 0.68-1.94) in women with > or =3 components of the MetS, as compared to no component.  Results were similar for colon and rectal cancers.  CONCLUSION:  This study supports a direct association between MetS and both colon and rectal cancers in men, but not in women.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSQCpvg6KvC4QMthz5_Rx5rfW6udTcc2eapSKYNm22oQLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3crgvVKruw%253D%253D&md5=5672c912f26d0ad358a2d55444f88673</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.ejca.2010.03.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejca.2010.03.010%26sid%3Dliteratum%253Aachs%26aulast%3DPelucchi%26aufirst%3DC.%26aulast%3DNegri%26aufirst%3DE.%26aulast%3DTalamini%26aufirst%3DR.%26aulast%3DLevi%26aufirst%3DF.%26aulast%3DGiacosa%26aufirst%3DA.%26aulast%3DCrispo%26aufirst%3DA.%26aulast%3DBidoli%26aufirst%3DE.%26aulast%3DMontella%26aufirst%3DM.%26aulast%3DFranceschi%26aufirst%3DS.%26aulast%3DLa%2BVecchia%26aufirst%3DC.%26atitle%3DMetabolic%2520syndrome%2520is%2520associated%2520with%2520colorectal%2520cancer%2520in%2520men%26jtitle%3DEur.%2520J.%2520Cancer%26date%3D2010%26volume%3D46%26spage%3D1866%26epage%3D1872%26doi%3D10.1016%2Fj.ejca.2010.03.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Song, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartlett, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwon, Y. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, Y. J.</span></span> <span> </span><span class="NLM_article-title">Role of AMP-activated protein kinase in cross-talk between apoptosis and autophagy in human colon cancer</span>. <i>Cell Death Dis.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">e1504</span>, <span class="refDoi"> DOI: 10.1038/cddis.2014.463</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=10.1038%2Fcddis.2014.463" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=25356873" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVKmtLfK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=e1504&author=X.+Songauthor=S.+Y.+Kimauthor=L.+Zhangauthor=D.+Tangauthor=D.+L.+Bartlettauthor=Y.+T.+Kwonauthor=Y.+J.+Lee&title=Role+of+AMP-activated+protein+kinase+in+cross-talk+between+apoptosis+and+autophagy+in+human+colon+cancer&doi=10.1038%2Fcddis.2014.463"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Role of AMP-activated protein kinase in cross-talk between apoptosis and autophagy in human colon cancer</span></div><div class="casAuthors">Song, X.; Kim, S.-Y.; Zhang, L.; Tang, D.; Bartlett, D. L.; Kwon, Y. T.; Lee, Y. J.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Disease</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">e1504</span>CODEN:
                <span class="NLM_cas:coden">CDDEA4</span>;
        ISSN:<span class="NLM_cas:issn">2041-4889</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Unresectable colorectal liver metastases remain a major unresolved issue and more effective novel regimens are urgently needed.  While screening synergistic drug combinations for colon cancer therapy, we identified a novel multidrug treatment for colon cancer: chemotherapeutic agent melphalan in combination with proteasome inhibitor bortezomib and mTOR (mammalian target of rapamycin) inhibitor rapamycin.  We investigated the mechanisms of synergistic antitumor efficacy during the multidrug treatment.  All expts. were performed with highly metastatic human colon cancer CX-1 and HCT116 cells, and selected crit. expts. were repeated with human colon cancer stem Tu-22 cells and mouse embryo fibroblast (MEF) cells.  We used immunochem. techniques to investigate a cross-talk between apoptosis and autophagy during the multidrug treatment.  We obsd. that melphalan triggered apoptosis, bortezomib induced apoptosis and autophagy, rapamycin caused autophagy and the combinatorial treatment-induced synergistic apoptosis, which was mediated through an increase in caspase activation.  We also obsd. that mitochondrial dysfunction induced by the combination was linked with altered cellular metab., which induced adenosine monophosphate-activated protein kinase (AMPK) activation, resulting in Beclin-1 phosphorylated at Ser 93/96.  Interestingly, Beclin-1 phosphorylated at Ser 93/96 is sufficient to induce Beclin-1 cleavage by caspase-8, which switches off autophagy to achieve the synergistic induction of apoptosis.  Similar results were obsd. with the essential autophagy gene, autophagy-related protein 7, -deficient MEF cells.  The multidrug treatment-induced Beclin-1 cleavage was abolished in Beclin-1 double-mutant (D133A/D146A) knock-in HCT116 cells, restoring the autophagy-promoting function of Beclin-1 and suppressing the apoptosis induced by the combination therapy.  These observations identify a novel mechanism for AMPK-induced apoptosis through interplay between autophagy and apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIUWI7ARnuYrVg90H21EOLACvtfcHk0lh5KxTVu42jjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVKmtLfK&md5=d065754171b8c8d2244b9256cac3afa8</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1038%2Fcddis.2014.463&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcddis.2014.463%26sid%3Dliteratum%253Aachs%26aulast%3DSong%26aufirst%3DX.%26aulast%3DKim%26aufirst%3DS.%2BY.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DTang%26aufirst%3DD.%26aulast%3DBartlett%26aufirst%3DD.%2BL.%26aulast%3DKwon%26aufirst%3DY.%2BT.%26aulast%3DLee%26aufirst%3DY.%2BJ.%26atitle%3DRole%2520of%2520AMP-activated%2520protein%2520kinase%2520in%2520cross-talk%2520between%2520apoptosis%2520and%2520autophagy%2520in%2520human%2520colon%2520cancer%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2014%26volume%3D5%26spage%3De1504%26doi%3D10.1038%2Fcddis.2014.463" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, Y. Y.</span></span> <span> </span><span class="NLM_article-title">Targeting the AMP-activated protein kinase for cancer prevention and therapy</span>. <i>Front. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">175</span>, <span class="refDoi"> DOI: 10.3389/fonc.2013.00175</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=10.3389%2Ffonc.2013.00175" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=23875169" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=1%3ACAS%3A280%3ADC%252BC3sfivVeltw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2013&pages=175&author=I.+Kimauthor=Y.+Y.+He&title=Targeting+the+AMP-activated+protein+kinase+for+cancer+prevention+and+therapy&doi=10.3389%2Ffonc.2013.00175"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the AMP-Activated Protein Kinase for Cancer Prevention and Therapy</span></div><div class="casAuthors">Kim Inyoung; He Yu-Ying</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in oncology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">175</span>
        ISSN:<span class="NLM_cas:issn">2234-943X</span>.
    </div><div class="casAbstract">Despite the advances in biomedical research and clinical applications, cancer remains a leading cause of death worldwide.  Given the limitations of conventional chemotherapeutics, including serious toxicities and reduced quality of life for patients, the development of safe and efficacious alternatives with known mechanism of action is much needed.  Prevention of cancer through dietary intervention may hold promise and has been investigated extensively in the recent years.  AMP-activated protein kinase (AMPK) is an energy sensor that plays a key role in the regulation of protein and lipid metabolism in response to changes in fuel availability.  When activated, AMPK promotes energy-producing catabolic pathways while inhibiting anabolic pathways, such as cell growth and proliferation - thereby antagonizing carcinogenesis.  Other anti-cancer effects of AMPK may include promoting autophagy and DNA repair upon UVB damage.  In the last decade, interest in AMPK has grown extensively as it emerged as an attractive target molecule for cancer prevention and treatment.  Among the latest developments is the activation of AMPK by naturally occurring dietary constituents and plant products - termed phytochemicals.  Owing to their efficacy and safety, phytochemicals are considered as an alternative to the conventional harmful chemotherapy.  The rising popularity of using phytochemicals for cancer prevention and therapy is supported by a substantial progress in identifying the molecular pathways involved, including AMPK.  In this article, we review the recent progress in this budding field that suggests AMPK as a new molecular target in the prevention and treatment of cancer by phytochemicals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT4H8fzaLSSUtLIORRPd5lbfW6udTcc2ebWYOtgp6c5erntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3sfivVeltw%253D%253D&md5=f9042799e2826a9703323cecf854f7c2</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.3389%2Ffonc.2013.00175&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffonc.2013.00175%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DI.%26aulast%3DHe%26aufirst%3DY.%2BY.%26atitle%3DTargeting%2520the%2520AMP-activated%2520protein%2520kinase%2520for%2520cancer%2520prevention%2520and%2520therapy%26jtitle%3DFront.%2520Oncol.%26date%3D2013%26volume%3D3%26spage%3D175%26doi%3D10.3389%2Ffonc.2013.00175" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zulato, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergamo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Paoli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griguolo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esposito, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Salvo, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mescoli, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rugge, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nardin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Grazia, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lonardi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Indraccolo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zagonel, V.</span></span> <span> </span><span class="NLM_article-title">Prognostic significance of AMPK activation in advanced stage colorectal cancer treated with chemotherapy plus bevacizumab</span>. <i>Br. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>111</i></span>,  <span class="NLM_fpage">25</span>– <span class="NLM_lpage">32</span>, <span class="refDoi"> DOI: 10.1038/bjc.2014.274</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=10.1038%2Fbjc.2014.274" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=24892446" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpsVansLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2014&pages=25-32&author=E.+Zulatoauthor=F.+Bergamoauthor=A.+De+Paoliauthor=G.+Griguoloauthor=G.+Espositoauthor=G.+L.+De+Salvoauthor=C.+Mescoliauthor=M.+Ruggeauthor=M.+Nardinauthor=L.+Di+Graziaauthor=S.+Lonardiauthor=S.+Indraccoloauthor=V.+Zagonel&title=Prognostic+significance+of+AMPK+activation+in+advanced+stage+colorectal+cancer+treated+with+chemotherapy+plus+bevacizumab&doi=10.1038%2Fbjc.2014.274"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Prognostic significance of AMPK activation in advanced stage colorectal cancer treated with chemotherapy plus bevacizumab</span></div><div class="casAuthors">Zulato, E.; Bergamo, F.; De Paoli, A.; Griguolo, G.; Esposito, G.; De Salvo, G. L.; Mescoli, C.; Rugge, M.; Nardin, M.; Di Grazia, L.; Lonardi, S.; Indraccolo, S.; Zagonel, V.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">25-32</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Background: AMP-activated protein kinase (AMPK) has a central role in cellular energy sensing and is activated in preclin. tumor models following anti-vascular endothelial growth factor (VEGF) therapy.  The possible predictive or prognostic role of AMPK status in cancer patients treated with anti-VEGF drugs has not been investigated so far.  Methods: Expression of components of the AMPK pathway including phosphorylated AMPK (pAMPK), phosphorylated acetyl-Coa carboxylase (pACC) and liver kinase B1 (LKB1) was investigated by immunohistochem. in 48 colorectal cancers treated with FOLFIRI plus bevacizumab.  Correlation between pAMPK and pACC and assocns. between the AMPK pathway scores and clinico-pathol. characteristics were assessed.  Overall survival (OS) was estd. through Kaplan-Meier method, whereas hazard ratios were computed to identify prognostic factors.  Results: Fourteen patients (29.2%) were included in the pAMPK-neg. group (score ≤5), whereas 34 patients (70.8%) were included in the pAMPK-pos. group (score >5).  The Spearman's coeff. for the correlation between pAMPK and pACC scores in primary tumor samples was 0.514 (P=0.0002).  Low pAMPK levels were assocd. with worse OS (P-value 0.0002) but not with PFS, whereas low pACC levels were assocd. both with worse OS and PFS (P-value 0.0007 and 0.01, resp.).  Conclusions: Our findings suggest that high tissue AMPK activation is a prognostic biomarker in this cohort of metastatic colorectal cancer patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlctDDEerg-rVg90H21EOLACvtfcHk0lj1k2WCe7AyXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpsVansLc%253D&md5=aa23f7da603767dfc5edd9c1ddf378c3</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1038%2Fbjc.2014.274&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbjc.2014.274%26sid%3Dliteratum%253Aachs%26aulast%3DZulato%26aufirst%3DE.%26aulast%3DBergamo%26aufirst%3DF.%26aulast%3DDe%2BPaoli%26aufirst%3DA.%26aulast%3DGriguolo%26aufirst%3DG.%26aulast%3DEsposito%26aufirst%3DG.%26aulast%3DDe%2BSalvo%26aufirst%3DG.%2BL.%26aulast%3DMescoli%26aufirst%3DC.%26aulast%3DRugge%26aufirst%3DM.%26aulast%3DNardin%26aufirst%3DM.%26aulast%3DDi%2BGrazia%26aufirst%3DL.%26aulast%3DLonardi%26aufirst%3DS.%26aulast%3DIndraccolo%26aufirst%3DS.%26aulast%3DZagonel%26aufirst%3DV.%26atitle%3DPrognostic%2520significance%2520of%2520AMPK%2520activation%2520in%2520advanced%2520stage%2520colorectal%2520cancer%2520treated%2520with%2520chemotherapy%2520plus%2520bevacizumab%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2014%26volume%3D111%26spage%3D25%26epage%3D32%26doi%3D10.1038%2Fbjc.2014.274" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Din, F. V. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valanciute, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houde, V. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zibrova, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakamoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alessi, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunlop, M. G.</span></span> <span> </span><span class="NLM_article-title">Aspirin inhibits mTOR signaling, activates AMP-activated protein kinase, and induces autophagy in colorectal cancer cells</span>. <i>Gastroenterology</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>142</i></span>,  <span class="NLM_fpage">1504</span>– <span class="NLM_lpage">15</span>, <span class="refDoi"> DOI: 10.1053/j.gastro.2012.02.050</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=10.1053%2Fj.gastro.2012.02.050" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=22406476" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=1%3ACAS%3A528%3ADC%252BC38XnslShsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=142&publication_year=2012&pages=1504-15&author=F.+V.+N.+Dinauthor=A.+Valanciuteauthor=V.+P.+Houdeauthor=D.+Zibrovaauthor=K.+A.+Greenauthor=K.+Sakamotoauthor=D.+R.+Alessiauthor=M.+G.+Dunlop&title=Aspirin+inhibits+mTOR+signaling%2C+activates+AMP-activated+protein+kinase%2C+and+induces+autophagy+in+colorectal+cancer+cells&doi=10.1053%2Fj.gastro.2012.02.050"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Aspirin Inhibits mTOR Signaling, Activates AMP-Activated Protein Kinase, and Induces Autophagy in Colorectal Cancer Cells</span></div><div class="casAuthors">Din, Farhat V. N.; Valanciute, Asta; Houde, Vanessa P.; Zibrova, Daria; Green, Kevin A.; Sakamoto, Kei; Alessi, Dario R.; Dunlop, Malcolm G.</div><div class="citationInfo"><span class="NLM_cas:title">Gastroenterology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">142</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1504-1515.e3</span>CODEN:
                <span class="NLM_cas:coden">GASTAB</span>;
        ISSN:<span class="NLM_cas:issn">0016-5085</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Aspirin reduces the incidence of and mortality from colorectal cancer (CRC) by unknown mechanisms.  Cancer cells have defects in signaling via the mechanistic target of rapamycin (mTOR), which regulates proliferation.  We investigated whether aspirin affects adenosine monophosphate-activated protein kinase (AMPK) and mTOR signaling in CRC cells.  The effects of aspirin on mTOR signaling, the ribosomal protein S6, S6 kinase 1 (S6K1), and eukaryotic translation initiation factor 4E binding protein 1 (4E-BP1) were examd. in CRC cells by immunoblotting.  Phosphorylation of AMPK was measured; the effects of loss of AMPKα on the aspirin-induced effects of mTOR were detd. using small interfering RNA (siRNA) in CRC cells and in AMPKα1/a2-/- mouse embryonic fibroblasts.  LC3 and ULK1 were used as markers of autophagy.  We analyzed rectal mucosa samples from patients given 600 mg aspirin, once daily for 1 wk.  Aspirin reduced mTOR signaling in CRC cells by inhibiting the mTOR effectors S6K1 and 4E-BP1.  Aspirin changed nucleotide ratios and activated AMPK in CRC cells. mTOR was still inhibited by aspirin in CRC cells after siRNA knockdown of AMPKα, indicating AMPK-dependent and AMPK-independent mechanisms of aspirin-induced inhibition of mTOR.  Aspirin induced autophagy, a feature of mTOR inhibition.  Aspirin and metformin (an activator of AMPK) increased inhibition of mTOR and Akt, as well as autophagy in CRC cells.  Rectal mucosal samples from patients given aspirin had reduced phosphorylation of S6K1 and S6.  Aspirin is an inhibitor of mTOR and an activator of AMPK, targeting regulators of intracellular energy homeostasis and metab.  These could contribute to its protective effects against development of CRC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqreBjSRON-CLVg90H21EOLACvtfcHk0lj1k2WCe7AyXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnslShsLw%253D&md5=1c774a4ac04f9ac551f414f7bd57b45b</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1053%2Fj.gastro.2012.02.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1053%252Fj.gastro.2012.02.050%26sid%3Dliteratum%253Aachs%26aulast%3DDin%26aufirst%3DF.%2BV.%2BN.%26aulast%3DValanciute%26aufirst%3DA.%26aulast%3DHoude%26aufirst%3DV.%2BP.%26aulast%3DZibrova%26aufirst%3DD.%26aulast%3DGreen%26aufirst%3DK.%2BA.%26aulast%3DSakamoto%26aufirst%3DK.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26aulast%3DDunlop%26aufirst%3DM.%2BG.%26atitle%3DAspirin%2520inhibits%2520mTOR%2520signaling%252C%2520activates%2520AMP-activated%2520protein%2520kinase%252C%2520and%2520induces%2520autophagy%2520in%2520colorectal%2520cancer%2520cells%26jtitle%3DGastroenterology%26date%3D2012%26volume%3D142%26spage%3D1504%26epage%3D15%26doi%3D10.1053%2Fj.gastro.2012.02.050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lea, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pourat, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">desBordes, C.</span></span> <span> </span><span class="NLM_article-title">Growth inhibition of colon cancer cells by compounds affecting AMPK activity</span>. <i>World J. Gastrointest. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">244</span>– <span class="NLM_lpage">252</span>, <span class="refDoi"> DOI: 10.4251/wjgo.v6.i7.244</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=10.4251%2Fwjgo.v6.i7.244" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=25024815" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=1%3ACAS%3A280%3ADC%252BC2cbisFWksg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=244-252&author=M.+A.+Leaauthor=J.+Pouratauthor=R.+Patelauthor=C.+desBordes&title=Growth+inhibition+of+colon+cancer+cells+by+compounds+affecting+AMPK+activity&doi=10.4251%2Fwjgo.v6.i7.244"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Growth inhibition of colon cancer cells by compounds affecting AMPK activity</span></div><div class="casAuthors">Lea Michael A; Pourat Jacob; Patel Rupali; desBordes Charles</div><div class="citationInfo"><span class="NLM_cas:title">World journal of gastrointestinal oncology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">244-52</span>
        ISSN:<span class="NLM_cas:issn">1948-5204</span>.
    </div><div class="casAbstract">AIM:  To determine if other molecules reported to modulate AMP-dependent protein kinase (AMPK) activity would have effects resembling those of metformin and phenformin on colon cancer cell proliferation and metabolism.  METHODS:  Studies were performed with four human colon cancer cell lines, Caco-2, HCT116, HT29 and SW1116.  The compounds that were studied included A-769662, 5-aminoimidazole-4-carboxamide-1-ribofuranoside, butyrate, (-)-epigallocatechin gallate (EGCG), KU-55933, quercetin, resveratrol and salicylates.  The parameters that were measured were cell proliferation and viability, glucose uptake, lactate production and acidification of the incubation medium.  RESULTS:  Investigations with several molecules that have been reported to be associated with AMPK activation (A-769662, 5-aminoimidazole-4-carboxamide-1-b-D-ribofuranoside, EGCG, KU-55933, quercetin, resveratrol and salicylates) or AMPK inhibition (compound C) failed to reveal increased medium acidification and increased glucose uptake in colon cancer cells as previously established with metformin and phenformin.  The only exception was 5-aminosalicylic acid with which there were apparently lower glucose levels in the medium after incubation for 72 h.  Further study in the absence of cells revealed that the effect was an artifact due to inhibition of the enzyme-linked glucose assay.  The compounds were studied at concentrations that inhibited cell proliferation.  CONCLUSION:  It was concluded that treatment with several agents that can affect AMPK activity resulted in the inhibition of the proliferation of colon cancer cells under conditions in which glucose metabolism is not enhanced, in contrast to the effect of biguanides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT__DMPwHFhGOdfST00W0BcfW6udTcc2eZiBVTrDrl4Irntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cbisFWksg%253D%253D&md5=0cce380e5276fdc219377a257b970e7f</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.4251%2Fwjgo.v6.i7.244&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4251%252Fwjgo.v6.i7.244%26sid%3Dliteratum%253Aachs%26aulast%3DLea%26aufirst%3DM.%2BA.%26aulast%3DPourat%26aufirst%3DJ.%26aulast%3DPatel%26aufirst%3DR.%26aulast%3DdesBordes%26aufirst%3DC.%26atitle%3DGrowth%2520inhibition%2520of%2520colon%2520cancer%2520cells%2520by%2520compounds%2520affecting%2520AMPK%2520activity%26jtitle%3DWorld%2520J.%2520Gastrointest.%2520Oncol.%26date%3D2014%26volume%3D6%26spage%3D244%26epage%3D252%26doi%3D10.4251%2Fwjgo.v6.i7.244" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ling, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, K.</span></span> <span> </span><span class="NLM_article-title">NPC-26 kills human colorectal cancer cells via activating AMPK signaling</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">18312</span>– <span class="NLM_lpage">18321</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.15436</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=10.18632%2Foncotarget.15436" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=28407688" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=1%3ACAS%3A280%3ADC%252BC1cvns1Chtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=18312-18321&author=Z.+Zhaoauthor=L.+Fengauthor=J.+Wangauthor=D.+Chengauthor=M.+Liuauthor=M.+Lingauthor=W.+Xuauthor=K.+Sun&title=NPC-26+kills+human+colorectal+cancer+cells+via+activating+AMPK+signaling&doi=10.18632%2Foncotarget.15436"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">NPC-26 kills human colorectal cancer cells via activating AMPK signaling</span></div><div class="casAuthors">Zhao Zhen; Feng Li; Wang Jiqin; Cheng Deshan; Liu Mei; Ling Meirong; Sun Keyu; Xu Weiping</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">18312-18321</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">NPC-26 is novel mitochondrion-interfering compound.  The current study tested its potential effect against colorectal cancer (CRC) cells.  We demonstrated that NPC-26 induced potent anti-proliferative and cytotoxic activities against CRC cell lines (HCT-116, DLD-1 and HT-29).  Activation of AMP-activated protein kinase (AMPK) signaling mediated NPC-26-induced CRC cell death.  AMPKα1 shRNA knockdown or dominant negative mutation abolished NPC-26-induced AMPK activation and subsequent CRC cell death.  NPC-26 disrupted mitochondrial function, causing mitochondrial permeability transition pore (mPTP) opening and reactive oxygen species (ROS) production.  ROS scavengers (NAC or MnTBAP) and mPTP blockers (cyclosporin A or sanglifehrin A) blocked NPC-26-induced AMPK activation and attenuated CRC cell death.  Significantly, intraperitoneal injection of NPC-26 potently inhibited HCT-116 tumor growth in severe combined immuno-deficient (SCID) mice.  Yet, its anti-tumor activity was significantly weakened against AMPKα1-silenced HCT-116 tumors.  Together, we conclude that NPC-26 kills CRC cells possibly via activating AMPK signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRDBx0_VHiayLP3FVUi_gf8fW6udTcc2eaPKyJMt_EXT7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cvns1Chtg%253D%253D&md5=c1da476c1e20e4d4c5d1b6b1991c5b91</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.15436&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.15436%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DZ.%26aulast%3DFeng%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DCheng%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DLing%26aufirst%3DM.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DSun%26aufirst%3DK.%26atitle%3DNPC-26%2520kills%2520human%2520colorectal%2520cancer%2520cells%2520via%2520activating%2520AMPK%2520signaling%26jtitle%3DOncotarget%26date%3D2017%26volume%3D8%26spage%3D18312%26epage%3D18321%26doi%3D10.18632%2Foncotarget.15436" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mogavero, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maiorana, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zanutto, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varinelli, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bozzi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belfiore, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Volpi, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gloghini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pierotti, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gariboldi, M.</span></span> <span> </span><span class="NLM_article-title">Metformin transiently inhibits colorectal cancer cell proliferation as a result of either AMPK activation or increased ROS production</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">15992</span>, <span class="refDoi"> DOI: 10.1038/s41598-017-16149-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=10.1038%2Fs41598-017-16149-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=29167573" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=1%3ACAS%3A280%3ADC%252BC1M3ktFykuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=15992&author=A.+Mogaveroauthor=M.+V.+Maioranaauthor=S.+Zanuttoauthor=L.+Varinelliauthor=F.+Bozziauthor=A.+Belfioreauthor=C.+C.+Volpiauthor=A.+Gloghiniauthor=M.+A.+Pierottiauthor=M.+Gariboldi&title=Metformin+transiently+inhibits+colorectal+cancer+cell+proliferation+as+a+result+of+either+AMPK+activation+or+increased+ROS+production&doi=10.1038%2Fs41598-017-16149-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Metformin transiently inhibits colorectal cancer cell proliferation as a result of either AMPK activation or increased ROS production</span></div><div class="casAuthors">Mogavero Angela; Maiorana Maria Valeria; Zanutto Susanna; Varinelli Luca; Gariboldi Manuela; Mogavero Angela; Maiorana Maria Valeria; Zanutto Susanna; Varinelli Luca; Pierotti Marco A; Gariboldi Manuela; Bozzi Fabio; Belfiore Antonino; Volpi Chiara C; Gloghini Annunziata</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">15992</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Metformin is a widely used and well-tolerated anti-diabetic drug that can reduce cancer risk and improve the prognosis of certain malignancies.  However, the mechanism underlying its anti-cancer effect is still unclear.  We studied the anti-cancer activity of metformin on colorectal cancer (CRC) by using the drug to treat HT29, HCT116 and HCT116 p53-/- CRC cells.  Metformin reduced cell proliferation and migration by inducing cell cycle arrest in the G0/G1 phase.  This was accompanied by a sharp decrease in the expression of c-Myc and down-regulation of IGF1R.  The anti-proliferative action of metformin was mediated by two different mechanisms: AMPK activation and increase in the production of reactive oxygen species, which suppressed the mTOR pathway and its downstream targets S6 and 4EBP1.  A reduction in CD44 and LGR5 expression suggested that the drug had an effect on tumour cells with stem characteristics.  However, a colony formation assay showed that metformin slowed the cells' ability to form colonies without arresting cell growth, as confirmed by absence of apoptosis, autophagy or senescence.  Our finding that metformin only transiently arrests CRC cell growth suggests that efforts should be made to identify compounds that combined with the biguanide can act synergistically to induce cell death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRlRnWYxiDmx9NTrvPZP1IpfW6udTcc2eaPKyJMt_EXT7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1M3ktFykuw%253D%253D&md5=3b5e9ba4c67d27e364579cbf0ee97398</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1038%2Fs41598-017-16149-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-017-16149-z%26sid%3Dliteratum%253Aachs%26aulast%3DMogavero%26aufirst%3DA.%26aulast%3DMaiorana%26aufirst%3DM.%2BV.%26aulast%3DZanutto%26aufirst%3DS.%26aulast%3DVarinelli%26aufirst%3DL.%26aulast%3DBozzi%26aufirst%3DF.%26aulast%3DBelfiore%26aufirst%3DA.%26aulast%3DVolpi%26aufirst%3DC.%2BC.%26aulast%3DGloghini%26aufirst%3DA.%26aulast%3DPierotti%26aufirst%3DM.%2BA.%26aulast%3DGariboldi%26aufirst%3DM.%26atitle%3DMetformin%2520transiently%2520inhibits%2520colorectal%2520cancer%2520cell%2520proliferation%2520as%2520a%2520result%2520of%2520either%2520AMPK%2520activation%2520or%2520increased%2520ROS%2520production%26jtitle%3DSci.%2520Rep.%26date%3D2017%26volume%3D7%26spage%3D15992%26doi%3D10.1038%2Fs41598-017-16149-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Horn, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferretti, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ebel, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tam, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harbinski, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farsidjani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zubrowski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sellers, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlegel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porter, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wuerthner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeay, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greshock, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halilovic, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garraway, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caponigro, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehár, J.</span></span> <span> </span><span class="NLM_article-title">High-order drug combinations are required to effectively kill colorectal cancer cells</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>76</i></span>,  <span class="NLM_fpage">6950</span>– <span class="NLM_lpage">6963</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-15-3425</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=10.1158%2F0008-5472.CAN-15-3425" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=27659046" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvFyntrjN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2016&pages=6950-6963&author=T.+Hornauthor=S.+Ferrettiauthor=N.+Ebelauthor=A.+Tamauthor=S.+Hoauthor=F.+Harbinskiauthor=A.+Farsidjaniauthor=M.+Zubrowskiauthor=W.+R.+Sellersauthor=R.+Schlegelauthor=D.+Porterauthor=E.+Morrisauthor=J.+Wuerthnerauthor=S.+Jeayauthor=J.+Greshockauthor=E.+Halilovicauthor=L.+A.+Garrawayauthor=G.+Caponigroauthor=J.+Leh%C3%A1r&title=High-order+drug+combinations+are+required+to+effectively+kill+colorectal+cancer+cells&doi=10.1158%2F0008-5472.CAN-15-3425"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">High-Order Drug Combinations Are Required to Effectively Kill Colorectal Cancer Cells</span></div><div class="casAuthors">Horn, Thomas; Ferretti, Stephane; Ebel, Nicolas; Tam, Angela; Ho, Samuel; Harbinski, Fred; Farsidjani, Ali; Zubrowski, Matthew; Sellers, William R.; Schlegel, Robert; Porter, Dale; Morris, Erick; Wuerthner, Jens; Jeay, Seebastien; Greshock, Joel; Halilovic, Ensar; Garraway, Levi A.; Caponigro, Giordano; Leheear, Joseph</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">6950-6963</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Like classical chemotherapy regimens used to treat cancer, targeted therapies will also rely upon polypharmacol., but tools are still lacking to predict which combinations of molecularly targeted drugs may be most efficacious.  In this study, we used image-based proliferation and apoptosis assays in colorectal cancer cell lines to systematically investigate the efficacy of combinations of two to six drugs that target crit. oncogenic pathways.  Drug pairs targeting key signaling pathways resulted in synergies across a broad spectrum of genetic backgrounds but often yielded only cytostatic responses.  Enhanced cytotoxicity was obsd. when addnl. processes including apoptosis and cell cycle were targeted as part of the combination.  In some cases, where cell lines were resistant to paired and tripled drugs, increased expression of antiapoptotic proteins was obsd., requiring a fourth-order combination to induce cytotoxicity.  Our results illustrate how high-order drug combinations are needed to kill drug-resistant cancer cells, and they also show how systematic drug combination screening together with a mol. understanding of drug responses may help define optimal cocktails to overcome aggressive cancers.  Cancer Res; 76(23); 6950-63. ©2016 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZzaN2TMxr4bVg90H21EOLACvtfcHk0lh9iYmCdEzh8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvFyntrjN&md5=5f788ac6a1a4d8d8f71f559902e8239e</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-15-3425&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-15-3425%26sid%3Dliteratum%253Aachs%26aulast%3DHorn%26aufirst%3DT.%26aulast%3DFerretti%26aufirst%3DS.%26aulast%3DEbel%26aufirst%3DN.%26aulast%3DTam%26aufirst%3DA.%26aulast%3DHo%26aufirst%3DS.%26aulast%3DHarbinski%26aufirst%3DF.%26aulast%3DFarsidjani%26aufirst%3DA.%26aulast%3DZubrowski%26aufirst%3DM.%26aulast%3DSellers%26aufirst%3DW.%2BR.%26aulast%3DSchlegel%26aufirst%3DR.%26aulast%3DPorter%26aufirst%3DD.%26aulast%3DMorris%26aufirst%3DE.%26aulast%3DWuerthner%26aufirst%3DJ.%26aulast%3DJeay%26aufirst%3DS.%26aulast%3DGreshock%26aufirst%3DJ.%26aulast%3DHalilovic%26aufirst%3DE.%26aulast%3DGarraway%26aufirst%3DL.%2BA.%26aulast%3DCaponigro%26aufirst%3DG.%26aulast%3DLeh%25C3%25A1r%26aufirst%3DJ.%26atitle%3DHigh-order%2520drug%2520combinations%2520are%2520required%2520to%2520effectively%2520kill%2520colorectal%2520cancer%2520cells%26jtitle%3DCancer%2520Res.%26date%3D2016%26volume%3D76%26spage%3D6950%26epage%3D6963%26doi%3D10.1158%2F0008-5472.CAN-15-3425" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, K.</span></span> <span> </span><span class="NLM_article-title">Identification and optimization of new dual inhibitors of B-Raf and epidermal growth factor receptor kinases for overcoming resistance against vemurafenib</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">2692</span>– <span class="NLM_lpage">2703</span>, <span class="refDoi"> DOI: 10.1021/jm500007h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500007h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjsVehsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=2692-2703&author=H.+Chengauthor=Y.+Changauthor=L.+Zhangauthor=J.+Luoauthor=Z.+Tuauthor=X.+Luauthor=Q.+Zhangauthor=J.+Luauthor=X.+Renauthor=K.+Ding&title=Identification+and+optimization+of+new+dual+inhibitors+of+B-Raf+and+epidermal+growth+factor+receptor+kinases+for+overcoming+resistance+against+vemurafenib&doi=10.1021%2Fjm500007h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and Optimization of New Dual Inhibitors of B-Raf and Epidermal Growth Factor Receptor Kinases for Overcoming Resistance against Vemurafenib</span></div><div class="casAuthors">Cheng, Huimin; Chang, Yu; Zhang, Lianwen; Luo, Jinfeng; Tu, Zhengchao; Lu, Xiaoyun; Zhang, Qingwen; Lu, Jibu; Ren, Xiaomei; Ding, Ke</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2692-2703</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Epidermal growth factor receptor (EGFR) amplification has been demonstrated to be crit. for the inherent and/or acquired resistance against current B-RafV600E inhibitor therapy for melanoma and colorectal cancer patients.  We describe the discovery and structure-activity relationship study of a series of 1H-pyrazolo[3,4-b]pyridine-5-carboxamide analogs as novel dual inhibitors of EGFR and B-RafV600E mutant.  One of the most promising compds., 6a, potently inhibited both of the kinases with IC50 values of 8.0 and 51 nM, resp.  The compd. also strongly suppressed the proliferation of a panel of intrinsic and acquired resistant melanoma and/or colorectal cancer cells harboring overexpressed EGFR with submicromolar IC50 values.  Further mechanism investigation revealed that 6a could sustainably inhibit the activation of the MAPK path way in the resistant SK-MEL-28 PR30 melanoma cancer cells and WiDr colorectal cancer cells with EGFR amplification.  Our results support the hypothesis that the EGFR/B-RafV600E dual inhibition might be a tractable strategy to overcome the intrinsic and acquired resistance of melanoma and/or colorectal cancers against the current B-RafV600E inhibitor therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMF_c1uFQz1rVg90H21EOLACvtfcHk0lh9iYmCdEzh8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjsVehsb4%253D&md5=1a7ab1f2017832bc3c1f4414efa2406b</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fjm500007h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500007h%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DH.%26aulast%3DChang%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DLuo%26aufirst%3DJ.%26aulast%3DTu%26aufirst%3DZ.%26aulast%3DLu%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DRen%26aufirst%3DX.%26aulast%3DDing%26aufirst%3DK.%26atitle%3DIdentification%2520and%2520optimization%2520of%2520new%2520dual%2520inhibitors%2520of%2520B-Raf%2520and%2520epidermal%2520growth%2520factor%2520receptor%2520kinases%2520for%2520overcoming%2520resistance%2520against%2520vemurafenib%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D2692%26epage%3D2703%26doi%3D10.1021%2Fjm500007h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lian, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, S. C.</span></span> <span> </span><span class="NLM_article-title">AMP as a low-energy charge signal autonomously initiates assembly of AXIN-AMPK-LKB1 complex for AMPK activation</span>. <i>Cell Metab.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">546</span>– <span class="NLM_lpage">555</span>, <span class="refDoi"> DOI: 10.1016/j.cmet.2013.09.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=10.1016%2Fj.cmet.2013.09.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=24093678" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFGnsrrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2013&pages=546-555&author=Y.+L.+Zhangauthor=H.+Guoauthor=C.+S.+Zhangauthor=S.+Y.+Linauthor=Z.+Yinauthor=Y.+Pengauthor=H.+Luoauthor=Y.+Shiauthor=G.+Lianauthor=C.+Zhangauthor=M.+Liauthor=Z.+Yeauthor=J.+Yeauthor=J.+Hanauthor=P.+Liauthor=J.+W.+Wuauthor=S.+C.+Lin&title=AMP+as+a+low-energy+charge+signal+autonomously+initiates+assembly+of+AXIN-AMPK-LKB1+complex+for+AMPK+activation&doi=10.1016%2Fj.cmet.2013.09.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">AMP as a Low-Energy Charge Signal Autonomously Initiates Assembly of AXIN-AMPK-LKB1 Complex for AMPK Activation</span></div><div class="casAuthors">Zhang, Ya-Lin; Guo, Huiling; Zhang, Chen-Song; Lin, Shu-Yong; Yin, Zhenyu; Peng, Yongying; Luo, Hui; Shi, Yuzhe; Lian, Guili; Zhang, Cixiong; Li, Mengqi; Ye, Zhiyun; Ye, Jing; Han, Jiahuai; Li, Peng; Wu, Jia-Wei; Lin, Sheng-Cai</div><div class="citationInfo"><span class="NLM_cas:title">Cell Metabolism</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">546-555</span>CODEN:
                <span class="NLM_cas:coden">CMEEB5</span>;
        ISSN:<span class="NLM_cas:issn">1550-4131</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">The AMP-activated protein kinase (AMPK) is a master regulator of metabolic homeostasis by sensing cellular energy status.  AMPK is mainly activated via phosphorylation by LKB1 when cellular AMP/ADP levels are increased.  However, how AMP/ADP brings about AMPK phosphorylation remains unclear.  Here, we show that it is AMP, but not ADP, that drives AXIN to directly tether LKB1 to phosphorylate AMPK.  The complex formation of AXIN-AMPK-LKB1 is greatly enhanced in glucose-starved or AICAR-treated cells and in cell-free systems supplemented with exogenous AMP.  Depletion of AXIN abrogated starvation-induced AMPK-LKB1 colocalization.  Importantly, adenovirus-based knockdown of AXIN in the mouse liver impaired AMPK activation and caused exacerbated fatty liver after starvation, underscoring an essential role of AXIN in AMPK activation.  These findings demonstrate an initiating role of AMP and demonstrate that AXIN directly transmits AMP binding of AMPK to its activation by LKB1, uncovering the mechanistic route for AMP to elicit AMPK activation by LKB1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoeX8mxHU1qyrVg90H21EOLACvtfcHk0lgbNH2RMCOoNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFGnsrrI&md5=47faacddecb471a0403172e9ea5dc557</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2Fj.cmet.2013.09.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cmet.2013.09.005%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DY.%2BL.%26aulast%3DGuo%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DC.%2BS.%26aulast%3DLin%26aufirst%3DS.%2BY.%26aulast%3DYin%26aufirst%3DZ.%26aulast%3DPeng%26aufirst%3DY.%26aulast%3DLuo%26aufirst%3DH.%26aulast%3DShi%26aufirst%3DY.%26aulast%3DLian%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DM.%26aulast%3DYe%26aufirst%3DZ.%26aulast%3DYe%26aufirst%3DJ.%26aulast%3DHan%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DP.%26aulast%3DWu%26aufirst%3DJ.%2BW.%26aulast%3DLin%26aufirst%3DS.%2BC.%26atitle%3DAMP%2520as%2520a%2520low-energy%2520charge%2520signal%2520autonomously%2520initiates%2520assembly%2520of%2520AXIN-AMPK-LKB1%2520complex%2520for%2520AMPK%2520activation%26jtitle%3DCell%2520Metab.%26date%3D2013%26volume%3D18%26spage%3D546%26epage%3D555%26doi%3D10.1016%2Fj.cmet.2013.09.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Obianom, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shu, Y.</span></span> <span> </span><span class="NLM_article-title">Tankyrases are druggable targets for the treatment of metabolic disorders</span>. <i>FASEB J.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">1189.5</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2016&pages=1189.5&author=O.+Obianomauthor=W.+Yangauthor=F.+Xueauthor=Y.+Shu&title=Tankyrases+are+druggable+targets+for+the+treatment+of+metabolic+disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DObianom%26aufirst%3DO.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DXue%26aufirst%3DF.%26aulast%3DShu%26aufirst%3DY.%26atitle%3DTankyrases%2520are%2520druggable%2520targets%2520for%2520the%2520treatment%2520of%2520metabolic%2520disorders%26jtitle%3DFASEB%2520J.%26date%3D2016%26volume%3D30%26spage%3D1189.5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hewitt, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMarlin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kleiner, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wersto, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsoskas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stamp, G. W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stetler-Stevenson, W. G.</span></span> <span> </span><span class="NLM_article-title">Validation of a model of colon cancer progression</span>. <i>J. Pathol.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>192</i></span>,  <span class="NLM_fpage">446</span>– <span class="NLM_lpage">454</span>, <span class="refDoi"> DOI: 10.1002/1096-9896(2000)9999:9999<::AID-PATH775>3.0.CO;2-K</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=10.1002%2F1096-9896%282000%299999%3A9999%3C%3A%3AAID-PATH775%3E3.0.CO%3B2-K" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=11113861" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=1%3ACAS%3A280%3ADC%252BD3M7hsFKisA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=192&publication_year=2000&pages=446-454&author=R.+E.+Hewittauthor=A.+McMarlinauthor=D.+Kleinerauthor=R.+Werstoauthor=P.+Martinauthor=M.+Tsoskasauthor=G.+W.+H.+Stampauthor=W.+G.+Stetler-Stevenson&title=Validation+of+a+model+of+colon+cancer+progression&doi=10.1002%2F1096-9896%282000%299999%3A9999%3C%3A%3AAID-PATH775%3E3.0.CO%3B2-K"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Validation of a model of colon cancer progression</span></div><div class="casAuthors">Hewitt R E; McMarlin A; Kleiner D; Wersto R; Martin P; Tsokos M; Stamp G W; Stetler-Stevenson W G; Tsoskas M</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of pathology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">192</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">446-54</span>
        ISSN:<span class="NLM_cas:issn">0022-3417</span>.
    </div><div class="casAbstract">A unique feature of SW480 and SW620 colon carcinoma cell lines is that they are derived from primary and secondary tumours resected from a single patient.  As such, they may represent a valuable resource for examining genetic changes late in colon cancer progression.  In order to verify this, both cell lines have been characterized to determine whether phenotypic differences have been retained despite long-term cell culture in vitro.  The primary tumour-derived SW480 cells have an epithelioid morphology in vitro, while metastasis-derived SW620 cells have a fibroblast-like appearance.  Xenografts of SW480 cells form gland-like structures in vivo, while SW620 xenografts form solid sheets of tumour cells.  SW620 cells have a higher BrdU labelling index than SW480 cells, and are more highly tumourigenic and metastatic.  Furthermore, SW620 cells show less susceptibility to apoptosis induction by TNFalpha and anti-Fas monoclonal.  Findings from these investigations therefore indicate that SW480 and SW620 cell lines do show appropriate phenotypic differences and represent an interesting model for studying the genetic events in the late stages of colon cancer progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSkuxKQQB4KCrFU0A1HOshhfW6udTcc2eZG_L9He6S-Mbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3M7hsFKisA%253D%253D&md5=18264cb57471ec8d24079784fe05500b</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1002%2F1096-9896%282000%299999%3A9999%3C%3A%3AAID-PATH775%3E3.0.CO%3B2-K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F1096-9896%25282000%25299999%253A9999%253C%253A%253AAID-PATH775%253E3.0.CO%253B2-K%26sid%3Dliteratum%253Aachs%26aulast%3DHewitt%26aufirst%3DR.%2BE.%26aulast%3DMcMarlin%26aufirst%3DA.%26aulast%3DKleiner%26aufirst%3DD.%26aulast%3DWersto%26aufirst%3DR.%26aulast%3DMartin%26aufirst%3DP.%26aulast%3DTsoskas%26aufirst%3DM.%26aulast%3DStamp%26aufirst%3DG.%2BW.%2BH.%26aulast%3DStetler-Stevenson%26aufirst%3DW.%2BG.%26atitle%3DValidation%2520of%2520a%2520model%2520of%2520colon%2520cancer%2520progression%26jtitle%3DJ.%2520Pathol.%26date%3D2000%26volume%3D192%26spage%3D446%26epage%3D454%26doi%3D10.1002%2F1096-9896%282000%299999%3A9999%3C%3A%3AAID-PATH775%3E3.0.CO%3B2-K" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45a"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45a'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit45a"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Myers, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fenyk-Melody, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ventre, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doebber, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujii, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Musi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirshman, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodyear, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">M?ller, D. E.</span></span> <span> </span><span class="NLM_article-title">Role of AMP-activated protein kinase in mechanism of metformin action</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>108</i></span>,  <span class="NLM_fpage">1167</span>– <span class="NLM_lpage">1174</span>, <span class="refDoi"> DOI: 10.1172/JCI13505</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45a/cit45a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=10.1172%2FJCI13505" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45a/cit45a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=11602624" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45a/cit45a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=1%3ACAS%3A528%3ADC%252BD3MXns1ChsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2001&pages=1167-1174&author=G.+Zhouauthor=R.+Myersauthor=Y.+Liauthor=Y.+Chenauthor=X.+Shenauthor=J.+Fenyk-Melodyauthor=M.+Wuauthor=J.+Ventreauthor=T.+Doebberauthor=N.+Fujiiauthor=N.+Musiauthor=M.+F.+Hirshmanauthor=L.+J.+Goodyearauthor=D.+E.+M%3Fller&title=Role+of+AMP-activated+protein+kinase+in+mechanism+of+metformin+action&doi=10.1172%2FJCI13505"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45aR"><div class="casContent"><span class="casTitleNuber">45a</span><div class="casTitle"><span class="NLM_cas:atitle">Role of AMP-activated protein kinase in mechanism of metformin action</span></div><div class="casAuthors">Zhou, Gaochao; Myers, Robert; Li, Ying; Chen, Yuli; Shen, Xiaolan; Fenyk-Melody, Judy; Wu, Margaret; Ventre, John; Doebber, Thomas; Fujii, Nobuharu; Musi, Nicolas; Hirshman, Michael F.; Goodyear, Laurie J.; Moller, David E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1167-1174</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    
            (<span class="NLM_cas:orgname">American Society for Clinical Investigation</span>)
        </div><div class="casAbstract">Metformin is a widely used drug for treatment of type 2 diabetes with no defined cellular mechanism of action.  Its glucose-lowering effect results from decreased hepatic glucose prodn. and increased glucose utilization.  Metformin's beneficial effects on circulating lipids have been linked to reduced fatty liver.  AMP-activated protein kinase (AMPK) is a major cellular regulator of lipid and glucose metab.  Here we report that metformin activates AMPK in hepatocytes; as a result, acetyl-CoA carboxylase (ACC) activity is reduced, fatty acid oxidn. is induced, and expression of lipogenic enzymes is suppressed.  Activation of AMPK by metformin or an adenosine analog suppresses expression of SREBP-1, a key lipogenic transcription factor.  In metformin-treated rats, hepatic expression of SREBP-1 (and other lipogenic) mRNAs and protein is reduced; activity of the AMPK target, ACC, is also reduced.  Using a novel AMPK inhibitor, we find that AMPK activation is required for metformin's inhibitory effect on glucose prodn. by hepatocytes.  In isolated rat skeletal muscles, metformin stimulates glucose uptake coincident with AMPK activation.  Activation of AMPK provides a unified explanation for the pleiotropic beneficial effects of this drug; these results also suggest that alternative means of modulating AMPK should be useful for the treatment of metabolic disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoT3nG6tsYQkLVg90H21EOLACvtfcHk0lh7UpBiNTcfhA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXns1ChsL4%253D&md5=a086134de3fd5ed011ed15761b46cf84</span></div><a href="/servlet/linkout?suffix=cit45a&amp;dbid=16384&amp;doi=10.1172%2FJCI13505&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI13505%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DG.%26aulast%3DMyers%26aufirst%3DR.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DShen%26aufirst%3DX.%26aulast%3DFenyk-Melody%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DM.%26aulast%3DVentre%26aufirst%3DJ.%26aulast%3DDoebber%26aufirst%3DT.%26aulast%3DFujii%26aufirst%3DN.%26aulast%3DMusi%26aufirst%3DN.%26aulast%3DHirshman%26aufirst%3DM.%2BF.%26aulast%3DGoodyear%26aufirst%3DL.%2BJ.%26aulast%3DM%253Fller%26aufirst%3DD.%2BE.%26atitle%3DRole%2520of%2520AMP-activated%2520protein%2520kinase%2520in%2520mechanism%2520of%2520metformin%2520action%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2001%26volume%3D108%26spage%3D1167%26epage%3D1174%26doi%3D10.1172%2FJCI13505" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hawley, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fullerton, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schertzer, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chevtzoff, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peggie, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zibrova, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mustard, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kemp, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakamoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinberg, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hardie, D. G.</span></span> <span> </span><span class="NLM_article-title">The ancient drug salicylate directly activates AMP-activated protein kinase</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>336</i></span>,  <span class="NLM_fpage">918</span>– <span class="NLM_lpage">922</span>, <span class="refDoi"> DOI: 10.1126/science.1215327</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=10.1126%2Fscience.1215327" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=22517326" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=1%3ACAS%3A528%3ADC%252BC38XmvFensLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=336&publication_year=2012&pages=918-922&author=S.+A.+Hawleyauthor=M.+D.+Fullertonauthor=F.+A.+Rossauthor=J.+D.+Schertzerauthor=C.+Chevtzoffauthor=K.+J.+Walkerauthor=M.+W.+Peggieauthor=D.+Zibrovaauthor=K.+A.+Greenauthor=K.+J.+Mustardauthor=B.+E.+Kempauthor=K.+Sakamotoauthor=G.+R.+Steinbergauthor=D.+G.+Hardie&title=The+ancient+drug+salicylate+directly+activates+AMP-activated+protein+kinase&doi=10.1126%2Fscience.1215327"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">The Ancient Drug Salicylate Directly Activates AMP-Activated Protein Kinase</span></div><div class="casAuthors">Hawley, Simon A.; Fullerton, Morgan D.; Ross, Fiona A.; Schertzer, Jonathan D.; Chevtzoff, Cyrille; Walker, Katherine J.; Peggie, Mark W.; Zibrova, Darya; Green, Kevin A.; Mustard, Kirsty J.; Kemp, Bruce E.; Sakamoto, Kei; Steinberg, Gregory R.; Hardie, D. Grahame</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">336</span>
        (<span class="NLM_cas:issue">6083</span>),
    <span class="NLM_cas:pages">918-922</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Salicylate, a plant product, has been in medicinal use since ancient times.  More recently, it has been replaced by synthetic derivs. such as aspirin and salsalate, both of which are rapidly broken down to salicylate in vivo.  At concns. reached in plasma after administration of salsalate or of aspirin at high doses, salicylate activates adenosine monophosphate-activated protein kinase (AMPK), a central regulator of cell growth and metab.  Salicylate binds at the same site as the synthetic activator A-769662 to cause allosteric activation and inhibition of dephosphorylation of the activating phosphorylation site, threonine-172.  In AMPK knockout mice, effects of salicylate to increase fat utilization and to lower plasma fatty acids in vivo were lost.  Our results suggest that AMPK activation could explain some beneficial effects of salsalate and aspirin in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPaLSPB1U5J7Vg90H21EOLACvtfcHk0lh7UpBiNTcfhA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmvFensLc%253D&md5=8abec5b63807f08dcdb74ed0332bb44a</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1126%2Fscience.1215327&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1215327%26sid%3Dliteratum%253Aachs%26aulast%3DHawley%26aufirst%3DS.%2BA.%26aulast%3DFullerton%26aufirst%3DM.%2BD.%26aulast%3DRoss%26aufirst%3DF.%2BA.%26aulast%3DSchertzer%26aufirst%3DJ.%2BD.%26aulast%3DChevtzoff%26aufirst%3DC.%26aulast%3DWalker%26aufirst%3DK.%2BJ.%26aulast%3DPeggie%26aufirst%3DM.%2BW.%26aulast%3DZibrova%26aufirst%3DD.%26aulast%3DGreen%26aufirst%3DK.%2BA.%26aulast%3DMustard%26aufirst%3DK.%2BJ.%26aulast%3DKemp%26aufirst%3DB.%2BE.%26aulast%3DSakamoto%26aufirst%3DK.%26aulast%3DSteinberg%26aufirst%3DG.%2BR.%26aulast%3DHardie%26aufirst%3DD.%2BG.%26atitle%3DThe%2520ancient%2520drug%2520salicylate%2520directly%2520activates%2520AMP-activated%2520protein%2520kinase%26jtitle%3DScience%26date%3D2012%26volume%3D336%26spage%3D918%26epage%3D922%26doi%3D10.1126%2Fscience.1215327" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hewitt, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMarlin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kleiner, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wersto, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsoskas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stamp, G. W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stetler-Stevenson, W. G.</span></span> <span> </span><span class="NLM_article-title">Validation of a model of colon cancer progressioin</span>. <i>J. Pathol.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>192</i></span>,  <span class="NLM_fpage">446</span>– <span class="NLM_lpage">454</span>, <span class="refDoi"> DOI: 10.1002/1096-9896(2000)9999:9999<::AID-PATH775>3.0.CO;2-K</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=10.1002%2F1096-9896%282000%299999%3A9999%3C%3A%3AAID-PATH775%3E3.0.CO%3B2-K" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=11113861" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=1%3ACAS%3A280%3ADC%252BD3M7hsFKisA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=192&publication_year=2000&pages=446-454&author=R.+E.+Hewittauthor=A.+McMarlinauthor=D.+Kleinerauthor=R.+Werstoauthor=P.+Martinauthor=M.+Tsoskasauthor=G.+W.+H.+Stampauthor=W.+G.+Stetler-Stevenson&title=Validation+of+a+model+of+colon+cancer+progressioin&doi=10.1002%2F1096-9896%282000%299999%3A9999%3C%3A%3AAID-PATH775%3E3.0.CO%3B2-K"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Validation of a model of colon cancer progression</span></div><div class="casAuthors">Hewitt R E; McMarlin A; Kleiner D; Wersto R; Martin P; Tsokos M; Stamp G W; Stetler-Stevenson W G; Tsoskas M</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of pathology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">192</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">446-54</span>
        ISSN:<span class="NLM_cas:issn">0022-3417</span>.
    </div><div class="casAbstract">A unique feature of SW480 and SW620 colon carcinoma cell lines is that they are derived from primary and secondary tumours resected from a single patient.  As such, they may represent a valuable resource for examining genetic changes late in colon cancer progression.  In order to verify this, both cell lines have been characterized to determine whether phenotypic differences have been retained despite long-term cell culture in vitro.  The primary tumour-derived SW480 cells have an epithelioid morphology in vitro, while metastasis-derived SW620 cells have a fibroblast-like appearance.  Xenografts of SW480 cells form gland-like structures in vivo, while SW620 xenografts form solid sheets of tumour cells.  SW620 cells have a higher BrdU labelling index than SW480 cells, and are more highly tumourigenic and metastatic.  Furthermore, SW620 cells show less susceptibility to apoptosis induction by TNFalpha and anti-Fas monoclonal.  Findings from these investigations therefore indicate that SW480 and SW620 cell lines do show appropriate phenotypic differences and represent an interesting model for studying the genetic events in the late stages of colon cancer progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSkuxKQQB4KCrFU0A1HOshhfW6udTcc2eaTjPwqfqst_Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3M7hsFKisA%253D%253D&md5=18264cb57471ec8d24079784fe05500b</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1002%2F1096-9896%282000%299999%3A9999%3C%3A%3AAID-PATH775%3E3.0.CO%3B2-K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F1096-9896%25282000%25299999%253A9999%253C%253A%253AAID-PATH775%253E3.0.CO%253B2-K%26sid%3Dliteratum%253Aachs%26aulast%3DHewitt%26aufirst%3DR.%2BE.%26aulast%3DMcMarlin%26aufirst%3DA.%26aulast%3DKleiner%26aufirst%3DD.%26aulast%3DWersto%26aufirst%3DR.%26aulast%3DMartin%26aufirst%3DP.%26aulast%3DTsoskas%26aufirst%3DM.%26aulast%3DStamp%26aufirst%3DG.%2BW.%2BH.%26aulast%3DStetler-Stevenson%26aufirst%3DW.%2BG.%26atitle%3DValidation%2520of%2520a%2520model%2520of%2520colon%2520cancer%2520progressioin%26jtitle%3DJ.%2520Pathol.%26date%3D2000%26volume%3D192%26spage%3D446%26epage%3D454%26doi%3D10.1002%2F1096-9896%282000%299999%3A9999%3C%3A%3AAID-PATH775%3E3.0.CO%3B2-K" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cardia, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corda, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fadda, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maccioni, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maccioni, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plumitallo, A.</span></span> <span> </span><span class="NLM_article-title">New cycloalkylpyrazoles as potential cyclooxygenase inhibitors</span>. <i>Farmaco</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">698</span>– <span class="NLM_lpage">708</span>, <span class="refDoi"> DOI: 10.1016/S0014-827X(98)00090-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=10.1016%2FS0014-827X%2898%2900090-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=10205857" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=1%3ACAS%3A528%3ADyaK1MXisVCht7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=1998&pages=698-708&author=M.+C.+Cardiaauthor=L.+Cordaauthor=A.+M.+Faddaauthor=A.+M.+Maccioniauthor=E.+Maccioniauthor=A.+Plumitallo&title=New+cycloalkylpyrazoles+as+potential+cyclooxygenase+inhibitors&doi=10.1016%2FS0014-827X%2898%2900090-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">New cycloalkylpyrazoles as potential cyclooxygenase inhibitors</span></div><div class="casAuthors">Cardia, M. C.; Corda, L.; Fadda, A. M.; Maccioni, A. M.; Maccioni, E.; Plumitallo, A.</div><div class="citationInfo"><span class="NLM_cas:title">Farmaco</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">10,11</span>),
    <span class="NLM_cas:pages">698-708</span>CODEN:
                <span class="NLM_cas:coden">FRMCE8</span>;
        ISSN:<span class="NLM_cas:issn">0014-827X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science S.A.</span>)
        </div><div class="casAbstract">In this study some cycloalkyl-3-(N-substituted carbamoyl)-1-phenylpyrazoles I (R = 3-NO2, 3-CF3, 4-Cl, 4-Me, 4-F, NR'R'' = morpholino, pyrrolidino, N-methylpiperazino) have been synthesized in order to screen their capability to inhibit human cyclooxygenase.  The synthetic pathway is based on the well known property of nitrilimines to undergo 1,3-dipolar cycloaddn. reactions.  Thus, cyclization of RPhNHN:CClCO2Et with enamine II (n = 1, 2) gave ester cycloadducts which were hydrolyzed and converted to the amide I.  The structures of all the synthesized compds. have been elucidated by means of both anal. and spectroscopic methods.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFxH3o5eGwV7Vg90H21EOLACvtfcHk0ligMUSFE6MxUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXisVCht7s%253D&md5=8b1953908b7ae56f0024641a50a727bc</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2FS0014-827X%2898%2900090-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-827X%252898%252900090-1%26sid%3Dliteratum%253Aachs%26aulast%3DCardia%26aufirst%3DM.%2BC.%26aulast%3DCorda%26aufirst%3DL.%26aulast%3DFadda%26aufirst%3DA.%2BM.%26aulast%3DMaccioni%26aufirst%3DA.%2BM.%26aulast%3DMaccioni%26aufirst%3DE.%26aulast%3DPlumitallo%26aufirst%3DA.%26atitle%3DNew%2520cycloalkylpyrazoles%2520as%2520potential%2520cyclooxygenase%2520inhibitors%26jtitle%3DFarmaco%26date%3D1998%26volume%3D53%26spage%3D698%26epage%3D708%26doi%3D10.1016%2FS0014-827X%2898%2900090-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Datterl, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trostner, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kucharski, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holzer, W.</span></span> <span> </span><span class="NLM_article-title">Heterocyclic analogues of xanthone and xanthione. 1<i>H</i>-pyrano[2,3-c:6,5-c]dipyrazol-4(7<i>H</i>)-ones and thiones: synthesis and NMR data</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">6106</span>– <span class="NLM_lpage">6126</span>, <span class="refDoi"> DOI: 10.3390/molecules15096106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=10.3390%2Fmolecules15096106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=20877210" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFejs7zF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2010&pages=6106-6126&author=B.+Datterlauthor=N.+Trostnerauthor=D.+Kucharskiauthor=W.+Holzer&title=Heterocyclic+analogues+of+xanthone+and+xanthione.+1H-pyrano%5B2%2C3-c%3A6%2C5-c%5Ddipyrazol-4%287H%29-ones+and+thiones%3A+synthesis+and+NMR+data&doi=10.3390%2Fmolecules15096106"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Preparation of 1H-pyrano[2,3-c:6,5-c]dipyrazol-4(7H)-ones and thiones as heterocyclic analogues of xanthone and xanthione</span></div><div class="casAuthors">Datterl, Barbara; Troestner, Nicole; Kucharski, Dorota; Holzer, Wolfgang</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">6106-6126</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">Molecular Diversity Preservation International</span>)
        </div><div class="casAbstract">The synthesis of the title compds. is described.  Reaction of 1-substituted 2-pyrazolin-5-ones with 5-chloro-1-phenyl-1H-pyrazole-4-carbonyl chloride or 5-chloro-3-methyl-1-phenyl-1H-pyrazole-4-carbonyl chloride, resp., using calcium hydroxide in refluxing 1,4-dioxane gave the corresponding 4-heteroaroylpyrazol-5-ols, e.g., I, which were cyclized into 1H-pyrano[2,3-c:6,5-c]dipyrazol-4(7H)-ones, e.g., II, by treatment with K2CO3/DMF.  The latter were converted into the corresponding thiones upon reaction with Lawesson's reagent.  Detailed NMR spectroscopic investigations (1H, 13C, 15N) of the ring systems and their precursors are presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqw9rBjDvGygLVg90H21EOLACvtfcHk0lhjt95j1KmkMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFejs7zF&md5=4d64ad6228f30f583626fb9ae67c2d7e</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.3390%2Fmolecules15096106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules15096106%26sid%3Dliteratum%253Aachs%26aulast%3DDatterl%26aufirst%3DB.%26aulast%3DTrostner%26aufirst%3DN.%26aulast%3DKucharski%26aufirst%3DD.%26aulast%3DHolzer%26aufirst%3DW.%26atitle%3DHeterocyclic%2520analogues%2520of%2520xanthone%2520and%2520xanthione.%25201H-pyrano%255B2%252C3-c%253A6%252C5-c%255Ddipyrazol-4%25287H%2529-ones%2520and%2520thiones%253A%2520synthesis%2520and%2520NMR%2520data%26jtitle%3DMolecules%26date%3D2010%26volume%3D15%26spage%3D6106%26epage%3D6126%26doi%3D10.3390%2Fmolecules15096106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref45a':['cit45a'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 10 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Zhiqing Liu, Pingyuan Wang, Eric A. Wold, Qiaoling Song, Chenyang Zhao, Changyun Wang, <span class="NLM_string-name hlFld-ContribAuthor">Jia Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Small-Molecule Inhibitors Targeting the Canonical WNT Signaling Pathway for the Treatment of Cancer. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (8)
                                     , 4257-4288. <a href="https://doi.org/10.1021/acs.jmedchem.0c01799" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01799</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01799&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01799%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSmall-Molecule%252BInhibitors%252BTargeting%252Bthe%252BCanonical%252BWNT%252BSignaling%252BPathway%252Bfor%252Bthe%252BTreatment%252Bof%252BCancer%26aulast%3DLiu%26aufirst%3DZhiqing%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D14102020%26date%3D06042021%26volume%3D64%26issue%3D8%26spage%3D4257%26epage%3D4288" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vrushabendra  Basavanna</span>, <span class="hlFld-ContribAuthor ">Srikantamurthy  Ningaiah</span>, <span class="hlFld-ContribAuthor ">Manasa  Chandramouli</span>, <span class="hlFld-ContribAuthor ">Anjali  Sobha</span>, <span class="hlFld-ContribAuthor ">Shridevi  Doddamani</span>. </span><span class="cited-content_cbyCitation_article-title">Quinolinyl-pyrazoles: synthesis and pharmacological evolution in the recent decennial. </span><span class="cited-content_cbyCitation_journal-name">Journal of the Iranian Chemical Society</span><span> <strong>2021,</strong> <em>18 </em>
                                    (7)
                                     , 1479-1522. <a href="https://doi.org/10.1007/s13738-020-02152-1" title="DOI URL">https://doi.org/10.1007/s13738-020-02152-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s13738-020-02152-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs13738-020-02152-1%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520Iranian%2520Chemical%2520Society%26atitle%3DQuinolinyl-pyrazoles%25253A%252Bsynthesis%252Band%252Bpharmacological%252Bevolution%252Bin%252Bthe%252Brecent%252Bdecennial%26aulast%3DBasavanna%26aufirst%3DVrushabendra%26date%3D2021%26date%3D2021%26volume%3D18%26issue%3D7%26spage%3D1479%26epage%3D1522" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">You-Guang  Zheng</span>, <span class="hlFld-ContribAuthor ">Xin  Pei</span>, <span class="hlFld-ContribAuthor ">De-Xin  Xia</span>, <span class="hlFld-ContribAuthor ">Yuan-Bo  Wang</span>, <span class="hlFld-ContribAuthor ">Ping  Jiang</span>, <span class="hlFld-ContribAuthor ">Lin  An</span>, <span class="hlFld-ContribAuthor ">Tong-Hui  Huang</span>, <span class="hlFld-ContribAuthor ">Yun-Sheng  Xue</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, and cytotoxic activity of novel 2H-imidazo[1,2-c]pyrazolo[3,4-e]pyrimidine derivatives. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2021,</strong> <em>109 </em>, 104711. <a href="https://doi.org/10.1016/j.bioorg.2021.104711" title="DOI URL">https://doi.org/10.1016/j.bioorg.2021.104711</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2021.104711&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2021.104711%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Band%252Bcytotoxic%252Bactivity%252Bof%252Bnovel%252B2H-imidazo%25255B1%25252C2-c%25255Dpyrazolo%25255B3%25252C4-e%25255Dpyrimidine%252Bderivatives%26aulast%3DZheng%26aufirst%3DYou-Guang%26date%3D2021%26volume%3D109%26spage%3D104711" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shiwei  Zhou</span>, <span class="hlFld-ContribAuthor ">Obinna  Obianom</span>, <span class="hlFld-ContribAuthor ">Jiangsheng  Huang</span>, <span class="hlFld-ContribAuthor ">Dong  Guo</span>, <span class="hlFld-ContribAuthor ">Hong  Yang</span>, <span class="hlFld-ContribAuthor ">Qing  Li</span>, <span class="hlFld-ContribAuthor ">Yan  Shu</span>. </span><span class="cited-content_cbyCitation_article-title">Pyrvinium Treatment Confers Hepatic Metabolic Benefits via β-Catenin Downregulation and AMPK Activation. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceutics</span><span> <strong>2021,</strong> <em>13 </em>
                                    (3)
                                     , 330. <a href="https://doi.org/10.3390/pharmaceutics13030330" title="DOI URL">https://doi.org/10.3390/pharmaceutics13030330</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/pharmaceutics13030330&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fpharmaceutics13030330%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceutics%26atitle%3DPyrvinium%252BTreatment%252BConfers%252BHepatic%252BMetabolic%252BBenefits%252Bvia%252B%2525CE%2525B2-Catenin%252BDownregulation%252Band%252BAMPK%252BActivation%26aulast%3DZhou%26aufirst%3DShiwei%26date%3D2021%26date%3D2021%26volume%3D13%26issue%3D3%26spage%3D330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wasim  Akhtar</span>, <span class="hlFld-ContribAuthor ">Akranth  Marella</span>, <span class="hlFld-ContribAuthor ">Mohammad Mumtaz  Alam</span>, <span class="hlFld-ContribAuthor ">Mohemmed F.  Khan</span>, <span class="hlFld-ContribAuthor ">Mymoona  Akhtar</span>, <span class="hlFld-ContribAuthor ">Tariq  Anwer</span>, <span class="hlFld-ContribAuthor ">Farah  Khan</span>, <span class="hlFld-ContribAuthor ">Md.  Naematullah</span>, <span class="hlFld-ContribAuthor ">Faizul  Azam</span>, <span class="hlFld-ContribAuthor ">Moshahid A.  Rizvi</span>, <span class="hlFld-ContribAuthor ">Mohammad  Shaquiquzzaman</span>. </span><span class="cited-content_cbyCitation_article-title">Design and synthesis of pyrazole–pyrazoline hybrids as cancer‐associated selective COX‐2 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Archiv der Pharmazie</span><span> <strong>2021,</strong> <em>354 </em>
                                    (1)
                                     , 2000116. <a href="https://doi.org/10.1002/ardp.202000116" title="DOI URL">https://doi.org/10.1002/ardp.202000116</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ardp.202000116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fardp.202000116%26sid%3Dliteratum%253Aachs%26jtitle%3DArchiv%2520der%2520Pharmazie%26atitle%3DDesign%252Band%252Bsynthesis%252Bof%252Bpyrazole%2525E2%252580%252593pyrazoline%252Bhybrids%252Bas%252Bcancer%2525E2%252580%252590associated%252Bselective%252BCOX%2525E2%252580%2525902%252Binhibitors%26aulast%3DAkhtar%26aufirst%3DWasim%26date%3D2021%26date%3D2020%26volume%3D354%26issue%3D1%26spage%3D2000116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">S.  Saranyadevi</span>, <span class="hlFld-ContribAuthor ">V.  Shanthi</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular simulation strategies for the discovery of selective inhibitors of β-catenin. </span><span class="cited-content_cbyCitation_journal-name">Journal of Theoretical and Computational Chemistry</span><span> <strong>2020,</strong> <em>19 </em>
                                    (07)
                                     , 2050022. <a href="https://doi.org/10.1142/S0219633620500224" title="DOI URL">https://doi.org/10.1142/S0219633620500224</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1142/S0219633620500224&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1142%2FS0219633620500224%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Theoretical%2520and%2520Computational%2520Chemistry%26atitle%3DMolecular%252Bsimulation%252Bstrategies%252Bfor%252Bthe%252Bdiscovery%252Bof%252Bselective%252Binhibitors%252Bof%252B%2525CE%2525B2-catenin%26aulast%3DSaranyadevi%26aufirst%3DS.%26date%3D2020%26date%3D2020%26volume%3D19%26issue%3D07%26spage%3D2050022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Garima  Tripathi</span>, <span class="hlFld-ContribAuthor ">Anil Kumar  Singh</span>, <span class="hlFld-ContribAuthor ">Abhijeet  Kumar</span>. </span><span class="cited-content_cbyCitation_article-title">Arylpyrazoles: Heterocyclic Scaffold of Immense Therapeutic Application. </span><span class="cited-content_cbyCitation_journal-name">Current Organic Chemistry</span><span> <strong>2020,</strong> <em>24 </em>
                                    (14)
                                     , 1555-1581. <a href="https://doi.org/10.2174/1570179417999200628035645" title="DOI URL">https://doi.org/10.2174/1570179417999200628035645</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1570179417999200628035645&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1570179417999200628035645%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Organic%2520Chemistry%26atitle%3DArylpyrazoles%25253A%252BHeterocyclic%252BScaffold%252Bof%252BImmense%252BTherapeutic%252BApplication%26aulast%3DTripathi%26aufirst%3DGarima%26date%3D2020%26volume%3D24%26issue%3D14%26spage%3D1555%26epage%3D1581" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dmitrii L.  Obydennov</span>, <span class="hlFld-ContribAuthor ">Elena V.  Chernyshova</span>, <span class="hlFld-ContribAuthor ">Vyacheslav Ya.  Sosnovskikh</span>. </span><span class="cited-content_cbyCitation_article-title">Acyclic Enaminodiones in the Synthesis of Heterocyclic Compounds. </span><span class="cited-content_cbyCitation_journal-name">Chemistry of Heterocyclic Compounds</span><span> <strong>2020,</strong> <em>56 </em>
                                    (10)
                                     , 1241-1253. <a href="https://doi.org/10.1007/s10593-020-02807-0" title="DOI URL">https://doi.org/10.1007/s10593-020-02807-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10593-020-02807-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10593-020-02807-0%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520of%2520Heterocyclic%2520Compounds%26atitle%3DAcyclic%252BEnaminodiones%252Bin%252Bthe%252BSynthesis%252Bof%252BHeterocyclic%252BCompounds%26aulast%3DObydennov%26aufirst%3DDmitrii%2BL.%26date%3D2020%26date%3D2020%26volume%3D56%26issue%3D10%26spage%3D1241%26epage%3D1253" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sendoa  Tajada</span>, <span class="hlFld-ContribAuthor ">Carlos  Villalobos</span>. </span><span class="cited-content_cbyCitation_article-title">Calcium Permeable Channels in Cancer Hallmarks. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Pharmacology</span><span> <strong>2020,</strong> <em>11 </em><a href="https://doi.org/10.3389/fphar.2020.00968" title="DOI URL">https://doi.org/10.3389/fphar.2020.00968</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fphar.2020.00968&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffphar.2020.00968%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Pharmacology%26atitle%3DCalcium%252BPermeable%252BChannels%252Bin%252BCancer%252BHallmarks%26aulast%3DTajada%26aufirst%3DSendoa%26date%3D2020%26date%3D2020%26volume%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lihong  Tian</span>, <span class="hlFld-ContribAuthor ">Jie‐Ping  Wan</span>, <span class="hlFld-ContribAuthor ">Shouri  Sheng</span>. </span><span class="cited-content_cbyCitation_article-title">Transition Metal‐free C−H Sulfonylation and Pyrazole Annulation Cascade for the Synthesis of 4‐Sulfonyl Pyrazoles. </span><span class="cited-content_cbyCitation_journal-name">ChemCatChem</span><span> <strong>2020,</strong> <em>12 </em>
                                    (9)
                                     , 2533-2537. <a href="https://doi.org/10.1002/cctc.202000244" title="DOI URL">https://doi.org/10.1002/cctc.202000244</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cctc.202000244&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcctc.202000244%26sid%3Dliteratum%253Aachs%26jtitle%3DChemCatChem%26atitle%3DTransition%252BMetal%2525E2%252580%252590free%252BC%2525E2%252588%252592H%252BSulfonylation%252Band%252BPyrazole%252BAnnulation%252BCascade%252Bfor%252Bthe%252BSynthesis%252Bof%252B4%2525E2%252580%252590Sulfonyl%252BPyrazoles%26aulast%3DTian%26aufirst%3DLihong%26date%3D2020%26date%3D2020%26volume%3D12%26issue%3D9%26spage%3D2533%26epage%3D2537" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01252/20191219/images/medium/jm9b01252_0013.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01252/20191219/images/large/jm9b01252_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01252&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01252/20191219/images/medium/jm9b01252_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01252/20191219/images/large/jm9b01252_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Wnt/β-catenin signaling pathway and examples of known inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01252/20191219/images/large/jm9b01252_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01252&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01252/20191219/images/medium/jm9b01252_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01252/20191219/images/large/jm9b01252_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Design strategy of pyrazole-based compounds <b>1a</b>–<b>s</b> and <b>2a</b>–<b>e</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01252/20191219/images/large/jm9b01252_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01252&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01252/20191219/images/medium/jm9b01252_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01252/20191219/images/large/jm9b01252_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Compounds <b>1a</b>–<b>s</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01252/20191219/images/large/jm9b01252_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01252&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) DMF-DMA, EtOH, 60 °C, 97%; (b) R<sub>3</sub>-NHNH<sub>2</sub>, DIPEA, EtOH, 60 °C; (c) NaOH, EtOH/H<sub>2</sub>O, reflux, 40–98% for two steps; (d) aromatic amines, PyCIU, DIPEA, DCE, 80 °C, 24–88%.</p></p></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01252/20191219/images/medium/jm9b01252_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01252/20191219/images/large/jm9b01252_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Compounds <b>2a</b>–<b>e</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01252/20191219/images/large/jm9b01252_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01252&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) (i) NaNO<sub>2</sub>, HCl (aq.), 0 °C; (ii) ethyl 2-chloroacetoacetate NaOAc, EtOH/H<sub>2</sub>O, 0–25 °C, 88–95%; (b) (i) for <b>8a</b>–<b>c</b>, diethyl (2-oxopropyl)phosphonate, DME, LiOH, rt, 10 h; for <b>8d</b>,<b>e</b>, (ii) 4-(cyclopent-1-en-1-yl)morpholine or 4-(cyclohex-1-en-1-yl)morpholine, Et<sub>3</sub>N, 12 h, rt; (c) NaOH, MeOH, reflux, 70–85% for two steps; (d) 2-aminoquinoline, PyCIU, DIPEA, DCE, 80 °C, 63–71%.</p></p></figure><figure data-id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01252/20191219/images/medium/jm9b01252_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01252/20191219/images/large/jm9b01252_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (A) Antiproliferation activity of selected compounds on the growth of SW480 cells. (B)  GI<sub>50</sub> values were calculated, and data are expressed as mean GI<sub>50</sub> (μM) ± SD from three independent experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01252/20191219/images/large/jm9b01252_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01252&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01252/20191219/images/medium/jm9b01252_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01252/20191219/images/large/jm9b01252_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Dual function of YW2065 for Wnt signaling inhibition and AMPK activation. (A) Enhanced Axin-1 protein expression by YW2065 (1 μM) treatment. HEK293 cells were stained with anti-Axin-1 antibody and DAPI, and  images were taken under fluorescence microscopy. (B) Enhanced Axin-1 expression and increased β-catenin degradation by YW2065 or its analog FX1128 in HEK293 cells. (C) Increased AMPK phosphorylation by Axin-1 overexpression (empty pcDNA 3 vs. pcDNA3-Axin-1) in HEK293 cells. (D) Axin-1 knockdown abolished the effect of AMPK activation by YW2065 in HEK293 cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01252/20191219/images/large/jm9b01252_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01252&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01252/20191219/images/medium/jm9b01252_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01252/20191219/images/large/jm9b01252_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Inhibition of the Wnt/β-catenin pathway, and activation of AMPK by YW2065 in CRC cells. (A) TOPflash reporter assay was performed in SW480 and SW620 cells. (B) Dose response of β-catenin and Axin-1 levels upon treatment of YW2065. (C) Decreased mRNA levels of Wnt target genes in SW620 cells upon exposure to YW2065 for 24 h. (D) Dose response of AMPK and ACC phosphorylation upon  treatment of YW2065.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01252/20191219/images/large/jm9b01252_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01252&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01252/20191219/images/medium/jm9b01252_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01252/20191219/images/large/jm9b01252_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. YW2065 inhibited CRC cell proliferation and growth in vitro. (A) Inhibition of colony formation of CRC cells by YW2065 treatment. Cells (500 cells/well in 6-well plate) were treated with vehicle or YW2065 until visible colonies formed. (B) Induction of apoptosis by YW2065 treatment in SW620 cells. SW620 cells were treated with YW2065 for 48 h,  stained with AAD-7 and annexin V, and then analyzed by flow cytometry. (C) SW620 cells became resistant to YW2065 cytotoxicity when Axin-1 was knocked down by lentivrus encoding shRNA against Axin-1 or a constitutively active β-catenin mutant (S33Y) was overexpressed. Cells were treated with YW2065 or vehicle for 72 h.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01252/20191219/images/large/jm9b01252_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01252&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01252/20191219/images/medium/jm9b01252_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01252/20191219/images/large/jm9b01252_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. YW2065 suppressed SW620 tumor growth in vivo. Six-week old nude mice were injected with 2 × 10<sup>6</sup> SW620 cells subcutaneous. After tumors reach a volume of 100–200 mm<sup>2</sup>, mice were received ip injection of vehicle or 10 or 50 mg/kg of YW2065 each day (<i>n</i> = 6 each group). Tumor growth (A) was measured every other day. *<i>P</i> < 0.05 as compared to the vehicle control in <i>t</i> test. Mice were euthanized at day 32, and tumors were weighed (B). Phosphorylation of AMPK and ACC in the tumor tissues was detected by Western blot (C). Expression of Wnt pathway target genes (<i>Axin-2</i>, <i>MMP-7</i>, and <i>S100A4</i>) in tumor tissues was detected by RT-PCR (D).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01252/20191219/images/large/jm9b01252_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01252&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i76">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_48057" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_48057" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 50 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jemal, A.</span></span> <span> </span><span class="NLM_article-title">Cancer statistics, 2015</span>. <i>Ca-Cancer J. Clin.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">5</span>– <span class="NLM_lpage">29</span>, <span class="refDoi"> DOI: 10.3322/caac.21254</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=10.3322%2Fcaac.21254" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=25559415" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=1%3ACAS%3A280%3ADC%252BC2Mvjs1ersw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2015&pages=5-29&author=R.+L.+Siegelauthor=K.+D.+Millerauthor=A.+Jemal&title=Cancer+statistics%2C+2015&doi=10.3322%2Fcaac.21254"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer statistics, 2015</span></div><div class="casAuthors">Siegel Rebecca L; Miller Kimberly D; Jemal Ahmedin</div><div class="citationInfo"><span class="NLM_cas:title">CA: a cancer journal for clinicians</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">5-29</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Each year the American Cancer Society estimates the numbers of new cancer cases and deaths that will occur in the United States in the current year and compiles the most recent data on cancer incidence, mortality, and survival.  Incidence data were collected by the National Cancer Institute (Surveillance, Epidemiology, and End Results [SEER] Program), the Centers for Disease Control and Prevention (National Program of Cancer Registries), and the North American Association of Central Cancer Registries.  Mortality data were collected by the National Center for Health Statistics.  A total of 1,658,370 new cancer cases and 589,430 cancer deaths are projected to occur in the United States in 2015.  During the most recent 5 years for which there are data (2007-2011), delay-adjusted cancer incidence rates (13 oldest SEER registries) declined by 1.8% per year in men and were stable in women, while cancer death rates nationwide decreased by 1.8% per year in men and by 1.4% per year in women.  The overall cancer death rate decreased from 215.1 (per 100,000 population) in 1991 to 168.7 in 2011, a total relative decline of 22%.  However, the magnitude of the decline varied by state, and was generally lowest in the South (∼15%) and highest in the Northeast (≥20%).  For example, there were declines of 25% to 30% in Maryland, New Jersey, Massachusetts, New York, and Delaware, which collectively averted 29,000 cancer deaths in 2011 as a result of this progress.  Further gains can be accelerated by applying existing cancer control knowledge across all segments of the population.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR7d8BN92t5_sNIRw0GKUoEfW6udTcc2eYDcNd5AEgb2rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2Mvjs1ersw%253D%253D&md5=9b569d8b3f5e9da465900f1c428a9218</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.3322%2Fcaac.21254&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3322%252Fcaac.21254%26sid%3Dliteratum%253Aachs%26aulast%3DSiegel%26aufirst%3DR.%2BL.%26aulast%3DMiller%26aufirst%3DK.%2BD.%26aulast%3DJemal%26aufirst%3DA.%26atitle%3DCancer%2520statistics%252C%25202015%26jtitle%3DCa-Cancer%2520J.%2520Clin.%26date%3D2015%26volume%3D65%26spage%3D5%26epage%3D29%26doi%3D10.3322%2Fcaac.21254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desantis, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jemal, A.</span></span> <span> </span><span class="NLM_article-title">Colorectal cancer statistics, 2014</span>. <i>Ca-Cancer J. Clin.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">104</span>– <span class="NLM_lpage">117</span>, <span class="refDoi"> DOI: 10.3322/caac.21220</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=10.3322%2Fcaac.21220" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=24639052" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=1%3ACAS%3A280%3ADC%252BC2crksVyhsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2014&pages=104-117&author=R.+Siegelauthor=C.+Desantisauthor=A.+Jemal&title=Colorectal+cancer+statistics%2C+2014&doi=10.3322%2Fcaac.21220"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Colorectal cancer statistics, 2014</span></div><div class="casAuthors">Siegel Rebecca; Desantis Carol; Jemal Ahmedin</div><div class="citationInfo"><span class="NLM_cas:title">CA: a cancer journal for clinicians</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">104-17</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Colorectal cancer is the third most common cancer and the third leading cause of cancer death in men and women in the United States.  This article provides an overview of colorectal cancer statistics, including the most current data on incidence, survival, and mortality rates and trends.  Incidence data were provided by the National Cancer Institute's Surveillance, Epidemiology, and End Results program and the North American Association of Central Cancer Registries.  Mortality data were provided by the National Center for Health Statistics.  In 2014, an estimated 71,830 men and 65,000 women will be diagnosed with colorectal cancer and 26,270 men and 24,040 women will die of the disease.  Greater than one-third of all deaths (29% in men and 43% in women) will occur in individuals aged 80 years and older.  There is substantial variation in tumor location by age.  For example, 26% of colorectal cancers in women aged younger than 50 years occur in the proximal colon, compared with 56% of cases in women aged 80 years and older.  Incidence and death rates are highest in blacks and lowest in Asians/Pacific Islanders; among males during 2006 through 2010, death rates in blacks (29.4 per 100,000 population) were more than double those in Asians/Pacific Islanders (13.1) and 50% higher than those in non-Hispanic whites (19.2).  Overall, incidence rates decreased by approximately 3% per year during the past decade (2001-2010).  Notably, the largest drops occurred in adults aged 65 and older.  For instance, rates for tumors located in the distal colon decreased by more than 5% per year.  In contrast, rates increased during this time period among adults younger than 50 years.  Colorectal cancer death rates declined by approximately 2% per year during the 1990s and by approximately 3% per year during the past decade.  Progress in reducing colorectal cancer death rates can be accelerated by improving access to and use of screening and standard treatment in all populations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTAbMaHe6k5ARdUSIfHIn4FfW6udTcc2eYDcNd5AEgb2rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2crksVyhsg%253D%253D&md5=74be82effbcba53a25422ac832e5a8af</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.3322%2Fcaac.21220&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3322%252Fcaac.21220%26sid%3Dliteratum%253Aachs%26aulast%3DSiegel%26aufirst%3DR.%26aulast%3DDesantis%26aufirst%3DC.%26aulast%3DJemal%26aufirst%3DA.%26atitle%3DColorectal%2520cancer%2520statistics%252C%25202014%26jtitle%3DCa-Cancer%2520J.%2520Clin.%26date%3D2014%26volume%3D64%26spage%3D104%26epage%3D117%26doi%3D10.3322%2Fcaac.21220" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chibaudel, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tournigand, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andre, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Gramont, A.</span></span> <span> </span><span class="NLM_article-title">Therapeutic strategy in unresectable metastatic colorectal cancer</span>. <i>Ther. Adv. Med. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">75</span>– <span class="NLM_lpage">89</span>, <span class="refDoi"> DOI: 10.1177/1758834011431592</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=10.1177%2F1758834011431592" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=22423266" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=1%3ACAS%3A528%3ADC%252BC38XlsV2ltLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2012&pages=75-89&author=B.+Chibaudelauthor=C.+Tournigandauthor=T.+Andreauthor=A.+de+Gramont&title=Therapeutic+strategy+in+unresectable+metastatic+colorectal+cancer&doi=10.1177%2F1758834011431592"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic strategy in unresectable metastatic colorectal cancer</span></div><div class="casAuthors">Chibaudel, Benoist; Tournigand, Christophe; Andre, Thierry; de Gramont, Aimery</div><div class="citationInfo"><span class="NLM_cas:title">Therapeutic Advances in Medical Oncology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">75-89</span>CODEN:
                <span class="NLM_cas:coden">TAMOB8</span>;
        ISSN:<span class="NLM_cas:issn">1758-8340</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications Ltd.</span>)
        </div><div class="casAbstract">A review.  While surgery is the cornerstone treatment for early-stage colorectal cancer, chemotherapy is the first treatment option for metastatic disease when tumor lesions are frequently not fully resectable at presentation.  Mortality from colon cancer has decreased over the past 30 years, but there is still a huge heterogeneity in survival rates that can be mainly explained by patient and tumor characteristics, host response factors, and treatment modalities.  The management of unresectable metastatic colorectal cancer is a global treatment strategy, which applies several lines of therapy, salvage surgery, maintenance, and treatment-free intervals.  The individualization of cancer treatment is based on the evaluation of prognostic factors for survival (serum lactate dehydrogenase level, performance status), and predictive factors for treatment efficacy [Kirsten rat sarcoma viral oncogene homolog (KRAS) mutation status].  The available treatment modalities for metastatic colorectal cancer are chemotherapy (fluoropyrimidine, oxaliplatin, irinotecan), anti-angiogenic agents (e.g. bevacizumab), and anti-epidermal growth factor agents (cetuximab, panitumumab).  The increasing no. of active compds. dictates the strategy of trials evaluating these treatments either in combination or sequentially.  Alternative outcomes that can be measured earlier than overall survival are needed to shorten the duration and reduce the size and cost of clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDdZ-yKhZQ4rVg90H21EOLACvtfcHk0lhk6upB0bJGdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlsV2ltLw%253D&md5=cb5771a779b8a5389d8794b59531c049</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1177%2F1758834011431592&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1758834011431592%26sid%3Dliteratum%253Aachs%26aulast%3DChibaudel%26aufirst%3DB.%26aulast%3DTournigand%26aufirst%3DC.%26aulast%3DAndre%26aufirst%3DT.%26aulast%3Dde%2BGramont%26aufirst%3DA.%26atitle%3DTherapeutic%2520strategy%2520in%2520unresectable%2520metastatic%2520colorectal%2520cancer%26jtitle%3DTher.%2520Adv.%2520Med.%2520Oncol.%26date%3D2012%26volume%3D4%26spage%3D75%26epage%3D89%26doi%3D10.1177%2F1758834011431592" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gustavsson, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carlsson, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Machover, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petrelli, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmoll, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tveit, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibson, F.</span></span> <span> </span><span class="NLM_article-title">A review of the evolution of systemic chemotherapy in the management of colorectal cancer</span>. <i>Clin. Colorectal Cancer</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">10</span>, <span class="refDoi"> DOI: 10.1016/j.clcc.2014.11.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=10.1016%2Fj.clcc.2014.11.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=25579803" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=1%3ACAS%3A280%3ADC%252BC2MvlsFantA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2015&pages=1-10&author=B.+Gustavssonauthor=G.+Carlssonauthor=D.+Machoverauthor=N.+Petrelliauthor=A.+Rothauthor=H.+J.+Schmollauthor=K.+M.+Tveitauthor=F.+Gibson&title=A+review+of+the+evolution+of+systemic+chemotherapy+in+the+management+of+colorectal+cancer&doi=10.1016%2Fj.clcc.2014.11.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">A review of the evolution of systemic chemotherapy in the management of colorectal cancer</span></div><div class="casAuthors">Gustavsson Bengt; Carlsson Goran; Machover David; Petrelli Nicholas; Roth Arnaud; Schmoll Hans-Joachim; Tveit Kjell-Magne; Gibson Fernando</div><div class="citationInfo"><span class="NLM_cas:title">Clinical colorectal cancer</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-10</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Herein we present a historical review of the development of systemic chemotherapy for colorectal cancer (CRC) in the metastatic and adjuvant treatment settings.  We describe the discovery of 5-fluorouracil (5-FU) by Heidelberger and colleagues in 1957, the potentiation of 5-FU cytotoxicity by the reduced folate leucovorin, and the advent of novel cytotoxic agents, including the topoisomerase I inhibitor irinotecan, the platinum-containing agent oxaliplatin, and the 5-FU prodrug capecitabine.  The combination therapies, FOLFOX (5-FU/leucovorin and oxaliplatin) and FOLFIRI (5-FU/leucovorin and irinotecan), have become established as efficacious cytotoxic regimens for the treatment of metastatic CRC, resulting in overall survival times of approximately 2 years.  When used as adjuvant therapy, FOLFOX also improves survival and is now the gold standard of care in this setting.  Biological agents have been discovered that enhance the effect of cytotoxic therapy, including bevacizumab (a humanized monoclonal antibody that targets vascular endothelial growth factor, a central regulator of angiogenesis) and cetuximab/panitumumab (monoclonal antibodies directed against the epidermal growth factor receptor).  Despite the ongoing development of novel antitumor agents and therapeutic principles as we enter the era of personalized cancer medicine, systemic chemotherapy involving infusional 5-FU/leucovorin continues to be the cornerstone of treatment for patients with CRC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQnb7jb2mUwwLjnyZkbE8yXfW6udTcc2eaNz8jvzzMRdrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MvlsFantA%253D%253D&md5=4d0583247d91277974430ca002021d8a</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.clcc.2014.11.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.clcc.2014.11.002%26sid%3Dliteratum%253Aachs%26aulast%3DGustavsson%26aufirst%3DB.%26aulast%3DCarlsson%26aufirst%3DG.%26aulast%3DMachover%26aufirst%3DD.%26aulast%3DPetrelli%26aufirst%3DN.%26aulast%3DRoth%26aufirst%3DA.%26aulast%3DSchmoll%26aufirst%3DH.%2BJ.%26aulast%3DTveit%26aufirst%3DK.%2BM.%26aulast%3DGibson%26aufirst%3DF.%26atitle%3DA%2520review%2520of%2520the%2520evolution%2520of%2520systemic%2520chemotherapy%2520in%2520the%2520management%2520of%2520colorectal%2520cancer%26jtitle%3DClin.%2520Colorectal%2520Cancer%26date%3D2015%26volume%3D14%26spage%3D1%26epage%3D10%26doi%3D10.1016%2Fj.clcc.2014.11.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Venook, A. P.</span></span> <span> </span><span class="NLM_article-title">Epidermal growth factor receptor-targeted treatment for advanced colorectal carcinoma</span>. <i>Cancer</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>103</i></span>,  <span class="NLM_fpage">2435</span>– <span class="NLM_lpage">2446</span>, <span class="refDoi"> DOI: 10.1002/cncr.21123</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=10.1002%2Fcncr.21123" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=15880563" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlvVCktL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2005&pages=2435-2446&author=A.+P.+Venook&title=Epidermal+growth+factor+receptor-targeted+treatment+for+advanced+colorectal+carcinoma&doi=10.1002%2Fcncr.21123"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Epidermal growth factor receptor-targeted treatment for advanced colorectal carcinoma</span></div><div class="casAuthors">Venook, Alan P.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2435-2446</span>CODEN:
                <span class="NLM_cas:coden">CANCAR</span>;
        ISSN:<span class="NLM_cas:issn">0008-543X</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  Substantial effort has focused on the development of novel targeted agents for treating patients with late-stage colorectal carcinoma.  These agents are designed specifically to inhibit biochem. processes assocd. with pathogenesis.  Numerous mols. targeting the epidermal growth factor receptor have been investigated as therapeutic agents and appear to herald a shift in the treatment paradigm for colorectal carcinoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptbkdBEYtEgLVg90H21EOLACvtfcHk0lhk6upB0bJGdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlvVCktL4%253D&md5=97639c5493a6b77360b58fdc8e952946</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1002%2Fcncr.21123&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcncr.21123%26sid%3Dliteratum%253Aachs%26aulast%3DVenook%26aufirst%3DA.%2BP.%26atitle%3DEpidermal%2520growth%2520factor%2520receptor-targeted%2520treatment%2520for%2520advanced%2520colorectal%2520carcinoma%26jtitle%3DCancer%26date%3D2005%26volume%3D103%26spage%3D2435%26epage%3D2446%26doi%3D10.1002%2Fcncr.21123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, W.</span></span> <span> </span><span class="NLM_article-title">Angiogenesis in metastatic colorectal cancer and the benefits of targeted therapy</span>. <i>J. Hematol. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">63</span>, <span class="refDoi"> DOI: 10.1186/1756-8722-5-63</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=10.1186%2F1756-8722-5-63" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=23057939" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFWqt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2012&pages=63&author=W.+Sun&title=Angiogenesis+in+metastatic+colorectal+cancer+and+the+benefits+of+targeted+therapy&doi=10.1186%2F1756-8722-5-63"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Angiogenesis in metastatic colorectal cancer and the benefits of targeted therapy</span></div><div class="casAuthors">Sun, Weijing</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Hematology & Oncology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">63</span>CODEN:
                <span class="NLM_cas:coden">JHOOAO</span>;
        ISSN:<span class="NLM_cas:issn">1756-8722</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">A review.  The diverse pathways and mols. involved in angiogenesis, the formation of new blood vessels, have been targeted for the treatment of colorectal and other cancers.  Vascular endothelial growth factor (VEGF)-A binding to VEGF receptor (VEGFR)-2 is believed to be the key signaling pathway mediating angiogenesis.  Other VEGF pathways involved in angiogenesis include VEGF-A, VEGF-B, and placental growth factor binding to VEGFR-1, and VEGF-C and VEGF-D binding to VEGFR-2 and VEGFR-3.  VEGF signaling also intersects with other pathways, including angiopoietin/Tie, Notch, hypoxia-inducible factor, and integrin pathways.  The roles of these pathways in tumor angiogenesis and in various human cancers will be explored in this article.  In addn., preclin. and clin. data on bevacizumab, aflibercept (known as ziv-aflibercept in the US), and investigational antiangiogenic agents in development for the treatment of colorectal and other cancers will be reviewed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnzUshgX4HurVg90H21EOLACvtfcHk0lhk6upB0bJGdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFWqt7o%253D&md5=28d560d9e2cfdc0fcee38d375d6a0dc4</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1186%2F1756-8722-5-63&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1756-8722-5-63%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DW.%26atitle%3DAngiogenesis%2520in%2520metastatic%2520colorectal%2520cancer%2520and%2520the%2520benefits%2520of%2520targeted%2520therapy%26jtitle%3DJ.%2520Hematol.%2520Oncol.%26date%3D2012%26volume%3D5%26spage%3D63%26doi%3D10.1186%2F1756-8722-5-63" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Muzny, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bainbridge, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, K.</span></span> <span> </span><span class="NLM_article-title">Comprehensive molecular characterization of human colon and rectal cancer</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>487</i></span>,  <span class="NLM_fpage">330</span>– <span class="NLM_lpage">337</span>, <span class="refDoi"> DOI: 10.1038/nature11252</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=10.1038%2Fnature11252" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=22810696" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVKnu7%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=487&publication_year=2012&pages=330-337&author=D.+Muznyauthor=M.+Bainbridgeauthor=K.+Chang&title=Comprehensive+molecular+characterization+of+human+colon+and+rectal+cancer&doi=10.1038%2Fnature11252"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Comprehensive molecular characterization of human colon and rectal cancer</span></div><div class="casAuthors">Muzny, Donna M.; Bainbridge, Matthew N.; Chang, Kyle; Dinh, Huyen H.; Drummond, Jennifer A.; Fowler, Gerald; Kovar, Christie L.; Lewis, Lora R.; Morgan, Margaret B.; Newsham, Irene F.; Reid, Jeffrey G.; Santibanez, Jireh; Shinbrot, Eve; Trevino, Lisa R.; Wu, Yuan-Qing; Wang, Min; Gunaratne, Preethi; Donehower, Lawrence A.; Creighton, Chad J.; Wheeler, David A.; Gibbs, Richard A.; Lawrence, Michael S.; Voet, Douglas; Jing, Rui; Cibulskis, Kristian; Sivachenko, Andrey; Stojanov, Petar; McKenna, Aaron; Lander, Eric S.; Gabriel, Stacey; Getz, Gad; Ding, Li; Fulton, Robert S.; Koboldt, Daniel C.; Wylie, Todd; Walker, Jason; Dooling, David J.; Fulton, Lucinda; Delehaunty, Kim D.; Fronick, Catrina C.; Demeter, Ryan; Mardis, Elaine R.; Wilson, Richard K.; Chu, Andy; Chun, Hye-Jung E.; Mungall, Andrew J.; Pleasance, Erin; Robertson, A. Gordon; Stoll, Dominik; Balasundaram, Miruna; Birol, Inanc; Butterfield, Yaron S. N.; Chuah, Eric; Coope, Robin J. N.; Dhalla, Noreen; Guin, Ranabir; Hirst, Carrie; Hirst, Martin; Holt, Robert A.; Lee, Darlene; Li, Haiyan I.; Mayo, Michael; Moore, Richard A.; Schein, Jacqueline E.; Slobodan, Jared R.; Tam, Angela; Thiessen, Nina; Varhol, Richard; Zeng, Thomas; Zhao, Yongjun; Jones, Steven J. M.; Marra, Marco A.; Bass, Adam J.; Ramos, Alex H.; Saksena, Gordon; Cherniack, Andrew D.; Schumacher, Stephen E.; Tabak, Barbara; Carter, Scott L.; Pho, Nam H.; Nguyen, Huy; Onofrio, Robert C.; Crenshaw, Andrew; Ardlie, Kristin; Beroukhim, Rameen; Winckler, Wendy; Getz, Gad; Meyerson, Matthew; Protopopov, Alexei; Zhang, Juinhua; Hadjipanayis, Angela; Lee, Eunjung; Xi, Ruibin; Yang, Lixing; Ren, Xiaojia; Zhang, Hailei; Sathiamoorthy, Narayanan; Shukla, Sachet; Chen, Peng-Chieh; Haseley, Psalm; Xiao, Yonghong; Lee, Semin; Seidman, Jonathan; Chin, Lynda; Park, Peter J.; Kucherlapati, Raju; Todd Auman, J.; Hoadley, Katherine A.; Du, Ying; Wilkerson, Matthew D.; Shi, Yan; Liquori, Christina; Meng, Shaowu; Li, Ling; Turman, Yidi J.; Topal, Michael D.; Tan, Donghui; Waring, Scot; Buda, Elizabeth; Walsh, Jesse; Jones, Corbin D.; Mieczkowski, Piotr A.; Singh, Darshan; Wu, Junyuan; Gulabani, Anisha; Dolina, Peter; Bodenheimer, Tom; Hoyle, Alan P.; Simons, Janae V.; Soloway, Matthew; Mose, Lisle E.; Jefferys, Stuart R.; Balu, Saianand; O'Connor, Brian D.; Prins, Jan F.; Chiang, Derek Y.; Neil Hayes, D.; Perou, Charles M.; Hinoue, Toshinori; Weisenberger, Daniel J.; Maglinte, Dennis T.; Pan, Fei; Berman, Benjamin P.; Van Den Berg, David J.; Shen, Hui; Triche, Timothy, Jr.; Baylin, Stephen B.; Laird, Peter W.; Getz, Gad; Noble, Michael; Voet, Doug; Saksena, Gordon; Gehlenborg, Nils; Di Cara, Daniel; Zhang, Juinhua; Zhang, Hailei; Wu, Chang-Jiun; Liu, Spring Yingchun; Shukla, Sachet; Lawrence, Michael S.; Zhou, Lihua; Sivachenko, Andrey; Lin, Pei; Stojanov, Petar; Jing, Rui; Park, Richard W.; Nazaire, Marc-Danie; Robinson, Jim; Thorvaldsdottir, Helga; Mesirov, Jill; Park, Peter J.; Chin, Lynda; Thorsson, Vesteinn; Reynolds, Sheila M.; Bernard, Brady; Kreisberg, Richard; Lin, Jake; Iype, Lisa; Bressler, Ryan; Erkkilae, Timo; Gundapuneni, Madhumati; Liu, Yuexin; Norberg, Adam; Robinson, Tom; Yang, Da; Zhang, Wei; Shmulevich, Ilya; de Ronde, Jorma J.; Schultz, Nikolaus; Cerami, Ethan; Ciriello, Giovanni; Goldberg, Arthur P.; Gross, Benjamin; Jacobsen, Anders; Gao, Jianjiong; Kaczkowski, Bogumil; Sinha, Rileen; Arman Aksoy, B.; Antipin, Yevgeniy; Reva, Boris; Shen, Ronglai; Taylor, Barry S.; Chan, Timothy A.; Ladanyi, Marc; Sander, Chris; Akbani, Rehan; Zhang, Nianxiang; Broom, Bradley M.; Casasent, Tod; Unruh, Anna; Wakefield, Chris; Hamilton, Stanley R.; Cason, R. Craig; Baggerly, Keith A.; Weinstein, John N.; Haussler, David; Benz, Christopher C.; Stuart, Joshua M.; Benz, Stephen C.; Zachary Sanborn, J.; Vaske, Charles J.; Zhu, Jingchun; Szeto, Christopher; Scott, Gary K.; Yau, Christina; Ng, Sam; Goldstein, Ted; Ellrott, Kyle; Collisson, Eric; Cozen, Aaron E.; Zerbino, Daniel; Wilks, Christopher; Craft, Brian; Spellman, Paul; Penny, Robert; Shelton, Troy; Hatfield, Martha; Morris, Scott; Yena, Peggy; Shelton, Candace; Sherman, Mark; Paulauskis, Joseph; Gastier-Foster, Julie M.; Bowen, Jay; Ramirez, Nilsa C.; Black, Aaron; Pyatt, Robert; Wise, Lisa; White, Peter; Bertagnolli, Monica; Brown, Jen; Chan, Timothy A.; Chu, Gerald C.; Czerwinski, Christine; Denstman, Fred; Dhir, Rajiv; Doerner, Arnulf; Fuchs, Charles S.; Guillem, Jose G.; Iacocca, Mary; Juhl, Hartmut; Kaufman, Andrew; Kohl, Bernard, III; Le, Xuan Van; Mariano, Maria C.; Medina, Elizabeth N.; Meyers, Michael; Nash, Garrett M.; Paty, Phillip B.; Petrelli, Nicholas; Rabeno, Brenda; Richards, William G.; Solit, David; Swanson, Pat; Temple, Larissa; Tepper, Joel E.; Thorp, Richard; Vakiani, Efsevia; Weiser, Martin R.; Willis, Joseph E.; Witkin, Gary; Zeng, Zhaoshi; Zinner, Michael J.; Zornig, Carsten; Jensen, Mark A.; Sfeir, Robert; Kahn, Ari B.; Chu, Anna L.; Kothiyal, Prachi; Wang, Zhining; Snyder, Eric E.; Pontius, Joan; Pihl, Todd D.; Ayala, Brenda; Backus, Mark; Walton, Jessica; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">487</span>
        (<span class="NLM_cas:issue">7407</span>),
    <span class="NLM_cas:pages">330-337</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">To characterize somatic alterations in colorectal carcinoma, we conducted a genome-scale anal. of 276 samples, analyzing exome sequence, DNA copy no., promoter methylation and mRNA and microRNA expression.  A subset of these samples (97) underwent low-depth-of-coverage whole-genome sequencing.  In total, 16% of colorectal carcinomas were found to be hypermutated: three-quarters of these had the expected high microsatellite instability, usually with hypermethylation and MLH1 silencing, and one-quarter had somatic mismatch-repair gene and polymerase ε (POLE) mutations.  Excluding the hypermutated cancers, colon and rectum cancers were found to have considerably similar patterns of genomic alteration.  Twenty-four genes were significantly mutated, and in addn. to the expected APC, TP53, SMAD4, PIK3CA and KRAS mutations, we found frequent mutations in ARID1A, SOX9 and FAM123B.  Recurrent copy-no. alterations include potentially drug-targetable amplifications of ERBB2 and newly discovered amplification of IGF2.  Recurrent chromosomal translocations include the fusion of NAV2 and WNT pathway member TCF7L1.  Integrative analyses suggest new markers for aggressive colorectal carcinoma and an important role for MYC-directed transcriptional activation and repression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIGEnTdXSes7Vg90H21EOLACvtfcHk0lhq6Hxl18m6ig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVKnu7%252FP&md5=082a16335ddd81779d2cd4c9e6458c75</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnature11252&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature11252%26sid%3Dliteratum%253Aachs%26aulast%3DMuzny%26aufirst%3DD.%26aulast%3DBainbridge%26aufirst%3DM.%26aulast%3DChang%26aufirst%3DK.%26atitle%3DComprehensive%2520molecular%2520characterization%2520of%2520human%2520colon%2520and%2520rectal%2520cancer%26jtitle%3DNature%26date%3D2012%26volume%3D487%26spage%3D330%26epage%3D337%26doi%3D10.1038%2Fnature11252" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Clevers, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nusse, R.</span></span> <span> </span><span class="NLM_article-title">Wnt/beta-catenin signaling and disease</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>149</i></span>,  <span class="NLM_fpage">1192</span>– <span class="NLM_lpage">1205</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2012.05.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=10.1016%2Fj.cell.2012.05.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=22682243" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=1%3ACAS%3A528%3ADC%252BC38XosVaktrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=149&publication_year=2012&pages=1192-1205&author=H.+Cleversauthor=R.+Nusse&title=Wnt%2Fbeta-catenin+signaling+and+disease&doi=10.1016%2Fj.cell.2012.05.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Wnt/β-catenin signaling and disease</span></div><div class="casAuthors">Clevers, Hans; Nusse, Roel</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">149</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1192-1205</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  The WNT signal transduction cascade controls myriad biol. phenomena throughout development and adult life of all animals.  In parallel, aberrant Wnt signaling underlies a wide range of pathologies in humans.  In this Review, we provide an update of the core Wnt/β-catenin signaling pathway, discuss how its various components contribute to disease, and pose outstanding questions to be addressed in the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDPj3TZSiR1rVg90H21EOLACvtfcHk0lhq6Hxl18m6ig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XosVaktrg%253D&md5=441540f5c9e168b2a4e657a19bbe31c7</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2012.05.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2012.05.012%26sid%3Dliteratum%253Aachs%26aulast%3DClevers%26aufirst%3DH.%26aulast%3DNusse%26aufirst%3DR.%26atitle%3DWnt%252Fbeta-catenin%2520signaling%2520and%2520disease%26jtitle%3DCell%26date%3D2012%26volume%3D149%26spage%3D1192%26epage%3D1205%26doi%3D10.1016%2Fj.cell.2012.05.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bahrami, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amerizadeh, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">ShahidSales, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khazaei, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghayour-Mobarhan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadeghnia, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maftouh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hassanian, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avan, A.</span></span> <span> </span><span class="NLM_article-title">Therapeutic potential of targeting Wnt/beta-catenin pathway in treatment of colorectal cancer: rational and progress</span>. <i>J. Cell. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>118</i></span>,  <span class="NLM_fpage">1979</span>– <span class="NLM_lpage">1983</span>, <span class="refDoi"> DOI: 10.1002/jcb.25903</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=10.1002%2Fjcb.25903" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=28109136" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmsVejsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2017&pages=1979-1983&author=A.+Bahramiauthor=F.+Amerizadehauthor=S.+ShahidSalesauthor=M.+Khazaeiauthor=M.+Ghayour-Mobarhanauthor=H.+R.+Sadeghniaauthor=M.+Maftouhauthor=S.+M.+Hassanianauthor=A.+Avan&title=Therapeutic+potential+of+targeting+Wnt%2Fbeta-catenin+pathway+in+treatment+of+colorectal+cancer%3A+rational+and+progress&doi=10.1002%2Fjcb.25903"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic Potential of Targeting Wnt/β-Catenin Pathway in Treatment of Colorectal Cancer: Rational and Progress</span></div><div class="casAuthors">Bahrami, Afsane; Amerizadeh, Forouzan; ShahidSales, Soodabeh; Khazaei, Majid; Ghayour-Mobarhan, Majid; Sadeghnia, Hamid Reza; Maftouh, Mina; Hassanian, Seyed Mahdi; Avan, Amir</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cellular Biochemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">118</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1979-1983</span>CODEN:
                <span class="NLM_cas:coden">JCEBD5</span>;
        ISSN:<span class="NLM_cas:issn">0730-2312</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Wnt/β-catenin pathway is one of the main/frequent dysregulated pathways in several tumor types, including colon cancer.  Aberrant activation of this pathway is assocd. with cell proliferation, invasive behaviors, and cell resistance, suggesting its potential value as a therapeutic target in treatment of CRC.  Several agents have been developed for targeting of this pathway (e.g, natural agents: curcumin, 3,3-diindolylmethane, phytoestrogen; Synthetic/small Wnt inhibitors: Rofecoxib; PRI-724, CWP232291; and monoclonal antibody against frizzled receptors, Vanituctumab).  This review summarizes the current knowledge about the therapeutic potential of targeting Wnt pathway with particular emphasis on preclin./clin. studies in treatment of colorectal cancer.  J. Cell. Biochem. 9999: 1-5, 2017. © 2017 Wiley Periodicals, Inc.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDz4pOeyoB8LVg90H21EOLACvtfcHk0lhq6Hxl18m6ig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmsVejsrY%253D&md5=f1a22336b05c41bbacef61389a34b679</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1002%2Fjcb.25903&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcb.25903%26sid%3Dliteratum%253Aachs%26aulast%3DBahrami%26aufirst%3DA.%26aulast%3DAmerizadeh%26aufirst%3DF.%26aulast%3DShahidSales%26aufirst%3DS.%26aulast%3DKhazaei%26aufirst%3DM.%26aulast%3DGhayour-Mobarhan%26aufirst%3DM.%26aulast%3DSadeghnia%26aufirst%3DH.%2BR.%26aulast%3DMaftouh%26aufirst%3DM.%26aulast%3DHassanian%26aufirst%3DS.%2BM.%26aulast%3DAvan%26aufirst%3DA.%26atitle%3DTherapeutic%2520potential%2520of%2520targeting%2520Wnt%252Fbeta-catenin%2520pathway%2520in%2520treatment%2520of%2520colorectal%2520cancer%253A%2520rational%2520and%2520progress%26jtitle%3DJ.%2520Cell.%2520Biochem.%26date%3D2017%26volume%3D118%26spage%3D1979%26epage%3D1983%26doi%3D10.1002%2Fjcb.25903" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farr, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopes, F. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Raay, T. J.</span></span> <span> </span><span class="NLM_article-title">Wnt drug discovery: weaving through the screens, patents and clinical trials</span>. <i>Cancers</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">82</span>, <span class="refDoi"> DOI: 10.3390/cancers8090082</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=10.3390%2Fcancers8090082" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=1%3ACAS%3A528%3ADC%252BC1cXoslamt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2016&pages=82&author=B.+Luauthor=B.+A.+Greenauthor=J.+M.+Farrauthor=F.+C.+Lopesauthor=T.+J.+Van+Raay&title=Wnt+drug+discovery%3A+weaving+through+the+screens%2C+patents+and+clinical+trials&doi=10.3390%2Fcancers8090082"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Wnt drug discovery: weaving through the screens, patents and clinical trials</span></div><div class="casAuthors">Lu, Benjamin; Green, Brooke A.; Farr, Jacqueline M.; Lopes, Flavia C. M.; Van Raay, Terence J.</div><div class="citationInfo"><span class="NLM_cas:title">Cancers</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">82/1-82/15</span>CODEN:
                <span class="NLM_cas:coden">CANCCT</span>;
        ISSN:<span class="NLM_cas:issn">2072-6694</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">The Wnt signaling pathway is intricately involved in many aspects of development and is the root cause of an increasing no. of diseases.  For example, colorectal cancer is the second leading cause of death in the industrialized world and aberration of Wnt signaling within the colonic stem cell is the cause of more than 90% of these cancers.  Despite our advances in successfully targeting other pathways, such as Human Epidermal Growth Factor Receptor 2 (HER2), there are no clin. relevant therapies available for Wnt-related diseases.  Here, we investigated where research activities are focused with respect to Wnt signaling modulators by searching the United States Patent and Trade Office (USPTO) for patents and patent applications related to Wnt modulators and compared this to clin. trials focusing on Wnt modulation.  We found that while the transition of intellectual property surrounding the Wnt ligand-receptor interface to clin. trials is robust, this is not true for specific inhibitors of β-catenin, which is constitutively active in many cancers.  Considering the ubiquitous use of the synthetic T-cell Factor/Lymphoid Enhancer Factor (TCF/Lef) reporter system and its success in identifying novel modulators in vitro, we speculate that this model of drug discovery does not capture the complexity of in vivo Wnt signaling that may be required if we are to successfully target the Wnt pathway in the clinic.  Notwithstanding, increasingly more complex models are being developed, which may not be high throughput, but more pragmatic in our pursuit to control Wnt signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1HKmzswkzsLVg90H21EOLACvtfcHk0lgthDLd0Sf4ig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXoslamt7w%253D&md5=bccbdd5dd4138747c9ea2226871151c5</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.3390%2Fcancers8090082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fcancers8090082%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DB.%26aulast%3DGreen%26aufirst%3DB.%2BA.%26aulast%3DFarr%26aufirst%3DJ.%2BM.%26aulast%3DLopes%26aufirst%3DF.%2BC.%26aulast%3DVan%2BRaay%26aufirst%3DT.%2BJ.%26atitle%3DWnt%2520drug%2520discovery%253A%2520weaving%2520through%2520the%2520screens%252C%2520patents%2520and%2520clinical%2520trials%26jtitle%3DCancers%26date%3D2016%26volume%3D8%26spage%3D82%26doi%3D10.3390%2Fcancers8090082" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, J.</span></span> <span> </span><span class="NLM_article-title">Development of anticancer agents targeting the Wnt/beta-catenin signaling</span>. <i>Am. J. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">2344</span>– <span class="NLM_lpage">2360</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=26396911" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=1%3ACAS%3A528%3ADC%252BC1cXls1KjsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=2344-2360&author=X.+Zhangauthor=J.+Hao&title=Development+of+anticancer+agents+targeting+the+Wnt%2Fbeta-catenin+signaling"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Development of anticancer agents targeting the Wnt/β-catenin signaling</span></div><div class="casAuthors">Zhang, Xiangqian; Hao, Jijun</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Cancer Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2344-2360</span>CODEN:
                <span class="NLM_cas:coden">AJCRFT</span>;
        ISSN:<span class="NLM_cas:issn">2156-6976</span>.
    
            (<span class="NLM_cas:orgname">e-Century Publishing Corp.</span>)
        </div><div class="casAbstract">Wnt/β-catenin signaling plays indispensable roles in both embryonic development and adult homeostasis.  Abnormal regulation of this pathway is implicated in many types of cancer.  Consequently, substantial efforts have made to develop therapeutic agents as anticancer drugs by specifically targeting the Wnt/β-catenin pathway.  Here we systematically review the potential therapeutic agents that have been developed to date for inhibition of the Wnt/β-catenin cascade as well as current status of clin. trials of some of these agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozJYSqo-TjeLVg90H21EOLACvtfcHk0lgthDLd0Sf4ig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXls1KjsL0%253D&md5=a23ae5ff959b5666c014b59bfd11fa3e</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DHao%26aufirst%3DJ.%26atitle%3DDevelopment%2520of%2520anticancer%2520agents%2520targeting%2520the%2520Wnt%252Fbeta-catenin%2520signaling%26jtitle%3DAm.%2520J.%2520Cancer%2520Res.%26date%3D2015%26volume%3D5%26spage%3D2344%26epage%3D2360" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lenz, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kahn, M.</span></span> <span> </span><span class="NLM_article-title">Safely targeting cancer stem cells via selective catenin coactivator antagonism</span>. <i>Cancer Sci.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>105</i></span>,  <span class="NLM_fpage">1087</span>– <span class="NLM_lpage">1092</span>, <span class="refDoi"> DOI: 10.1111/cas.12471</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=10.1111%2Fcas.12471" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=24975284" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFymu7rN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2014&pages=1087-1092&author=H.+J.+Lenzauthor=M.+Kahn&title=Safely+targeting+cancer+stem+cells+via+selective+catenin+coactivator+antagonism&doi=10.1111%2Fcas.12471"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Safely targeting cancer stem cells via selective catenin coactivator antagonism</span></div><div class="casAuthors">Lenz, Heinz-Josef; Kahn, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Science</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1087-1092</span>CODEN:
                <span class="NLM_cas:coden">CSACCM</span>;
        ISSN:<span class="NLM_cas:issn">1349-7006</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Throughout our life, long-lived somatic stem cells (SSC) regenerate adult tissues both during homeostatic processes and repair after injury.  The role of aberrant regulation of SSC has also recently gained prominence in the field of cancer research.  Following malignant transformation, so termed cancer stem cells (CSC), endowed with the same properties as SSC (i.e. the ability to both self-renew and generate differentiated progenitors), play a major part in tumor initiation, therapy resistance and ultimately relapse.  The same signaling pathways involved in regulating SSC maintenance are involved in the regulation of CSC.  CSC exist in a wide array of tumor types, including leukemias, and brain, breast, prostate and colon tumors.  Consequently, one of the key goals in cancer research over the past decade has been to develop therapeutic strategies to safely eliminate the CSC population without damaging the endogenous SSC population.  A major hurdle to this goal lies in the identification of the key mechanisms that distinguish CSC from the normal endogenous tissue stem cells.  This review will discuss the discovery of the specific CBP/catenin antagonist ICG-001 and the ongoing clin. development of the second generation CBP/catenin antagonist PRI-724.  Importantly, specific CBP/catenin antagonists appear to have the ability to safely eliminate CSC by taking advantage of an intrinsic differential preference in the way SSC and CSC divide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpb-k-p-7uTHrVg90H21EOLACvtfcHk0lgthDLd0Sf4ig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFymu7rN&md5=dc580aeb47d1aeb8d95b1c02f428fca8</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1111%2Fcas.12471&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcas.12471%26sid%3Dliteratum%253Aachs%26aulast%3DLenz%26aufirst%3DH.%2BJ.%26aulast%3DKahn%26aufirst%3DM.%26atitle%3DSafely%2520targeting%2520cancer%2520stem%2520cells%2520via%2520selective%2520catenin%2520coactivator%2520antagonism%26jtitle%3DCancer%2520Sci.%26date%3D2014%26volume%3D105%26spage%3D1087%26epage%3D1092%26doi%3D10.1111%2Fcas.12471" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Blagodatski, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poteryaev, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katanaev, V. L.</span></span> <span> </span><span class="NLM_article-title">Targeting the Wnt pathways for therapies</span>. <i>Mol. Cell. Thera.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">28</span>, <span class="refDoi"> DOI: 10.1186/2052-8426-2-28</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=10.1186%2F2052-8426-2-28" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=26056595" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2014&pages=28&author=A.+Blagodatskiauthor=D.+Poteryaevauthor=V.+L.+Katanaev&title=Targeting+the+Wnt+pathways+for+therapies&doi=10.1186%2F2052-8426-2-28"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1186%2F2052-8426-2-28&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F2052-8426-2-28%26sid%3Dliteratum%253Aachs%26aulast%3DBlagodatski%26aufirst%3DA.%26aulast%3DPoteryaev%26aufirst%3DD.%26aulast%3DKatanaev%26aufirst%3DV.%2BL.%26atitle%3DTargeting%2520the%2520Wnt%2520pathways%2520for%2520therapies%26jtitle%3DMol.%2520Cell.%2520Thera.%26date%3D2014%26volume%3D2%26spage%3D28%26doi%3D10.1186%2F2052-8426-2-28" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsieh, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasibhatla, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuller, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tompkins, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pferdekamper, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steffy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kowal, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phung, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flynn, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brenner, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villarroel, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schultz, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNamara, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sellers, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petruzzelli, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boral, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seidel, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLaughlin, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Che, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carey, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanasse, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, J. L.</span></span> <span> </span><span class="NLM_article-title">Targeting Wnt-driven cancer through the inhibition of porcupine by LGK974</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>110</i></span>,  <span class="NLM_fpage">20224</span>– <span class="NLM_lpage">20229</span>, <span class="refDoi"> DOI: 10.1073/pnas.1314239110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=10.1073%2Fpnas.1314239110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=24277854" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFKmsL%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=20224-20229&author=J.+Liuauthor=S.+Panauthor=M.+H.+Hsiehauthor=N.+Ngauthor=F.+Sunauthor=T.+Wangauthor=S.+Kasibhatlaauthor=A.+G.+Schullerauthor=A.+G.+Liauthor=D.+Chengauthor=J.+Liauthor=C.+Tompkinsauthor=A.+Pferdekamperauthor=A.+Steffyauthor=J.+Chengauthor=C.+Kowalauthor=V.+Phungauthor=G.+Guoauthor=Y.+Wangauthor=M.+P.+Grahamauthor=S.+Flynnauthor=J.+C.+Brennerauthor=C.+Liauthor=M.+C.+Villarroelauthor=P.+G.+Schultzauthor=X.+Wuauthor=P.+McNamaraauthor=W.+R.+Sellersauthor=L.+Petruzzelliauthor=A.+L.+Boralauthor=H.+M.+Seidelauthor=M.+E.+McLaughlinauthor=J.+Cheauthor=T.+E.+Careyauthor=G.+Vanasseauthor=J.+L.+Harris&title=Targeting+Wnt-driven+cancer+through+the+inhibition+of+porcupine+by+LGK974&doi=10.1073%2Fpnas.1314239110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Wnt-driven cancer through the inhibition of Porcupine by LGK974</span></div><div class="casAuthors">Liu, Jun; Pan, Shifeng; Hsieh, Mindy H.; Ng, Nicholas; Sun, Fangxian; Wang, Tao; Kasibhatla, Shailaja; Schuller, Alwin G.; Li, Allen G.; Cheng, Dai; Li, Jie; Tompkins, Celin; Pferdekamper, Anne Marie; Steffy, Auzon; Cheng, Jane; Kowal, Colleen; Phung, Van; Guo, Guirong; Wang, Yan; Graham, Martin P.; Flynn, Shannon; Brenner, J. Chad; Li, Chun; Villarroel, M. Cristina; Schultz, Peter G.; Wu, Xu; McNamara, Peter; Sellers, William R.; Petruzzelli, Lilli; Boral, Anthony L.; Seidel, H. Martin; McLaughlin, Margaret E.; Che, Jianwei; Carey, Thomas E.; Vanasse, Gary; Harris, Jennifer L.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">50</span>),
    <span class="NLM_cas:pages">20224-20229,S20224/1-S20224/10</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Wnt signaling is one of the key oncogenic pathways in multiple cancers, and targeting this pathway is an attractive therapeutic approach.  However, therapeutic success was limited because of the lack of therapeutic agents for targets in the Wnt pathway and the lack of a defined patient population that would be sensitive to a Wnt inhibitor.  We developed a screen for small mols. that block Wnt secretion.  This effort led to the discovery of LGK974, a potent and specific small-mol. Porcupine (PORCN) inhibitor.  PORCN is a membrane-bound O-acyltransferase that is required for and dedicated to palmitoylation of Wnt ligands, a necessary step in the processing of Wnt ligand secretion.  We show that LGK974 potently inhibits Wnt signaling in vitro and in vivo, including redn. of the Wnt-dependent LRP6 phosphorylation and the expression of Wnt target genes, such as AXIN2.  LGK974 is potent and efficacious in multiple tumor models at well-tolerated doses in vivo, including murine and rat mechanistic breast cancer models driven by MMTV-Wnt1 and a human head and neck squamous cell carcinoma model (HN30).  We also show that head and neck cancer cell lines with loss-of-function mutations in the Notch signaling pathway have a high response rate to LGK974.  Together, these findings provide both a strategy and tools for targeting Wnt-driven cancers through the inhibition of PORCN.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAJMitDc62tbVg90H21EOLACvtfcHk0lgAqm774xabgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFKmsL%252FL&md5=5fac5db1bd762356350f11706f1a70ae</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1314239110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1314239110%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DPan%26aufirst%3DS.%26aulast%3DHsieh%26aufirst%3DM.%2BH.%26aulast%3DNg%26aufirst%3DN.%26aulast%3DSun%26aufirst%3DF.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DKasibhatla%26aufirst%3DS.%26aulast%3DSchuller%26aufirst%3DA.%2BG.%26aulast%3DLi%26aufirst%3DA.%2BG.%26aulast%3DCheng%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DTompkins%26aufirst%3DC.%26aulast%3DPferdekamper%26aufirst%3DA.%26aulast%3DSteffy%26aufirst%3DA.%26aulast%3DCheng%26aufirst%3DJ.%26aulast%3DKowal%26aufirst%3DC.%26aulast%3DPhung%26aufirst%3DV.%26aulast%3DGuo%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DGraham%26aufirst%3DM.%2BP.%26aulast%3DFlynn%26aufirst%3DS.%26aulast%3DBrenner%26aufirst%3DJ.%2BC.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DVillarroel%26aufirst%3DM.%2BC.%26aulast%3DSchultz%26aufirst%3DP.%2BG.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DMcNamara%26aufirst%3DP.%26aulast%3DSellers%26aufirst%3DW.%2BR.%26aulast%3DPetruzzelli%26aufirst%3DL.%26aulast%3DBoral%26aufirst%3DA.%2BL.%26aulast%3DSeidel%26aufirst%3DH.%2BM.%26aulast%3DMcLaughlin%26aufirst%3DM.%2BE.%26aulast%3DChe%26aufirst%3DJ.%26aulast%3DCarey%26aufirst%3DT.%2BE.%26aulast%3DVanasse%26aufirst%3DG.%26aulast%3DHarris%26aufirst%3DJ.%2BL.%26atitle%3DTargeting%2520Wnt-driven%2520cancer%2520through%2520the%2520inhibition%2520of%2520porcupine%2520by%2520LGK974%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2013%26volume%3D110%26spage%3D20224%26epage%3D20229%26doi%3D10.1073%2Fpnas.1314239110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsieh, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasibhatla, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tompkins, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steffy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seidel, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, S.</span></span> <span> </span><span class="NLM_article-title">Discovery of pyridinyl acetamide derivatives as potent, selective, and orally bioavailable porcupine inhibitors</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">676</span>– <span class="NLM_lpage">680</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.6b00038</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.6b00038" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=1%3ACAS%3A528%3ADC%252BC28XnsFWitb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=676-680&author=D.+Chengauthor=J.+Liuauthor=D.+Hanauthor=G.+Zhangauthor=W.+Gaoauthor=M.+H.+Hsiehauthor=N.+Ngauthor=S.+Kasibhatlaauthor=C.+Tompkinsauthor=J.+Liauthor=A.+Steffyauthor=F.+Sunauthor=C.+Liauthor=H.+M.+Seidelauthor=J.+L.+Harrisauthor=S.+Pan&title=Discovery+of+pyridinyl+acetamide+derivatives+as+potent%2C+selective%2C+and+orally+bioavailable+porcupine+inhibitors&doi=10.1021%2Facsmedchemlett.6b00038"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Pyridinyl Acetamide Derivatives as Potent, Selective, and Orally Bioavailable Porcupine Inhibitors</span></div><div class="casAuthors">Cheng, Dai; Liu, Jun; Han, Dong; Zhang, Guobao; Gao, Wenqi; Hsieh, Mindy H.; Ng, Nicholas; Kasibhatla, Shailaja; Tompkins, Celin; Li, Jie; Steffy, Auzon; Sun, Fangxian; Li, Chun; Seidel, H. Martin; Harris, Jennifer L.; Pan, Shifeng</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">676-680</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Blockade of aberrant Wnt signaling is an attractive therapeutic approach in multiple cancers.  We developed and performed a cellular high-throughput screen for inhibitors of Wnt secretion and pathway activation.  A lead structure (GNF-1331) was identified from the screen.  Further studies identified the mol. target of GNF-1331 as Porcupine, a membrane bound O-acyl transferase.  Structure-activity relationship studies led to the discovery of a novel series of potent and selective Porcupine inhibitors.  Compd. 19, GNF-6231, demonstrated excellent pathway inhibition and induced robust antitumor efficacy in a mouse MMTV-WNT1 xenograft tumor model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPGZaZIx4MI7Vg90H21EOLACvtfcHk0lgAqm774xabgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XnsFWitb8%253D&md5=b4634dbc71bdfade7e5a71de96b37e2b</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.6b00038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.6b00038%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DHan%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DG.%26aulast%3DGao%26aufirst%3DW.%26aulast%3DHsieh%26aufirst%3DM.%2BH.%26aulast%3DNg%26aufirst%3DN.%26aulast%3DKasibhatla%26aufirst%3DS.%26aulast%3DTompkins%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DSteffy%26aufirst%3DA.%26aulast%3DSun%26aufirst%3DF.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DSeidel%26aufirst%3DH.%2BM.%26aulast%3DHarris%26aufirst%3DJ.%2BL.%26aulast%3DPan%26aufirst%3DS.%26atitle%3DDiscovery%2520of%2520pyridinyl%2520acetamide%2520derivatives%2520as%2520potent%252C%2520selective%252C%2520and%2520orally%2520bioavailable%2520porcupine%2520inhibitors%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26spage%3D676%26epage%3D680%26doi%3D10.1021%2Facsmedchemlett.6b00038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dodge, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, C.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kilgore, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amatruda, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lum, L.</span></span> <span> </span><span class="NLM_article-title">Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">100</span>– <span class="NLM_lpage">107</span>, <span class="refDoi"> DOI: 10.1038/nchembio.137</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=10.1038%2Fnchembio.137" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=19125156" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlWjtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&pages=100-107&author=B.+Chenauthor=M.+E.+Dodgeauthor=W.+Tangauthor=J.+Luauthor=Z.+Maauthor=C.-W.+Fanauthor=S.+Weiauthor=W.+Haoauthor=J.+Kilgoreauthor=N.+S.+Williamsauthor=M.+G.+Rothauthor=J.+F.+Amatrudaauthor=C.+Chenauthor=L.+Lum&title=Small+molecule-mediated+disruption+of+Wnt-dependent+signaling+in+tissue+regeneration+and+cancer&doi=10.1038%2Fnchembio.137"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer</span></div><div class="casAuthors">Chen, Baozhi; Dodge, Michael E.; Tang, Wei; Lu, Jianming; Ma, Zhiqiang; Fan, Chih-Wei; Wei, Shuguang; Hao, Wayne; Kilgore, Jessica; Williams, Noelle S.; Roth, Michael G.; Amatruda, James F.; Chen, Chuo; Lum, Lawrence</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">100-107</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The pervasive influence of secreted Wnt signaling proteins in tissue homeostasis and tumorigenesis has galvanized efforts to identify small mols. that target Wnt-mediated cellular responses.  By screening a diverse synthetic chem. library, we have discovered two new classes of small mols. that disrupt Wnt pathway responses; whereas one class inhibits the activity of Porcupine, a membrane-bound acyltransferase that is essential to the prodn. of Wnt proteins, the other abrogates destruction of Axin proteins, which are suppressors of Wnt/β-catenin pathway activity.  With these small mols., we establish a chem. genetic approach for studying Wnt pathway responses and stem cell function in adult tissue.  We achieve transient, reversible suppression of Wnt/β-catenin pathway response in vivo, and we establish a mechanism-based approach to target cancerous cell growth.  The signal transduction mechanisms shown here to be chem. tractable addnl. contribute to Wnt-independent signal transduction pathways and thus could be broadly exploited for chem. genetics and therapeutic goals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAMJCu3QDiYrVg90H21EOLACvtfcHk0lgAqm774xabgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlWjtw%253D%253D&md5=32516a31ce8f691b654ee33c0df83bc5</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.137&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.137%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DB.%26aulast%3DDodge%26aufirst%3DM.%2BE.%26aulast%3DTang%26aufirst%3DW.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DMa%26aufirst%3DZ.%26aulast%3DFan%26aufirst%3DC.-W.%26aulast%3DWei%26aufirst%3DS.%26aulast%3DHao%26aufirst%3DW.%26aulast%3DKilgore%26aufirst%3DJ.%26aulast%3DWilliams%26aufirst%3DN.%2BS.%26aulast%3DRoth%26aufirst%3DM.%2BG.%26aulast%3DAmatruda%26aufirst%3DJ.%2BF.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DLum%26aufirst%3DL.%26atitle%3DSmall%2520molecule-mediated%2520disruption%2520of%2520Wnt-dependent%2520signaling%2520in%2520tissue%2520regeneration%2520and%2520cancer%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2009%26volume%3D5%26spage%3D100%26epage%3D107%26doi%3D10.1038%2Fnchembio.137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lepourcelet, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">France, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crews, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petersen, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruseo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shivdasani, R. A.</span></span> <span> </span><span class="NLM_article-title">Small-molecule antagonists of the oncogenic Tcf/beta-catenin protein complex</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">91</span>– <span class="NLM_lpage">102</span>, <span class="refDoi"> DOI: 10.1016/S1535-6108(03)00334-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=10.1016%2FS1535-6108%2803%2900334-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=14749129" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtFGrsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2004&pages=91-102&author=M.+Lepourceletauthor=Y.+N.+Chenauthor=D.+S.+Franceauthor=H.+Wangauthor=P.+Crewsauthor=F.+Petersenauthor=C.+Bruseoauthor=A.+W.+Woodauthor=R.+A.+Shivdasani&title=Small-molecule+antagonists+of+the+oncogenic+Tcf%2Fbeta-catenin+protein+complex&doi=10.1016%2FS1535-6108%2803%2900334-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecule antagonists of the oncogenic Tcf/β-catenin protein complex</span></div><div class="casAuthors">Lepourcelet, Maina; Chen, Ying-Nan P.; France, Dennis S.; Wang, Huisheng; Crews, Phillip; Petersen, Frank; Bruseo, Charles; Wood, Alexander W.; Shivdasani, Ramesh A.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">91-102</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Key mol. lesions in colorectal and other cancers cause β-catenin-dependent transactivation of T cell factor (Tcf)-dependent genes.  Disruption of this signal represents an opportunity for rational cancer therapy.  To identify compds. that inhibit assocn. between Tcf4 and β-catenin, we screened libraries of natural compds. in a high-throughput assay for immunoenzymic detection of the protein-protein interaction.  Selected compds. disrupt Tcf/β-catenin complexes in several independent in vitro assays and potently antagonize cellular effects of β-catenin-dependent activities, including reporter gene activation, c-myc or cyclin D1 expression, cell proliferation, and duplication of the Xenopus embryonic dorsal axis.  These compds. thus meet predicted criteria for disrupting Tcf/β-catenin complexes and define a general std. to establish mechanism-based activity of small mol. inhibitors of this pathogenic protein-protein interaction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGHpdE0U0vA7Vg90H21EOLACvtfcHk0lhxtt-0ozxbOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtFGrsbw%253D&md5=ddf90ca6f63e3d11421138f5e2bccc17</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2FS1535-6108%2803%2900334-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1535-6108%252803%252900334-9%26sid%3Dliteratum%253Aachs%26aulast%3DLepourcelet%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DY.%2BN.%26aulast%3DFrance%26aufirst%3DD.%2BS.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DCrews%26aufirst%3DP.%26aulast%3DPetersen%26aufirst%3DF.%26aulast%3DBruseo%26aufirst%3DC.%26aulast%3DWood%26aufirst%3DA.%2BW.%26aulast%3DShivdasani%26aufirst%3DR.%2BA.%26atitle%3DSmall-molecule%2520antagonists%2520of%2520the%2520oncogenic%2520Tcf%252Fbeta-catenin%2520protein%2520complex%26jtitle%3DCancer%2520Cell%26date%3D2004%26volume%3D5%26spage%3D91%26epage%3D102%26doi%3D10.1016%2FS1535-6108%2803%2900334-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gonsalves, F. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klein, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carson, B. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ekas, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagourney, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cardozo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DasGupta, R.</span></span> <span> </span><span class="NLM_article-title">An RNAi-based chemical genetic screen identifies three small-molecule inhibitors of the Wnt/wingless signaling pathway</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>108</i></span>,  <span class="NLM_fpage">5954</span>– <span class="NLM_lpage">5963</span>, <span class="refDoi"> DOI: 10.1073/pnas.1017496108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=10.1073%2Fpnas.1017496108" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=21393571" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=1%3ACAS%3A528%3ADC%252BC3MXltVymt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2011&pages=5954-5963&author=F.+C.+Gonsalvesauthor=K.+Kleinauthor=B.+B.+Carsonauthor=S.+Katzauthor=L.+A.+Ekasauthor=S.+Evansauthor=R.+Nagourneyauthor=T.+Cardozoauthor=A.+M.+Brownauthor=R.+DasGupta&title=An+RNAi-based+chemical+genetic+screen+identifies+three+small-molecule+inhibitors+of+the+Wnt%2Fwingless+signaling+pathway&doi=10.1073%2Fpnas.1017496108"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">An RNAi-based chemical genetic screen identifies three small-molecule inhibitors of the Wnt/wingless signaling pathway</span></div><div class="casAuthors">Gonsalves, Foster C.; Klein, Keren; Carson, Brittany B.; Katz, Shauna; Ekas, Laura A.; Evans, Steve; Nagourney, Robert; Cardozo, Timothy; Brown, Anthony M. C.; Das Gupta, Ramanuj</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">5954-5963, S5954/1-S5954/9</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Misregulated β-catenin responsive transcription (CRT) has been implicated in the genesis of various malignancies, including colorectal carcinomas, and it is a key therapeutic target in combating various cancers.  Despite significant effort, successful clin. implementation of CRT inhibitory therapeutics remains a challenging goal.  This is, in part, because of the challenge of identifying inhibitory compds. that specifically modulate the nuclear transcriptional activity of β-catenin while not affecting its cytoskeletal function in stabilizing adherens junctions at the cell membrane.  Here, we report an RNAi-based modifier screening strategy for the identification of CRT inhibitors.  Our data provide support for the specificity of these inhibitory compds. in antagonizing the transcriptional function of nuclear β-catenin.  We show that these inhibitors efficiently block Wnt/β-catenin-induced target genes and phenotypes in various mammalian and cancer cell lines.  Importantly, these Wnt inhibitors are specifically cytotoxic to human colon tumor biopsy cultures as well as colon cancer cell lines that exhibit deregulated Wnt signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr94ZMZYTd807Vg90H21EOLACvtfcHk0lhxtt-0ozxbOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXltVymt70%253D&md5=566aa3c22ccee9ae88aeda4e523699db</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1017496108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1017496108%26sid%3Dliteratum%253Aachs%26aulast%3DGonsalves%26aufirst%3DF.%2BC.%26aulast%3DKlein%26aufirst%3DK.%26aulast%3DCarson%26aufirst%3DB.%2BB.%26aulast%3DKatz%26aufirst%3DS.%26aulast%3DEkas%26aufirst%3DL.%2BA.%26aulast%3DEvans%26aufirst%3DS.%26aulast%3DNagourney%26aufirst%3DR.%26aulast%3DCardozo%26aufirst%3DT.%26aulast%3DBrown%26aufirst%3DA.%2BM.%26aulast%3DDasGupta%26aufirst%3DR.%26atitle%3DAn%2520RNAi-based%2520chemical%2520genetic%2520screen%2520identifies%2520three%2520small-molecule%2520inhibitors%2520of%2520the%2520Wnt%252Fwingless%2520signaling%2520pathway%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2011%26volume%3D108%26spage%3D5954%26epage%3D5963%26doi%3D10.1073%2Fpnas.1017496108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Emami, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeong, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eguchi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moon, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teo, J.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oh, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moon, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ha, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kahn, M.</span></span> <span> </span><span class="NLM_article-title">A small molecule inhibitor of beta-catenin/CREB-binding protein transcription [corrected]</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>101</i></span>,  <span class="NLM_fpage">12682</span>– <span class="NLM_lpage">12687</span>, <span class="refDoi"> DOI: 10.1073/pnas.0404875101</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=10.1073%2Fpnas.0404875101" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=15314234" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnsVent70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2004&pages=12682-12687&author=K.+H.+Emamiauthor=C.+Nguyenauthor=H.+Maauthor=D.+H.+Kimauthor=K.+W.+Jeongauthor=M.+Eguchiauthor=R.+T.+Moonauthor=J.-L.+Teoauthor=S.+W.+Ohauthor=H.+Y.+Kimauthor=S.+H.+Moonauthor=J.+R.+Haauthor=M.+Kahn&title=A+small+molecule+inhibitor+of+beta-catenin%2FCREB-binding+protein+transcription+%5Bcorrected%5D&doi=10.1073%2Fpnas.0404875101"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">A small molecule inhibitor of β-catenin/cyclic AMP response element-binding protein transcription</span></div><div class="casAuthors">Emami, Katayoon H.; Nguyen, Cu; Ma, Hong; Kim, Dae Hoon; Jeong, Kwang Won; Eguchi, Masakatsu; Moon, Randall T.; Teo, Jia-Ling; Oh, Se Wong; Kim, Hak Yeop; Moon, Sung Hwan; Ha, Jong Ryul; Kahn, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">34</span>),
    <span class="NLM_cas:pages">12682-12687</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Inherited and somatic mutations in the adenomatous polyposis coli occur in most colon cancers, leading to activation of β-catenin-responsive genes.  To identify small mol. antagonists of this pathway, the authors challenged transformed colorectal cells with a secondary structure-templated chem. library, looking for compds. that inhibit a β-catenin-responsive reporter.  The authors identified ICG-001, a small mol. that down-regulates β-catenin/T cell factor signaling by specifically binding to cAMP response element-binding protein.  ICG-001 selectively induces apoptosis in transformed cells but not in normal colon cells, reduces in vitro growth of colon carcinoma cells, and is efficacious in the Min mouse and nude mouse xenograft models of colon cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGok6tlzXLGU-rVg90H21EOLACvtfcHk0li6KZ3p8rLPAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnsVent70%253D&md5=51d20409871c490734e66d23987348ee</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0404875101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0404875101%26sid%3Dliteratum%253Aachs%26aulast%3DEmami%26aufirst%3DK.%2BH.%26aulast%3DNguyen%26aufirst%3DC.%26aulast%3DMa%26aufirst%3DH.%26aulast%3DKim%26aufirst%3DD.%2BH.%26aulast%3DJeong%26aufirst%3DK.%2BW.%26aulast%3DEguchi%26aufirst%3DM.%26aulast%3DMoon%26aufirst%3DR.%2BT.%26aulast%3DTeo%26aufirst%3DJ.-L.%26aulast%3DOh%26aufirst%3DS.%2BW.%26aulast%3DKim%26aufirst%3DH.%2BY.%26aulast%3DMoon%26aufirst%3DS.%2BH.%26aulast%3DHa%26aufirst%3DJ.%2BR.%26aulast%3DKahn%26aufirst%3DM.%26atitle%3DA%2520small%2520molecule%2520inhibitor%2520of%2520beta-catenin%252FCREB-binding%2520protein%2520transcription%2520%255Bcorrected%255D%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2004%26volume%3D101%26spage%3D12682%26epage%3D12687%26doi%3D10.1073%2Fpnas.0404875101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mishina, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheung, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stegmeier, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michaud, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charlat, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiellette, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiessner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hild, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mickanin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Myer, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fazal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomlinson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serluca, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shultz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schirle, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlegl, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghidelli, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fawell, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curtis, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirschner, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lengauer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finan, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tallarico, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouwmeester, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porter, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cong, F.</span></span> <span> </span><span class="NLM_article-title">Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>461</i></span>,  <span class="NLM_fpage">614</span>– <span class="NLM_lpage">620</span>, <span class="refDoi"> DOI: 10.1038/nature08356</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=10.1038%2Fnature08356" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=19759537" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFentbzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=461&publication_year=2009&pages=614-620&author=S.+M.+Huangauthor=Y.+M.+Mishinaauthor=S.+Liuauthor=A.+Cheungauthor=F.+Stegmeierauthor=G.+A.+Michaudauthor=O.+Charlatauthor=E.+Wielletteauthor=Y.+Zhangauthor=S.+Wiessnerauthor=M.+Hildauthor=X.+Shiauthor=C.+J.+Wilsonauthor=C.+Mickaninauthor=V.+Myerauthor=A.+Fazalauthor=R.+Tomlinsonauthor=F.+Serlucaauthor=W.+Shaoauthor=H.+Chengauthor=M.+Shultzauthor=C.+Rauauthor=M.+Schirleauthor=J.+Schleglauthor=S.+Ghidelliauthor=S.+Fawellauthor=C.+Luauthor=D.+Curtisauthor=M.+W.+Kirschnerauthor=C.+Lengauerauthor=P.+M.+Finanauthor=J.+A.+Tallaricoauthor=T.+Bouwmeesterauthor=J.+A.+Porterauthor=A.+Bauerauthor=F.+Cong&title=Tankyrase+inhibition+stabilizes+axin+and+antagonizes+Wnt+signalling&doi=10.1038%2Fnature08356"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling</span></div><div class="casAuthors">Huang, Shih-Min A.; Mishina, Yuji M.; Liu, Shanming; Cheung, Atwood; Stegmeier, Frank; Michaud, Gregory A.; Charlat, Olga; Wiellette, Elizabeth; Zhang, Yue; Wiessner, Stephanie; Hild, Marc; Shi, Xiaoying; Wilson, Christopher J.; Mickanin, Craig; Myer, Vic; Fazal, Aleem; Tomlinson, Ronald; Serluca, Fabrizio; Shao, Wenlin; Cheng, Hong; Shultz, Michael; Rau, Christina; Schirle, Markus; Schlegl, Judith; Ghidelli, Sonja; Fawell, Stephen; Lu, Chris; Curtis, Daniel; Kirschner, Marc W.; Lengauer, Christoph; Finan, Peter M.; Tallarico, John A.; Bouwmeester, Tewis; Porter, Jeffery A.; Bauer, Andreas; Cong, Feng</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">461</span>
        (<span class="NLM_cas:issue">7264</span>),
    <span class="NLM_cas:pages">614-620</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The stability of the Wnt pathway transcription factor β-catenin is tightly regulated by the multi-subunit destruction complex.  Deregulated Wnt pathway activity has been implicated in many cancers, making this pathway an attractive target for anticancer therapies.  However, the development of targeted Wnt pathway inhibitors has been hampered by the limited no. of pathway components that are amenable to small mol. inhibition.  Here, we used a chem. genetic screen to identify a small mol., XAV939, which selectively inhibits β-catenin-mediated transcription.  XAV939 stimulates β-catenin degrdn. by stabilizing axin, the concn.-limiting component of the destruction complex.  Using a quant. chem. proteomic approach, we discovered that XAV939 stabilizes axin by inhibiting the poly-ADP-ribosylating enzymes tankyrase 1 and tankyrase 2.  Both tankyrase isoforms interact with a highly conserved domain of axin and stimulate its degrdn. through the ubiquitin-proteasome pathway.  Thus, our study provides new mechanistic insights into the regulation of axin protein homeostasis and presents new avenues for targeted Wnt pathway therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGom3c1M4OoOarVg90H21EOLACvtfcHk0li6KZ3p8rLPAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFentbzP&md5=6a76dfa7ed2a57b29e0c1ee367bd652c</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1038%2Fnature08356&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature08356%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DS.%2BM.%26aulast%3DMishina%26aufirst%3DY.%2BM.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DCheung%26aufirst%3DA.%26aulast%3DStegmeier%26aufirst%3DF.%26aulast%3DMichaud%26aufirst%3DG.%2BA.%26aulast%3DCharlat%26aufirst%3DO.%26aulast%3DWiellette%26aufirst%3DE.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DWiessner%26aufirst%3DS.%26aulast%3DHild%26aufirst%3DM.%26aulast%3DShi%26aufirst%3DX.%26aulast%3DWilson%26aufirst%3DC.%2BJ.%26aulast%3DMickanin%26aufirst%3DC.%26aulast%3DMyer%26aufirst%3DV.%26aulast%3DFazal%26aufirst%3DA.%26aulast%3DTomlinson%26aufirst%3DR.%26aulast%3DSerluca%26aufirst%3DF.%26aulast%3DShao%26aufirst%3DW.%26aulast%3DCheng%26aufirst%3DH.%26aulast%3DShultz%26aufirst%3DM.%26aulast%3DRau%26aufirst%3DC.%26aulast%3DSchirle%26aufirst%3DM.%26aulast%3DSchlegl%26aufirst%3DJ.%26aulast%3DGhidelli%26aufirst%3DS.%26aulast%3DFawell%26aufirst%3DS.%26aulast%3DLu%26aufirst%3DC.%26aulast%3DCurtis%26aufirst%3DD.%26aulast%3DKirschner%26aufirst%3DM.%2BW.%26aulast%3DLengauer%26aufirst%3DC.%26aulast%3DFinan%26aufirst%3DP.%2BM.%26aulast%3DTallarico%26aufirst%3DJ.%2BA.%26aulast%3DBouwmeester%26aufirst%3DT.%26aulast%3DPorter%26aufirst%3DJ.%2BA.%26aulast%3DBauer%26aufirst%3DA.%26aulast%3DCong%26aufirst%3DF.%26atitle%3DTankyrase%2520inhibition%2520stabilizes%2520axin%2520and%2520antagonizes%2520Wnt%2520signalling%26jtitle%3DNature%26date%3D2009%26volume%3D461%26spage%3D614%26epage%3D620%26doi%3D10.1038%2Fnature08356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Voronkov, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holsworth, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waaler, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ekblad, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perdreau-Dahl, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinh, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drewes, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hopf, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morth, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krauss, S.</span></span> <span> </span><span class="NLM_article-title">Structural basis and SAR for G007-LK, a lead stage 1,2,4-triazole based specific tankyrase 1/2 inhibitor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">3012</span>– <span class="NLM_lpage">3023</span>, <span class="refDoi"> DOI: 10.1021/jm4000566</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm4000566" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjslGht7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=3012-3023&author=A.+Voronkovauthor=D.+D.+Holsworthauthor=J.+Waalerauthor=S.+R.+Wilsonauthor=B.+Ekbladauthor=H.+Perdreau-Dahlauthor=H.+Dinhauthor=G.+Drewesauthor=C.+Hopfauthor=J.+P.+Morthauthor=S.+Krauss&title=Structural+basis+and+SAR+for+G007-LK%2C+a+lead+stage+1%2C2%2C4-triazole+based+specific+tankyrase+1%2F2+inhibitor&doi=10.1021%2Fjm4000566"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis and SAR for G007-LK, a Lead Stage 1,2,4-Triazole Based Specific Tankyrase 1/2 Inhibitor</span></div><div class="casAuthors">Voronkov, Andrew; Holsworth, Daniel D.; Waaler, Jo; Wilson, Steven R.; Ekblad, Bie; Perdreau-Dahl, Harmonie; Dinh, Huyen; Drewes, Gerard; Hopf, Carsten; Morth, Jens P.; Krauss, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3012-3023</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Tankyrases 1 and 2 (TNKS1/2) are promising pharmacol. biotargets with possible applications for the development of novel anticancer therapeutics.  A focused structure-activity relationship study was conducted based on the tankyrase inhibitor JW74 (1).  Chem. analoging of 1 improved the 1,2,4-triazole based core and led to 4-{5-[(E)-2-{4-(2-chlorophenyl)-5-[5-(methylsulfonyl)pyridin-2-yl]-4H-1,2,4-triazol-3-yl}ethenyl]-1,3,4-oxadiazol-2-yl}benzonitrile (G007-LK), a potent, "rule of 5" compliant and a metabolically stable TNKS1/2 inhibitor.  G007-LK (66) displayed high selectivity toward tankyrases 1 and 2 with biochem. IC50 values of 46 nM and 25 nM, resp., and a cellular IC50 value of 50 nM combined with an excellent pharmacokinetic profile in mice.  The PARP domain of TNKS2 was cocrystd. with 66, and the X-ray structure was detd. at 2.8 Å resoln. in the space group P3221.  The structure revealed that 66 binds to unique structural features in the extended adenosine binding pocket which forms the structural basis for the compd.'s high target selectivity and specificity.  Our study provides a significantly optimized compd. for targeting TNKS1/2 in vitro and in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvUxhCxkLuYbVg90H21EOLACvtfcHk0lgqhlhYXjFing"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjslGht7o%253D&md5=f2bee61f0fdc326e3e798b3705072e9d</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm4000566&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4000566%26sid%3Dliteratum%253Aachs%26aulast%3DVoronkov%26aufirst%3DA.%26aulast%3DHolsworth%26aufirst%3DD.%2BD.%26aulast%3DWaaler%26aufirst%3DJ.%26aulast%3DWilson%26aufirst%3DS.%2BR.%26aulast%3DEkblad%26aufirst%3DB.%26aulast%3DPerdreau-Dahl%26aufirst%3DH.%26aulast%3DDinh%26aufirst%3DH.%26aulast%3DDrewes%26aufirst%3DG.%26aulast%3DHopf%26aufirst%3DC.%26aulast%3DMorth%26aufirst%3DJ.%2BP.%26aulast%3DKrauss%26aufirst%3DS.%26atitle%3DStructural%2520basis%2520and%2520SAR%2520for%2520G007-LK%252C%2520a%2520lead%2520stage%25201%252C2%252C4-triazole%2520based%2520specific%2520tankyrase%25201%252F2%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D3012%26epage%3D3023%26doi%3D10.1021%2Fjm4000566" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shultz, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheung, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirby, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Firestone, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chin, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dipietro, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fazal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fortin, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gould, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lagu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lei, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lenoir, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Majumdar, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ochala, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palermo, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pham, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stams, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomlinson, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toure, B. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Visser, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waters, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, W.</span></span> <span> </span><span class="NLM_article-title">Identification of NVP-TNKS656: the use of structure-efficiency relationships to generate a highly potent, selective, and orally active tankyrase inhibitor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">6495</span>– <span class="NLM_lpage">6511</span>, <span class="refDoi"> DOI: 10.1021/jm400807n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400807n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtV2msbfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=6495-6511&author=M.+D.+Shultzauthor=A.+K.+Cheungauthor=C.+A.+Kirbyauthor=B.+Firestoneauthor=J.+Fanauthor=C.+H.+Chenauthor=Z.+Chenauthor=D.+N.+Chinauthor=L.+Dipietroauthor=A.+Fazalauthor=Y.+Fengauthor=P.+D.+Fortinauthor=T.+Gouldauthor=B.+Laguauthor=H.+Leiauthor=F.+Lenoirauthor=D.+Majumdarauthor=E.+Ochalaauthor=M.+G.+Palermoauthor=L.+Phamauthor=M.+Puauthor=T.+Smithauthor=T.+Stamsauthor=R.+C.+Tomlinsonauthor=B.+B.+Toureauthor=M.+Visserauthor=R.+M.+Wangauthor=N.+J.+Watersauthor=W.+Shao&title=Identification+of+NVP-TNKS656%3A+the+use+of+structure-efficiency+relationships+to+generate+a+highly+potent%2C+selective%2C+and+orally+active+tankyrase+inhibitor&doi=10.1021%2Fjm400807n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of NVP-TNKS656: The Use of Structure-Efficiency Relationships To Generate a Highly Potent, Selective, and Orally Active Tankyrase Inhibitor</span></div><div class="casAuthors">Shultz, Michael D.; Cheung, Atwood K.; Kirby, Christina A.; Firestone, Brant; Fan, Jianmei; Chen, Christine Hiu-Tung; Chen, Zhouliang; Chin, Donovan N.; DiPietro, Lucian; Fazal, Aleem; Feng, Yun; Fortin, Pascal D.; Gould, Ty; Lagu, Bharat; Lei, Huangshu; Lenoir, Francois; Majumdar, Dyuti; Ochala, Etienne; Palermo, M. G.; Pham, Ly; Pu, Minying; Smith, Troy; Stams, Travis; Tomlinson, Ronald C.; Toure, B. Barry; Visser, Michael; Wang, Run Ming; Waters, Nigel J.; Shao, Wenlin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">6495-6511</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Tankyrase 1 and 2 have been shown to be redundant, druggable nodes in the Wnt pathway.  As such, there has been intense interest in developing agents suitable for modulating the Wnt pathway in vivo by targeting this enzyme pair.  By utilizing a combination of structure-based design and LipE-based structure efficiency relationships, the core of XAV939 was optimized into a more stable, more efficient, but less potent dihydropyran motif 7.  This core was combined with elements of screening hits 2, 19, and 33 and resulted in highly potent, selective tankyrase inhibitors that are novel three pocket binders.  NVP-TNKS656 (43) was identified as an orally active antagonist of Wnt pathway activity in the MMTV-Wnt1 mouse xenograft model.  With an enthalpy-driven thermodn. signature of binding, highly favorable physicochem. properties, and high lipophilic efficiency, NVP-TNKS656 is a novel tankyrase inhibitor that is well suited for further in vivo validation studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDGWOimaJ0I7Vg90H21EOLACvtfcHk0lgqhlhYXjFing"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtV2msbfE&md5=db3f1a471ca757e0219a5175c5017e9b</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm400807n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400807n%26sid%3Dliteratum%253Aachs%26aulast%3DShultz%26aufirst%3DM.%2BD.%26aulast%3DCheung%26aufirst%3DA.%2BK.%26aulast%3DKirby%26aufirst%3DC.%2BA.%26aulast%3DFirestone%26aufirst%3DB.%26aulast%3DFan%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DC.%2BH.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DChin%26aufirst%3DD.%2BN.%26aulast%3DDipietro%26aufirst%3DL.%26aulast%3DFazal%26aufirst%3DA.%26aulast%3DFeng%26aufirst%3DY.%26aulast%3DFortin%26aufirst%3DP.%2BD.%26aulast%3DGould%26aufirst%3DT.%26aulast%3DLagu%26aufirst%3DB.%26aulast%3DLei%26aufirst%3DH.%26aulast%3DLenoir%26aufirst%3DF.%26aulast%3DMajumdar%26aufirst%3DD.%26aulast%3DOchala%26aufirst%3DE.%26aulast%3DPalermo%26aufirst%3DM.%2BG.%26aulast%3DPham%26aufirst%3DL.%26aulast%3DPu%26aufirst%3DM.%26aulast%3DSmith%26aufirst%3DT.%26aulast%3DStams%26aufirst%3DT.%26aulast%3DTomlinson%26aufirst%3DR.%2BC.%26aulast%3DToure%26aufirst%3DB.%2BB.%26aulast%3DVisser%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DR.%2BM.%26aulast%3DWaters%26aufirst%3DN.%2BJ.%26aulast%3DShao%26aufirst%3DW.%26atitle%3DIdentification%2520of%2520NVP-TNKS656%253A%2520the%2520use%2520of%2520structure-efficiency%2520relationships%2520to%2520generate%2520a%2520highly%2520potent%252C%2520selective%252C%2520and%2520orally%2520active%2520tankyrase%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D6495%26epage%3D6511%26doi%3D10.1021%2Fjm400807n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mariotti, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Templeton, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ranes, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paracuellos, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cronin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beuron, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guettler, S.</span></span> <span> </span><span class="NLM_article-title">Tankyrase requires SAM domain-dependent polymerization to support Wnt-beta-catenin signaling</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">498</span>– <span class="NLM_lpage">513</span>, <span class="refDoi"> DOI: 10.1016/j.molcel.2016.06.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=10.1016%2Fj.molcel.2016.06.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=27494558" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlWjtbjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2016&pages=498-513&author=L.+Mariottiauthor=C.+M.+Templetonauthor=M.+Ranesauthor=P.+Paracuellosauthor=N.+Croninauthor=F.+Beuronauthor=E.+Morrisauthor=S.+Guettler&title=Tankyrase+requires+SAM+domain-dependent+polymerization+to+support+Wnt-beta-catenin+signaling&doi=10.1016%2Fj.molcel.2016.06.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Tankyrase Requires SAM Domain-Dependent Polymerization to Support Wnt-β-Catenin Signaling</span></div><div class="casAuthors">Mariotti, Laura; Templeton, Catherine M.; Ranes, Michael; Paracuellos, Patricia; Cronin, Nora; Beuron, Fabienne; Morris, Edward; Guettler, Sebastian</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">498-513</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">The poly(ADP-ribose) polymerase (PARP) Tankyrase (TNKS and TNKS2) is paramount to Wnt-β-catenin signaling and a promising therapeutic target in Wnt-dependent cancers.  The pool of active β-catenin is normally limited by destruction complexes, whose assembly depends on the polymeric master scaffolding protein AXIN.  Tankyrase, which poly(ADP-ribosyl)ates and thereby destabilizes AXIN, also can polymerize, but the relevance of these polymers has remained unclear.  We report crystal structures of the polymg. TNKS and TNKS2 sterile alpha motif (SAM) domains, revealing versatile head-to-tail interactions.  Biochem. studies informed by these structures demonstrate that polymn. is required for Tankyrase to drive β-catenin-dependent transcription.  We show that the polymeric state supports PARP activity and allows Tankyrase to effectively access destruction complexes through enabling avidity-dependent AXIN binding.  This study provides an example for regulated signal transduction in non-membrane-enclosed compartments (signalosomes), and it points to novel potential strategies to inhibit Tankyrase function in oncogenic Wnt signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryzcx6EN_QfbVg90H21EOLACvtfcHk0lgqhlhYXjFing"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlWjtbjK&md5=58094437e4a6509989c5db6355ccb7d0</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2016.06.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2016.06.019%26sid%3Dliteratum%253Aachs%26aulast%3DMariotti%26aufirst%3DL.%26aulast%3DTempleton%26aufirst%3DC.%2BM.%26aulast%3DRanes%26aufirst%3DM.%26aulast%3DParacuellos%26aufirst%3DP.%26aulast%3DCronin%26aufirst%3DN.%26aulast%3DBeuron%26aufirst%3DF.%26aulast%3DMorris%26aufirst%3DE.%26aulast%3DGuettler%26aufirst%3DS.%26atitle%3DTankyrase%2520requires%2520SAM%2520domain-dependent%2520polymerization%2520to%2520support%2520Wnt-beta-catenin%2520signaling%26jtitle%3DMol.%2520Cell%26date%3D2016%26volume%3D63%26spage%3D498%26epage%3D513%26doi%3D10.1016%2Fj.molcel.2016.06.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sbodio, J. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chi, N. W.</span></span> <span> </span><span class="NLM_article-title">Identification of a tankyrase-binding motif shared by IRAP, TAB182, and human TRF1 but not mouse TRF1. NuMA contains this RXXPDG motif and is a novel tankyrase partner</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>277</i></span>,  <span class="NLM_fpage">31887</span>– <span class="NLM_lpage">31892</span>, <span class="refDoi"> DOI: 10.1074/jbc.M203916200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=10.1074%2Fjbc.M203916200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=12080061" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=1%3ACAS%3A528%3ADC%252BD38XmslOqtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=2002&pages=31887-31892&author=J.+I.+Sbodioauthor=N.+W.+Chi&title=Identification+of+a+tankyrase-binding+motif+shared+by+IRAP%2C+TAB182%2C+and+human+TRF1+but+not+mouse+TRF1.+NuMA+contains+this+RXXPDG+motif+and+is+a+novel+tankyrase+partner&doi=10.1074%2Fjbc.M203916200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a tankyrase-binding motif shared by IRAP, TAB182, and human TRF1 but not mouse TRF1. NuMA contains this RXXPDG motif and is a novel tankyrase partner</span></div><div class="casAuthors">Sbodio, Juan I.; Chi, Nai-Wen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">277</span>
        (<span class="NLM_cas:issue">35</span>),
    <span class="NLM_cas:pages">31887-31892</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Tankyrase-1 and -2 are closely related poly(ADP-ribose) polymerases that use an ankyrin-repeat domain to bind diverse proteins, including TRF (telomere-repeat binding factor)-1, IRAP (insulin-responsive aminopeptidase), and TAB182 (182-kDa tankyrase-binding protein).  TRF1 binding allows tankyrase to regulate telomere dynamics in human cells, whereas IRAP binding presumably allows tankyrase to regulate the targeting of IRAP.  The mechanism by which tankyrase binds to diverse proteins has not been investigated.  Herein we describe a novel RXXPDG motif shared by IRAP, TAB182, and human TRF1 that mediates their binding to tankyrases.  Interestingly, mouse TRF1 lacks this motif and thus does not bind either tankyrase-1 or -2.  Using the ankyrin domain of tankyrase as a bait in a yeast two-hybrid screen, we also found the RXXPDG motif in six candidate tankyrase partners, including the nuclear/mitotic app. protein (NuMA).  We verified NuMA as an RXXPDG-mediated partner of tankyrase and suggest that this interaction contributes to the known colocalization of tankyrase and NuMA at mitotic spindle poles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0bIhUisnbdLVg90H21EOLACvtfcHk0lh4YpMeiBD-nw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XmslOqtbc%253D&md5=a29cff4af939c58fd7d74d9191da7aa5</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M203916200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M203916200%26sid%3Dliteratum%253Aachs%26aulast%3DSbodio%26aufirst%3DJ.%2BI.%26aulast%3DChi%26aufirst%3DN.%2BW.%26atitle%3DIdentification%2520of%2520a%2520tankyrase-binding%2520motif%2520shared%2520by%2520IRAP%252C%2520TAB182%252C%2520and%2520human%2520TRF1%2520but%2520not%2520mouse%2520TRF1.%2520NuMA%2520contains%2520this%2520RXXPDG%2520motif%2520and%2520is%2520a%2520novel%2520tankyrase%2520partner%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2002%26volume%3D277%26spage%3D31887%26epage%3D31892%26doi%3D10.1074%2Fjbc.M203916200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, J.</span></span> <span> </span><span class="NLM_article-title">USP25 regulates Wnt signaling by controlling the stability of tankyrases</span>. <i>Genes Dev.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">1024</span>– <span class="NLM_lpage">1035</span>, <span class="refDoi"> DOI: 10.1101/gad.300889.117</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=10.1101%2Fgad.300889.117" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=28619731" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFKnt7fP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2017&pages=1024-1035&author=D.+Xuauthor=J.+Liuauthor=T.+Fuauthor=B.+Shanauthor=L.+Qianauthor=L.+Panauthor=J.+Yuan&title=USP25+regulates+Wnt+signaling+by+controlling+the+stability+of+tankyrases&doi=10.1101%2Fgad.300889.117"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">USP25 regulates Wnt signaling by controlling the stability of tankyrases</span></div><div class="casAuthors">Xu, Daichao; Liu, Jianping; Fu, Tao; Shan, Bing; Qian, Lihui; Pan, Lifeng; Yuan, Junying</div><div class="citationInfo"><span class="NLM_cas:title">Genes & Development</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1024-1035</span>CODEN:
                <span class="NLM_cas:coden">GEDEEP</span>;
        ISSN:<span class="NLM_cas:issn">0890-9369</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">Aberrant activation of the Wnt signaling pathway plays an important role in human cancer development.  Wnt signaling is neg. regulated by Axin, a scaffolding protein that controls a rate-limiting step in the destruction of β-catenin, the central activator of the Wnt pathway.  In Wnt-stimulated cells, Axin is rapidly modified by tankyrase-mediated poly(ADP-ribosyl)ation, which promotes the proteolysis of Axin and consequent stabilization of β-catenin.  Thus, regulation of the levels and activity of tankyrases is mechanistically important in controlling Wnt signaling.  Here, we identify ubiquitin-specific protease 25 (USP25) as a pos. regulator of Wnt/β-catenin signaling.  We found that USP25 directly interacted with tankyrases to promote their deubiquitination and stabilization.  We demonstrated that USP25 deficiency could promote the degrdn. of tankyrases and consequent stabilization of Axin to antagonize Wnt signaling.  We further characterized the interaction between TNKS1 and USP25 by X-ray crystal structure detn.  Our results provide important new insights into the mol. mechanism that regulates the turnover of tankyrases and the possibility of targeting the stability of tankyrases by antagonizing their interaction with USP25 to modulate the Wnt/β-catenin pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiEk5oDBHsgbVg90H21EOLACvtfcHk0lh4YpMeiBD-nw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFKnt7fP&md5=062e583d7984c1ebec175850903fc91c</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1101%2Fgad.300889.117&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.300889.117%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DFu%26aufirst%3DT.%26aulast%3DShan%26aufirst%3DB.%26aulast%3DQian%26aufirst%3DL.%26aulast%3DPan%26aufirst%3DL.%26aulast%3DYuan%26aufirst%3DJ.%26atitle%3DUSP25%2520regulates%2520Wnt%2520signaling%2520by%2520controlling%2520the%2520stability%2520of%2520tankyrases%26jtitle%3DGenes%2520Dev.%26date%3D2017%26volume%3D31%26spage%3D1024%26epage%3D1035%26doi%3D10.1101%2Fgad.300889.117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eisemann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCauley, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langelier, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Duyne, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pascal, J. M.</span></span> <span> </span><span class="NLM_article-title">Tankyrase-1 ankyrin repeats form an adaptable binding platform for targets of ADP-ribose modification</span>. <i>Structure</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">1679</span>– <span class="NLM_lpage">1692</span>, <span class="refDoi"> DOI: 10.1016/j.str.2016.07.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=10.1016%2Fj.str.2016.07.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=27594684" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVOqsLzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2016&pages=1679-1692&author=T.+Eisemannauthor=M.+McCauleyauthor=M.+F.+Langelierauthor=K.+Guptaauthor=S.+Royauthor=G.+D.+Van+Duyneauthor=J.+M.+Pascal&title=Tankyrase-1+ankyrin+repeats+form+an+adaptable+binding+platform+for+targets+of+ADP-ribose+modification&doi=10.1016%2Fj.str.2016.07.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Tankyrase-1 Ankyrin Repeats Form an Adaptable Binding Platform for Targets of ADP-Ribose Modification</span></div><div class="casAuthors">Eisemann, Travis; McCauley, Michael; Langelier, Marie-France; Gupta, Kushol; Roy, Swati; Van Duyne, Gregory D.; Pascal, John M.</div><div class="citationInfo"><span class="NLM_cas:title">Structure (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1679-1692</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The poly(ADP-ribose) polymerase enzyme Tankyrase-1 (TNKS) regulates multiple cellular processes and interacts with diverse proteins using five ankyrin repeat clusters (ARCs).  There are limited structural insights into functional roles of the multiple ARCs of TNKS.  Here we present the ARC1-3 crystal structure and employ small-angle X-ray scattering (SAXS) to investigate soln. conformations of the complete ankyrin repeat domain.  Mutagenesis and binding studies using the bivalent TNKS binding domain of Axin1 demonstrate that only certain ARC combinations function together.  The phys. basis for these restrictions is explained by both rigid and flexible ankyrin repeat elements detd. in our structural anal.  SAXS anal. is consistent with a dynamic ensemble of TNKS ankyrin repeat conformations modulated by Axin1 interaction.  TNKS ankyrin repeat domain is thus an adaptable binding platform with structural features that can explain selectivity toward diverse proteins, and has implications for TNKS positioning of bound targets for poly(ADP-ribose) modification.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrm8oxgI6qS5bVg90H21EOLACvtfcHk0lh4YpMeiBD-nw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVOqsLzJ&md5=b6887cad0ba9a862d8d78a6c2ccbec4f</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.str.2016.07.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.str.2016.07.014%26sid%3Dliteratum%253Aachs%26aulast%3DEisemann%26aufirst%3DT.%26aulast%3DMcCauley%26aufirst%3DM.%26aulast%3DLangelier%26aufirst%3DM.%2BF.%26aulast%3DGupta%26aufirst%3DK.%26aulast%3DRoy%26aufirst%3DS.%26aulast%3DVan%2BDuyne%26aufirst%3DG.%2BD.%26aulast%3DPascal%26aufirst%3DJ.%2BM.%26atitle%3DTankyrase-1%2520ankyrin%2520repeats%2520form%2520an%2520adaptable%2520binding%2520platform%2520for%2520targets%2520of%2520ADP-ribose%2520modification%26jtitle%3DStructure%26date%3D2016%26volume%3D24%26spage%3D1679%26epage%3D1692%26doi%3D10.1016%2Fj.str.2016.07.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katavolos, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lau, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boggs, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sambrone, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merchant, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harstad, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schutten, M.</span></span> <span> </span><span class="NLM_article-title">Tankyrase inhibition causes reversible intestinal toxicity in mice with a therapeutic index < 1</span>. <i>Toxicol. Pathol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">267</span>– <span class="NLM_lpage">278</span>, <span class="refDoi"> DOI: 10.1177/0192623315621192</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=10.1177%2F0192623315621192" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=26692561" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlWgsLvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2016&pages=267-278&author=Y.+Zhongauthor=P.+Katavolosauthor=T.+Nguyenauthor=T.+Lauauthor=J.+Boggsauthor=A.+Sambroneauthor=D.+Kanauthor=M.+Merchantauthor=E.+Harstadauthor=D.+Diazauthor=M.+Costaauthor=M.+Schutten&title=Tankyrase+inhibition+causes+reversible+intestinal+toxicity+in+mice+with+a+therapeutic+index+%3C+1&doi=10.1177%2F0192623315621192"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Tankyrase inhibition causes reversible intestinal toxicity in mice with a therapeutic index < 1</span></div><div class="casAuthors">Zhong, Yu; Katavolos, Paula; Nguyen, Trung; Lau, Ted; Boggs, Jason; Sambrone, Amy; Kan, David; Merchant, Mark; Harstad, Eric; Diaz, Dolores; Costa, Mike; Schutten, Melissa</div><div class="citationInfo"><span class="NLM_cas:title">Toxicologic Pathology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">267-278</span>CODEN:
                <span class="NLM_cas:coden">TOPADD</span>;
        ISSN:<span class="NLM_cas:issn">0192-6233</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">Activated Wnt/β-catenin signaling is frequently assocd. with colorectal cancer.  Wnt inhibitors, including tankyrase inhibitors, are being explored as potential anticancer agents.  Wnt signaling is also crit. for intestinal tissue homeostasis, and Wnt inhibitors have been shown to cause intestinal toxicity in mice by affecting intestinal stem cells.  This study sought to characterize the intestinal toxicity of tankyrase inhibitors, including reversibility, and to assess their therapeutic index.  Novel tankyrase inhibitor G-631 caused dose-dependent intestinal toxicity with a therapeutic index < 1 after 14 days of dosing in mice.  At a tolerated subtherapeutic dose level, the intestinal toxicity was composed of enteritis characterized by villus blunting, epithelial degeneration, and inflammation, which fully reversed after 14 days of recovery.  Doubled exposure showed weak antitumor activity in a xenograft colorectal cancer model but also caused more severe intestinal toxicity characterized by multifocal-regionally extensive necrotizing and ulcerative enteritis leading to morbidity or moribundity in some animals.  This toxicity was only partially reversed after 14 days of recovery, with evidence of crypt and villus regeneration, mildly blunted villi, and/or scarring in assocn. with chronic inflammation of the submucosa.  Therefore, the clin. utility of tankyrase inhibitors is likely limited by the on-target intestinal toxicity and a therapeutic index < 1 in mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrE6KF-WKDKTrVg90H21EOLACvtfcHk0lhrHrB8lJMnbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlWgsLvF&md5=b4276e4b15fae2aa0bbc53d0f9f1f680</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1177%2F0192623315621192&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F0192623315621192%26sid%3Dliteratum%253Aachs%26aulast%3DZhong%26aufirst%3DY.%26aulast%3DKatavolos%26aufirst%3DP.%26aulast%3DNguyen%26aufirst%3DT.%26aulast%3DLau%26aufirst%3DT.%26aulast%3DBoggs%26aufirst%3DJ.%26aulast%3DSambrone%26aufirst%3DA.%26aulast%3DKan%26aufirst%3DD.%26aulast%3DMerchant%26aufirst%3DM.%26aulast%3DHarstad%26aufirst%3DE.%26aulast%3DDiaz%26aufirst%3DD.%26aulast%3DCosta%26aufirst%3DM.%26aulast%3DSchutten%26aufirst%3DM.%26atitle%3DTankyrase%2520inhibition%2520causes%2520reversible%2520intestinal%2520toxicity%2520in%2520mice%2520with%2520a%2520therapeutic%2520index%2520%253C%25201%26jtitle%3DToxicol.%2520Pathol.%26date%3D2016%26volume%3D44%26spage%3D267%26epage%3D278%26doi%3D10.1177%2F0192623315621192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mariotti, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pollock, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guettler, S.</span></span> <span> </span><span class="NLM_article-title">Regulation of Wnt/beta-catenin signalling by tankyrase-dependent poly(ADP-ribosyl)ation and scaffolding</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>174</i></span>,  <span class="NLM_fpage">4611</span>– <span class="NLM_lpage">4636</span>, <span class="refDoi"> DOI: 10.1111/bph.14038</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=10.1111%2Fbph.14038" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=28910490" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslGqs7bE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=174&publication_year=2017&pages=4611-4636&author=L.+Mariottiauthor=K.+Pollockauthor=S.+Guettler&title=Regulation+of+Wnt%2Fbeta-catenin+signalling+by+tankyrase-dependent+poly%28ADP-ribosyl%29ation+and+scaffolding&doi=10.1111%2Fbph.14038"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of Wnt/β-catenin signalling by tankyrase-dependent poly(ADP-ribosyl)ation and scaffolding</span></div><div class="casAuthors">Mariotti, Laura; Pollock, Katie; Guettler, Sebastian</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">174</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">4611-4636</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The Wnt/β-catenin signalling pathway is pivotal for stem cell function and the control of cellular differentiation, both during embryonic development and tissue homeostasis in adults.  Its activity is carefully controlled through the concerted interactions of concn.-limited pathway components and a wide range of post-translational modifications, including phosphorylation, ubiquitylation, sumoylation, poly(ADP-ribosyl)ation (PARylation) and acetylation.  Regulation of Wnt/β-catenin signalling by PARylation was discovered relatively recently.  The PARP tankyrase PARylates AXIN1/2, an essential central scaffolding protein in the β-catenin destruction complex, and targets it for degrdn., thereby fine-tuning the responsiveness of cells to the Wnt signal.  The past few years have not only seen much progress in our understanding of the mol. mechanisms by which PARylation controls the pathway but also witnessed the successful development of tankyrase inhibitors as tool compds. and promising agents for the therapy of Wnt-dependent dysfunctions, including colorectal cancer.  Recent work has hinted at more complex roles of tankyrase in Wnt/β-catenin signalling as well as challenges and opportunities in the development of tankyrase inhibitors.  Here we review some of the latest advances in our understanding of tankyrase function in the pathway and efforts to modulate tankyrase activity to re-tune Wnt/β-catenin signalling in colorectal cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbg-X7McNWebVg90H21EOLACvtfcHk0lhrHrB8lJMnbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslGqs7bE&md5=4ba71faa4fc2064e57390dae08b88c0f</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1111%2Fbph.14038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.14038%26sid%3Dliteratum%253Aachs%26aulast%3DMariotti%26aufirst%3DL.%26aulast%3DPollock%26aufirst%3DK.%26aulast%3DGuettler%26aufirst%3DS.%26atitle%3DRegulation%2520of%2520Wnt%252Fbeta-catenin%2520signalling%2520by%2520tankyrase-dependent%2520poly%2528ADP-ribosyl%2529ation%2520and%2520scaffolding%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2017%26volume%3D174%26spage%3D4611%26epage%3D4636%26doi%3D10.1111%2Fbph.14038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thorne, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanson, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tahinci, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orton, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cselenyi, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jernigan, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyers, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hang, B. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waterson, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melancon, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghidu, V. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sulikowski, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaFleur, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salic, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, E.</span></span> <span> </span><span class="NLM_article-title">Small-molecule inhibition of Wnt signaling through activation of casein kinase 1 alpha</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">829</span>– <span class="NLM_lpage">836</span>, <span class="refDoi"> DOI: 10.1038/nchembio.453</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=10.1038%2Fnchembio.453" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=20890287" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1elu7zO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=829-836&author=C.+A.+Thorneauthor=A.+J.+Hansonauthor=J.+Schneiderauthor=E.+Tahinciauthor=D.+Ortonauthor=C.+S.+Cselenyiauthor=K.+K.+Jerniganauthor=K.+C.+Meyersauthor=B.+I.+Hangauthor=A.+G.+Watersonauthor=K.+Kimauthor=B.+Melanconauthor=V.+P.+Ghiduauthor=G.+A.+Sulikowskiauthor=B.+LaFleurauthor=A.+Salicauthor=L.+A.+Leeauthor=D.+M.+Millerauthor=E.+Lee&title=Small-molecule+inhibition+of+Wnt+signaling+through+activation+of+casein+kinase+1+alpha&doi=10.1038%2Fnchembio.453"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecule inhibition of Wnt signaling through activation of casein kinase 1α</span></div><div class="casAuthors">Thorne, Curtis A.; Hanson, Alison J.; Schneider, Judsen; Tahinci, Emilios; Orton, Darren; Cselenyi, Christopher S.; Jernigan, Kristin K.; Meyers, Kelly C.; Hang, Brian I.; Waterson, Alex G.; Kim, Kwangho; Melancon, Bruce; Ghidu, Victor P.; Sulikowski, Gary A.; LaFleur, Bonnie; Salic, Adrian; Lee, Laura A.; Miller, David M.; Lee, Ethan</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">829-836</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Wnt/β-catenin signaling is critically involved in metazoan development, stem cell maintenance and human disease.  Using Xenopus laevis egg ext. to screen for compds. that both stabilize Axin and promote β-catenin turnover, we identified an FDA-approved drug, pyrvinium, as a potent inhibitor of Wnt signaling (EC50 of ∼ 10 nM).  We show pyrvinium binds all casein kinase 1 (CK1) family members in vitro at low nanomolar concns. and pyrvinium selectively potentiates casein kinase 1α (CK1α) kinase activity.  CK1α knockdown abrogates the effects of pyrvinium on the Wnt pathway.  In addn. to its effects on Axin and β-catenin levels, pyrvinium promotes degrdn. of Pygopus, a Wnt transcriptional component.  Pyrvinium treatment of colon cancer cells with mutation of the gene for adenomatous polyposis coli (APC) or β-catenin inhibits both Wnt signaling and proliferation.  Our findings reveal allosteric activation of CK1α as an effective mechanism to inhibit Wnt signaling and highlight a new strategy for targeted therapeutics directed against the Wnt pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqr7QzU0tiGpLVg90H21EOLACvtfcHk0lhrHrB8lJMnbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1elu7zO&md5=1412b6b25b26689f9191145151e91608</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.453&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.453%26sid%3Dliteratum%253Aachs%26aulast%3DThorne%26aufirst%3DC.%2BA.%26aulast%3DHanson%26aufirst%3DA.%2BJ.%26aulast%3DSchneider%26aufirst%3DJ.%26aulast%3DTahinci%26aufirst%3DE.%26aulast%3DOrton%26aufirst%3DD.%26aulast%3DCselenyi%26aufirst%3DC.%2BS.%26aulast%3DJernigan%26aufirst%3DK.%2BK.%26aulast%3DMeyers%26aufirst%3DK.%2BC.%26aulast%3DHang%26aufirst%3DB.%2BI.%26aulast%3DWaterson%26aufirst%3DA.%2BG.%26aulast%3DKim%26aufirst%3DK.%26aulast%3DMelancon%26aufirst%3DB.%26aulast%3DGhidu%26aufirst%3DV.%2BP.%26aulast%3DSulikowski%26aufirst%3DG.%2BA.%26aulast%3DLaFleur%26aufirst%3DB.%26aulast%3DSalic%26aufirst%3DA.%26aulast%3DLee%26aufirst%3DL.%2BA.%26aulast%3DMiller%26aufirst%3DD.%2BM.%26aulast%3DLee%26aufirst%3DE.%26atitle%3DSmall-molecule%2520inhibition%2520of%2520Wnt%2520signaling%2520through%2520activation%2520of%2520casein%2520kinase%25201%2520alpha%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2010%26volume%3D6%26spage%3D829%26epage%3D836%26doi%3D10.1038%2Fnchembio.453" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smith, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kinkei, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gryczko, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goulet, J. R.</span></span> <span> </span><span class="NLM_article-title">Absorption of pyrvinium pamoate</span>. <i>Clin. Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">1976</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">802</span>– <span class="NLM_lpage">806</span>, <span class="refDoi"> DOI: 10.1002/cpt1976196802</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=10.1002%2Fcpt1976196802" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=1269218" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=1%3ACAS%3A528%3ADyaE28XksFKmsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1976&pages=802-806&author=T.+C.+Smithauthor=A.+W.+Kinkeiauthor=C.+M.+Gryczkoauthor=J.+R.+Goulet&title=Absorption+of+pyrvinium+pamoate&doi=10.1002%2Fcpt1976196802"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Absorption of pyrvinium pamoate</span></div><div class="casAuthors">Smith, T. C.; Kinkel, A. W.; Gryczko, C. M.; Goulet, J. R.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacology & Therapeutics (St. Louis, MO, United States)</span>
        (<span class="NLM_cas:date">1976</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">802-6</span>CODEN:
                <span class="NLM_cas:coden">CLPTAT</span>;
        ISSN:<span class="NLM_cas:issn">0009-9236</span>.
    </div><div class="casAbstract">Pyrvinium pamoate (I) [3546-41-6] tablets and suspension, was administered as single 350-mg doses to volunteers to det. whether there had been any systemic absorption.  Six subjects received tablets and 6 received suspension on the 1st day; on day 8, subjects received the other dose form.  Up to 4 days after administration there was no evidence of drug in blood and urine by spectrofluorometric assay.  Metabolic studies in rats showed minute quantities of drug in the liver and plasma but not of any metabolites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsgG9D2rQd_7Vg90H21EOLACvtfcHk0ljkTwBCQYzfWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE28XksFKmsr0%253D&md5=b75842be1943ee8afced9ce38b5fec0c</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1002%2Fcpt1976196802&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcpt1976196802%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DT.%2BC.%26aulast%3DKinkei%26aufirst%3DA.%2BW.%26aulast%3DGryczko%26aufirst%3DC.%2BM.%26aulast%3DGoulet%26aufirst%3DJ.%2BR.%26atitle%3DAbsorption%2520of%2520pyrvinium%2520pamoate%26jtitle%3DClin.%2520Pharmacol.%2520Ther.%26date%3D1976%26volume%3D19%26spage%3D802%26epage%3D806%26doi%3D10.1002%2Fcpt1976196802" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Obianom, O. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakamuru, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shu, Y.</span></span> <span> </span><span class="NLM_article-title">Triazole-based inhibitors of the Wnt/β-catenin signaling pathway improve glucose and lipid metabolisms in diet-induced obese mice</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">727</span>– <span class="NLM_lpage">741</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01408</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01408" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=1%3ACAS%3A528%3ADC%252BC1MXktV2htA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=727-741&author=O.+N.+Obianomauthor=Y.+Aiauthor=Y.+Liauthor=W.+Yangauthor=D.+Guoauthor=H.+Yangauthor=S.+Sakamuruauthor=M.+Xiaauthor=F.+Xueauthor=Y.+Shu&title=Triazole-based+inhibitors+of+the+Wnt%2F%CE%B2-catenin+signaling+pathway+improve+glucose+and+lipid+metabolisms+in+diet-induced+obese+mice&doi=10.1021%2Facs.jmedchem.8b01408"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Triazole-based inhibitors of the Wnt/β-catenin signaling pathway improve glucose and lipid metabolisms in diet-induced obese mice</span></div><div class="casAuthors">Obianom, Obinna N.; Ai, Yong; Li, Yingjun; Yang, Wei; Guo, Dong; Yang, Hong; Sakamuru, Srilatha; Xia, Menghang; Xue, Fengtian; Shu, Yan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">727-741</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Wnt/β-catenin signaling pathway is implicated in the etiol. and progression of metabolic disorders.  Although lines of genetic evidence suggest that blockage of this pathway yields favorable outcomes in treating such ailments, few inhibitors have been used to validate the promising genetic findings.  Here, we synthesized and characterized a novel class of triazole-based Wnt/β-catenin signaling inhibitors and assessed their effects on energy metab.  One of the top inhibitors, I, promoted Axin stabilization, which led to the proteasome degrdn. of β-catenin and subsequent inhibition of the Wnt/β-catenin signaling in cells.  Treatment of hepatocytes and high fat diet-fed mice with I resulted in significantly decreased hepatic lipid accumulation.  Moreover, I improved glucose tolerance of high fat diet-fed mice without noticeable toxicity, while downregulating the genes involved in the glucose and fatty acid anabolisms.  The new inhibitors are expected to be further developed for the treatment of metabolic disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXKGFvqIaGm7Vg90H21EOLACvtfcHk0ljkTwBCQYzfWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXktV2htA%253D%253D&md5=687c708054033b18b9185f2ebca1d82b</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01408&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01408%26sid%3Dliteratum%253Aachs%26aulast%3DObianom%26aufirst%3DO.%2BN.%26aulast%3DAi%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DGuo%26aufirst%3DD.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DSakamuru%26aufirst%3DS.%26aulast%3DXia%26aufirst%3DM.%26aulast%3DXue%26aufirst%3DF.%26aulast%3DShu%26aufirst%3DY.%26atitle%3DTriazole-based%2520inhibitors%2520of%2520the%2520Wnt%252F%25CE%25B2-catenin%2520signaling%2520pathway%2520improve%2520glucose%2520and%2520lipid%2520metabolisms%2520in%2520diet-induced%2520obese%2520mice%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D727%26epage%3D741%26doi%3D10.1021%2Facs.jmedchem.8b01408" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hagland, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berg, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jolma, I. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carlsen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soreide, K.</span></span> <span> </span><span class="NLM_article-title">Molecular pathways and cellular metabolism in colorectal cancer</span>. <i>Dig. Surg.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">12</span>– <span class="NLM_lpage">25</span>, <span class="refDoi"> DOI: 10.1159/000347166</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=10.1159%2F000347166" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=23595116" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVGlt73I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2013&pages=12-25&author=H.+R.+Haglandauthor=M.+Bergauthor=I.+W.+Jolmaauthor=A.+Carlsenauthor=K.+Soreide&title=Molecular+pathways+and+cellular+metabolism+in+colorectal+cancer&doi=10.1159%2F000347166"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Pathways and Cellular Metabolism in Colorectal Cancer</span></div><div class="casAuthors">Hagland, Hanne R.; Berg, Marianne; Jolma, Ingunn W.; Carlsen, Arne; Soreide, Kjetil</div><div class="citationInfo"><span class="NLM_cas:title">Digestive Surgery</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">12-25</span>CODEN:
                <span class="NLM_cas:coden">DSIUAN</span>;
        ISSN:<span class="NLM_cas:issn">0253-4886</span>.
    
            (<span class="NLM_cas:orgname">S. Karger AG</span>)
        </div><div class="casAbstract">A review.  Colorectal cancer (CRC) is, for sporadic forms, most strongly related to lifestyle factors.  The epidemic of obesity and phys. inactivity has great impact on disease patterns.  Likewise, an altered metab. has consequences at the cellular and mol. level with implications for cancer initiation and growth.  Understanding the genetic hallmarks of cancers has improved over the years and now also includes cancer metabolic reprogramming.  The initiation of cancer through genetic instability, including chromosomal instability, microsatellite instability and epigenetic silencing through the CpG island methylator phenotype follows pathways with distinct clin., pathol., and genetic characteristics.  These can potentially be used for mol. classification and comprehensive tumor profiling for improved diagnostics, prognosis and treatment in CRC.  For one, epidermal growth factor receptor-directed treatment now considerably prolongs survival in metastatic disease, but defining the true responders from non-responders has emerged as complex.  Further, the use of both non-steroidal anti-inflammatory drugs including cyclooxygenase-2 inhibitors is assocd. with a decreased incidence of adenoma and reduced mortality rate of CRC.  This review gives a brief yet updated overview of the current understanding of CRC as a genetic and mol. disease with potential for clin. pathways of prevention, improved prediction and better prognosis in the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrogpMoI8_yQrVg90H21EOLACvtfcHk0ljkTwBCQYzfWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVGlt73I&md5=8470fa5f1d0f5e7d4e5d013cfe4b9b1a</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1159%2F000347166&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000347166%26sid%3Dliteratum%253Aachs%26aulast%3DHagland%26aufirst%3DH.%2BR.%26aulast%3DBerg%26aufirst%3DM.%26aulast%3DJolma%26aufirst%3DI.%2BW.%26aulast%3DCarlsen%26aufirst%3DA.%26aulast%3DSoreide%26aufirst%3DK.%26atitle%3DMolecular%2520pathways%2520and%2520cellular%2520metabolism%2520in%2520colorectal%2520cancer%26jtitle%3DDig.%2520Surg.%26date%3D2013%26volume%3D30%26spage%3D12%26epage%3D25%26doi%3D10.1159%2F000347166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pelucchi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Negri, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talamini, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giacosa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crispo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bidoli, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montella, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franceschi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La Vecchia, C.</span></span> <span> </span><span class="NLM_article-title">Metabolic syndrome is associated with colorectal cancer in men</span>. <i>Eur. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">1866</span>– <span class="NLM_lpage">1872</span>, <span class="refDoi"> DOI: 10.1016/j.ejca.2010.03.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=10.1016%2Fj.ejca.2010.03.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=20395126" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=1%3ACAS%3A280%3ADC%252BC3crgvVKruw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2010&pages=1866-1872&author=C.+Pelucchiauthor=E.+Negriauthor=R.+Talaminiauthor=F.+Leviauthor=A.+Giacosaauthor=A.+Crispoauthor=E.+Bidoliauthor=M.+Montellaauthor=S.+Franceschiauthor=C.+La+Vecchia&title=Metabolic+syndrome+is+associated+with+colorectal+cancer+in+men&doi=10.1016%2Fj.ejca.2010.03.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolic syndrome is associated with colorectal cancer in men</span></div><div class="casAuthors">Pelucchi Claudio; Negri Eva; Talamini Renato; Levi Fabio; Giacosa Attilio; Crispo Anna; Bidoli Ettore; Montella Maurizio; Franceschi Silvia; La Vecchia Carlo</div><div class="citationInfo"><span class="NLM_cas:title">European journal of cancer (Oxford, England : 1990)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1866-72</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">AIM OF THE STUDY:  We assessed the relation between metabolic syndrome (MetS) and its components and colorectal cancer.  METHODS:  We analysed data from a multicentre case-control study conducted in Italy and Switzerland, including 1378 cases of colon cancer, 878 cases of rectal cancer and 4661 controls.  All cases were incident and histologically confirmed.  Controls were subjects admitted to the same hospitals as cases with acute non-malignant conditions.  MetS was defined according to the International Diabetes Federation criteria.  Odds ratios (ORs) and the corresponding 95% confidence intervals (CIs) were estimated by multiple logistic regression models, including terms for major identified confounding factors for colorectal cancer.  RESULTS:  With reference to each component of the MetS, the ORs of colorectal cancer in men were 1.27 (95% CI, 0.95-1.69) for diabetes, 1.24 (95% CI, 1.03-1.48) for hypertension, 1.14 (95% CI, 0.93-1.40) for hypercholesterolaemia and 1.26 (95% CI, 1.08-1.48) for overweight at age 30.  The corresponding ORs in women were 1.20 (95% CI, 0.82-1.75), 0.87 (95% CI, 0.71-1.06), 0.83 (95% CI, 0.66-1.03) and 1.06 (95% CI, 0.86-1.30).  Colorectal cancer risk was increased in men (OR=1.86; 95% CI, 1.21-2.86), but not in women (OR=1.13; 95% CI, 0.66-1.93), with MetS.  The ORs were 2.09 (95% CI, 1.38-3.18) in men and 1.15 (95% CI, 0.68-1.94) in women with > or =3 components of the MetS, as compared to no component.  Results were similar for colon and rectal cancers.  CONCLUSION:  This study supports a direct association between MetS and both colon and rectal cancers in men, but not in women.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSQCpvg6KvC4QMthz5_Rx5rfW6udTcc2eaREOfSPX2fMrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3crgvVKruw%253D%253D&md5=5672c912f26d0ad358a2d55444f88673</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.ejca.2010.03.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejca.2010.03.010%26sid%3Dliteratum%253Aachs%26aulast%3DPelucchi%26aufirst%3DC.%26aulast%3DNegri%26aufirst%3DE.%26aulast%3DTalamini%26aufirst%3DR.%26aulast%3DLevi%26aufirst%3DF.%26aulast%3DGiacosa%26aufirst%3DA.%26aulast%3DCrispo%26aufirst%3DA.%26aulast%3DBidoli%26aufirst%3DE.%26aulast%3DMontella%26aufirst%3DM.%26aulast%3DFranceschi%26aufirst%3DS.%26aulast%3DLa%2BVecchia%26aufirst%3DC.%26atitle%3DMetabolic%2520syndrome%2520is%2520associated%2520with%2520colorectal%2520cancer%2520in%2520men%26jtitle%3DEur.%2520J.%2520Cancer%26date%3D2010%26volume%3D46%26spage%3D1866%26epage%3D1872%26doi%3D10.1016%2Fj.ejca.2010.03.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Song, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartlett, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwon, Y. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, Y. J.</span></span> <span> </span><span class="NLM_article-title">Role of AMP-activated protein kinase in cross-talk between apoptosis and autophagy in human colon cancer</span>. <i>Cell Death Dis.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">e1504</span>, <span class="refDoi"> DOI: 10.1038/cddis.2014.463</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=10.1038%2Fcddis.2014.463" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=25356873" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVKmtLfK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=e1504&author=X.+Songauthor=S.+Y.+Kimauthor=L.+Zhangauthor=D.+Tangauthor=D.+L.+Bartlettauthor=Y.+T.+Kwonauthor=Y.+J.+Lee&title=Role+of+AMP-activated+protein+kinase+in+cross-talk+between+apoptosis+and+autophagy+in+human+colon+cancer&doi=10.1038%2Fcddis.2014.463"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Role of AMP-activated protein kinase in cross-talk between apoptosis and autophagy in human colon cancer</span></div><div class="casAuthors">Song, X.; Kim, S.-Y.; Zhang, L.; Tang, D.; Bartlett, D. L.; Kwon, Y. T.; Lee, Y. J.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Disease</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">e1504</span>CODEN:
                <span class="NLM_cas:coden">CDDEA4</span>;
        ISSN:<span class="NLM_cas:issn">2041-4889</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Unresectable colorectal liver metastases remain a major unresolved issue and more effective novel regimens are urgently needed.  While screening synergistic drug combinations for colon cancer therapy, we identified a novel multidrug treatment for colon cancer: chemotherapeutic agent melphalan in combination with proteasome inhibitor bortezomib and mTOR (mammalian target of rapamycin) inhibitor rapamycin.  We investigated the mechanisms of synergistic antitumor efficacy during the multidrug treatment.  All expts. were performed with highly metastatic human colon cancer CX-1 and HCT116 cells, and selected crit. expts. were repeated with human colon cancer stem Tu-22 cells and mouse embryo fibroblast (MEF) cells.  We used immunochem. techniques to investigate a cross-talk between apoptosis and autophagy during the multidrug treatment.  We obsd. that melphalan triggered apoptosis, bortezomib induced apoptosis and autophagy, rapamycin caused autophagy and the combinatorial treatment-induced synergistic apoptosis, which was mediated through an increase in caspase activation.  We also obsd. that mitochondrial dysfunction induced by the combination was linked with altered cellular metab., which induced adenosine monophosphate-activated protein kinase (AMPK) activation, resulting in Beclin-1 phosphorylated at Ser 93/96.  Interestingly, Beclin-1 phosphorylated at Ser 93/96 is sufficient to induce Beclin-1 cleavage by caspase-8, which switches off autophagy to achieve the synergistic induction of apoptosis.  Similar results were obsd. with the essential autophagy gene, autophagy-related protein 7, -deficient MEF cells.  The multidrug treatment-induced Beclin-1 cleavage was abolished in Beclin-1 double-mutant (D133A/D146A) knock-in HCT116 cells, restoring the autophagy-promoting function of Beclin-1 and suppressing the apoptosis induced by the combination therapy.  These observations identify a novel mechanism for AMPK-induced apoptosis through interplay between autophagy and apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIUWI7ARnuYrVg90H21EOLACvtfcHk0lgJ2f32H23omw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVKmtLfK&md5=d065754171b8c8d2244b9256cac3afa8</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1038%2Fcddis.2014.463&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcddis.2014.463%26sid%3Dliteratum%253Aachs%26aulast%3DSong%26aufirst%3DX.%26aulast%3DKim%26aufirst%3DS.%2BY.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DTang%26aufirst%3DD.%26aulast%3DBartlett%26aufirst%3DD.%2BL.%26aulast%3DKwon%26aufirst%3DY.%2BT.%26aulast%3DLee%26aufirst%3DY.%2BJ.%26atitle%3DRole%2520of%2520AMP-activated%2520protein%2520kinase%2520in%2520cross-talk%2520between%2520apoptosis%2520and%2520autophagy%2520in%2520human%2520colon%2520cancer%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2014%26volume%3D5%26spage%3De1504%26doi%3D10.1038%2Fcddis.2014.463" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, Y. Y.</span></span> <span> </span><span class="NLM_article-title">Targeting the AMP-activated protein kinase for cancer prevention and therapy</span>. <i>Front. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">175</span>, <span class="refDoi"> DOI: 10.3389/fonc.2013.00175</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=10.3389%2Ffonc.2013.00175" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=23875169" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=1%3ACAS%3A280%3ADC%252BC3sfivVeltw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2013&pages=175&author=I.+Kimauthor=Y.+Y.+He&title=Targeting+the+AMP-activated+protein+kinase+for+cancer+prevention+and+therapy&doi=10.3389%2Ffonc.2013.00175"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the AMP-Activated Protein Kinase for Cancer Prevention and Therapy</span></div><div class="casAuthors">Kim Inyoung; He Yu-Ying</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in oncology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">175</span>
        ISSN:<span class="NLM_cas:issn">2234-943X</span>.
    </div><div class="casAbstract">Despite the advances in biomedical research and clinical applications, cancer remains a leading cause of death worldwide.  Given the limitations of conventional chemotherapeutics, including serious toxicities and reduced quality of life for patients, the development of safe and efficacious alternatives with known mechanism of action is much needed.  Prevention of cancer through dietary intervention may hold promise and has been investigated extensively in the recent years.  AMP-activated protein kinase (AMPK) is an energy sensor that plays a key role in the regulation of protein and lipid metabolism in response to changes in fuel availability.  When activated, AMPK promotes energy-producing catabolic pathways while inhibiting anabolic pathways, such as cell growth and proliferation - thereby antagonizing carcinogenesis.  Other anti-cancer effects of AMPK may include promoting autophagy and DNA repair upon UVB damage.  In the last decade, interest in AMPK has grown extensively as it emerged as an attractive target molecule for cancer prevention and treatment.  Among the latest developments is the activation of AMPK by naturally occurring dietary constituents and plant products - termed phytochemicals.  Owing to their efficacy and safety, phytochemicals are considered as an alternative to the conventional harmful chemotherapy.  The rising popularity of using phytochemicals for cancer prevention and therapy is supported by a substantial progress in identifying the molecular pathways involved, including AMPK.  In this article, we review the recent progress in this budding field that suggests AMPK as a new molecular target in the prevention and treatment of cancer by phytochemicals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT4H8fzaLSSUtLIORRPd5lbfW6udTcc2eaREOfSPX2fMrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3sfivVeltw%253D%253D&md5=f9042799e2826a9703323cecf854f7c2</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.3389%2Ffonc.2013.00175&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffonc.2013.00175%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DI.%26aulast%3DHe%26aufirst%3DY.%2BY.%26atitle%3DTargeting%2520the%2520AMP-activated%2520protein%2520kinase%2520for%2520cancer%2520prevention%2520and%2520therapy%26jtitle%3DFront.%2520Oncol.%26date%3D2013%26volume%3D3%26spage%3D175%26doi%3D10.3389%2Ffonc.2013.00175" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zulato, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergamo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Paoli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griguolo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esposito, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Salvo, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mescoli, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rugge, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nardin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Grazia, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lonardi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Indraccolo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zagonel, V.</span></span> <span> </span><span class="NLM_article-title">Prognostic significance of AMPK activation in advanced stage colorectal cancer treated with chemotherapy plus bevacizumab</span>. <i>Br. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>111</i></span>,  <span class="NLM_fpage">25</span>– <span class="NLM_lpage">32</span>, <span class="refDoi"> DOI: 10.1038/bjc.2014.274</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=10.1038%2Fbjc.2014.274" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=24892446" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpsVansLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2014&pages=25-32&author=E.+Zulatoauthor=F.+Bergamoauthor=A.+De+Paoliauthor=G.+Griguoloauthor=G.+Espositoauthor=G.+L.+De+Salvoauthor=C.+Mescoliauthor=M.+Ruggeauthor=M.+Nardinauthor=L.+Di+Graziaauthor=S.+Lonardiauthor=S.+Indraccoloauthor=V.+Zagonel&title=Prognostic+significance+of+AMPK+activation+in+advanced+stage+colorectal+cancer+treated+with+chemotherapy+plus+bevacizumab&doi=10.1038%2Fbjc.2014.274"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Prognostic significance of AMPK activation in advanced stage colorectal cancer treated with chemotherapy plus bevacizumab</span></div><div class="casAuthors">Zulato, E.; Bergamo, F.; De Paoli, A.; Griguolo, G.; Esposito, G.; De Salvo, G. L.; Mescoli, C.; Rugge, M.; Nardin, M.; Di Grazia, L.; Lonardi, S.; Indraccolo, S.; Zagonel, V.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">25-32</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Background: AMP-activated protein kinase (AMPK) has a central role in cellular energy sensing and is activated in preclin. tumor models following anti-vascular endothelial growth factor (VEGF) therapy.  The possible predictive or prognostic role of AMPK status in cancer patients treated with anti-VEGF drugs has not been investigated so far.  Methods: Expression of components of the AMPK pathway including phosphorylated AMPK (pAMPK), phosphorylated acetyl-Coa carboxylase (pACC) and liver kinase B1 (LKB1) was investigated by immunohistochem. in 48 colorectal cancers treated with FOLFIRI plus bevacizumab.  Correlation between pAMPK and pACC and assocns. between the AMPK pathway scores and clinico-pathol. characteristics were assessed.  Overall survival (OS) was estd. through Kaplan-Meier method, whereas hazard ratios were computed to identify prognostic factors.  Results: Fourteen patients (29.2%) were included in the pAMPK-neg. group (score ≤5), whereas 34 patients (70.8%) were included in the pAMPK-pos. group (score >5).  The Spearman's coeff. for the correlation between pAMPK and pACC scores in primary tumor samples was 0.514 (P=0.0002).  Low pAMPK levels were assocd. with worse OS (P-value 0.0002) but not with PFS, whereas low pACC levels were assocd. both with worse OS and PFS (P-value 0.0007 and 0.01, resp.).  Conclusions: Our findings suggest that high tissue AMPK activation is a prognostic biomarker in this cohort of metastatic colorectal cancer patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlctDDEerg-rVg90H21EOLACvtfcHk0lgabNmPytUbjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpsVansLc%253D&md5=aa23f7da603767dfc5edd9c1ddf378c3</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1038%2Fbjc.2014.274&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbjc.2014.274%26sid%3Dliteratum%253Aachs%26aulast%3DZulato%26aufirst%3DE.%26aulast%3DBergamo%26aufirst%3DF.%26aulast%3DDe%2BPaoli%26aufirst%3DA.%26aulast%3DGriguolo%26aufirst%3DG.%26aulast%3DEsposito%26aufirst%3DG.%26aulast%3DDe%2BSalvo%26aufirst%3DG.%2BL.%26aulast%3DMescoli%26aufirst%3DC.%26aulast%3DRugge%26aufirst%3DM.%26aulast%3DNardin%26aufirst%3DM.%26aulast%3DDi%2BGrazia%26aufirst%3DL.%26aulast%3DLonardi%26aufirst%3DS.%26aulast%3DIndraccolo%26aufirst%3DS.%26aulast%3DZagonel%26aufirst%3DV.%26atitle%3DPrognostic%2520significance%2520of%2520AMPK%2520activation%2520in%2520advanced%2520stage%2520colorectal%2520cancer%2520treated%2520with%2520chemotherapy%2520plus%2520bevacizumab%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2014%26volume%3D111%26spage%3D25%26epage%3D32%26doi%3D10.1038%2Fbjc.2014.274" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Din, F. V. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valanciute, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houde, V. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zibrova, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakamoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alessi, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunlop, M. G.</span></span> <span> </span><span class="NLM_article-title">Aspirin inhibits mTOR signaling, activates AMP-activated protein kinase, and induces autophagy in colorectal cancer cells</span>. <i>Gastroenterology</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>142</i></span>,  <span class="NLM_fpage">1504</span>– <span class="NLM_lpage">15</span>, <span class="refDoi"> DOI: 10.1053/j.gastro.2012.02.050</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=10.1053%2Fj.gastro.2012.02.050" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=22406476" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=1%3ACAS%3A528%3ADC%252BC38XnslShsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=142&publication_year=2012&pages=1504-15&author=F.+V.+N.+Dinauthor=A.+Valanciuteauthor=V.+P.+Houdeauthor=D.+Zibrovaauthor=K.+A.+Greenauthor=K.+Sakamotoauthor=D.+R.+Alessiauthor=M.+G.+Dunlop&title=Aspirin+inhibits+mTOR+signaling%2C+activates+AMP-activated+protein+kinase%2C+and+induces+autophagy+in+colorectal+cancer+cells&doi=10.1053%2Fj.gastro.2012.02.050"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Aspirin Inhibits mTOR Signaling, Activates AMP-Activated Protein Kinase, and Induces Autophagy in Colorectal Cancer Cells</span></div><div class="casAuthors">Din, Farhat V. N.; Valanciute, Asta; Houde, Vanessa P.; Zibrova, Daria; Green, Kevin A.; Sakamoto, Kei; Alessi, Dario R.; Dunlop, Malcolm G.</div><div class="citationInfo"><span class="NLM_cas:title">Gastroenterology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">142</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1504-1515.e3</span>CODEN:
                <span class="NLM_cas:coden">GASTAB</span>;
        ISSN:<span class="NLM_cas:issn">0016-5085</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Aspirin reduces the incidence of and mortality from colorectal cancer (CRC) by unknown mechanisms.  Cancer cells have defects in signaling via the mechanistic target of rapamycin (mTOR), which regulates proliferation.  We investigated whether aspirin affects adenosine monophosphate-activated protein kinase (AMPK) and mTOR signaling in CRC cells.  The effects of aspirin on mTOR signaling, the ribosomal protein S6, S6 kinase 1 (S6K1), and eukaryotic translation initiation factor 4E binding protein 1 (4E-BP1) were examd. in CRC cells by immunoblotting.  Phosphorylation of AMPK was measured; the effects of loss of AMPKα on the aspirin-induced effects of mTOR were detd. using small interfering RNA (siRNA) in CRC cells and in AMPKα1/a2-/- mouse embryonic fibroblasts.  LC3 and ULK1 were used as markers of autophagy.  We analyzed rectal mucosa samples from patients given 600 mg aspirin, once daily for 1 wk.  Aspirin reduced mTOR signaling in CRC cells by inhibiting the mTOR effectors S6K1 and 4E-BP1.  Aspirin changed nucleotide ratios and activated AMPK in CRC cells. mTOR was still inhibited by aspirin in CRC cells after siRNA knockdown of AMPKα, indicating AMPK-dependent and AMPK-independent mechanisms of aspirin-induced inhibition of mTOR.  Aspirin induced autophagy, a feature of mTOR inhibition.  Aspirin and metformin (an activator of AMPK) increased inhibition of mTOR and Akt, as well as autophagy in CRC cells.  Rectal mucosal samples from patients given aspirin had reduced phosphorylation of S6K1 and S6.  Aspirin is an inhibitor of mTOR and an activator of AMPK, targeting regulators of intracellular energy homeostasis and metab.  These could contribute to its protective effects against development of CRC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqreBjSRON-CLVg90H21EOLACvtfcHk0lgabNmPytUbjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnslShsLw%253D&md5=1c774a4ac04f9ac551f414f7bd57b45b</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1053%2Fj.gastro.2012.02.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1053%252Fj.gastro.2012.02.050%26sid%3Dliteratum%253Aachs%26aulast%3DDin%26aufirst%3DF.%2BV.%2BN.%26aulast%3DValanciute%26aufirst%3DA.%26aulast%3DHoude%26aufirst%3DV.%2BP.%26aulast%3DZibrova%26aufirst%3DD.%26aulast%3DGreen%26aufirst%3DK.%2BA.%26aulast%3DSakamoto%26aufirst%3DK.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26aulast%3DDunlop%26aufirst%3DM.%2BG.%26atitle%3DAspirin%2520inhibits%2520mTOR%2520signaling%252C%2520activates%2520AMP-activated%2520protein%2520kinase%252C%2520and%2520induces%2520autophagy%2520in%2520colorectal%2520cancer%2520cells%26jtitle%3DGastroenterology%26date%3D2012%26volume%3D142%26spage%3D1504%26epage%3D15%26doi%3D10.1053%2Fj.gastro.2012.02.050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lea, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pourat, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">desBordes, C.</span></span> <span> </span><span class="NLM_article-title">Growth inhibition of colon cancer cells by compounds affecting AMPK activity</span>. <i>World J. Gastrointest. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">244</span>– <span class="NLM_lpage">252</span>, <span class="refDoi"> DOI: 10.4251/wjgo.v6.i7.244</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=10.4251%2Fwjgo.v6.i7.244" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=25024815" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=1%3ACAS%3A280%3ADC%252BC2cbisFWksg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=244-252&author=M.+A.+Leaauthor=J.+Pouratauthor=R.+Patelauthor=C.+desBordes&title=Growth+inhibition+of+colon+cancer+cells+by+compounds+affecting+AMPK+activity&doi=10.4251%2Fwjgo.v6.i7.244"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Growth inhibition of colon cancer cells by compounds affecting AMPK activity</span></div><div class="casAuthors">Lea Michael A; Pourat Jacob; Patel Rupali; desBordes Charles</div><div class="citationInfo"><span class="NLM_cas:title">World journal of gastrointestinal oncology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">244-52</span>
        ISSN:<span class="NLM_cas:issn">1948-5204</span>.
    </div><div class="casAbstract">AIM:  To determine if other molecules reported to modulate AMP-dependent protein kinase (AMPK) activity would have effects resembling those of metformin and phenformin on colon cancer cell proliferation and metabolism.  METHODS:  Studies were performed with four human colon cancer cell lines, Caco-2, HCT116, HT29 and SW1116.  The compounds that were studied included A-769662, 5-aminoimidazole-4-carboxamide-1-ribofuranoside, butyrate, (-)-epigallocatechin gallate (EGCG), KU-55933, quercetin, resveratrol and salicylates.  The parameters that were measured were cell proliferation and viability, glucose uptake, lactate production and acidification of the incubation medium.  RESULTS:  Investigations with several molecules that have been reported to be associated with AMPK activation (A-769662, 5-aminoimidazole-4-carboxamide-1-b-D-ribofuranoside, EGCG, KU-55933, quercetin, resveratrol and salicylates) or AMPK inhibition (compound C) failed to reveal increased medium acidification and increased glucose uptake in colon cancer cells as previously established with metformin and phenformin.  The only exception was 5-aminosalicylic acid with which there were apparently lower glucose levels in the medium after incubation for 72 h.  Further study in the absence of cells revealed that the effect was an artifact due to inhibition of the enzyme-linked glucose assay.  The compounds were studied at concentrations that inhibited cell proliferation.  CONCLUSION:  It was concluded that treatment with several agents that can affect AMPK activity resulted in the inhibition of the proliferation of colon cancer cells under conditions in which glucose metabolism is not enhanced, in contrast to the effect of biguanides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT__DMPwHFhGOdfST00W0BcfW6udTcc2eZf-bKYXQYl5rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cbisFWksg%253D%253D&md5=0cce380e5276fdc219377a257b970e7f</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.4251%2Fwjgo.v6.i7.244&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4251%252Fwjgo.v6.i7.244%26sid%3Dliteratum%253Aachs%26aulast%3DLea%26aufirst%3DM.%2BA.%26aulast%3DPourat%26aufirst%3DJ.%26aulast%3DPatel%26aufirst%3DR.%26aulast%3DdesBordes%26aufirst%3DC.%26atitle%3DGrowth%2520inhibition%2520of%2520colon%2520cancer%2520cells%2520by%2520compounds%2520affecting%2520AMPK%2520activity%26jtitle%3DWorld%2520J.%2520Gastrointest.%2520Oncol.%26date%3D2014%26volume%3D6%26spage%3D244%26epage%3D252%26doi%3D10.4251%2Fwjgo.v6.i7.244" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ling, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, K.</span></span> <span> </span><span class="NLM_article-title">NPC-26 kills human colorectal cancer cells via activating AMPK signaling</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">18312</span>– <span class="NLM_lpage">18321</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.15436</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=10.18632%2Foncotarget.15436" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=28407688" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=1%3ACAS%3A280%3ADC%252BC1cvns1Chtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=18312-18321&author=Z.+Zhaoauthor=L.+Fengauthor=J.+Wangauthor=D.+Chengauthor=M.+Liuauthor=M.+Lingauthor=W.+Xuauthor=K.+Sun&title=NPC-26+kills+human+colorectal+cancer+cells+via+activating+AMPK+signaling&doi=10.18632%2Foncotarget.15436"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">NPC-26 kills human colorectal cancer cells via activating AMPK signaling</span></div><div class="casAuthors">Zhao Zhen; Feng Li; Wang Jiqin; Cheng Deshan; Liu Mei; Ling Meirong; Sun Keyu; Xu Weiping</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">18312-18321</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">NPC-26 is novel mitochondrion-interfering compound.  The current study tested its potential effect against colorectal cancer (CRC) cells.  We demonstrated that NPC-26 induced potent anti-proliferative and cytotoxic activities against CRC cell lines (HCT-116, DLD-1 and HT-29).  Activation of AMP-activated protein kinase (AMPK) signaling mediated NPC-26-induced CRC cell death.  AMPKα1 shRNA knockdown or dominant negative mutation abolished NPC-26-induced AMPK activation and subsequent CRC cell death.  NPC-26 disrupted mitochondrial function, causing mitochondrial permeability transition pore (mPTP) opening and reactive oxygen species (ROS) production.  ROS scavengers (NAC or MnTBAP) and mPTP blockers (cyclosporin A or sanglifehrin A) blocked NPC-26-induced AMPK activation and attenuated CRC cell death.  Significantly, intraperitoneal injection of NPC-26 potently inhibited HCT-116 tumor growth in severe combined immuno-deficient (SCID) mice.  Yet, its anti-tumor activity was significantly weakened against AMPKα1-silenced HCT-116 tumors.  Together, we conclude that NPC-26 kills CRC cells possibly via activating AMPK signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRDBx0_VHiayLP3FVUi_gf8fW6udTcc2ebL9AVVIzPA-rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cvns1Chtg%253D%253D&md5=c1da476c1e20e4d4c5d1b6b1991c5b91</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.15436&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.15436%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DZ.%26aulast%3DFeng%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DCheng%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DLing%26aufirst%3DM.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DSun%26aufirst%3DK.%26atitle%3DNPC-26%2520kills%2520human%2520colorectal%2520cancer%2520cells%2520via%2520activating%2520AMPK%2520signaling%26jtitle%3DOncotarget%26date%3D2017%26volume%3D8%26spage%3D18312%26epage%3D18321%26doi%3D10.18632%2Foncotarget.15436" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mogavero, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maiorana, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zanutto, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varinelli, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bozzi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belfiore, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Volpi, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gloghini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pierotti, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gariboldi, M.</span></span> <span> </span><span class="NLM_article-title">Metformin transiently inhibits colorectal cancer cell proliferation as a result of either AMPK activation or increased ROS production</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">15992</span>, <span class="refDoi"> DOI: 10.1038/s41598-017-16149-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=10.1038%2Fs41598-017-16149-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=29167573" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=1%3ACAS%3A280%3ADC%252BC1M3ktFykuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=15992&author=A.+Mogaveroauthor=M.+V.+Maioranaauthor=S.+Zanuttoauthor=L.+Varinelliauthor=F.+Bozziauthor=A.+Belfioreauthor=C.+C.+Volpiauthor=A.+Gloghiniauthor=M.+A.+Pierottiauthor=M.+Gariboldi&title=Metformin+transiently+inhibits+colorectal+cancer+cell+proliferation+as+a+result+of+either+AMPK+activation+or+increased+ROS+production&doi=10.1038%2Fs41598-017-16149-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Metformin transiently inhibits colorectal cancer cell proliferation as a result of either AMPK activation or increased ROS production</span></div><div class="casAuthors">Mogavero Angela; Maiorana Maria Valeria; Zanutto Susanna; Varinelli Luca; Gariboldi Manuela; Mogavero Angela; Maiorana Maria Valeria; Zanutto Susanna; Varinelli Luca; Pierotti Marco A; Gariboldi Manuela; Bozzi Fabio; Belfiore Antonino; Volpi Chiara C; Gloghini Annunziata</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">15992</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Metformin is a widely used and well-tolerated anti-diabetic drug that can reduce cancer risk and improve the prognosis of certain malignancies.  However, the mechanism underlying its anti-cancer effect is still unclear.  We studied the anti-cancer activity of metformin on colorectal cancer (CRC) by using the drug to treat HT29, HCT116 and HCT116 p53-/- CRC cells.  Metformin reduced cell proliferation and migration by inducing cell cycle arrest in the G0/G1 phase.  This was accompanied by a sharp decrease in the expression of c-Myc and down-regulation of IGF1R.  The anti-proliferative action of metformin was mediated by two different mechanisms: AMPK activation and increase in the production of reactive oxygen species, which suppressed the mTOR pathway and its downstream targets S6 and 4EBP1.  A reduction in CD44 and LGR5 expression suggested that the drug had an effect on tumour cells with stem characteristics.  However, a colony formation assay showed that metformin slowed the cells' ability to form colonies without arresting cell growth, as confirmed by absence of apoptosis, autophagy or senescence.  Our finding that metformin only transiently arrests CRC cell growth suggests that efforts should be made to identify compounds that combined with the biguanide can act synergistically to induce cell death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRlRnWYxiDmx9NTrvPZP1IpfW6udTcc2ebL9AVVIzPA-rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1M3ktFykuw%253D%253D&md5=3b5e9ba4c67d27e364579cbf0ee97398</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1038%2Fs41598-017-16149-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-017-16149-z%26sid%3Dliteratum%253Aachs%26aulast%3DMogavero%26aufirst%3DA.%26aulast%3DMaiorana%26aufirst%3DM.%2BV.%26aulast%3DZanutto%26aufirst%3DS.%26aulast%3DVarinelli%26aufirst%3DL.%26aulast%3DBozzi%26aufirst%3DF.%26aulast%3DBelfiore%26aufirst%3DA.%26aulast%3DVolpi%26aufirst%3DC.%2BC.%26aulast%3DGloghini%26aufirst%3DA.%26aulast%3DPierotti%26aufirst%3DM.%2BA.%26aulast%3DGariboldi%26aufirst%3DM.%26atitle%3DMetformin%2520transiently%2520inhibits%2520colorectal%2520cancer%2520cell%2520proliferation%2520as%2520a%2520result%2520of%2520either%2520AMPK%2520activation%2520or%2520increased%2520ROS%2520production%26jtitle%3DSci.%2520Rep.%26date%3D2017%26volume%3D7%26spage%3D15992%26doi%3D10.1038%2Fs41598-017-16149-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Horn, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferretti, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ebel, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tam, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harbinski, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farsidjani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zubrowski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sellers, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlegel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porter, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wuerthner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeay, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greshock, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halilovic, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garraway, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caponigro, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehár, J.</span></span> <span> </span><span class="NLM_article-title">High-order drug combinations are required to effectively kill colorectal cancer cells</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>76</i></span>,  <span class="NLM_fpage">6950</span>– <span class="NLM_lpage">6963</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-15-3425</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=10.1158%2F0008-5472.CAN-15-3425" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=27659046" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvFyntrjN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2016&pages=6950-6963&author=T.+Hornauthor=S.+Ferrettiauthor=N.+Ebelauthor=A.+Tamauthor=S.+Hoauthor=F.+Harbinskiauthor=A.+Farsidjaniauthor=M.+Zubrowskiauthor=W.+R.+Sellersauthor=R.+Schlegelauthor=D.+Porterauthor=E.+Morrisauthor=J.+Wuerthnerauthor=S.+Jeayauthor=J.+Greshockauthor=E.+Halilovicauthor=L.+A.+Garrawayauthor=G.+Caponigroauthor=J.+Leh%C3%A1r&title=High-order+drug+combinations+are+required+to+effectively+kill+colorectal+cancer+cells&doi=10.1158%2F0008-5472.CAN-15-3425"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">High-Order Drug Combinations Are Required to Effectively Kill Colorectal Cancer Cells</span></div><div class="casAuthors">Horn, Thomas; Ferretti, Stephane; Ebel, Nicolas; Tam, Angela; Ho, Samuel; Harbinski, Fred; Farsidjani, Ali; Zubrowski, Matthew; Sellers, William R.; Schlegel, Robert; Porter, Dale; Morris, Erick; Wuerthner, Jens; Jeay, Seebastien; Greshock, Joel; Halilovic, Ensar; Garraway, Levi A.; Caponigro, Giordano; Leheear, Joseph</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">6950-6963</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Like classical chemotherapy regimens used to treat cancer, targeted therapies will also rely upon polypharmacol., but tools are still lacking to predict which combinations of molecularly targeted drugs may be most efficacious.  In this study, we used image-based proliferation and apoptosis assays in colorectal cancer cell lines to systematically investigate the efficacy of combinations of two to six drugs that target crit. oncogenic pathways.  Drug pairs targeting key signaling pathways resulted in synergies across a broad spectrum of genetic backgrounds but often yielded only cytostatic responses.  Enhanced cytotoxicity was obsd. when addnl. processes including apoptosis and cell cycle were targeted as part of the combination.  In some cases, where cell lines were resistant to paired and tripled drugs, increased expression of antiapoptotic proteins was obsd., requiring a fourth-order combination to induce cytotoxicity.  Our results illustrate how high-order drug combinations are needed to kill drug-resistant cancer cells, and they also show how systematic drug combination screening together with a mol. understanding of drug responses may help define optimal cocktails to overcome aggressive cancers.  Cancer Res; 76(23); 6950-63. ©2016 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZzaN2TMxr4bVg90H21EOLACvtfcHk0ljHNFgCd2P7xw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvFyntrjN&md5=5f788ac6a1a4d8d8f71f559902e8239e</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-15-3425&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-15-3425%26sid%3Dliteratum%253Aachs%26aulast%3DHorn%26aufirst%3DT.%26aulast%3DFerretti%26aufirst%3DS.%26aulast%3DEbel%26aufirst%3DN.%26aulast%3DTam%26aufirst%3DA.%26aulast%3DHo%26aufirst%3DS.%26aulast%3DHarbinski%26aufirst%3DF.%26aulast%3DFarsidjani%26aufirst%3DA.%26aulast%3DZubrowski%26aufirst%3DM.%26aulast%3DSellers%26aufirst%3DW.%2BR.%26aulast%3DSchlegel%26aufirst%3DR.%26aulast%3DPorter%26aufirst%3DD.%26aulast%3DMorris%26aufirst%3DE.%26aulast%3DWuerthner%26aufirst%3DJ.%26aulast%3DJeay%26aufirst%3DS.%26aulast%3DGreshock%26aufirst%3DJ.%26aulast%3DHalilovic%26aufirst%3DE.%26aulast%3DGarraway%26aufirst%3DL.%2BA.%26aulast%3DCaponigro%26aufirst%3DG.%26aulast%3DLeh%25C3%25A1r%26aufirst%3DJ.%26atitle%3DHigh-order%2520drug%2520combinations%2520are%2520required%2520to%2520effectively%2520kill%2520colorectal%2520cancer%2520cells%26jtitle%3DCancer%2520Res.%26date%3D2016%26volume%3D76%26spage%3D6950%26epage%3D6963%26doi%3D10.1158%2F0008-5472.CAN-15-3425" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, K.</span></span> <span> </span><span class="NLM_article-title">Identification and optimization of new dual inhibitors of B-Raf and epidermal growth factor receptor kinases for overcoming resistance against vemurafenib</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">2692</span>– <span class="NLM_lpage">2703</span>, <span class="refDoi"> DOI: 10.1021/jm500007h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500007h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjsVehsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=2692-2703&author=H.+Chengauthor=Y.+Changauthor=L.+Zhangauthor=J.+Luoauthor=Z.+Tuauthor=X.+Luauthor=Q.+Zhangauthor=J.+Luauthor=X.+Renauthor=K.+Ding&title=Identification+and+optimization+of+new+dual+inhibitors+of+B-Raf+and+epidermal+growth+factor+receptor+kinases+for+overcoming+resistance+against+vemurafenib&doi=10.1021%2Fjm500007h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and Optimization of New Dual Inhibitors of B-Raf and Epidermal Growth Factor Receptor Kinases for Overcoming Resistance against Vemurafenib</span></div><div class="casAuthors">Cheng, Huimin; Chang, Yu; Zhang, Lianwen; Luo, Jinfeng; Tu, Zhengchao; Lu, Xiaoyun; Zhang, Qingwen; Lu, Jibu; Ren, Xiaomei; Ding, Ke</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2692-2703</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Epidermal growth factor receptor (EGFR) amplification has been demonstrated to be crit. for the inherent and/or acquired resistance against current B-RafV600E inhibitor therapy for melanoma and colorectal cancer patients.  We describe the discovery and structure-activity relationship study of a series of 1H-pyrazolo[3,4-b]pyridine-5-carboxamide analogs as novel dual inhibitors of EGFR and B-RafV600E mutant.  One of the most promising compds., 6a, potently inhibited both of the kinases with IC50 values of 8.0 and 51 nM, resp.  The compd. also strongly suppressed the proliferation of a panel of intrinsic and acquired resistant melanoma and/or colorectal cancer cells harboring overexpressed EGFR with submicromolar IC50 values.  Further mechanism investigation revealed that 6a could sustainably inhibit the activation of the MAPK path way in the resistant SK-MEL-28 PR30 melanoma cancer cells and WiDr colorectal cancer cells with EGFR amplification.  Our results support the hypothesis that the EGFR/B-RafV600E dual inhibition might be a tractable strategy to overcome the intrinsic and acquired resistance of melanoma and/or colorectal cancers against the current B-RafV600E inhibitor therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMF_c1uFQz1rVg90H21EOLACvtfcHk0lhZKqqXFf7ilQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjsVehsb4%253D&md5=1a7ab1f2017832bc3c1f4414efa2406b</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fjm500007h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500007h%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DH.%26aulast%3DChang%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DLuo%26aufirst%3DJ.%26aulast%3DTu%26aufirst%3DZ.%26aulast%3DLu%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DRen%26aufirst%3DX.%26aulast%3DDing%26aufirst%3DK.%26atitle%3DIdentification%2520and%2520optimization%2520of%2520new%2520dual%2520inhibitors%2520of%2520B-Raf%2520and%2520epidermal%2520growth%2520factor%2520receptor%2520kinases%2520for%2520overcoming%2520resistance%2520against%2520vemurafenib%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D2692%26epage%3D2703%26doi%3D10.1021%2Fjm500007h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lian, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, S. C.</span></span> <span> </span><span class="NLM_article-title">AMP as a low-energy charge signal autonomously initiates assembly of AXIN-AMPK-LKB1 complex for AMPK activation</span>. <i>Cell Metab.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">546</span>– <span class="NLM_lpage">555</span>, <span class="refDoi"> DOI: 10.1016/j.cmet.2013.09.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=10.1016%2Fj.cmet.2013.09.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=24093678" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFGnsrrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2013&pages=546-555&author=Y.+L.+Zhangauthor=H.+Guoauthor=C.+S.+Zhangauthor=S.+Y.+Linauthor=Z.+Yinauthor=Y.+Pengauthor=H.+Luoauthor=Y.+Shiauthor=G.+Lianauthor=C.+Zhangauthor=M.+Liauthor=Z.+Yeauthor=J.+Yeauthor=J.+Hanauthor=P.+Liauthor=J.+W.+Wuauthor=S.+C.+Lin&title=AMP+as+a+low-energy+charge+signal+autonomously+initiates+assembly+of+AXIN-AMPK-LKB1+complex+for+AMPK+activation&doi=10.1016%2Fj.cmet.2013.09.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">AMP as a Low-Energy Charge Signal Autonomously Initiates Assembly of AXIN-AMPK-LKB1 Complex for AMPK Activation</span></div><div class="casAuthors">Zhang, Ya-Lin; Guo, Huiling; Zhang, Chen-Song; Lin, Shu-Yong; Yin, Zhenyu; Peng, Yongying; Luo, Hui; Shi, Yuzhe; Lian, Guili; Zhang, Cixiong; Li, Mengqi; Ye, Zhiyun; Ye, Jing; Han, Jiahuai; Li, Peng; Wu, Jia-Wei; Lin, Sheng-Cai</div><div class="citationInfo"><span class="NLM_cas:title">Cell Metabolism</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">546-555</span>CODEN:
                <span class="NLM_cas:coden">CMEEB5</span>;
        ISSN:<span class="NLM_cas:issn">1550-4131</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">The AMP-activated protein kinase (AMPK) is a master regulator of metabolic homeostasis by sensing cellular energy status.  AMPK is mainly activated via phosphorylation by LKB1 when cellular AMP/ADP levels are increased.  However, how AMP/ADP brings about AMPK phosphorylation remains unclear.  Here, we show that it is AMP, but not ADP, that drives AXIN to directly tether LKB1 to phosphorylate AMPK.  The complex formation of AXIN-AMPK-LKB1 is greatly enhanced in glucose-starved or AICAR-treated cells and in cell-free systems supplemented with exogenous AMP.  Depletion of AXIN abrogated starvation-induced AMPK-LKB1 colocalization.  Importantly, adenovirus-based knockdown of AXIN in the mouse liver impaired AMPK activation and caused exacerbated fatty liver after starvation, underscoring an essential role of AXIN in AMPK activation.  These findings demonstrate an initiating role of AMP and demonstrate that AXIN directly transmits AMP binding of AMPK to its activation by LKB1, uncovering the mechanistic route for AMP to elicit AMPK activation by LKB1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoeX8mxHU1qyrVg90H21EOLACvtfcHk0lhZKqqXFf7ilQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFGnsrrI&md5=47faacddecb471a0403172e9ea5dc557</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2Fj.cmet.2013.09.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cmet.2013.09.005%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DY.%2BL.%26aulast%3DGuo%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DC.%2BS.%26aulast%3DLin%26aufirst%3DS.%2BY.%26aulast%3DYin%26aufirst%3DZ.%26aulast%3DPeng%26aufirst%3DY.%26aulast%3DLuo%26aufirst%3DH.%26aulast%3DShi%26aufirst%3DY.%26aulast%3DLian%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DM.%26aulast%3DYe%26aufirst%3DZ.%26aulast%3DYe%26aufirst%3DJ.%26aulast%3DHan%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DP.%26aulast%3DWu%26aufirst%3DJ.%2BW.%26aulast%3DLin%26aufirst%3DS.%2BC.%26atitle%3DAMP%2520as%2520a%2520low-energy%2520charge%2520signal%2520autonomously%2520initiates%2520assembly%2520of%2520AXIN-AMPK-LKB1%2520complex%2520for%2520AMPK%2520activation%26jtitle%3DCell%2520Metab.%26date%3D2013%26volume%3D18%26spage%3D546%26epage%3D555%26doi%3D10.1016%2Fj.cmet.2013.09.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Obianom, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shu, Y.</span></span> <span> </span><span class="NLM_article-title">Tankyrases are druggable targets for the treatment of metabolic disorders</span>. <i>FASEB J.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">1189.5</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2016&pages=1189.5&author=O.+Obianomauthor=W.+Yangauthor=F.+Xueauthor=Y.+Shu&title=Tankyrases+are+druggable+targets+for+the+treatment+of+metabolic+disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DObianom%26aufirst%3DO.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DXue%26aufirst%3DF.%26aulast%3DShu%26aufirst%3DY.%26atitle%3DTankyrases%2520are%2520druggable%2520targets%2520for%2520the%2520treatment%2520of%2520metabolic%2520disorders%26jtitle%3DFASEB%2520J.%26date%3D2016%26volume%3D30%26spage%3D1189.5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hewitt, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMarlin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kleiner, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wersto, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsoskas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stamp, G. W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stetler-Stevenson, W. G.</span></span> <span> </span><span class="NLM_article-title">Validation of a model of colon cancer progression</span>. <i>J. Pathol.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>192</i></span>,  <span class="NLM_fpage">446</span>– <span class="NLM_lpage">454</span>, <span class="refDoi"> DOI: 10.1002/1096-9896(2000)9999:9999<::AID-PATH775>3.0.CO;2-K</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=10.1002%2F1096-9896%282000%299999%3A9999%3C%3A%3AAID-PATH775%3E3.0.CO%3B2-K" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=11113861" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=1%3ACAS%3A280%3ADC%252BD3M7hsFKisA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=192&publication_year=2000&pages=446-454&author=R.+E.+Hewittauthor=A.+McMarlinauthor=D.+Kleinerauthor=R.+Werstoauthor=P.+Martinauthor=M.+Tsoskasauthor=G.+W.+H.+Stampauthor=W.+G.+Stetler-Stevenson&title=Validation+of+a+model+of+colon+cancer+progression&doi=10.1002%2F1096-9896%282000%299999%3A9999%3C%3A%3AAID-PATH775%3E3.0.CO%3B2-K"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Validation of a model of colon cancer progression</span></div><div class="casAuthors">Hewitt R E; McMarlin A; Kleiner D; Wersto R; Martin P; Tsokos M; Stamp G W; Stetler-Stevenson W G; Tsoskas M</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of pathology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">192</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">446-54</span>
        ISSN:<span class="NLM_cas:issn">0022-3417</span>.
    </div><div class="casAbstract">A unique feature of SW480 and SW620 colon carcinoma cell lines is that they are derived from primary and secondary tumours resected from a single patient.  As such, they may represent a valuable resource for examining genetic changes late in colon cancer progression.  In order to verify this, both cell lines have been characterized to determine whether phenotypic differences have been retained despite long-term cell culture in vitro.  The primary tumour-derived SW480 cells have an epithelioid morphology in vitro, while metastasis-derived SW620 cells have a fibroblast-like appearance.  Xenografts of SW480 cells form gland-like structures in vivo, while SW620 xenografts form solid sheets of tumour cells.  SW620 cells have a higher BrdU labelling index than SW480 cells, and are more highly tumourigenic and metastatic.  Furthermore, SW620 cells show less susceptibility to apoptosis induction by TNFalpha and anti-Fas monoclonal.  Findings from these investigations therefore indicate that SW480 and SW620 cell lines do show appropriate phenotypic differences and represent an interesting model for studying the genetic events in the late stages of colon cancer progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSkuxKQQB4KCrFU0A1HOshhfW6udTcc2ebiPjkwoEjTarntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3M7hsFKisA%253D%253D&md5=18264cb57471ec8d24079784fe05500b</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1002%2F1096-9896%282000%299999%3A9999%3C%3A%3AAID-PATH775%3E3.0.CO%3B2-K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F1096-9896%25282000%25299999%253A9999%253C%253A%253AAID-PATH775%253E3.0.CO%253B2-K%26sid%3Dliteratum%253Aachs%26aulast%3DHewitt%26aufirst%3DR.%2BE.%26aulast%3DMcMarlin%26aufirst%3DA.%26aulast%3DKleiner%26aufirst%3DD.%26aulast%3DWersto%26aufirst%3DR.%26aulast%3DMartin%26aufirst%3DP.%26aulast%3DTsoskas%26aufirst%3DM.%26aulast%3DStamp%26aufirst%3DG.%2BW.%2BH.%26aulast%3DStetler-Stevenson%26aufirst%3DW.%2BG.%26atitle%3DValidation%2520of%2520a%2520model%2520of%2520colon%2520cancer%2520progression%26jtitle%3DJ.%2520Pathol.%26date%3D2000%26volume%3D192%26spage%3D446%26epage%3D454%26doi%3D10.1002%2F1096-9896%282000%299999%3A9999%3C%3A%3AAID-PATH775%3E3.0.CO%3B2-K" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45a"><div class="reference"><strong class="refLabel"><a href="#ref45a" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit45a"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Myers, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fenyk-Melody, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ventre, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doebber, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujii, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Musi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirshman, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodyear, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">M?ller, D. E.</span></span> <span> </span><span class="NLM_article-title">Role of AMP-activated protein kinase in mechanism of metformin action</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>108</i></span>,  <span class="NLM_fpage">1167</span>– <span class="NLM_lpage">1174</span>, <span class="refDoi"> DOI: 10.1172/JCI13505</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45a/cit45a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=10.1172%2FJCI13505" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45a/cit45a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=11602624" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45a/cit45a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=1%3ACAS%3A528%3ADC%252BD3MXns1ChsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2001&pages=1167-1174&author=G.+Zhouauthor=R.+Myersauthor=Y.+Liauthor=Y.+Chenauthor=X.+Shenauthor=J.+Fenyk-Melodyauthor=M.+Wuauthor=J.+Ventreauthor=T.+Doebberauthor=N.+Fujiiauthor=N.+Musiauthor=M.+F.+Hirshmanauthor=L.+J.+Goodyearauthor=D.+E.+M%3Fller&title=Role+of+AMP-activated+protein+kinase+in+mechanism+of+metformin+action&doi=10.1172%2FJCI13505"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45aR"><div class="casContent"><span class="casTitleNuber">45a</span><div class="casTitle"><span class="NLM_cas:atitle">Role of AMP-activated protein kinase in mechanism of metformin action</span></div><div class="casAuthors">Zhou, Gaochao; Myers, Robert; Li, Ying; Chen, Yuli; Shen, Xiaolan; Fenyk-Melody, Judy; Wu, Margaret; Ventre, John; Doebber, Thomas; Fujii, Nobuharu; Musi, Nicolas; Hirshman, Michael F.; Goodyear, Laurie J.; Moller, David E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1167-1174</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    
            (<span class="NLM_cas:orgname">American Society for Clinical Investigation</span>)
        </div><div class="casAbstract">Metformin is a widely used drug for treatment of type 2 diabetes with no defined cellular mechanism of action.  Its glucose-lowering effect results from decreased hepatic glucose prodn. and increased glucose utilization.  Metformin's beneficial effects on circulating lipids have been linked to reduced fatty liver.  AMP-activated protein kinase (AMPK) is a major cellular regulator of lipid and glucose metab.  Here we report that metformin activates AMPK in hepatocytes; as a result, acetyl-CoA carboxylase (ACC) activity is reduced, fatty acid oxidn. is induced, and expression of lipogenic enzymes is suppressed.  Activation of AMPK by metformin or an adenosine analog suppresses expression of SREBP-1, a key lipogenic transcription factor.  In metformin-treated rats, hepatic expression of SREBP-1 (and other lipogenic) mRNAs and protein is reduced; activity of the AMPK target, ACC, is also reduced.  Using a novel AMPK inhibitor, we find that AMPK activation is required for metformin's inhibitory effect on glucose prodn. by hepatocytes.  In isolated rat skeletal muscles, metformin stimulates glucose uptake coincident with AMPK activation.  Activation of AMPK provides a unified explanation for the pleiotropic beneficial effects of this drug; these results also suggest that alternative means of modulating AMPK should be useful for the treatment of metabolic disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoT3nG6tsYQkLVg90H21EOLACvtfcHk0lgFQzp-1ylELw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXns1ChsL4%253D&md5=a086134de3fd5ed011ed15761b46cf84</span></div><a href="/servlet/linkout?suffix=cit45a&amp;dbid=16384&amp;doi=10.1172%2FJCI13505&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI13505%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DG.%26aulast%3DMyers%26aufirst%3DR.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DShen%26aufirst%3DX.%26aulast%3DFenyk-Melody%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DM.%26aulast%3DVentre%26aufirst%3DJ.%26aulast%3DDoebber%26aufirst%3DT.%26aulast%3DFujii%26aufirst%3DN.%26aulast%3DMusi%26aufirst%3DN.%26aulast%3DHirshman%26aufirst%3DM.%2BF.%26aulast%3DGoodyear%26aufirst%3DL.%2BJ.%26aulast%3DM%253Fller%26aufirst%3DD.%2BE.%26atitle%3DRole%2520of%2520AMP-activated%2520protein%2520kinase%2520in%2520mechanism%2520of%2520metformin%2520action%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2001%26volume%3D108%26spage%3D1167%26epage%3D1174%26doi%3D10.1172%2FJCI13505" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hawley, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fullerton, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schertzer, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chevtzoff, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peggie, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zibrova, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mustard, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kemp, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakamoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinberg, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hardie, D. G.</span></span> <span> </span><span class="NLM_article-title">The ancient drug salicylate directly activates AMP-activated protein kinase</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>336</i></span>,  <span class="NLM_fpage">918</span>– <span class="NLM_lpage">922</span>, <span class="refDoi"> DOI: 10.1126/science.1215327</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=10.1126%2Fscience.1215327" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=22517326" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=1%3ACAS%3A528%3ADC%252BC38XmvFensLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=336&publication_year=2012&pages=918-922&author=S.+A.+Hawleyauthor=M.+D.+Fullertonauthor=F.+A.+Rossauthor=J.+D.+Schertzerauthor=C.+Chevtzoffauthor=K.+J.+Walkerauthor=M.+W.+Peggieauthor=D.+Zibrovaauthor=K.+A.+Greenauthor=K.+J.+Mustardauthor=B.+E.+Kempauthor=K.+Sakamotoauthor=G.+R.+Steinbergauthor=D.+G.+Hardie&title=The+ancient+drug+salicylate+directly+activates+AMP-activated+protein+kinase&doi=10.1126%2Fscience.1215327"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">The Ancient Drug Salicylate Directly Activates AMP-Activated Protein Kinase</span></div><div class="casAuthors">Hawley, Simon A.; Fullerton, Morgan D.; Ross, Fiona A.; Schertzer, Jonathan D.; Chevtzoff, Cyrille; Walker, Katherine J.; Peggie, Mark W.; Zibrova, Darya; Green, Kevin A.; Mustard, Kirsty J.; Kemp, Bruce E.; Sakamoto, Kei; Steinberg, Gregory R.; Hardie, D. Grahame</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">336</span>
        (<span class="NLM_cas:issue">6083</span>),
    <span class="NLM_cas:pages">918-922</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Salicylate, a plant product, has been in medicinal use since ancient times.  More recently, it has been replaced by synthetic derivs. such as aspirin and salsalate, both of which are rapidly broken down to salicylate in vivo.  At concns. reached in plasma after administration of salsalate or of aspirin at high doses, salicylate activates adenosine monophosphate-activated protein kinase (AMPK), a central regulator of cell growth and metab.  Salicylate binds at the same site as the synthetic activator A-769662 to cause allosteric activation and inhibition of dephosphorylation of the activating phosphorylation site, threonine-172.  In AMPK knockout mice, effects of salicylate to increase fat utilization and to lower plasma fatty acids in vivo were lost.  Our results suggest that AMPK activation could explain some beneficial effects of salsalate and aspirin in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPaLSPB1U5J7Vg90H21EOLACvtfcHk0liQpJBcVEJVQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmvFensLc%253D&md5=8abec5b63807f08dcdb74ed0332bb44a</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1126%2Fscience.1215327&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1215327%26sid%3Dliteratum%253Aachs%26aulast%3DHawley%26aufirst%3DS.%2BA.%26aulast%3DFullerton%26aufirst%3DM.%2BD.%26aulast%3DRoss%26aufirst%3DF.%2BA.%26aulast%3DSchertzer%26aufirst%3DJ.%2BD.%26aulast%3DChevtzoff%26aufirst%3DC.%26aulast%3DWalker%26aufirst%3DK.%2BJ.%26aulast%3DPeggie%26aufirst%3DM.%2BW.%26aulast%3DZibrova%26aufirst%3DD.%26aulast%3DGreen%26aufirst%3DK.%2BA.%26aulast%3DMustard%26aufirst%3DK.%2BJ.%26aulast%3DKemp%26aufirst%3DB.%2BE.%26aulast%3DSakamoto%26aufirst%3DK.%26aulast%3DSteinberg%26aufirst%3DG.%2BR.%26aulast%3DHardie%26aufirst%3DD.%2BG.%26atitle%3DThe%2520ancient%2520drug%2520salicylate%2520directly%2520activates%2520AMP-activated%2520protein%2520kinase%26jtitle%3DScience%26date%3D2012%26volume%3D336%26spage%3D918%26epage%3D922%26doi%3D10.1126%2Fscience.1215327" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hewitt, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMarlin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kleiner, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wersto, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsoskas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stamp, G. W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stetler-Stevenson, W. G.</span></span> <span> </span><span class="NLM_article-title">Validation of a model of colon cancer progressioin</span>. <i>J. Pathol.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>192</i></span>,  <span class="NLM_fpage">446</span>– <span class="NLM_lpage">454</span>, <span class="refDoi"> DOI: 10.1002/1096-9896(2000)9999:9999<::AID-PATH775>3.0.CO;2-K</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=10.1002%2F1096-9896%282000%299999%3A9999%3C%3A%3AAID-PATH775%3E3.0.CO%3B2-K" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=11113861" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=1%3ACAS%3A280%3ADC%252BD3M7hsFKisA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=192&publication_year=2000&pages=446-454&author=R.+E.+Hewittauthor=A.+McMarlinauthor=D.+Kleinerauthor=R.+Werstoauthor=P.+Martinauthor=M.+Tsoskasauthor=G.+W.+H.+Stampauthor=W.+G.+Stetler-Stevenson&title=Validation+of+a+model+of+colon+cancer+progressioin&doi=10.1002%2F1096-9896%282000%299999%3A9999%3C%3A%3AAID-PATH775%3E3.0.CO%3B2-K"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Validation of a model of colon cancer progression</span></div><div class="casAuthors">Hewitt R E; McMarlin A; Kleiner D; Wersto R; Martin P; Tsokos M; Stamp G W; Stetler-Stevenson W G; Tsoskas M</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of pathology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">192</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">446-54</span>
        ISSN:<span class="NLM_cas:issn">0022-3417</span>.
    </div><div class="casAbstract">A unique feature of SW480 and SW620 colon carcinoma cell lines is that they are derived from primary and secondary tumours resected from a single patient.  As such, they may represent a valuable resource for examining genetic changes late in colon cancer progression.  In order to verify this, both cell lines have been characterized to determine whether phenotypic differences have been retained despite long-term cell culture in vitro.  The primary tumour-derived SW480 cells have an epithelioid morphology in vitro, while metastasis-derived SW620 cells have a fibroblast-like appearance.  Xenografts of SW480 cells form gland-like structures in vivo, while SW620 xenografts form solid sheets of tumour cells.  SW620 cells have a higher BrdU labelling index than SW480 cells, and are more highly tumourigenic and metastatic.  Furthermore, SW620 cells show less susceptibility to apoptosis induction by TNFalpha and anti-Fas monoclonal.  Findings from these investigations therefore indicate that SW480 and SW620 cell lines do show appropriate phenotypic differences and represent an interesting model for studying the genetic events in the late stages of colon cancer progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSkuxKQQB4KCrFU0A1HOshhfW6udTcc2eaNpvSjz48Rdbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3M7hsFKisA%253D%253D&md5=18264cb57471ec8d24079784fe05500b</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1002%2F1096-9896%282000%299999%3A9999%3C%3A%3AAID-PATH775%3E3.0.CO%3B2-K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F1096-9896%25282000%25299999%253A9999%253C%253A%253AAID-PATH775%253E3.0.CO%253B2-K%26sid%3Dliteratum%253Aachs%26aulast%3DHewitt%26aufirst%3DR.%2BE.%26aulast%3DMcMarlin%26aufirst%3DA.%26aulast%3DKleiner%26aufirst%3DD.%26aulast%3DWersto%26aufirst%3DR.%26aulast%3DMartin%26aufirst%3DP.%26aulast%3DTsoskas%26aufirst%3DM.%26aulast%3DStamp%26aufirst%3DG.%2BW.%2BH.%26aulast%3DStetler-Stevenson%26aufirst%3DW.%2BG.%26atitle%3DValidation%2520of%2520a%2520model%2520of%2520colon%2520cancer%2520progressioin%26jtitle%3DJ.%2520Pathol.%26date%3D2000%26volume%3D192%26spage%3D446%26epage%3D454%26doi%3D10.1002%2F1096-9896%282000%299999%3A9999%3C%3A%3AAID-PATH775%3E3.0.CO%3B2-K" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cardia, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corda, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fadda, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maccioni, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maccioni, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plumitallo, A.</span></span> <span> </span><span class="NLM_article-title">New cycloalkylpyrazoles as potential cyclooxygenase inhibitors</span>. <i>Farmaco</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">698</span>– <span class="NLM_lpage">708</span>, <span class="refDoi"> DOI: 10.1016/S0014-827X(98)00090-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=10.1016%2FS0014-827X%2898%2900090-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=10205857" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=1%3ACAS%3A528%3ADyaK1MXisVCht7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=1998&pages=698-708&author=M.+C.+Cardiaauthor=L.+Cordaauthor=A.+M.+Faddaauthor=A.+M.+Maccioniauthor=E.+Maccioniauthor=A.+Plumitallo&title=New+cycloalkylpyrazoles+as+potential+cyclooxygenase+inhibitors&doi=10.1016%2FS0014-827X%2898%2900090-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">New cycloalkylpyrazoles as potential cyclooxygenase inhibitors</span></div><div class="casAuthors">Cardia, M. C.; Corda, L.; Fadda, A. M.; Maccioni, A. M.; Maccioni, E.; Plumitallo, A.</div><div class="citationInfo"><span class="NLM_cas:title">Farmaco</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">10,11</span>),
    <span class="NLM_cas:pages">698-708</span>CODEN:
                <span class="NLM_cas:coden">FRMCE8</span>;
        ISSN:<span class="NLM_cas:issn">0014-827X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science S.A.</span>)
        </div><div class="casAbstract">In this study some cycloalkyl-3-(N-substituted carbamoyl)-1-phenylpyrazoles I (R = 3-NO2, 3-CF3, 4-Cl, 4-Me, 4-F, NR'R'' = morpholino, pyrrolidino, N-methylpiperazino) have been synthesized in order to screen their capability to inhibit human cyclooxygenase.  The synthetic pathway is based on the well known property of nitrilimines to undergo 1,3-dipolar cycloaddn. reactions.  Thus, cyclization of RPhNHN:CClCO2Et with enamine II (n = 1, 2) gave ester cycloadducts which were hydrolyzed and converted to the amide I.  The structures of all the synthesized compds. have been elucidated by means of both anal. and spectroscopic methods.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFxH3o5eGwV7Vg90H21EOLACvtfcHk0liQpJBcVEJVQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXisVCht7s%253D&md5=8b1953908b7ae56f0024641a50a727bc</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2FS0014-827X%2898%2900090-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-827X%252898%252900090-1%26sid%3Dliteratum%253Aachs%26aulast%3DCardia%26aufirst%3DM.%2BC.%26aulast%3DCorda%26aufirst%3DL.%26aulast%3DFadda%26aufirst%3DA.%2BM.%26aulast%3DMaccioni%26aufirst%3DA.%2BM.%26aulast%3DMaccioni%26aufirst%3DE.%26aulast%3DPlumitallo%26aufirst%3DA.%26atitle%3DNew%2520cycloalkylpyrazoles%2520as%2520potential%2520cyclooxygenase%2520inhibitors%26jtitle%3DFarmaco%26date%3D1998%26volume%3D53%26spage%3D698%26epage%3D708%26doi%3D10.1016%2FS0014-827X%2898%2900090-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Datterl, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trostner, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kucharski, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holzer, W.</span></span> <span> </span><span class="NLM_article-title">Heterocyclic analogues of xanthone and xanthione. 1<i>H</i>-pyrano[2,3-c:6,5-c]dipyrazol-4(7<i>H</i>)-ones and thiones: synthesis and NMR data</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">6106</span>– <span class="NLM_lpage">6126</span>, <span class="refDoi"> DOI: 10.3390/molecules15096106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=10.3390%2Fmolecules15096106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=20877210" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFejs7zF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2010&pages=6106-6126&author=B.+Datterlauthor=N.+Trostnerauthor=D.+Kucharskiauthor=W.+Holzer&title=Heterocyclic+analogues+of+xanthone+and+xanthione.+1H-pyrano%5B2%2C3-c%3A6%2C5-c%5Ddipyrazol-4%287H%29-ones+and+thiones%3A+synthesis+and+NMR+data&doi=10.3390%2Fmolecules15096106"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Preparation of 1H-pyrano[2,3-c:6,5-c]dipyrazol-4(7H)-ones and thiones as heterocyclic analogues of xanthone and xanthione</span></div><div class="casAuthors">Datterl, Barbara; Troestner, Nicole; Kucharski, Dorota; Holzer, Wolfgang</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">6106-6126</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">Molecular Diversity Preservation International</span>)
        </div><div class="casAbstract">The synthesis of the title compds. is described.  Reaction of 1-substituted 2-pyrazolin-5-ones with 5-chloro-1-phenyl-1H-pyrazole-4-carbonyl chloride or 5-chloro-3-methyl-1-phenyl-1H-pyrazole-4-carbonyl chloride, resp., using calcium hydroxide in refluxing 1,4-dioxane gave the corresponding 4-heteroaroylpyrazol-5-ols, e.g., I, which were cyclized into 1H-pyrano[2,3-c:6,5-c]dipyrazol-4(7H)-ones, e.g., II, by treatment with K2CO3/DMF.  The latter were converted into the corresponding thiones upon reaction with Lawesson's reagent.  Detailed NMR spectroscopic investigations (1H, 13C, 15N) of the ring systems and their precursors are presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqw9rBjDvGygLVg90H21EOLACvtfcHk0lgdzmMWczlIjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFejs7zF&md5=4d64ad6228f30f583626fb9ae67c2d7e</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.3390%2Fmolecules15096106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules15096106%26sid%3Dliteratum%253Aachs%26aulast%3DDatterl%26aufirst%3DB.%26aulast%3DTrostner%26aufirst%3DN.%26aulast%3DKucharski%26aufirst%3DD.%26aulast%3DHolzer%26aufirst%3DW.%26atitle%3DHeterocyclic%2520analogues%2520of%2520xanthone%2520and%2520xanthione.%25201H-pyrano%255B2%252C3-c%253A6%252C5-c%255Ddipyrazol-4%25287H%2529-ones%2520and%2520thiones%253A%2520synthesis%2520and%2520NMR%2520data%26jtitle%3DMolecules%26date%3D2010%26volume%3D15%26spage%3D6106%26epage%3D6126%26doi%3D10.3390%2Fmolecules15096106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i71"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01252">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_81356"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.9b01252?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b01252</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">SW480 cell viability assay for FX1128, mice weight gain study, 21-day mice toxicity study, and HPLC trace for YW2065 (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01252/suppl_file/jm9b01252_si_001.pdf">PDF</a>)</p></li><li><p class="inline"><sup>1</sup>H/<sup>13</sup>C NMR spectra of new compounds (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01252/suppl_file/jm9b01252_si_002.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01252/suppl_file/jm9b01252_si_003.xls">XLS</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01252/suppl_file/jm9b01252_si_001.pdf">jm9b01252_si_001.pdf (262.28 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01252/suppl_file/jm9b01252_si_002.pdf">jm9b01252_si_002.pdf (1.01 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01252/suppl_file/jm9b01252_si_003.xls">jm9b01252_si_003.xls (95.5 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.9b01252%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2019.62.issue-24%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.9b01252" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"677b3da0ad692495","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
